Docstoc

SDTM Terminology 2009-02-17 - EVS

Document Sample
SDTM Terminology 2009-02-17 - EVS Powered By Docstoc
					The controlled terminology in this spreadsheet supports Study Data Tabulation Model Implementation Guide
Version 3.1.1 (SDTMIG v3.1.1). It represents all SDTM controlled terminology developed and in production to
date, comprising SDTM Packages 1, 2A & 2B, 3 and Labtest Packages 1, 2 & 3. Also included in the release is
controlled terminology for one CDASH field. This is the final major release of terminology for SDTMIG v3.1.1.
Additional Labtest terminology will be developed on an ongoing basis. Other future additions to the v3.1.1
terminology set will be handled via a terminology maintenance process.

                      Column

Code (Column A)




Codelist Code (Column B)




Codelist Extensible (Yes/No) (Column C)




Codelist Name (Column D)




CDISC Submission Value (Column E)
CDISC Preferred Term (Column F)




CDISC Synonym(s) (Column G)




CDISC Definition (Column H)



NCI Preferred Term (Column I)


Pre-release / Production (Column J)



Notes (Reference for CDISC PT) (Column K)
dsheet supports Study Data Tabulation Model Implementation Guide
 nts all SDTM controlled terminology developed and in production to
  2B, 3 and Labtest Packages 1, 2 & 3. Also included in the release is
eld. This is the final major release of terminology for SDTMIG v3.1.1.
 veloped on an ongoing basis. Other future additions to the v3.1.1
minology maintenance process.

                                      Description

             Unique numeric code randomly generated by NCIt and
             assigned to individual CDISC controlled terms.
             Unique numeric code assigned to the SDTM parent codelist
             names. This code is repeated for each controlled term (aka
             permissible value) belonging to a codelist. As of 9/22/2008,
             this code was dropped for parent codelist entries, where it
             created confusion. **NOTE - light blue highlighting is used to
             identify the beginning of a new SDTM codelist and its
             applicable term set.
             Defines if controlled terms may be added to the codelist. New
             terms may be added to existing codelist values as long as they
             are not duplicates or synonyms of existing terms. The
             expectation is that sponsors will use the published controlled
             terminology as a standard baseline and codelists defined as
             “extensible” (or "Yes") may have terms added by the sponsor
             internally.

             Contains the descriptive name of the codelist which is also
             referred to as the codelist label in the SDTM IG. As with the
             Codelist Code, the Codelist Name is repeated for each
             controlled term belonging to a codelist.

             IMPORTANT COLUMN: Currently (as per SDTMIG 3.1.1) this
             is the specific value expected for submissions. Each value
             corresponds to an SDTM Codelist Name as indicated by light
             blue shading.

             **NOTE - when a Submission Value in Column E is shaded
             yellow, this indicates that a particular value differs from the
             CDISC Preferred Term in Column F. This is either due to: (a)
             an existing external reference noted in the SDTMIG 3.1.1 (e.g.
             see rows 63-67, 524, 645 and 721); or (b) where Test names
             are identified and repeated following a list of corresponding
             Test Codes (e.g. see TSPARM rows 746-767, VSTEST rows
             807-819, LBTEST rows 916-1004, and EGTEST rows 1222-
             1267). In many cases the discrepancies between the
             Submission Value and Preferred Term will be rectified in a
             future version release.
This is the CDISC preferred name for a term as identified in
the NCI Thesaurus (NCIt) environment and to which numeric
codes (Column A) are assigned. In most cases, the Preferred
Term or PT is redundant with the "CDISC Submission Value" in
Column E.

This identifies the applicable synonyms for a CDISC Preferred
Term in Column F.                            **NOTE - this is
especially important in instances where a Test name or
Parameter Test name contains a corresponding Test Code or
Parameter Test Code. Examples include: TSPARM rows 746-
767, VSTEST rows 807-819, LBTEST rows 916-1004 and
EGTEST rows 1222-1267.

This identifies the CDISC definition for a particular term. In
many cases an existing NCI definition has been used. The
source for a definition is noted in parentheses (e.g. NCI,
CDISC glossary, FDA).

This is the NCI preferred name for a term as identified in NCIt.

This indicates the workflow status for a particular term.
**NOTE - all terms in this spreadsheet are currently in
"Production".

Contains additional reference information for a particular term
as identified in SDTMIG 3.1.1.
Code     Codelist   Codelist     Codelist Name             CDISC Submission Value
         Code       Extensible
                    (Yes/No)
C66767              No           Action Taken with Study   ACN
                                 Treatment

C49503   C66767                  Action Taken with Study   DOSE INCREASED
                                 Treatment




C49504   C66767                  Action Taken with Study   DOSE NOT CHANGED
                                 Treatment




C49505   C66767                  Action Taken with Study   DOSE REDUCED
                                 Treatment




C49501   C66767                  Action Taken with Study   DRUG INTERRUPTED
                                 Treatment


C49502   C66767                  Action Taken with Study   DRUG WITHDRAWN
                                 Treatment




C48660   C66767                  Action Taken with Study   NOT APPLICABLE
                                 Treatment
C17998   C66767        Action Taken with Study   UNKNOWN
                       Treatment




C66768            No   Outcome of Event          OUT



C48275   C66768        Outcome of Event          FATAL




C49494   C66768        Outcome of Event          NOT RECOVERED/NOT
                                                 RESOLVED




C49498   C66768        Outcome of Event          RECOVERED/RESOLVED




C49495   C66768        Outcome of Event          RECOVERED/RESOLVED WITH
                                                 SEQUELAE




C49496   C66768        Outcome of Event          RECOVERING/RESOLVING
C17998   C66768         Outcome of Event   UNKNOWN




C66780            Yes   Age Span           AGESPAN

C27954   C66780         Age Span           ADOLESCENT (12-17 YEARS)




C49685   C66780         Age Span           ADULT (18-65)


C49683   C66780         Age Span           CHILDREN (2-11 YEARS)


C16268   C66780         Age Span           ELDERLY (> 65)


C49641   C66780         Age Span           IN UTERO




C49643   C66780         Age Span           INFANT AND TODDLER (28 DAYS -
                                           23 MONTHS)

C16731   C66780         Age Span           NEWBORN (0-27 DAYS)


C49642   C66780         Age Span           PRETERM NEWBORN INFANTS


C66781            No    Age Unit           AGEU

C25301   C66781         Age Unit           DAYS
C25529   C66781        Age Unit              HOURS




C29846   C66781        Age Unit              MONTHS




C29844   C66781        Age Unit              WEEKS




C29848   C66781        Age Unit              YEARS




C66797            No   Category for          IECAT
                       Inclusion/Exclusion



C25370   C66797        Category for          EXCLUSION
                       Inclusion/Exclusion
C25532   C66797        Category for               INCLUSION
                       Inclusion/Exclusion




C66783            No   CDISC System Organ Class   SOC

C35814   C66783        CDISC System Organ Class   BLOOD AND LYMPHATIC SYSTEM
                                                  DISORDERS

C3079    C66783        CDISC System Organ Class   CARDIAC DISORDERS


C49399   C66783        CDISC System Organ Class   CONGENITAL, FAMILIAL AND
                                                  GENETIC DISORDERS


C49400   C66783        CDISC System Organ Class   EAR AND LABYRINTH
                                                  DISORDERS

C3009    C66783        CDISC System Organ Class   ENDOCRINE DISORDERS


C26767   C66783        CDISC System Organ Class   EYE DISORDERS



C2990    C66783        CDISC System Organ Class   GASTROINTESTINAL DISORDERS


C49401   C66783        CDISC System Organ Class   GENERAL DISORDERS AND
                                                  ADMINISTRATION SITE
                                                  CONDITIONS


C3959    C66783        CDISC System Organ Class   HEPATOBILIARY DISORDERS


C3507    C66783        CDISC System Organ Class   IMMUNE SYSTEM DISORDERS

C26726   C66783        CDISC System Organ Class   INFECTIONS AND INFESTATIONS
C49402   C66783   CDISC System Organ Class   INJURY, POISONING AND
                                             PROCEDURAL COMPLICATIONS

C41198   C66783   CDISC System Organ Class   INVESTIGATIONS




C49403   C66783   CDISC System Organ Class   METABOLISM AND NUTRITION
                                             DISORDERS

C27574   C66783   CDISC System Organ Class   MUSCULOSKELETAL AND
                                             CONNECTIVE TISSUE
                                             DISORDERS

C3262    C66783   CDISC System Organ Class   NEOPLASMS BENIGN,
                                             MALIGNANT AND UNSPECIFIED
                                             (INCL CYSTS AND POLYPS)




C26835   C66783   CDISC System Organ Class   NERVOUS SYSTEM DISORDERS



C49404   C66783   CDISC System Organ Class   PREGNANCY, PUERPERIUM AND
                                             PERINATAL CONDITIONS


C2893    C66783   CDISC System Organ Class   PSYCHIATRIC DISORDERS




C3430    C66783   CDISC System Organ Class   RENAL AND URINARY
                                             DISORDERS
C49405   C66783   CDISC System Organ Class   REPRODUCTIVE SYSTEM AND
                                             BREAST DISORDERS

C27669   C66783   CDISC System Organ Class   RESPIRATORY, THORACIC AND
                                             MEDIASTINAL DISORDERS


C3371    C66783   CDISC System Organ Class   SKIN AND SUBCUTANEOUS
                                             TISSUE DISORDERS
C20188   C66783        CDISC System Organ Class   SOCIAL CIRCUMSTANCES


C25218   C66783        CDISC System Organ Class   SURGICAL AND MEDICAL
                                                  PROCEDURES
C35117   C66783        CDISC System Organ Class   VASCULAR DISORDERS



C66784            No   Common Terminology Criteria TOXGR
                       for Adverse Events




C41338   C66784        Common Terminology Criteria 1
                       for Adverse Events




C41339   C66784        Common Terminology Criteria 2
                       for Adverse Events




C41340   C66784        Common Terminology Criteria 3
                       for Adverse Events
C41337   C66784         Common Terminology Criteria 4
                        for Adverse Events




C48275   C66784         Common Terminology Criteria 5
                        for Adverse Events




C66785            Yes   Control Type               TCNTRL




C49649   C66785         Control Type               ACTIVE




C41132   C66785         Control Type               NONE
C49648   C66785         Control Type               PLACEBO




C66786            No    Country                    COUNTRY




C17884   C66786         Country                    ABW
C16267   C66786   Country   AFG




C16292   C66786   Country   AGO




C20133   C66786   Country   AIA




C44481   C66786   Country   ALA




C16271   C66786   Country   ALB




C16289   C66786   Country   AND




C16904   C66786   Country   ANT




C17232   C66786   Country   ARE
C16305   C66786   Country   ARG




C16306   C66786   Country   ARM




C17739   C66786   Country   ASM




C18007   C66786   Country   ATA




C20105   C66786   Country   ATF




C16303   C66786   Country   ATG




C16311   C66786   Country   AUS




C16312   C66786   Country   AUT
C16316   C66786   Country   AZE




C16371   C66786   Country   BDI




C16329   C66786   Country   BEL




C16333   C66786   Country   BEN




C16369   C66786   Country   BFA




C16323   C66786   Country   BGD




C16368   C66786   Country   BGR




C16322   C66786   Country   BHR
C16321   C66786   Country   BHS




C16361   C66786   Country   BIH




C16372   C66786   Country   BLR




C16331   C66786   Country   BLZ




C16334   C66786   Country   BMU




C16359   C66786   Country   BOL




C16364   C66786   Country   BRA




C16324   C66786   Country   BRB
C16367   C66786   Country   BRN




C16336   C66786   Country   BTN




C20104   C66786   Country   BVT




C16363   C66786   Country   BWA




C16409   C66786   Country   CAF




C16380   C66786   Country   CAN




C16445   C66786   Country   CCK




C17181   C66786   Country   CHE
C16427   C66786   Country   CHL




C16428   C66786   Country   CHN




C16762   C66786   Country   CIV




C16379   C66786   Country   CMR




C17266   C66786   Country   COD




C16467   C66786   Country   COG




C16469   C66786   Country   COK




C16449   C66786   Country   COL
C16458   C66786   Country   COM




C16382   C66786   Country   CPV




C16470   C66786   Country   CRI




C16477   C66786   Country   CUB




C44482   C66786   Country   CXR




C16391   C66786   Country   CYM




C16480   C66786   Country   CYP




C17668   C66786   Country   CZE
C16636   C66786   Country   DEU




C16506   C66786   Country   DJI




C16519   C66786   Country   DMA




C16496   C66786   Country   DNK




C16520   C66786   Country   DOM



C16274   C66786   Country   DZA




C16528   C66786   Country   ECU




C16530   C66786   Country   EGY




C16558   C66786   Country   ERI
C20113   C66786   Country   ESH




C17152   C66786   Country   ESP




C16562   C66786   Country   EST




C16563   C66786   Country   ETH




C16584   C66786   Country   FIN




C16582   C66786   Country   FJI




C17954   C66786   Country   FLK




C16592   C66786   Country   FRA
C16573   C66786   Country   FRO




C17881   C66786   Country   FSM




C16596   C66786   Country   GAB




C17233   C66786   Country   GBR




C16634   C66786   Country   GEO




C64375   C66786   Country   GGY




C26330   C66786   Country   GHA




C16638   C66786   Country   GIB
C16655   C66786   Country   GIN




C16651   C66786   Country   GLP




C16598   C66786   Country   GMB




C16656   C66786   Country   GNB




C16557   C66786   Country   GNQ




C16645   C66786   Country   GRC


C16647   C66786   Country   GRD




C16646   C66786   Country   GRL




C16654   C66786   Country   GTM
C16593   C66786   Country   GUF




C16652   C66786   Country   GUM




C16657   C66786   Country   GUY




C16695   C66786   Country   HKG




C20106   C66786   Country   HMD

C16694   C66786   Country   HND




C16474   C66786   Country   HRV




C16660   C66786   Country   HTI




C16699   C66786   Country   HUN
C16728   C66786   Country   IDN




C16727   C66786   Country   IND




C16365   C66786   Country   IOT




C16757   C66786   Country   IRL




C16755   C66786   Country   IRN




C16756   C66786   Country   IRQ




C16704   C66786   Country   ISL




C16760   C66786   Country   ISR
C16761   C66786   Country   ITA




C16763   C66786   Country   JAM




C16765   C66786   Country   JOR




C16764   C66786   Country   JPN




C64374   C66786   Country   JRE




C20107   C66786   Country   KAZ




C16769   C66786   Country   KEN




C16771   C66786   Country   KGZ
C16378   C66786   Country   KHM




C16639   C66786   Country   KIR




C17885   C66786   Country   KNA




C16774   C66786   Country   KOR


C16775   C66786   Country   KWT




C16780   C66786   Country   LAO




C16784   C66786   Country   LBN




C16791   C66786   Country   LBR




C16793   C66786   Country   LBY
C17113   C66786   Country   LCA




C16794   C66786   Country   LIE




C17163   C66786   Country   LKA




C16787   C66786   Country   LSO




C16799   C66786   Country   LTU




C16803   C66786   Country   LUX




C16783   C66786   Country   LVA




C16807   C66786   Country   MAC
C16878   C66786   Country   MAR




C16874   C66786   Country   MCO




C16871   C66786   Country   MDA




C16808   C66786   Country   MDG




C16815   C66786   Country   MDV




C16850   C66786   Country   MEX




C16822   C66786   Country   MHL




C17654   C66786   Country   MKD
C16816   C66786   Country   MLI




C16817   C66786   Country   MLT




C16370   C66786   Country   MMR




C64378   C66786   Country   MNE




C16875   C66786   Country   MNG




C17882   C66786   Country   MNP




C16882   C66786   Country   MOZ




C16826   C66786   Country   MRT




C16876   C66786   Country   MSR
C16823   C66786   Country   MTQ




C16827   C66786   Country   MUS

C16813   C66786   Country   MWI




C16814   C66786   Country   MYS




C16828   C66786   Country   MYT




C16891   C66786   Country   NAM




C16913   C66786   Country   NCL




C16916   C66786   Country   NER




C16919   C66786   Country   NFK
C16917   C66786   Country   NGA




C16915   C66786   Country   NIC




C16918   C66786   Country   NIU




C16903   C66786   Country   NLD




C16920   C66786   Country   NOR




C16901   C66786   Country   NPL




C16896   C66786   Country   NRU




C16914   C66786   Country   NZL
C16933   C66786   Country   OMN




C16949   C66786   Country   PAK




C16951   C66786   Country   PAN




C16993   C66786   Country   PCN




C16972   C66786   Country   PER




C16978   C66786   Country   PHL




C17733   C66786   Country   PLW




C16952   C66786   Country   PNG
C17002   C66786   Country   POL




C17043   C66786   Country   PRI




C16773   C66786   Country   PRK




C17006   C66786   Country   PRT




C16953   C66786   Country   PRY




C20110   C66786   Country   PSE




C16594   C66786   Country   PYF




C17045   C66786   Country   QAT
C17095   C66786   Country   REU




C17108   C66786   Country   ROU




C17111   C66786   Country   RUS




C17112   C66786   Country   RWA




C17117   C66786   Country   SAU




C64377   C66786   Country   SCG




C17170   C66786   Country   SDN




C17121   C66786   Country   SEN
C17134   C66786   Country   SGP




C20111   C66786   Country   SGS




C17164   C66786   Country   SHN




C17178   C66786   Country   SJM




C17148   C66786   Country   SLB




C17130   C66786   Country   SLE




C16532   C66786   Country   SLV




C17115   C66786   Country   SMR
C17149   C66786   Country   SOM




C17165   C66786   Country   SPM




C17116   C66786   Country   STP




C17175   C66786   Country   SUR




C17669   C66786   Country   SVK




C17138   C66786   Country   SVN




C17180   C66786   Country   SWE




C17179   C66786   Country   SWZ
C17129   C66786   Country   SYC




C17182   C66786   Country   SYR




C17224   C66786   Country   TCA




C16412   C66786   Country   TCD




C17202   C66786   Country   TGO




C17192   C66786   Country   THA




C17183   C66786   Country   TJK




C17704   C66786   Country   TKL
C17223   C66786   Country   TKM




C17200   C66786   Country   TLS




C17205   C66786   Country   TON

C17217   C66786   Country   TTO




C17221   C66786   Country   TUN




C17222   C66786   Country   TUR




C17225   C66786   Country   TUV




C17184   C66786   Country   TWN




C17185   C66786   Country   TZA
C17228   C66786   Country   UGA




C17229   C66786   Country   UKR




C20112   C66786   Country   UMI




C17244   C66786   Country   URY

C17234   C66786   Country   USA




C17246   C66786   Country   UZB




C17249   C66786   Country   VAT




C17114   C66786   Country   VCT




C17250   C66786   Country   VEN


C17653   C66786   Country   VGB
C17255   C66786   Country   VIR




C17252   C66786   Country   VNM




C17247   C66786   Country   VUT




C17259   C66786   Country   WLF




C17740   C66786   Country   WSM




C17264   C66786   Country   YEM




C17151   C66786   Country   ZAF




C17267   C66786   Country   ZMB
C17268   C66786         Country           ZWE




C66787            Yes   Diagnosis Group   TDIGRP




C49651   C66787         Diagnosis Group   HEALTHY SUBJECTS


C66788            Yes   Dictionary Name   DICTNAM




C49471   C66788         Dictionary Name   COSTART


C49474   C66788         Dictionary Name   ICD




C49476   C66788         Dictionary Name   LOINC


C43820   C66788         Dictionary Name   MedDRA




C53489   C66788         Dictionary Name   SNOMED
C49468   C66788         Dictionary Name        WHOART


C49475   C66788         Dictionary Name        WHODD


C66789            No    Not Done               ND

C49484   C66789         Not Done               NOT DONE




C66790            Yes   Patient Ethnic Group   ETHNIC




C17459   C66790         Patient Ethnic Group   HISPANIC OR LATINO




C41222   C66790         Patient Ethnic Group   NOT HISPANIC OR LATINO




C43234   C66790         Patient Ethnic Group   NOT REPORTED




C17998   C66790         Patient Ethnic Group   UNKNOWN
C66726            Yes   Pharmaceutical Dosage Form FRM




C42887   C66726         Pharmaceutical Dosage Form AEROSOL




C42888   C66726         Pharmaceutical Dosage Form AEROSOL, FOAM




C42960   C66726         Pharmaceutical Dosage Form AEROSOL, METERED




C42971   C66726         Pharmaceutical Dosage Form AEROSOL, POWDER




C42889   C66726         Pharmaceutical Dosage Form AEROSOL, SPRAY
C42892   C66726   Pharmaceutical Dosage Form BAR, CHEWABLE




C42890   C66726   Pharmaceutical Dosage Form BEAD




C43451   C66726   Pharmaceutical Dosage Form BEAD, IMPLANT, EXTENDED
                                             RELEASE




C42891   C66726   Pharmaceutical Dosage Form BLOCK




C25158   C66726   Pharmaceutical Dosage Form CAPSULE




C42895   C66726   Pharmaceutical Dosage Form CAPSULE, COATED




C42896   C66726   Pharmaceutical Dosage Form CAPSULE, COATED PELLETS
C42917   C66726   Pharmaceutical Dosage Form CAPSULE, COATED, EXTENDED
                                             RELEASE




C42902   C66726   Pharmaceutical Dosage Form CAPSULE, DELAYED RELEASE




C42904   C66726   Pharmaceutical Dosage Form CAPSULE, DELAYED RELEASE
                                             PELLETS




C42916   C66726   Pharmaceutical Dosage Form CAPSULE, EXTENDED RELEASE




C42928   C66726   Pharmaceutical Dosage Form CAPSULE, FILM COATED,
                                             EXTENDED RELEASE




C42936   C66726   Pharmaceutical Dosage Form CAPSULE, GELATIN COATED




C42954   C66726   Pharmaceutical Dosage Form CAPSULE, LIQUID FILLED
C45414   C66726   Pharmaceutical Dosage Form CEMENT




C42678   C66726   Pharmaceutical Dosage Form CIGARETTE




C60884   C66726   Pharmaceutical Dosage Form CLOTH




C60891   C66726   Pharmaceutical Dosage Form CONCENTRATE




C42900   C66726   Pharmaceutical Dosage Form CONE




C42919   C66726   Pharmaceutical Dosage Form CORE, EXTENDED RELEASE



C28944   C66726   Pharmaceutical Dosage Form CREAM
C60897   C66726   Pharmaceutical Dosage Form CREAM, AUGMENTED




C42901   C66726   Pharmaceutical Dosage Form CRYSTAL




C45415   C66726   Pharmaceutical Dosage Form CULTURE




C47890   C66726   Pharmaceutical Dosage Form DIAPHRAGM




C43525   C66726   Pharmaceutical Dosage Form DISC




C42679   C66726   Pharmaceutical Dosage Form DOUCHE




C42763   C66726   Pharmaceutical Dosage Form DRESSING
C17423   C66726   Pharmaceutical Dosage Form DRUG DELIVERY SYSTEM




C42912   C66726   Pharmaceutical Dosage Form ELIXIR




C42913   C66726   Pharmaceutical Dosage Form EMULSION




C42915   C66726   Pharmaceutical Dosage Form ENEMA




C42929   C66726   Pharmaceutical Dosage Form EXTRACT




C60926   C66726   Pharmaceutical Dosage Form FIBER, EXTENDED RELEASE
C42932   C66726   Pharmaceutical Dosage Form FILM




C42920   C66726   Pharmaceutical Dosage Form FILM, EXTENDED RELEASE




C42984   C66726   Pharmaceutical Dosage Form FILM, SOLUBLE




C60927   C66726   Pharmaceutical Dosage Form FOR SOLUTION




C60928   C66726   Pharmaceutical Dosage Form FOR SUSPENSION




C60929   C66726   Pharmaceutical Dosage Form FOR SUSPENSION, EXTENDED
                                             RELEASE




C42933   C66726   Pharmaceutical Dosage Form GAS
C42934   C66726   Pharmaceutical Dosage Form GEL




C42906   C66726   Pharmaceutical Dosage Form GEL, DENTIFRICE




C60930   C66726   Pharmaceutical Dosage Form GEL, METERED




C48193   C66726   Pharmaceutical Dosage Form GENERATOR




C42937   C66726   Pharmaceutical Dosage Form GLOBULE




C45416   C66726   Pharmaceutical Dosage Form GRAFT
C42938   C66726   Pharmaceutical Dosage Form GRANULE




C42903   C66726   Pharmaceutical Dosage Form GRANULE, DELAYED RELEASE




C42909   C66726   Pharmaceutical Dosage Form GRANULE, EFFERVESCENT




C42939   C66726   Pharmaceutical Dosage Form GRANULE, FOR SOLUTION




C42940   C66726   Pharmaceutical Dosage Form GRANULE, FOR SUSPENSION




C42921   C66726   Pharmaceutical Dosage Form GRANULE, FOR SUSPENSION,
                                             EXTENDED RELEASE




C42941   C66726   Pharmaceutical Dosage Form GUM
C42894   C66726   Pharmaceutical Dosage Form GUM, CHEWING




C42978   C66726   Pharmaceutical Dosage Form GUM, RESIN




C42942   C66726   Pharmaceutical Dosage Form IMPLANT




C42944   C66726   Pharmaceutical Dosage Form INHALANT




C60931   C66726   Pharmaceutical Dosage Form INJECTABLE, LIPOSOMAL




C42946   C66726   Pharmaceutical Dosage Form INJECTION




C42914   C66726   Pharmaceutical Dosage Form INJECTION, EMULSION
C42950   C66726   Pharmaceutical Dosage Form INJECTION, LIPID COMPLEX




C42974   C66726   Pharmaceutical Dosage Form INJECTION, POWDER, FOR
                                             SOLUTION




C42976   C66726   Pharmaceutical Dosage Form INJECTION, POWDER, FOR
                                             SUSPENSION




C42977   C66726   Pharmaceutical Dosage Form INJECTION, POWDER, FOR
                                             SUSPENSION, EXTENDED
                                             RELEASE




C42959   C66726   Pharmaceutical Dosage Form INJECTION, POWDER,
                                             LYOPHILIZED, FOR LIPOSOMAL
                                             SUSPENSION




C42957   C66726   Pharmaceutical Dosage Form INJECTION, POWDER,
                                             LYOPHILIZED, FOR SOLUTION




C42958   C66726   Pharmaceutical Dosage Form INJECTION, POWDER,
                                             LYOPHILIZED, FOR SUSPENSION
C42956   C66726   Pharmaceutical Dosage Form INJECTION, POWDER,
                                             LYOPHILIZED, FOR SUSPENSION,
                                             EXTENDED RELEASE




C42945   C66726   Pharmaceutical Dosage Form INJECTION, SOLUTION




C42899   C66726   Pharmaceutical Dosage Form INJECTION, SOLUTION,
                                             CONCENTRATE




C42995   C66726   Pharmaceutical Dosage Form INJECTION, SUSPENSION




C42926   C66726   Pharmaceutical Dosage Form INJECTION, SUSPENSION,
                                             EXTENDED RELEASE




C42951   C66726   Pharmaceutical Dosage Form INJECTION, SUSPENSION,
                                             LIPOSOMAL




C42988   C66726   Pharmaceutical Dosage Form INJECTION, SUSPENSION,
                                             SONICATED
C60933   C66726   Pharmaceutical Dosage Form INSERT




C42922   C66726   Pharmaceutical Dosage Form INSERT, EXTENDED RELEASE




C47915   C66726   Pharmaceutical Dosage Form INTRAUTERINE DEVICE




C42947   C66726   Pharmaceutical Dosage Form IRRIGANT




C42948   C66726   Pharmaceutical Dosage Form JELLY




C47916   C66726   Pharmaceutical Dosage Form KIT




C45413   C66726   Pharmaceutical Dosage Form LINER, DENTAL
C42949   C66726   Pharmaceutical Dosage Form LINIMENT




C42952   C66726   Pharmaceutical Dosage Form LIPSTICK




C42953   C66726   Pharmaceutical Dosage Form LIQUID




C60934   C66726   Pharmaceutical Dosage Form LIQUID, EXTENDED RELEASE




C29167   C66726   Pharmaceutical Dosage Form LOTION




C60957   C66726   Pharmaceutical Dosage Form LOTION. AUGMENTED




C60958   C66726   Pharmaceutical Dosage Form LOTION/SHAMPOO
C42955   C66726   Pharmaceutical Dosage Form LOZENGE




C29269   C66726   Pharmaceutical Dosage Form MOUTHWASH




C48624   C66726   Pharmaceutical Dosage Form NOT APPLICABLE




C42965   C66726   Pharmaceutical Dosage Form OIL




C42966   C66726   Pharmaceutical Dosage Form OINTMENT




C60984   C66726   Pharmaceutical Dosage Form OINTMENT, AUGMENTED
C47887   C66726   Pharmaceutical Dosage Form PACKING




C42967   C66726   Pharmaceutical Dosage Form PASTE




C42907   C66726   Pharmaceutical Dosage Form PASTE, DENTIFRICE




C60985   C66726   Pharmaceutical Dosage Form PASTILLE




C42968   C66726   Pharmaceutical Dosage Form PATCH




C42923   C66726   Pharmaceutical Dosage Form PATCH, EXTENDED RELEASE




C42911   C66726   Pharmaceutical Dosage Form PATCH, EXTENDED RELEASE,
                                             ELECTRICALLY CONTROLLED
C42969   C66726   Pharmaceutical Dosage Form PELLET




C42943   C66726   Pharmaceutical Dosage Form PELLET, IMPLANTABLE




C42918   C66726   Pharmaceutical Dosage Form PELLETS, COATED, EXTENDED
                                             RELEASE




C25394   C66726   Pharmaceutical Dosage Form PILL




C42970   C66726   Pharmaceutical Dosage Form PLASTER




C47913   C66726   Pharmaceutical Dosage Form POULTICE




C42972   C66726   Pharmaceutical Dosage Form POWDER
C42908   C66726   Pharmaceutical Dosage Form POWDER, DENTIFRICE




C42973   C66726   Pharmaceutical Dosage Form POWDER, FOR SOLUTION




C42975   C66726   Pharmaceutical Dosage Form POWDER, FOR SUSPENSION




C42961   C66726   Pharmaceutical Dosage Form POWDER, METERED




C60988   C66726   Pharmaceutical Dosage Form RING




C42979   C66726   Pharmaceutical Dosage Form RINSE




C42980   C66726   Pharmaceutical Dosage Form SALVE
C42981   C66726   Pharmaceutical Dosage Form SHAMPOO




C42982   C66726   Pharmaceutical Dosage Form SHAMPOO, SUSPENSION




C42983   C66726   Pharmaceutical Dosage Form SOAP




C42986   C66726   Pharmaceutical Dosage Form SOLUTION




C42898   C66726   Pharmaceutical Dosage Form SOLUTION, CONCENTRATE




C42987   C66726   Pharmaceutical Dosage Form SOLUTION, FOR SLUSH




C60994   C66726   Pharmaceutical Dosage Form SOLUTION, GEL FORMING /
                                             DROPS
C42935   C66726   Pharmaceutical Dosage Form SOLUTION, GEL FORMING,
                                             EXTENDED RELEASE




C60992   C66726   Pharmaceutical Dosage Form SOLUTION/ DROPS




C47912   C66726   Pharmaceutical Dosage Form SPONGE




C42989   C66726   Pharmaceutical Dosage Form SPRAY




C42962   C66726   Pharmaceutical Dosage Form SPRAY, METERED




C42990   C66726   Pharmaceutical Dosage Form SPRAY, SUSPENSION




C42991   C66726   Pharmaceutical Dosage Form STICK
C47914   C66726   Pharmaceutical Dosage Form STRIP




C42993   C66726   Pharmaceutical Dosage Form SUPPOSITORY




C42924   C66726   Pharmaceutical Dosage Form SUPPOSITORY, EXTENDED
                                             RELEASE




C42994   C66726   Pharmaceutical Dosage Form SUSPENSION




C42925   C66726   Pharmaceutical Dosage Form SUSPENSION, EXTENDED
                                             RELEASE




C60995   C66726   Pharmaceutical Dosage Form SUSPENSION/DROPS




C47889   C66726   Pharmaceutical Dosage Form SUTURE
C47898   C66726   Pharmaceutical Dosage Form SWAB




C42996   C66726   Pharmaceutical Dosage Form SYRUP




C42998   C66726   Pharmaceutical Dosage Form TABLET




C42893   C66726   Pharmaceutical Dosage Form TABLET, CHEWABLE




C42897   C66726   Pharmaceutical Dosage Form TABLET, COATED




C60997   C66726   Pharmaceutical Dosage Form TABLET, COATED PARTICLES




C42905   C66726   Pharmaceutical Dosage Form TABLET, DELAYED RELEASE
C42997   C66726   Pharmaceutical Dosage Form TABLET, DELAYED RELEASE
                                             PARTICLES




C42910   C66726   Pharmaceutical Dosage Form TABLET, EFFERVESCENT




C42927   C66726   Pharmaceutical Dosage Form TABLET, EXTENDED RELEASE




C42931   C66726   Pharmaceutical Dosage Form TABLET, FILM COATED




C42930   C66726   Pharmaceutical Dosage Form TABLET, FILM COATED,
                                             EXTENDED RELEASE




C61004   C66726   Pharmaceutical Dosage Form TABLET, FOR SOLUTION




C61005   C66726   Pharmaceutical Dosage Form TABLET, FOR SUSPENSION



C42964   C66726   Pharmaceutical Dosage Form TABLET, MULTILAYER
C42963   C66726   Pharmaceutical Dosage Form TABLET, MULTILAYER,
                                             EXTENDED RELEASE




C42999   C66726   Pharmaceutical Dosage Form TABLET, ORALLY
                                             DISINTEGRATING



C61006   C66726   Pharmaceutical Dosage Form TABLET, ORALLY
                                             DISINTEGRATING, DELAYED
                                             RELEASE




C42985   C66726   Pharmaceutical Dosage Form TABLET, SOLUBLE




C42992   C66726   Pharmaceutical Dosage Form TABLET, SUGAR COATED




C47892   C66726   Pharmaceutical Dosage Form TAMPON




C47897   C66726   Pharmaceutical Dosage Form TAPE



C43000   C66726   Pharmaceutical Dosage Form TINCTURE



C43001   C66726   Pharmaceutical Dosage Form TROCHE




C43002   C66726   Pharmaceutical Dosage Form UNASSIGNED
C43003   C66726         Pharmaceutical Dosage Form WAFER




C66727            Yes   Completion/Reason for Non-   NCOMPLT
                        Completion
C41331   C66727         Completion/Reason for Non-   ADVERSE EVENT
                        Completion




C25250   C66727         Completion/Reason for Non-   COMPLETED
                        Completion

C28554   C66727         Completion/Reason for Non-   DEATH
                        Completion
C48226   C66727         Completion/Reason for Non-   LACK OF EFFICACY
                        Completion
C48227   C66727         Completion/Reason for Non-   LOST TO FOLLOW-UP
                        Completion
C49631   C66727         Completion/Reason for Non-   NON-COMPLIANCE WITH STUDY
                        Completion                   DRUG

C17649   C66727         Completion/Reason for Non-   OTHER
                        Completion
C48250   C66727         Completion/Reason for Non-   PHYSICIAN DECISION
                        Completion

C25742   C66727         Completion/Reason for Non-   PREGNANCY
                        Completion




C35571   C66727         Completion/Reason for Non-   PROGRESSIVE DISEASE
                        Completion
C48251   C66727         Completion/Reason for Non-   PROTOCOL VIOLATION
                        Completion
C25746   C66727         Completion/Reason for Non-   RECOVERY
                        Completion

C49628   C66727         Completion/Reason for Non-   SCREEN FAILURE
                        Completion
C49632   C66727         Completion/Reason for Non-   STUDY TERMINATED BY
                        Completion                   SPONSOR
C49633   C66727         Completion/Reason for Non-   TECHNICAL PROBLEMS
                        Completion
C49634   C66727         Completion/Reason for Non-   WITHDRAWAL BY SUBJECT
                        Completion

C66728            No    Relation to Reference Period STENRF

C38008   C66728         Relation to Reference Period AFTER




C25629   C66728         Relation to Reference Period BEFORE




C25490   C66728         Relation to Reference Period DURING




C49640   C66728         Relation to Reference Period DURING/AFTER




C17998   C66728         Relation to Reference Period U




C66729            Yes   Route of Administration      ROUTE
C38192   C66729   Route of Administration   AURICULAR (OTIC)




C38193   C66729   Route of Administration   BUCCAL




C38194   C66729   Route of Administration   CONJUNCTIVAL




C38675   C66729   Route of Administration   CUTANEOUS




C38197   C66729   Route of Administration   DENTAL




C38633   C66729   Route of Administration   ELECTRO-OSMOSIS




C38205   C66729   Route of Administration   ENDOCERVICAL
C38206   C66729   Route of Administration   ENDOSINUSIAL




C38208   C66729   Route of Administration   ENDOTRACHEAL




C38209   C66729   Route of Administration   ENTERAL




C38210   C66729   Route of Administration   EPIDURAL




C38211   C66729   Route of Administration   EXTRA-AMNIOTIC




C38212   C66729   Route of Administration   EXTRACORPOREAL




C38200   C66729   Route of Administration   HEMODIALYSIS
C38215   C66729   Route of Administration   INFILTRATION




C38219   C66729   Route of Administration   INTERSTITIAL




C38220   C66729   Route of Administration   INTRA-ABDOMINAL




C38221   C66729   Route of Administration   INTRA-AMNIOTIC




C38222   C66729   Route of Administration   INTRA-ARTERIAL




C38223   C66729   Route of Administration   INTRA-ARTICULAR




C38224   C66729   Route of Administration   INTRABILIARY
C38225   C66729   Route of Administration   INTRABRONCHIAL




C38226   C66729   Route of Administration   INTRABURSAL




C38227   C66729   Route of Administration   INTRACARDIAC




C38228   C66729   Route of Administration   INTRACARTILAGINOUS




C38229   C66729   Route of Administration   INTRACAUDAL




C38230   C66729   Route of Administration   INTRACAVERNOUS




C38231   C66729   Route of Administration   INTRACAVITARY
C38232   C66729   Route of Administration   INTRACEREBRAL




C38233   C66729   Route of Administration   INTRACISTERNAL




C38234   C66729   Route of Administration   INTRACORNEAL




C38217   C66729   Route of Administration   INTRACORONAL, DENTAL




C38218   C66729   Route of Administration   INTRACORONARY




C38235   C66729   Route of Administration   INTRACORPORUS CAVERNOSUM




C38238   C66729   Route of Administration   INTRADERMAL
C38239   C66729   Route of Administration   INTRADISCAL




C38240   C66729   Route of Administration   INTRADUCTAL




C38241   C66729   Route of Administration   INTRADUODENAL




C38242   C66729   Route of Administration   INTRADURAL




C38243   C66729   Route of Administration   INTRAEPIDERMAL




C38245   C66729   Route of Administration   INTRAESOPHAGEAL




C38246   C66729   Route of Administration   INTRAGASTRIC
C38247   C66729   Route of Administration   INTRAGINGIVAL




C38249   C66729   Route of Administration   INTRAILEAL




C38250   C66729   Route of Administration   INTRALESIONAL




C38251   C66729   Route of Administration   INTRALUMINAL




C38252   C66729   Route of Administration   INTRALYMPHATIC




C38253   C66729   Route of Administration   INTRAMEDULLARY




C38254   C66729   Route of Administration   INTRAMENINGEAL
C28161   C66729   Route of Administration   INTRAMUSCULAR




C38255   C66729   Route of Administration   INTRAOCULAR




C38256   C66729   Route of Administration   INTRAOVARIAN




C38257   C66729   Route of Administration   INTRAPERICARDIAL




C38258   C66729   Route of Administration   INTRAPERITONEAL




C38259   C66729   Route of Administration   INTRAPLEURAL




C38260   C66729   Route of Administration   INTRAPROSTATIC
C38261   C66729   Route of Administration   INTRAPULMONARY




C38262   C66729   Route of Administration   INTRASINAL




C38263   C66729   Route of Administration   INTRASPINAL




C38264   C66729   Route of Administration   INTRASYNOVIAL




C38265   C66729   Route of Administration   INTRATENDINOUS




C38266   C66729   Route of Administration   INTRATESTICULAR




C38267   C66729   Route of Administration   INTRATHECAL
C38207   C66729   Route of Administration   INTRATHORACIC




C38268   C66729   Route of Administration   INTRATUBULAR




C38269   C66729   Route of Administration   INTRATUMOR



C38270   C66729   Route of Administration   INTRATYMPANIC




C38272   C66729   Route of Administration   INTRAUTERINE




C38273   C66729   Route of Administration   INTRAVASCULAR




C38276   C66729   Route of Administration   INTRAVENOUS




C38274   C66729   Route of Administration   INTRAVENOUS BOLUS
C38279   C66729   Route of Administration   INTRAVENOUS DRIP




C38277   C66729   Route of Administration   INTRAVENTRICULAR




C38278   C66729   Route of Administration   INTRAVESICAL




C38280   C66729   Route of Administration   INTRAVITREAL




C38203   C66729   Route of Administration   IONTOPHORESIS




C38281   C66729   Route of Administration   IRRIGATION




C38282   C66729   Route of Administration   LARYNGEAL
C38284   C66729   Route of Administration   NASAL




C38285   C66729   Route of Administration   NASOGASTRIC




C48623   C66729   Route of Administration   NOT APPLICABLE




C38286   C66729   Route of Administration   OCCLUSIVE DRESSING
                                            TECHNIQUE

C38287   C66729   Route of Administration   OPHTHALMIC




C38288   C66729   Route of Administration   ORAL




C38289   C66729   Route of Administration   OROPHARYNGEAL




C38290   C66729   Route of Administration   OTHER
C38291   C66729   Route of Administration   PARENTERAL




C38676   C66729   Route of Administration   PERCUTANEOUS




C38292   C66729   Route of Administration   PERIARTICULAR




C38677   C66729   Route of Administration   PERIDURAL




C38293   C66729   Route of Administration   PERINEURAL




C38294   C66729   Route of Administration   PERIODONTAL




C38295   C66729   Route of Administration   RECTAL
C38216   C66729   Route of Administration   RESPIRATORY (INHALATION)




C38296   C66729   Route of Administration   RETROBULBAR




C38198   C66729   Route of Administration   SOFT TISSUE




C38297   C66729   Route of Administration   SUBARACHNOID




C38298   C66729   Route of Administration   SUBCONJUNCTIVAL




C38299   C66729   Route of Administration   SUBCUTANEOUS




C38300   C66729   Route of Administration   SUBLINGUAL
C38301   C66729   Route of Administration   SUBMUCOSAL




C38304   C66729   Route of Administration   TOPICAL




C38305   C66729   Route of Administration   TRANSDERMAL




C38283   C66729   Route of Administration   TRANSMUCOSAL




C38307   C66729   Route of Administration   TRANSPLACENTAL




C38308   C66729   Route of Administration   TRANSTRACHEAL




C38309   C66729   Route of Administration   TRANSTYMPANIC
C38310   C66729        Route of Administration        UNASSIGNED




C38311   C66729        Route of Administration        UNKNOWN




C38312   C66729        Route of Administration        URETERAL




C38271   C66729        Route of Administration        URETHRAL




C38313   C66729        Route of Administration        VAGINAL




C66769            No   Severity/Intensity Scale for   AESEV
                       Adverse Events



C41338   C66769        Severity/Intensity Scale for   MILD
                       Adverse Events
C41339   C66769        Severity/Intensity Scale for   MODERATE
                       Adverse Events




C41340   C66769        Severity/Intensity Scale for   SEVERE
                       Adverse Events




C66731            No   Sex                            SEX



C16576   C66731        Sex                            F




C20197   C66731        Sex                            M




C17998   C66731        Sex                            U




C45908   C66731        Sex                            UN

C66732            No   Sex of Participants            SEXPOP

C49636   C66732        Sex of Participants            BOTH
C16576   C66732         Sex of Participants   F




C20197   C66732         Sex of Participants   M




C66733            Yes   Size                  SIZE

C49508   C66733         Size                  LARGE

C49507   C66733         Size                  MEDIUM

C25376   C66733         Size                  SMALL
C66734            Yes   Domain Abbreviation   DOMAIN




C49563   C66734         Domain Abbreviation   AD




C49562   C66734         Domain Abbreviation   AE




C49565   C66734         Domain Abbreviation   AU
C49566   C66734   Domain Abbreviation   BM




C49567   C66734   Domain Abbreviation   BR




C49568   C66734   Domain Abbreviation   CM




C49569   C66734   Domain Abbreviation   CO




C49578   C66734   Domain Abbreviation   DA




C49570   C66734   Domain Abbreviation   DC




C49572   C66734   Domain Abbreviation   DM
C49576   C66734   Domain Abbreviation   DS




C49585   C66734   Domain Abbreviation   DV




C49625   C66734   Domain Abbreviation   EE




C49626   C66734   Domain Abbreviation   EG




C49587   C66734   Domain Abbreviation   EX




C49588   C66734   Domain Abbreviation   FH


C49589   C66734   Domain Abbreviation   HU




C61536   C66734   Domain Abbreviation   IE
C49592   C66734   Domain Abbreviation   LB




C49602   C66734   Domain Abbreviation   MB




C49603   C66734   Domain Abbreviation   MH




C49604   C66734   Domain Abbreviation   ML




C61531   C66734   Domain Abbreviation   MS




C49605   C66734   Domain Abbreviation   OM




C49606   C66734   Domain Abbreviation   PC
C49608   C66734   Domain Abbreviation   PE




C61529   C66734   Domain Abbreviation   PG




C49607   C66734   Domain Abbreviation   PP




C49609   C66734   Domain Abbreviation   QS




C49610   C66734   Domain Abbreviation   SC




C49616   C66734   Domain Abbreviation   SE




C49611   C66734   Domain Abbreviation   SG
C49612   C66734   Domain Abbreviation   SK




C49613   C66734   Domain Abbreviation   SL




C49614   C66734   Domain Abbreviation   ST




C49615   C66734   Domain Abbreviation   SU




C49617   C66734   Domain Abbreviation   SV




C49618   C66734   Domain Abbreviation   TA




C49619   C66734   Domain Abbreviation   TE
C49620   C66734         Domain Abbreviation     TI




C53483   C66734         Domain Abbreviation     TS




C49621   C66734         Domain Abbreviation     TV




C49622   C66734         Domain Abbreviation     VS




C66735            Yes   Trial Blinding Schema   TBLIND

C15228   C66735         Trial Blinding Schema   DOUBLE BLIND



C49659   C66735         Trial Blinding Schema   OPEN LABEL


C28233   C66735         Trial Blinding Schema   SINGLE BLIND



C66736            Yes   Trial Indication Type   TINDTP

C49654   C66736         Trial Indication Type   CURE

C49653   C66736         Trial Indication Type   DIAGNOSIS


C49655   C66736         Trial Indication Type   MITIGATION
C49657   C66736         Trial Indication Type   PREVENTION



C49656   C66736         Trial Indication Type   TREATMENT


C66737            Yes   Trial Phase             TPHASE




C15600   C66737         Trial Phase             Phase I Trial




C15693   C66737         Trial Phase             Phase I/II Trial


C15601   C66737         Trial Phase             Phase II Trial




C15694   C66737         Trial Phase             Phase II/III Trial
C49686   C66737         Trial Phase               Phase IIa Trial


C49688   C66737         Trial Phase               Phase IIb Trial




C15602   C66737         Trial Phase               Phase III Trial




C49687   C66737         Trial Phase               Phase IIIaTrial


C49689   C66737         Trial Phase               Phase IIIb Trial




C15603   C66737         Trial Phase               Phase IV Trial




C47865   C66737         Trial Phase               Phase V Trial

C48660   C66737         Trial Phase               NA

C66738            Yes   Trial Summary Parameter   TSPARMCD
                        Test Code

C49703   C66738         Trial Summary Parameter   ADDON
                        Test Code

C49700   C66738         Trial Summary Parameter   AEDICT
                        Test Code
C49694   C66738   Trial Summary Parameter   AGEMAX
                  Test Code
C49693   C66738   Trial Summary Parameter   AGEMIN
                  Test Code
C20587   C66738   Trial Summary Parameter   AGESPAN
                  Test Code

C50400   C66738   Trial Summary Parameter   AGEU
                  Test Code
C25488   C66738   Trial Summary Parameter   DOSE
                  Test Code

C49701   C66738   Trial Summary Parameter   DRUGDICT
                  Test Code
C49697   C66738   Trial Summary Parameter   LENGTH
                  Test Code
C49702   C66738   Trial Summary Parameter   MHDICT
                  Test Code
C49692   C66738   Trial Summary Parameter   PLANSUB
                  Test Code
C25196   C66738   Trial Summary Parameter   RANDOM
                  Test Code




C38114   C66738   Trial Summary Parameter   ROUTE
                  Test Code
C49696   C66738   Trial Summary Parameter   SEXPOP
                  Test Code
C49698   C66738   Trial Summary Parameter   STOPRULE
                  Test Code
C49658   C66738   Trial Summary Parameter   TBLIND
                  Test Code
C49647   C66738   Trial Summary Parameter   TCNTRL
                  Test Code


C49650   C66738   Trial Summary Parameter   TDIGRP
                  Test Code




C49652   C66738   Trial Summary Parameter   TINDTP
                  Test Code
C49802   C66738   Trial Summary Parameter   TITLE
                  Test Code
C48281   C66738         Trial Summary Parameter   TPHASE
                        Test Code




C49660   C66738         Trial Summary Parameter   TTYPE
                        Test Code
C67152            Yes   Trial Summary Parameter   TSPARM
                        Test Name

C49703   C67152         Trial Summary Parameter   Added on to Existing Treatments
                        Test Name

C49700   C67152         Trial Summary Parameter   Adverse Event Dictionary
                        Test Name
C49694   C67152         Trial Summary Parameter   Planned Maximum Age of Subjects
                        Test Name
C49693   C67152         Trial Summary Parameter   Planned Minimum Age of Subjects
                        Test Name
C20587   C67152         Trial Summary Parameter   Age Group
                        Test Name
C50400   C67152         Trial Summary Parameter   Age Unit
                        Test Name
C25488   C67152         Trial Summary Parameter   Dose per Administration
                        Test Name

C49701   C67152         Trial Summary Parameter   Drug Dictionary
                        Test Name
C49697   C67152         Trial Summary Parameter   Trial Length
                        Test Name
C49702   C67152         Trial Summary Parameter   Medical History Dictionary
                        Test Name

C49692   C67152         Trial Summary Parameter   Planned Number of Subjects
                        Test Name
C25196   C67152         Trial Summary Parameter   Trial is Randomized
                        Test Name



C38114   C67152         Trial Summary Parameter   Route of Administration
                        Test Name



C49696   C67152         Trial Summary Parameter   Sex of Participants
                        Test Name
C49698   C67152         Trial Summary Parameter   Study Stop Rules
                        Test Name
C49658   C67152         Trial Summary Parameter   Trial Blinding Schema
                        Test Name

C49647   C67152         Trial Summary Parameter   Control Type
                        Test Name


C49650   C67152         Trial Summary Parameter   Diagnosis Group
                        Test Name


C49652   C67152         Trial Summary Parameter   Trial Indication Type
                        Test Name

C49802   C67152         Trial Summary Parameter   Trial Title
                        Test Name

C48281   C67152         Trial Summary Parameter   Trial Phase Classification
                        Test Name




C49660   C67152         Trial Summary Parameter   Trial Type
                        Test Name


C66739            Yes   Trial Type                TTYPE

C49664   C66739         Trial Type                BIO-AVAILABILITY




C49665   C66739         Trial Type                BIO-EQUIVALENCE




C49666   C66739         Trial Type                EFFICACY



C49662   C66739         Trial Type                PHARMACODYNAMIC
C39493   C66739         Trial Type                      PHARMACOECONOMIC




C49661   C66739         Trial Type                      PHARMACOGENOMIC




C49663   C66739         Trial Type                      PHARMACOKINETIC


C49667   C66739         Trial Type                      SAFETY

C66770            Yes   Units for Vital Signs Results   VSRESU



C25613   C66770         Units for Vital Signs Results   %

C49673   C66770         Units for Vital Signs Results   BEATS/MIN




C49674   C66770         Units for Vital Signs Results   BREATHS/MIN




C42559   C66770         Units for Vital Signs Results   C




C49668   C66770         Units for Vital Signs Results   cm
C44277   C66770         Units for Vital Signs Results   F




C48155   C66770         Units for Vital Signs Results   g

C48500   C66770         Units for Vital Signs Results   IN




C28252   C66770         Units for Vital Signs Results   kg




C49671   C66770         Units for Vital Signs Results   kg/m2

C48531   C66770         Units for Vital Signs Results   LB


C42569   C66770         Units for Vital Signs Results   m2



C49670   C66770         Units for Vital Signs Results   mmHg


C42554   C66770         Units for Vital Signs Results   ohm




C66741            Yes   Vital Signs Test Code           VSTESTCD


C16358   C66741         Vital Signs Test Code           BMI
C12472   C66741   Vital Signs Test Code   BODYFAT




C25157   C66741   Vital Signs Test Code   BSA




C25299   C66741   Vital Signs Test Code   DIABP




C49680   C66741   Vital Signs Test Code   FRMSIZE




C25347   C66741   Vital Signs Test Code   HEIGHT




C49677   C66741   Vital Signs Test Code   HR




C49679   C66741   Vital Signs Test Code   MAP
C49676   C66741         Vital Signs Test Code   PULSE




C49678   C66741         Vital Signs Test Code   RESP




C25298   C66741         Vital Signs Test Code   SYSBP




C25206   C66741         Vital Signs Test Code   TEMP




C25208   C66741         Vital Signs Test Code   WEIGHT




C67153            Yes   Vital Signs Test Name   VSTEST



C16358   C67153         Vital Signs Test Name   Body Mass Index
C12472   C67153   Vital Signs Test Name   Adipose Tissue




C25157   C67153   Vital Signs Test Name   Body Surface Area




C25299   C67153   Vital Signs Test Name   Diastolic Blood Pressure




C49680   C67153   Vital Signs Test Name   Body Frame Size




C25347   C67153   Vital Signs Test Name   Height


C49677   C67153   Vital Signs Test Name   Heart Rate




C49679   C67153   Vital Signs Test Name   Mean Arterial Pressure
C49676   C67153        Vital Signs Test Name   Pulse Rate




C49678   C67153        Vital Signs Test Name   Respiratory Rate




C25298   C67153        Vital Signs Test Name   Systolic Blood Pressure




C25206   C67153        Vital Signs Test Name   Temperature




C25208   C67153        Vital Signs Test Name   Weight




C66742            No   No Yes Response         NY




C49487   C66742        No Yes Response         N




C48660   C66742        No Yes Response         NA
C17998   C66742         No Yes Response        U




C49488   C66742         No Yes Response        Y




C65047            Yes   Laboratory Test Code   LBTESTCD


C35266   C65047         Laboratory Test Code   ANISO

C35267   C65047         Laboratory Test Code   POIKILO

C38037   C65047         Laboratory Test Code   BILI

C38462   C65047         Laboratory Test Code   APTT



C41376   C65047         Laboratory Test Code   GLUC
C45997   C65047         Laboratory Test Code   PH

C51946   C65047         Laboratory Test Code   RBC

C51947   C65047         Laboratory Test Code   RETI

C51948   C65047         Laboratory Test Code   WBC

C51949   C65047         Laboratory Test Code   LYM

C51951   C65047         Laboratory Test Code   PLAT
C61019   C65047         Laboratory Test Code   BUN

C61032   C65047         Laboratory Test Code   CHOL

C61041   C65047         Laboratory Test Code   HDL

C61042   C65047         Laboratory Test Code   LDL

C62656   C65047         Laboratory Test Code   PT
C63321   C65047   Laboratory Test Code   NEUT

C64431   C65047   Laboratory Test Code   ALB

C64432   C65047   Laboratory Test Code   ALP

C64433   C65047   Laboratory Test Code   ALT

C64434   C65047   Laboratory Test Code   AMYLASE

C64467   C65047   Laboratory Test Code   AST

C64469   C65047   Laboratory Test Code   BACT
C64470   C65047   Laboratory Test Code   BASO
C64471   C65047   Laboratory Test Code   BASOLE

C64481   C65047   Laboratory Test Code   BILDIR

C64483   C65047   Laboratory Test Code   BILIND

C64487   C65047   Laboratory Test Code   BLASTLE

C64488   C65047   Laboratory Test Code   CA
C64489   C65047   Laboratory Test Code   CK

C64490   C65047   Laboratory Test Code   CKBB

C64491   C65047   Laboratory Test Code   CKMB

C64494   C65047   Laboratory Test Code   CKMM

C64495   C65047   Laboratory Test Code   CL
C64545   C65047   Laboratory Test Code   CO2

C64546   C65047   Laboratory Test Code   COLOR
C64547   C65047   Laboratory Test Code   CREAT
C64548   C65047   Laboratory Test Code   CRP

C64549   C65047   Laboratory Test Code   ELLIPCY

C64550   C65047   Laboratory Test Code   EOS

C64604   C65047   Laboratory Test Code   EOSLE

C64605   C65047   Laboratory Test Code   EPIC

C64606   C65047   Laboratory Test Code   FIBRINO
C64796   C65047   Laboratory Test Code   HCT

C64797   C65047   Laboratory Test Code   MCH
C64798   C65047   Laboratory Test Code   MCHC


C64799   C65047   Laboratory Test Code   MCV

C64800   C65047   Laboratory Test Code   RDW


C64801   C65047   Laboratory Test Code   TEARDCY
C64802   C65047   Laboratory Test Code   HYPO


C64803   C65047   Laboratory Test Code   POLYCHR

C64805   C65047   Laboratory Test Code   INR




C64806   C65047   Laboratory Test Code   VLDL

C64807   C65047   Laboratory Test Code   LIPASE

C64809   C65047   Laboratory Test Code   SODIUM
C64810   C65047   Laboratory Test Code   NITRITE
C64812   C65047   Laboratory Test Code   TRIG

C64813   C65047   Laboratory Test Code   TSH

C64814   C65047   Laboratory Test Code   URATE
C64815   C65047   Laboratory Test Code   UREA
C64816   C65047   Laboratory Test Code   UROBIL

C64817   C65047   Laboratory Test Code   VITB12
C64818   C65047   Laboratory Test Code   LYMAT

C64819   C65047   Laboratory Test Code   LYMATLE

C64820   C65047   Laboratory Test Code   LYMLE

C64821   C65047   Laboratory Test Code   MACROCY

C64822   C65047   Laboratory Test Code   MICROCY

C64823   C65047   Laboratory Test Code   MONO

C64824   C65047   Laboratory Test Code   MONOLE

C64825   C65047   Laboratory Test Code   MYBLALE
C64826   C65047   Laboratory Test Code   MYCYLE

C64827   C65047   Laboratory Test Code   NEUTLE


C64828   C65047   Laboratory Test Code   RETIRBC

C64829   C65047   Laboratory Test Code   PRLYMLE

C64830   C65047   Laboratory Test Code   NEUTB

C64831   C65047   Laboratory Test Code   NEUTBLE

C64832   C65047   Laboratory Test Code   SPGRAV
C64840   C65047   Laboratory Test Code   MG

C64847   C65047   Laboratory Test Code   GGT

C64848   C65047   Laboratory Test Code   HGB

C64849   C65047   Laboratory Test Code   HBA1C

C64850   C65047   Laboratory Test Code   HBSAG

C64851   C65047   Laboratory Test Code   HCG

C64853   C65047   Laboratory Test Code   K

C64854   C65047   Laboratory Test Code   KETONES
C64855   C65047   Laboratory Test Code   LDH

C64856   C65047   Laboratory Test Code   LEUKASE

C64857   C65047   Laboratory Test Code   PHOS

C64858   C65047   Laboratory Test Code   PROT


C17634   C65047   Laboratory Test Code   PSA

C25747   C65047   Laboratory Test Code   CREATCLR


C74604   C65047   Laboratory Test Code   HAIRYCE


C74605   C65047   Laboratory Test Code   BLAST

C74606   C65047   Laboratory Test Code   CD19

C74607   C65047   Laboratory Test Code   CD3
C74608   C65047   Laboratory Test Code   CD4

C74609   C65047   Laboratory Test Code   CD8

C74610   C65047   Laboratory Test Code   DOHLE


C74611   C65047   Laboratory Test Code   ESR


C74612   C65047   Laboratory Test Code   HYPSEGCE

C74613   C65047   Laboratory Test Code   LYMMCE

C74614   C65047   Laboratory Test Code   MAYHEG

C74615   C65047   Laboratory Test Code   METAMY


C74616   C65047   Laboratory Test Code   PAPPEN


C74617   C65047   Laboratory Test Code   PELGERH

C74618   C65047   Laboratory Test Code   LYMPL



C74619   C65047   Laboratory Test Code   PLSPCE


C74620   C65047   Laboratory Test Code   PROLYM

C74621   C65047   Laboratory Test Code   PROMONO

C74622   C65047   Laboratory Test Code   PROMY

C74624   C65047   Laboratory Test Code   ROULEAUX

C74625   C65047   Laboratory Test Code   SEZCE

C74626   C65047   Laboratory Test Code   SCKLCE

C74627   C65047   Laboratory Test Code   SMDGCE

C74628   C65047   Laboratory Test Code   NEUTVAC

C74630   C65047   Laboratory Test Code   BLASTLM
C74631   C65047   Laboratory Test Code   MONOBL

C74632   C65047   Laboratory Test Code   MYBLA

C74633   C65047   Laboratory Test Code   ACANTRBC

C74634   C65047   Laboratory Test Code   BTECERBC



C74635   C65047   Laboratory Test Code   CD19LY

C74636   C65047   Laboratory Test Code   CD3LY

C74637   C65047   Laboratory Test Code   CD4CD8

C74638   C65047   Laboratory Test Code   CD4LY

C74639   C65047   Laboratory Test Code   CD8LY

C74640   C65047   Laboratory Test Code   HRYCELY


C74641   C65047   Laboratory Test Code   BLSTLMLY


C74643   C65047   Laboratory Test Code   MLIGCEBC


C74645   C65047   Laboratory Test Code   METAMYLE



C74646   C65047   Laboratory Test Code   MONOBLLE

C74647   C65047   Laboratory Test Code   RBCNURBC


C74648   C65047   Laboratory Test Code   LYMPLLY




C74649   C65047   Laboratory Test Code   POIKRBC


C74650   C65047   Laboratory Test Code   PLSPCELY
C74651   C65047   Laboratory Test Code   PROLYMLY


C74652   C65047   Laboratory Test Code   PROMONLE

C74653   C65047   Laboratory Test Code   PROMYLE


C74654   C65047   Laboratory Test Code   LYMRCTLY




C74655   C65047   Laboratory Test Code   SEZCELY


C74656   C65047   Laboratory Test Code   SCKCERBC


C74657   C65047   Laboratory Test Code   AUERRODS



C74658   C65047   Laboratory Test Code   HELMETCE


C74659   C65047   Laboratory Test Code   LGUNSCE



C74660   C65047   Laboratory Test Code   MLIGCE

C74661   C65047   Laboratory Test Code   PLSMCE

C74662   C65047   Laboratory Test Code   MYCY

C74663   C65047   Laboratory Test Code   SPERM

C74664   C65047   Laboratory Test Code   YEAST

C74665   C65047   Laboratory Test Code   CYAMORPH


C74666   C65047   Laboratory Test Code   AMORPHSD

C74667   C65047   Laboratory Test Code   BICARB

C74668   C65047   Laboratory Test Code   CYBILI

C74669   C65047   Laboratory Test Code   CYCACAR
C74670   C65047   Laboratory Test Code   CYCAOXA

C74671   C65047   Laboratory Test Code   CYCAPHOS

C74672   C65047   Laboratory Test Code   CYCHOL

C74673   C65047   Laboratory Test Code   CRYSTALS

C74674   C65047   Laboratory Test Code   CYCYSTIN

C74676   C65047   Laboratory Test Code   FOLICAC
C74677   C65047   Laboratory Test Code   CARNITF

C74678   C65047   Laboratory Test Code   FRUCT

C74679   C65047   Laboratory Test Code   IRON
C74680   C65047   Laboratory Test Code   CYLEUC

C74681   C65047   Laboratory Test Code   CYMSU

C74682   C65047   Laboratory Test Code   CARNIT

C74683   C65047   Laboratory Test Code   CYTYRO

C74684   C65047   Laboratory Test Code   CYURIAC

C74685   C65047   Laboratory Test Code   ANIONG


C74686   C65047   Laboratory Test Code   OCCBLD

C74687   C65047   Laboratory Test Code   AMPHET

C74688   C65047   Laboratory Test Code   BARB

C74689   C65047   Laboratory Test Code   CANNAB

C74690   C65047   Laboratory Test Code   COCAINE

C74698   C65047   Laboratory Test Code   EPIROCE

C74699   C65047   Laboratory Test Code   ACANT

C74700   C65047   Laboratory Test Code   BITECE


C74701   C65047   Laboratory Test Code   BURRCE
C74702   C65047   Laboratory Test Code   CABOT


C74703   C65047   Laboratory Test Code   CRENCE



C74704   C65047   Laboratory Test Code   HOWJOL



C74705   C65047   Laboratory Test Code   RBCNUC


C74706   C65047   Laboratory Test Code   SCHISTO

C74707   C65047   Laboratory Test Code   SPHERO

C74708   C65047   Laboratory Test Code   STOMCY


C74709   C65047   Laboratory Test Code   HEINZ


C74710   C65047   Laboratory Test Code   HASAB

C74711   C65047   Laboratory Test Code   HBSAB

C74712   C65047   Laboratory Test Code   HCSAB

C74713   C65047   Laboratory Test Code   HIV1AB

C74714   C65047   Laboratory Test Code   HIV12AB

C74715   C65047   Laboratory Test Code   HIV2AB

C74716   C65047   Laboratory Test Code   RPR


C74717   C65047   Laboratory Test Code   RF

C74718   C65047   Laboratory Test Code   IBCT

C74719   C65047   Laboratory Test Code   IBCU

C74721   C65047   Laboratory Test Code   MUCTHR

C74723   C65047   Laboratory Test Code   TURB
C74724   C65047   Laboratory Test Code   HAVPCR

C74725   C65047   Laboratory Test Code   HBVPCR
C74726   C65047   Laboratory Test Code   HCVPCR

C74727   C65047   Laboratory Test Code   HIVPCR

C74728   C65047   Laboratory Test Code   PLATGNT

C74729   C65047   Laboratory Test Code   PLATLRG

C74730   C65047   Laboratory Test Code   MPV

C74731   C65047   Laboratory Test Code   ALDOLASE

C74732   C65047   Laboratory Test Code   AFP

C74733   C65047   Laboratory Test Code   APOA1

C74734   C65047   Laboratory Test Code   APOB

C74735   C65047   Laboratory Test Code   BNP

C74736   C65047   Laboratory Test Code   CPEPTIDE

C74737   C65047   Laboratory Test Code   FERRITIN
C74738   C65047   Laboratory Test Code   GLOBUL

C74739   C65047   Laboratory Test Code   GLUTAM
C74740   C65047   Laboratory Test Code   HAPTOG

C74741   C65047   Laboratory Test Code   HOMOCY

C74743   C65047   Laboratory Test Code   NTELOP

C74744   C65047   Laboratory Test Code   OSTEOC

C74745   C65047   Laboratory Test Code   SHBG


C74746   C65047   Laboratory Test Code   TBG

C74747   C65047   Laboratory Test Code   T3

C74748   C65047   Laboratory Test Code   T3UP

C74749   C65047   Laboratory Test Code   TROPONI

C74750   C65047   Laboratory Test Code   TROPONT

C74751   C65047   Laboratory Test Code   TNF

C74753   C65047   Laboratory Test Code   BUNCREAT
C74754   C65047   Laboratory Test Code   CYHIPPAC

C74755   C65047   Laboratory Test Code   CYSULFA

C74756   C65047   Laboratory Test Code   CYTRPHOS

C74757   C65047   Laboratory Test Code   CYUNCLA

C74758   C65047   Laboratory Test Code   CYAMMBIU

C74759   C65047   Laboratory Test Code   CYAMMOX

C74761   C65047   Laboratory Test Code   ALBCREAT


C74762   C65047   Laboratory Test Code   CSBACT

C74763   C65047   Laboratory Test Code   CASTS

C74764   C65047   Laboratory Test Code   CSCELL


C74765   C65047   Laboratory Test Code   CSGRANC

C74766   C65047   Laboratory Test Code   CSFAT

C74767   C65047   Laboratory Test Code   FGRANCS

C74768   C65047   Laboratory Test Code   CSGRAN

C74769   C65047   Laboratory Test Code   CSGRANF

C74770   C65047   Laboratory Test Code   CSHYAL

C74771   C65047   Laboratory Test Code   CSMIX

C74772   C65047   Laboratory Test Code   CSRBC

C74773   C65047   Laboratory Test Code   EPISQCE

C74774   C65047   Laboratory Test Code   EPISQTCE


C74775   C65047   Laboratory Test Code   EPITUCE

C74776   C65047   Laboratory Test Code   CSUNCLA

C74777   C65047   Laboratory Test Code   CSWAX

C74778   C65047   Laboratory Test Code   CSWBC
C74779   C65047   Laboratory Test Code   CSEPI

C74780   C65047   Laboratory Test Code   ACTH

C74781   C65047   Laboratory Test Code   CORTISOL
C74782   C65047   Laboratory Test Code   ESTRDIOL
C74783   C65047   Laboratory Test Code   FSH

C74784   C65047   Laboratory Test Code   PTHFG

C74785   C65047   Laboratory Test Code   TESTOSFR

C74786   C65047   Laboratory Test Code   T4FR

C74787   C65047   Laboratory Test Code   T3FR

C74788   C65047   Laboratory Test Code   INSULIN
C74789   C65047   Laboratory Test Code   PTHI

C74790   C65047   Laboratory Test Code   LH

C74791   C65047   Laboratory Test Code   PROGEST

C74792   C65047   Laboratory Test Code   SOMATRO

C74793   C65047   Laboratory Test Code   TESTOS

C74794   C65047   Laboratory Test Code   T4

C74796   C65047   Laboratory Test Code   OPIATE

C74910   C65047   Laboratory Test Code   LYMMCELY


C74911   C65047   Laboratory Test Code   PLSMCELY


C74912   C65047   Laboratory Test Code   CYACIDU

C74913   C65047   Laboratory Test Code   ADSDNA

C74916   C65047   Laboratory Test Code   ANA


C79437   C65047   Laboratory Test Code   NCTD5P


C74876   C65047   Laboratory Test Code   SIXMAM

C74838   C65047   Laboratory Test Code   ACH
C74839   C65047   Laboratory Test Code   ADPNCTN

C74894   C65047   Laboratory Test Code   ALBGLOB

C74841   C65047   Laboratory Test Code   ALDSTRN

C79438   C65047   Laboratory Test Code   ALPCREAT


C79433   C65047   Laboratory Test Code   GSTAL

C74799   C65047   Laboratory Test Code   AMMONIA
C74842   C65047   Laboratory Test Code   ANDSTNDL

C74843   C65047   Laboratory Test Code   ANDSTNDN

C74844   C65047   Laboratory Test Code   ANGTNS1

C74845   C65047   Laboratory Test Code   ANGTNS2

C74846   C65047   Laboratory Test Code   ANGTNSGN

C74691   C65047   Laboratory Test Code   ANTIDPRS

C74847   C65047   Laboratory Test Code   ADH

C74886   C65047   Laboratory Test Code   ANP

C74692   C65047   Laboratory Test Code   BNZDZPN

C74800   C65047   Laboratory Test Code   BILEAC

C74634   C65047   Laboratory Test Code   BTECERBC



C74848   C65047   Laboratory Test Code   CLCTONN

C74849   C65047   Laboratory Test Code   CLCTRIOL

C79439   C65047   Laboratory Test Code   CACREAT

C79440   C65047   Laboratory Test Code   CLCREAT

C74850   C65047   Laboratory Test Code   CCK

C74877   C65047   Laboratory Test Code   CODEINE

C79434   C65047   Laboratory Test Code   CRTRONE
C74851   C65047   Laboratory Test Code   CRH


C79466   C65047   Laboratory Test Code   CKBBCK


C79441   C65047   Laboratory Test Code   CKMBCK


C79442   C65047   Laboratory Test Code   CKMMCK


C74852   C65047   Laboratory Test Code   DHEA

C79443   C65047   Laboratory Test Code   DPD

C79444   C65047   Laboratory Test Code   DPDCREAT

C74878   C65047   Laboratory Test Code   DIHYDCDN

C74853   C65047   Laboratory Test Code   DHT

C74854   C65047   Laboratory Test Code   DOPAMINE

C79445   C65047   Laboratory Test Code   EPIN

C74855   C65047   Laboratory Test Code   EPO

C74856   C65047   Laboratory Test Code   ESTRIOL

C74857   C65047   Laboratory Test Code   ESTRONE

C74693   C65047   Laboratory Test Code   ETHANOL

C79446   C65047   Laboratory Test Code   GGTCREAT


C74858   C65047   Laboratory Test Code   GASTRIN

C74859   C65047   Laboratory Test Code   GLUCAGON

C79447   C65047   Laboratory Test Code   GLUCCRT

C79448   C65047   Laboratory Test Code   GLDH

C79435   C65047   Laboratory Test Code   GSTCREAT


C74860   C65047   Laboratory Test Code   GNRH
C74861   C65047   Laboratory Test Code   GRWHIH

C75386   C65047   Laboratory Test Code   GRWH

C74862   C65047   Laboratory Test Code   GRWHRH

C74863   C65047   Laboratory Test Code   HVA

C74879   C65047   Laboratory Test Code   HYDCDN

C74880   C65047   Laboratory Test Code   HYDMRPHN

C74864   C65047   Laboratory Test Code   IGF1

C74865   C65047   Laboratory Test Code   IGF2

C74805   C65047   Laboratory Test Code   INTLK1

C74806   C65047   Laboratory Test Code   INTLK10

C74807   C65047   Laboratory Test Code   INTLK11

C74808   C65047   Laboratory Test Code   INTLK12

C74809   C65047   Laboratory Test Code   INTLK13

C74810   C65047   Laboratory Test Code   INTLK14

C74811   C65047   Laboratory Test Code   INTLK15

C74812   C65047   Laboratory Test Code   INTLK16

C74813   C65047   Laboratory Test Code   INTLK17

C74814   C65047   Laboratory Test Code   INTLK18

C74815   C65047   Laboratory Test Code   INTLK19

C74816   C65047   Laboratory Test Code   INTLK2

C74817   C65047   Laboratory Test Code   INTLK20

C74818   C65047   Laboratory Test Code   INTLK21

C74819   C65047   Laboratory Test Code   INTLK22

C74820   C65047   Laboratory Test Code   INTLK23

C74821   C65047   Laboratory Test Code   INTLK24

C74822   C65047   Laboratory Test Code   INTLK25
C74823   C65047   Laboratory Test Code   INTLK26

C74824   C65047   Laboratory Test Code   INTLK27

C74825   C65047   Laboratory Test Code   INTLK28

C74826   C65047   Laboratory Test Code   INTLK29

C74827   C65047   Laboratory Test Code   INTLK3

C74828   C65047   Laboratory Test Code   INTLK30

C74829   C65047   Laboratory Test Code   INTLK31

C74830   C65047   Laboratory Test Code   INTLK32

C74831   C65047   Laboratory Test Code   INTLK33

C74832   C65047   Laboratory Test Code   INTLK4

C74833   C65047   Laboratory Test Code   INTLK5

C74834   C65047   Laboratory Test Code   INTLK6

C74835   C65047   Laboratory Test Code   INTLK7

C74836   C65047   Laboratory Test Code   INTLK8

C74837   C65047   Laboratory Test Code   INTLK9

C74887   C65047   Laboratory Test Code   LDH1

C74888   C65047   Laboratory Test Code   LDH2

C74889   C65047   Laboratory Test Code   LDH3

C74890   C65047   Laboratory Test Code   LDH4

C74891   C65047   Laboratory Test Code   LDH5

C79449   C65047   Laboratory Test Code   LDHCREAT

C79450   C65047   Laboratory Test Code   LACTICAC


C79467   C65047   Laboratory Test Code   LGLUCLE


C79451   C65047   Laboratory Test Code   LDH1LDH
C79452   C65047   Laboratory Test Code   LDH2LDH


C79453   C65047   Laboratory Test Code   LDH3LDH


C79454   C65047   Laboratory Test Code   LDH4LDH


C79455   C65047   Laboratory Test Code   LDH5LDH


C74866   C65047   Laboratory Test Code   LEPTIN

C79456   C65047   Laboratory Test Code   MGCREAT

C74867   C65047   Laboratory Test Code   MLATONIN

C74881   C65047   Laboratory Test Code   METHDN

C74882   C65047   Laboratory Test Code   METHQLDN

C74883   C65047   Laboratory Test Code   MORPHINE

C79457   C65047   Laboratory Test Code   GSTMU

C79458   C65047   Laboratory Test Code   GSTMUCRT


C79436   C65047   Laboratory Test Code   MGB
C79459   C65047   Laboratory Test Code   NAG

C79460   C65047   Laboratory Test Code   NAGCREAT

C74892   C65047   Laboratory Test Code   NPY

C74868   C65047   Laboratory Test Code   NOREPIN

C74801   C65047   Laboratory Test Code   OSMLTY

C74884   C65047   Laboratory Test Code   OXYCDN

C74869   C65047   Laboratory Test Code   OXYTOCIN

C74694   C65047   Laboratory Test Code   PCP

C74695   C65047   Laboratory Test Code   PHENTHZ

C79461   C65047   Laboratory Test Code   PHOSCRT

C79462   C65047   Laboratory Test Code   KCREAT
C74870   C65047         Laboratory Test Code   PROLCTN

C74885   C65047         Laboratory Test Code   PROPOX

C79463   C65047         Laboratory Test Code   PROTCRT

C74696   C65047         Laboratory Test Code   PSDEPHD

C74629   C65047         Laboratory Test Code   LYMRCT


C74893   C65047         Laboratory Test Code   RENIN
C74871   C65047         Laboratory Test Code   SECRETIN

C74872   C65047         Laboratory Test Code   SRTONIN

C79464   C65047         Laboratory Test Code   NACREAT

C79465   C65047         Laboratory Test Code   SDH

C74873   C65047         Laboratory Test Code   THRMPTN

C74874   C65047         Laboratory Test Code   TRH


C74875   C65047         Laboratory Test Code   VMA

C74895   C65047         Laboratory Test Code   VITA
C74896   C65047         Laboratory Test Code   VITB1
C74897   C65047         Laboratory Test Code   VITB17
C74898   C65047         Laboratory Test Code   VITB2
C74899   C65047         Laboratory Test Code   VITB3
C74900   C65047         Laboratory Test Code   VITB5

C74901   C65047         Laboratory Test Code   VITB6

C74902   C65047         Laboratory Test Code   VITB7

C74903   C65047         Laboratory Test Code   VITC
C74904   C65047         Laboratory Test Code   VITD2

C74905   C65047         Laboratory Test Code   VITD3

C74906   C65047         Laboratory Test Code   VITE
C74907   C65047         Laboratory Test Code   VITK
C74720   C65047         Laboratory Test Code   VOLUME
C67154            Yes   Laboratory Test Name   LBTEST


C35266   C67154         Laboratory Test Name   Anisocytosis
C35267   C67154   Laboratory Test Name   Poikilocytes

C38037   C67154   Laboratory Test Name   Bilirubin

C38462   C67154   Laboratory Test Name   Activated Partial Thromboplastin
                                         Time


C41376   C67154   Laboratory Test Name   Glucose
C45997   C67154   Laboratory Test Name   pH

C51946   C67154   Laboratory Test Name   Erythrocytes

C51947   C67154   Laboratory Test Name   Reticulocytes

C51948   C67154   Laboratory Test Name   Leukocytes

C51949   C67154   Laboratory Test Name   Lymphocytes

C51951   C67154   Laboratory Test Name   Platelet
C61019   C67154   Laboratory Test Name   Blood Urea Nitrogen

C61032   C67154   Laboratory Test Name   Cholesterol

C61041   C67154   Laboratory Test Name   HDL Cholesterol

C61042   C67154   Laboratory Test Name   LDL Cholesterol

C62656   C67154   Laboratory Test Name   Prothrombin Time


C63321   C67154   Laboratory Test Name   Neutrophils

C64431   C67154   Laboratory Test Name   Albumin

C64432   C67154   Laboratory Test Name   Alkaline Phosphatase

C64433   C67154   Laboratory Test Name   Alanine Aminotransferase

C64434   C67154   Laboratory Test Name   Amylase

C64467   C67154   Laboratory Test Name   Aspartate Aminotransferase

C64469   C67154   Laboratory Test Name   Bacteria
C64470   C67154   Laboratory Test Name   Basophils
C64471   C67154   Laboratory Test Name   Basophils/Leukocytes

C64481   C67154   Laboratory Test Name   Direct Bilirubin

C64483   C67154   Laboratory Test Name   Indirect Bilirubin
C64487   C67154   Laboratory Test Name   Blasts/Leukocytes

C64488   C67154   Laboratory Test Name   Calcium
C64489   C67154   Laboratory Test Name   Creatine Kinase

C64490   C67154   Laboratory Test Name   Creatine Kinase BB

C64491   C67154   Laboratory Test Name   Creatine Kinase MB

C64494   C67154   Laboratory Test Name   Creatine Kinase MM

C64495   C67154   Laboratory Test Name   Chloride
C64545   C67154   Laboratory Test Name   Carbon Dioxide

C64546   C67154   Laboratory Test Name   Color
C64547   C67154   Laboratory Test Name   Creatinine
C64548   C67154   Laboratory Test Name   C Reactive Protein

C64549   C67154   Laboratory Test Name   Elliptocytes

C64550   C67154   Laboratory Test Name   Eosinophils

C64604   C67154   Laboratory Test Name   Eosinophils/Leukocytes

C64605   C67154   Laboratory Test Name   Epithelial Cells

C64606   C67154   Laboratory Test Name   Fibrinogen
C64796   C67154   Laboratory Test Name   Hematocrit

C64797   C67154   Laboratory Test Name   Ery. Mean Corpuscular Hemoglobin

C64798   C67154   Laboratory Test Name   Ery. Mean Corpuscular HB
                                         Concentration

C64799   C67154   Laboratory Test Name   Ery. Mean Corpuscular Volume

C64800   C67154   Laboratory Test Name   Erythrocytes Distribution Width


C64801   C67154   Laboratory Test Name   Dacryocytes
C64802   C67154   Laboratory Test Name   Hypochromia


C64803   C67154   Laboratory Test Name   Polychromasia

C64805   C67154   Laboratory Test Name   Prothrombin Intl. Normalized Ratio
C64806   C67154   Laboratory Test Name   VLDL Cholesterol

C64807   C67154   Laboratory Test Name   Triacylglycerol Lipase

C64809   C67154   Laboratory Test Name   Sodium
C64810   C67154   Laboratory Test Name   Nitrite
C64812   C67154   Laboratory Test Name   Triglycerides

C64813   C67154   Laboratory Test Name   Thyrotropin

C64814   C67154   Laboratory Test Name   Urate
C64815   C67154   Laboratory Test Name   Urea
C64816   C67154   Laboratory Test Name   Urobilinogen

C64817   C67154   Laboratory Test Name   Vitamin B12
C64818   C67154   Laboratory Test Name   Lymphocytes Atypical

C64819   C67154   Laboratory Test Name   Lymphocytes Atypical/Leukocytes

C64820   C67154   Laboratory Test Name   Lymphocytes/Leukocytes

C64821   C67154   Laboratory Test Name   Macrocytes

C64822   C67154   Laboratory Test Name   Microcytes

C64823   C67154   Laboratory Test Name   Monocytes

C64824   C67154   Laboratory Test Name   Monocytes/Leukocytes

C64825   C67154   Laboratory Test Name   Myeloblasts/Leukocytes

C64826   C67154   Laboratory Test Name   Myelocytes/Leukocytes

C64827   C67154   Laboratory Test Name   Neutrophils/Leukocytes


C64828   C67154   Laboratory Test Name   Reticulocytes/Erythrocytes

C64829   C67154   Laboratory Test Name   Prolymphocytes/Leukocytes

C64830   C67154   Laboratory Test Name   Neutrophils Band Form

C64831   C67154   Laboratory Test Name   Neutrophils Band Form/Leukocytes

C64832   C67154   Laboratory Test Name   Specific Gravity
C64840   C67154   Laboratory Test Name   Magnesium

C64847   C67154   Laboratory Test Name   Gamma Glutamyl Transferase

C64848   C67154   Laboratory Test Name   Hemoglobin
C64849   C67154   Laboratory Test Name   Hemoglobin A1C

C64850   C67154   Laboratory Test Name   Hepatitis B Virus Surface Antigen

C64851   C67154   Laboratory Test Name   Choriogonadotropin Beta

C64853   C67154   Laboratory Test Name   Potassium

C64854   C67154   Laboratory Test Name   Ketones
C64855   C67154   Laboratory Test Name   Lactate Dehydrogenase

C64856   C67154   Laboratory Test Name   Leukocyte Esterase

C64857   C67154   Laboratory Test Name   Phosphate

C64858   C67154   Laboratory Test Name   Protein


C17634   C67154   Laboratory Test Name   Prostate Specific Antigen

C25747   C67154   Laboratory Test Name   Creatinine Clearance


C74604   C67154   Laboratory Test Name   Hairy Cells


C74605   C67154   Laboratory Test Name   Blasts

C74606   C67154   Laboratory Test Name   CD19

C74607   C67154   Laboratory Test Name   CD3

C74608   C67154   Laboratory Test Name   CD4

C74609   C67154   Laboratory Test Name   CD8

C74610   C67154   Laboratory Test Name   Dohle Bodies


C74611   C67154   Laboratory Test Name   Erythrocyte Sedimentation Rate


C74612   C67154   Laboratory Test Name   Hypersegmented Cells

C74613   C67154   Laboratory Test Name   Lymphoma Cells

C74614   C67154   Laboratory Test Name   May-Hegglin Anomaly

C74615   C67154   Laboratory Test Name   Metamyelocytes
C74616   C67154   Laboratory Test Name   Pappenheimer Bodies


C74617   C67154   Laboratory Test Name   Pelger Huet Anomaly

C74618   C67154   Laboratory Test Name   Plasmacytoid Lymphocytes



C74619   C67154   Laboratory Test Name   Precursor Plasma Cells


C74620   C67154   Laboratory Test Name   Prolymphocytes

C74621   C67154   Laboratory Test Name   Promonocytes

C74622   C67154   Laboratory Test Name   Promyelocytes

C74624   C67154   Laboratory Test Name   Rouleaux Formation

C74625   C67154   Laboratory Test Name   Sezary Cells

C74626   C67154   Laboratory Test Name   Sickle Cells

C74627   C67154   Laboratory Test Name   Smudge Cells

C74628   C67154   Laboratory Test Name   Vacuolated Neutrophils

C74630   C67154   Laboratory Test Name   Leukemic Blasts



C74631   C67154   Laboratory Test Name   Monoblasts

C74632   C67154   Laboratory Test Name   Myeloblasts

C74633   C67154   Laboratory Test Name   Acanthocytes/Erythrocytes

C74634   C67154   Laboratory Test Name   Bite Cells/Erythrocytes



C74635   C67154   Laboratory Test Name   CD19/Lymphocytes

C74636   C67154   Laboratory Test Name   CD3/Lymphocytes

C74637   C67154   Laboratory Test Name   CD4/CD8

C74638   C67154   Laboratory Test Name   CD4/Lymphocytes

C74639   C67154   Laboratory Test Name   CD8/Lymphocytes
C74640   C67154   Laboratory Test Name   Hairy Cells/Lymphocytes


C74641   C67154   Laboratory Test Name   Leukemic Blasts/Lymphocytes


C74643   C67154   Laboratory Test Name   Malignant Cells, NOS/Blood Cells


C74645   C67154   Laboratory Test Name   Metamyelocytes/Leukocytes



C74646   C67154   Laboratory Test Name   Monoblasts/Leukocytes

C74647   C67154   Laboratory Test Name   Nucleated Erythrocytes/Erythrocytes


C74648   C67154   Laboratory Test Name   Plasmacytoid
                                         Lymphocytes/Lymphocytes



C74649   C67154   Laboratory Test Name   Poikilocytes/Erythrocytes


C74650   C67154   Laboratory Test Name   Precursor Plasma
                                         Cells/Lymphocytes


C74651   C67154   Laboratory Test Name   Prolymphocytes/Lymphocytes


C74652   C67154   Laboratory Test Name   Promonocytes/Leukocytes

C74653   C67154   Laboratory Test Name   Promyelocytes/Leukocytes


C74654   C67154   Laboratory Test Name   Reactive Lymphocytes/Lymphocytes




C74655   C67154   Laboratory Test Name   Sezary Cells/Lymphocytes


C74656   C67154   Laboratory Test Name   Sickle Cells/Erythrocytes
C74657   C67154   Laboratory Test Name   Auer Rods



C74658   C67154   Laboratory Test Name   Helmet Cells


C74659   C67154   Laboratory Test Name   Large Unstained Cells



C74660   C67154   Laboratory Test Name   Malignant Cells, NOS

C74661   C67154   Laboratory Test Name   Mature Plasma Cells

C74662   C67154   Laboratory Test Name   Myelocytes

C74663   C67154   Laboratory Test Name   Spermatozoa

C74664   C67154   Laboratory Test Name   Yeast Cells

C74665   C67154   Laboratory Test Name   Amorphous Crystals


C74666   C67154   Laboratory Test Name   Amorphous Sediment

C74667   C67154   Laboratory Test Name   Bicarbonate

C74668   C67154   Laboratory Test Name   Bilirubin Crystals

C74669   C67154   Laboratory Test Name   Calcium Carbonate Crystals

C74670   C67154   Laboratory Test Name   Calcium Oxalate Crystals

C74671   C67154   Laboratory Test Name   Calcium Phosphate Crystals

C74672   C67154   Laboratory Test Name   Cholesterol Crystals

C74673   C67154   Laboratory Test Name   Crystals

C74674   C67154   Laboratory Test Name   Cystine Crystals

C74676   C67154   Laboratory Test Name   Folic Acid
C74677   C67154   Laboratory Test Name   Carnitine, Free

C74678   C67154   Laboratory Test Name   Fructosamine

C74679   C67154   Laboratory Test Name   Iron
C74680   C67154   Laboratory Test Name   Leucine Crystals

C74681   C67154   Laboratory Test Name   Monosodium Urate Crystals
C74682   C67154   Laboratory Test Name   Carnitine

C74683   C67154   Laboratory Test Name   Tyrosine Crystals

C74684   C67154   Laboratory Test Name   Uric Acid Crystals

C74685   C67154   Laboratory Test Name   Anion Gap


C74686   C67154   Laboratory Test Name   Occult Blood

C74687   C67154   Laboratory Test Name   Amphetamine

C74688   C67154   Laboratory Test Name   Barbiturate

C74689   C67154   Laboratory Test Name   Cannabinoids

C74690   C67154   Laboratory Test Name   Cocaine

C74698   C67154   Laboratory Test Name   Round Epithelial Cells

C74699   C67154   Laboratory Test Name   Acanthocytes

C74700   C67154   Laboratory Test Name   Bite Cells


C74701   C67154   Laboratory Test Name   Burr Cells



C74702   C67154   Laboratory Test Name   Cabot Rings


C74703   C67154   Laboratory Test Name   Crenated Cells



C74704   C67154   Laboratory Test Name   Howell-Jolly Bodies



C74705   C67154   Laboratory Test Name   Nucleated Erythrocytes


C74706   C67154   Laboratory Test Name   Schistocytes

C74707   C67154   Laboratory Test Name   Spherocytes

C74708   C67154   Laboratory Test Name   Stomatocytes
C74709   C67154   Laboratory Test Name   Heinz Bodies


C74710   C67154   Laboratory Test Name   Hepatitis A Virus Surface Antibody

C74711   C67154   Laboratory Test Name   Hepatitis B Virus Surface Antibody

C74712   C67154   Laboratory Test Name   Hepatitis C Virus Surface Antibody

C74713   C67154   Laboratory Test Name   HIV-1 Antibody

C74714   C67154   Laboratory Test Name   HIV-1/2 Antibody

C74715   C67154   Laboratory Test Name   HIV-2 Antibody

C74716   C67154   Laboratory Test Name   Rapid Plasma Reagin


C74717   C67154   Laboratory Test Name   Rheumatoid Factor

C74718   C67154   Laboratory Test Name   Total Iron Binding Capacity

C74719   C67154   Laboratory Test Name   Unsaturated Iron Binding Capacity

C74721   C67154   Laboratory Test Name   Mucous Threads

C74723   C67154   Laboratory Test Name   Turbidity
C74724   C67154   Laboratory Test Name   HAV PCR Viral Load

C74725   C67154   Laboratory Test Name   HBV PCR Viral Load

C74726   C67154   Laboratory Test Name   HCV PCR Viral Load

C74727   C67154   Laboratory Test Name   HIV PCR Viral Load

C74728   C67154   Laboratory Test Name   Giant Platelets

C74729   C67154   Laboratory Test Name   Large Platelets

C74730   C67154   Laboratory Test Name   Mean Platelet Volume

C74731   C67154   Laboratory Test Name   Aldolase

C74732   C67154   Laboratory Test Name   Alpha Fetoprotein

C74733   C67154   Laboratory Test Name   Apolipoprotein A1

C74734   C67154   Laboratory Test Name   Apolipoprotein B

C74735   C67154   Laboratory Test Name   Brain Natriuretic Peptide
C74736   C67154   Laboratory Test Name   C-peptide

C74737   C67154   Laboratory Test Name   Ferritin
C74738   C67154   Laboratory Test Name   Globulin

C74739   C67154   Laboratory Test Name   Glutamate
C74740   C67154   Laboratory Test Name   Haptoglobin

C74741   C67154   Laboratory Test Name   Homocysteine

C74743   C67154   Laboratory Test Name   N-telopeptide

C74744   C67154   Laboratory Test Name   Osteocalcin

C74745   C67154   Laboratory Test Name   Sex Hormone Binding Globulin


C74746   C67154   Laboratory Test Name   Thyroxine Binding Globulin

C74747   C67154   Laboratory Test Name   Triiodothyronine

C74748   C67154   Laboratory Test Name   Triiodothyronine Uptake

C74749   C67154   Laboratory Test Name   Troponin I

C74750   C67154   Laboratory Test Name   Troponin T

C74751   C67154   Laboratory Test Name   Tumor Necrosis Factor

C74753   C67154   Laboratory Test Name   BUN/Creatinine Ratio


C74754   C67154   Laboratory Test Name   Hippuric Acid Crystals

C74755   C67154   Laboratory Test Name   Sulfa Crystals

C74756   C67154   Laboratory Test Name   Triple Phosphate Crystals

C74757   C67154   Laboratory Test Name   Unclassified Crystals

C74758   C67154   Laboratory Test Name   Ammonium Biurate Crystals

C74759   C67154   Laboratory Test Name   Ammonium Oxalate Crystals

C74761   C67154   Laboratory Test Name   Albumin/Creatinine Ratio


C74762   C67154   Laboratory Test Name   Bacterial Casts

C74763   C67154   Laboratory Test Name   Casts
C74764   C67154   Laboratory Test Name   Cellular Casts


C74765   C67154   Laboratory Test Name   Granular Coarse Casts

C74766   C67154   Laboratory Test Name   Fatty Casts

C74767   C67154   Laboratory Test Name   Fine Granular Casts

C74768   C67154   Laboratory Test Name   Granular Casts

C74769   C67154   Laboratory Test Name   Granular Fine Casts

C74770   C67154   Laboratory Test Name   Hyaline Casts

C74771   C67154   Laboratory Test Name   Mixed Casts

C74772   C67154   Laboratory Test Name   RBC Casts

C74773   C67154   Laboratory Test Name   Squamous Epithelial Cells

C74774   C67154   Laboratory Test Name   Squamous Transitional Epithelial
                                         Cells

C74775   C67154   Laboratory Test Name   Tubular Epithelial Cells

C74776   C67154   Laboratory Test Name   Unclassified Casts

C74777   C67154   Laboratory Test Name   Waxy Casts

C74778   C67154   Laboratory Test Name   WBC Casts

C74779   C67154   Laboratory Test Name   Epithelial Casts

C74780   C67154   Laboratory Test Name   Adrenocorticotropic Hormone

C74781   C67154   Laboratory Test Name   Cortisol
C74782   C67154   Laboratory Test Name   Estradiol
C74783   C67154   Laboratory Test Name   Follicle Stimulating Hormone

C74784   C67154   Laboratory Test Name   Parathyroid Hormone, Fragmented

C74785   C67154   Laboratory Test Name   Testosterone, Free

C74786   C67154   Laboratory Test Name   Thyroxin, Free

C74787   C67154   Laboratory Test Name   Triiodothyronine, Free

C74788   C67154   Laboratory Test Name   Insulin
C74789   C67154   Laboratory Test Name   Parathyroid Hormone, Intact
C74790   C67154   Laboratory Test Name   Luteinizing Hormone

C74791   C67154   Laboratory Test Name   Progesterone

C74792   C67154   Laboratory Test Name   Somatotropin

C74793   C67154   Laboratory Test Name   Testosterone

C74794   C67154   Laboratory Test Name   Thyroxine

C74796   C67154   Laboratory Test Name   Opiate

C74910   C67154   Laboratory Test Name   Lymphoma Cells/Lymphocytes


C74911   C67154   Laboratory Test Name   Mature Plasma Cells/Lymphocytes


C74912   C67154   Laboratory Test Name   Acid Urate Crystals

C74913   C67154   Laboratory Test Name   Anti-Double Stranded DNA

C74916   C67154   Laboratory Test Name   Antinuclear Antibodies


C79437   C67154   Laboratory Test Name   5 Prime Nucleotidase


C74876   C67154   Laboratory Test Name   6-Monoacetylmorphine

C74838   C67154   Laboratory Test Name   Acetylcholine

C74839   C67154   Laboratory Test Name   Adiponectin

C74894   C67154   Laboratory Test Name   Albumin/Globulin Ratio

C74841   C67154   Laboratory Test Name   Aldosterone

C79438   C67154   Laboratory Test Name   Alkaline Phosphatase/Creatinine


C79433   C67154   Laboratory Test Name   Alpha Glutathione-S-Transferase

C74799   C67154   Laboratory Test Name   Ammonia
C74842   C67154   Laboratory Test Name   Androstenediol

C74843   C67154   Laboratory Test Name   Androstenedione

C74844   C67154   Laboratory Test Name   Angiotensin I

C74845   C67154   Laboratory Test Name   Angiotensin II
C74846   C67154   Laboratory Test Name   Angiotensinogen

C74691   C67154   Laboratory Test Name   Antidepressants

C74847   C67154   Laboratory Test Name   Antidiuretic Hormone

C74886   C67154   Laboratory Test Name   Atrial Natriuretic Peptide

C74692   C67154   Laboratory Test Name   Benzodiazepine

C74800   C67154   Laboratory Test Name   Bile Acid

C74634   C67154   Laboratory Test Name   Bite Cells/Erythrocytes



C74848   C67154   Laboratory Test Name   Calcitonin

C74849   C67154   Laboratory Test Name   Calcitriol

C79439   C67154   Laboratory Test Name   Calcium/Creatinine

C79440   C67154   Laboratory Test Name   Chloride/Creatinine

C74850   C67154   Laboratory Test Name   Cholecystokinin

C74877   C67154   Laboratory Test Name   Codeine

C79434   C67154   Laboratory Test Name   Corticosterone

C74851   C67154   Laboratory Test Name   Corticotropin Releasing Hormone


C79466   C67154   Laboratory Test Name   Creatine Kinase BB/Total Creatine
                                         Kinase

C79441   C67154   Laboratory Test Name   Creatine Kinase MB/Total Creatine
                                         Kinase

C79442   C67154   Laboratory Test Name   Creatine Kinase MM/Total Creatine
                                         Kinase

C74852   C67154   Laboratory Test Name   Dehydroepiandrosterone

C79443   C67154   Laboratory Test Name   Deoxypyridinoline

C79444   C67154   Laboratory Test Name   Deoxypyridinoline/Creatinine

C74878   C67154   Laboratory Test Name   Dihydrocodeine

C74853   C67154   Laboratory Test Name   Dihydrotestosterone
C74854   C67154   Laboratory Test Name   Dopamine

C79445   C67154   Laboratory Test Name   Epinephrine

C74855   C67154   Laboratory Test Name   Erythropoietin

C74856   C67154   Laboratory Test Name   Estriol

C74857   C67154   Laboratory Test Name   Estrone

C74693   C67154   Laboratory Test Name   Ethanol

C79446   C67154   Laboratory Test Name   Gamma Glutamyl
                                         Transferase/Creatinine

C74858   C67154   Laboratory Test Name   Gastrin

C74859   C67154   Laboratory Test Name   Glucagon

C79447   C67154   Laboratory Test Name   Glucose/Creatinine

C79448   C67154   Laboratory Test Name   Glutamate Dehydrogenase

C79435   C67154   Laboratory Test Name   Glutathione-S-
                                         Transferase/Creatinine

C74860   C67154   Laboratory Test Name   Gonadotropin Releasing Hormone



C74861   C67154   Laboratory Test Name   Growth Hormone Inhibiting Hormone

C75386   C67154   Laboratory Test Name   Growth Hormone

C74862   C67154   Laboratory Test Name   Growth Hormone Releasing
                                         Hormone
C74863   C67154   Laboratory Test Name   Homovanillic Acid

C74879   C67154   Laboratory Test Name   Hydrocodone

C74880   C67154   Laboratory Test Name   Hydromorphone

C74864   C67154   Laboratory Test Name   Insulin-like Growth Factor-1

C74865   C67154   Laboratory Test Name   Insulin-like Growth Factor-2

C74805   C67154   Laboratory Test Name   Interleukin 1

C74806   C67154   Laboratory Test Name   Interleukin 10

C74807   C67154   Laboratory Test Name   Interleukin 11
C74808   C67154   Laboratory Test Name   Interleukin 12

C74809   C67154   Laboratory Test Name   Interleukin 13

C74810   C67154   Laboratory Test Name   Interleukin 14

C74811   C67154   Laboratory Test Name   Interleukin 15

C74812   C67154   Laboratory Test Name   Interleukin 16

C74813   C67154   Laboratory Test Name   Interleukin 17

C74814   C67154   Laboratory Test Name   Interleukin 18

C74815   C67154   Laboratory Test Name   Interleukin 19

C74816   C67154   Laboratory Test Name   Interleukin 2

C74817   C67154   Laboratory Test Name   Interleukin 20

C74818   C67154   Laboratory Test Name   Interleukin 21

C74819   C67154   Laboratory Test Name   Interleukin 22

C74820   C67154   Laboratory Test Name   Interleukin 23

C74821   C67154   Laboratory Test Name   Interleukin 24

C74822   C67154   Laboratory Test Name   Interleukin 25

C74823   C67154   Laboratory Test Name   Interleukin 26

C74824   C67154   Laboratory Test Name   Interleukin 27

C74825   C67154   Laboratory Test Name   Interleukin 28

C74826   C67154   Laboratory Test Name   Interleukin 29

C74827   C67154   Laboratory Test Name   Interleukin 3

C74828   C67154   Laboratory Test Name   Interleukin 30

C74829   C67154   Laboratory Test Name   Interleukin 31

C74830   C67154   Laboratory Test Name   Interleukin 32

C74831   C67154   Laboratory Test Name   Interleukin 33

C74832   C67154   Laboratory Test Name   Interleukin 4

C74833   C67154   Laboratory Test Name   Interleukin 5
C74834   C67154   Laboratory Test Name   Interleukin 6

C74835   C67154   Laboratory Test Name   Interleukin 7

C74836   C67154   Laboratory Test Name   Interleukin 8

C74837   C67154   Laboratory Test Name   Interleukin 9

C74887   C67154   Laboratory Test Name   LDH Isoenzyme 1

C74888   C67154   Laboratory Test Name   LDH Isoenzyme 2

C74889   C67154   Laboratory Test Name   LDH Isoenzyme 3

C74890   C67154   Laboratory Test Name   LDH Isoenzyme 4

C74891   C67154   Laboratory Test Name   LDH Isoenzyme 5

C79449   C67154   Laboratory Test Name   Lactate Dehydrogenase/Creatinine

C79450   C67154   Laboratory Test Name   Lactic Acid


C79467   C67154   Laboratory Test Name   Large Unstained Cells/Leukocytes


C79451   C67154   Laboratory Test Name   LDH Isoenzyme 1/LDH


C79452   C67154   Laboratory Test Name   LDH Isoenzyme 2/LDH


C79453   C67154   Laboratory Test Name   LDH Isoenzyme 3/LDH


C79454   C67154   Laboratory Test Name   LDH Isoenzyme 4/LDH


C79455   C67154   Laboratory Test Name   LDH Isoenzyme 5/LDH


C74866   C67154   Laboratory Test Name   Leptin

C79456   C67154   Laboratory Test Name   Magnesium/Creatinine

C74867   C67154   Laboratory Test Name   Melatonin

C74881   C67154   Laboratory Test Name   Methadone

C74882   C67154   Laboratory Test Name   Methaqualone
C74883   C67154   Laboratory Test Name   Morphine

C79457   C67154   Laboratory Test Name   Mu Glutathione-S-Transferase

C79458   C67154   Laboratory Test Name   Mu Glutathione-S-
                                         Transferase/Creatinine

C79436   C67154   Laboratory Test Name   Myoglobin
C79459   C67154   Laboratory Test Name   N-Acetyl Glucosamide

C79460   C67154   Laboratory Test Name   N-Acetyl Glucosamide/Creatinine

C74892   C67154   Laboratory Test Name   Neuropeptide Y

C74868   C67154   Laboratory Test Name   Norepinephrine

C74801   C67154   Laboratory Test Name   Osmolality

C74884   C67154   Laboratory Test Name   Oxycodone

C74869   C67154   Laboratory Test Name   Oxytocin

C74694   C67154   Laboratory Test Name   Phencyclidine

C74695   C67154   Laboratory Test Name   Phenothiazine

C79461   C67154   Laboratory Test Name   Phosphate/Creatinine

C79462   C67154   Laboratory Test Name   Potassium/Creatinine

C74870   C67154   Laboratory Test Name   Prolactin

C74885   C67154   Laboratory Test Name   Propoxyphene

C79463   C67154   Laboratory Test Name   Protein/Creatinine

C74696   C67154   Laboratory Test Name   Pseudoephedrine

C74629   C67154   Laboratory Test Name   Reactive Lymphocytes


C74893   C67154   Laboratory Test Name   Renin
C74871   C67154   Laboratory Test Name   Secretin

C74872   C67154   Laboratory Test Name   Serotonin

C79464   C67154   Laboratory Test Name   Sodium/Creatinine

C79465   C67154   Laboratory Test Name   Sorbitol Dehydrogenase

C74873   C67154   Laboratory Test Name   Thrombopoietin
C74874   C67154         Laboratory Test Name   Thyrotropin Releasing Hormone


C74875   C67154         Laboratory Test Name   Vanillyl Mandelic Acid

C74895   C67154         Laboratory Test Name   Vitamin A
C74896   C67154         Laboratory Test Name   Thiamine
C74897   C67154         Laboratory Test Name   Vitamin B17
C74898   C67154         Laboratory Test Name   Riboflavin
C74899   C67154         Laboratory Test Name   Niacin
C74900   C67154         Laboratory Test Name   Vitamin B5

C74901   C67154         Laboratory Test Name   Vitamin B6

C74902   C67154         Laboratory Test Name   Vitamin B7

C74903   C67154         Laboratory Test Name   Vitamin C
C74904   C67154         Laboratory Test Name   Vitamin D2

C74905   C67154         Laboratory Test Name   Vitamin D3

C74906   C67154         Laboratory Test Name   Vitamin E
C74907   C67154         Laboratory Test Name   Vitamin K
C74720   C67154         Laboratory Test Name   Volume
C71113            Yes   Frequency              FREQ

C17649   C71113         Frequency              OTHER

C17998   C71113         Frequency              UNKNOWN
C53279   C71113         Frequency              CONTINUOUS


C64496   C71113         Frequency              BID
C64497   C71113         Frequency              BIS
C64498   C71113         Frequency              QM
C64499   C71113         Frequency              PRN
C64500   C71113         Frequency              Q10H
C64501   C71113         Frequency              Q11H
C64502   C71113         Frequency              Q12H
C64503   C71113         Frequency              Q13H
C64504   C71113         Frequency              Q14H
C64505   C71113         Frequency              Q15H
C64506   C71113         Frequency              Q16H
C64507   C71113         Frequency              Q17H
C64508   C71113         Frequency              Q18H
C64509   C71113         Frequency              Q19H
C64510   C71113         Frequency              QH
C64511   C71113         Frequency              Q20H
C64512   C71113         Frequency              Q21H
C64513   C71113         Frequency              Q22H
C64514   C71113         Frequency              Q23H
C64515   C71113         Frequency   Q24H
C64516   C71113         Frequency   Q2H
C64517   C71113         Frequency   Q3H
C64518   C71113         Frequency   Q4H
C64519   C71113         Frequency   Q5H
C64520   C71113         Frequency   Q6H
C64521   C71113         Frequency   Q7H
C64523   C71113         Frequency   Q8H
C64524   C71113         Frequency   Q9H
C64525   C71113         Frequency   QOD
C64527   C71113         Frequency   TID
C64528   C71113         Frequency   TIS
C64529   C71113         Frequency   Q4S
C64530   C71113         Frequency   QID
C64531   C71113         Frequency   QIS
C64533   C71113         Frequency   Q3D
C64534   C71113         Frequency   Q4D
C64535   C71113         Frequency   Q3S
C64536   C71113         Frequency   Q2M
C64537   C71113         Frequency   Q3M
C64538   C71113         Frequency   Q4M
C64576   C71113         Frequency   ONCE
C67069   C71113         Frequency   QS
C71124   C71113         Frequency   Q5D
C71127   C71113         Frequency   Q2S
C71129   C71113         Frequency   BIM
C71325   C71113         Frequency   INTERMITTENT
C71148            Yes   Position    POSITION


C62122   C71148         Position    SITTING

C62165   C71148         Position    PRONE

C62166   C71148         Position    STANDING

C62167   C71148         Position    SUPINE

C62168   C71148         Position    TRENDELENBURG


C62169   C71148         Position    REVERSE TRENDELENBURG

C62171   C71148         Position    RIGHT LATERAL DECUBITUS

C62172   C71148         Position    LEFT LATERAL DECUBITUS
C62173   C71148         Position    FOWLERS
C62174   C71148         Position     SEMI-FOWLERS


C71150            Yes   ECG Result   EGSTRESC

C26889   C71150         ECG Result   SINUS TACHYCARDIA

C26923   C71150         ECG Result   SINUS BRADYCARDIA

C34786   C71150         ECG Result   VENTRICULAR ARRHYTHMIA
                                     ASSOCIATED WITH LONG QT
                                     SYNDROME




C34940   C71150         ECG Result   PRE-EXCITATION




C35058   C71150         ECG Result   AV NODE RE-ENTRY




C35059   C71150         ECG Result   JUNCTIONAL TACHYCARDIA




C35061   C71150         ECG Result   SUPRAVENTRICULAR
                                     TACHYCARDIA
C35132   C71150         ECG Result   WOLFF-PARKINSON-WHITE
                                     SYNDROME
C35481   C71150   ECG Result   ATRIAL TACHYCARDIA




C50466   C71150   ECG Result   ATRIAL FIBRILLATION




C50501   C71150   ECG Result   3RD DEGREE AV BLOCK

C50779   C71150   ECG Result   TORSADES DE POINTES




C50799   C71150   ECG Result   VENTRICULAR FIBRILLATION




C50800   C71150   ECG Result   VENTRICULAR FLUTTER




C50802   C71150   ECG Result   VENTRICULAR TACHYCARDIA

C51224   C71150   ECG Result   ATRIAL FLUTTER


C61395   C71150   ECG Result   R ON T PHENOMENON
C62015   C71150   ECG Result   1ST DEGREE AV BLOCK



C62016   C71150   ECG Result   2ND DEGREE AV BLOCK


C62234   C71150   ECG Result   VENTRICULAR TACHYCARDIA,
                               MONOMORPHIC


C62236   C71150   ECG Result   VENTRICULAR TACHYCARDIA,
                               POLYMORPHIC


C62239   C71150   ECG Result   SINUS ARRHYTHMIA




C62240   C71150   ECG Result   WANDERING ATRIAL
                               PACEMAKER



C62242   C71150   ECG Result   SINUS ARREST/PAUSE


C62243   C71150   ECG Result   SINUS NODE DYSFUNCTION
                               (BRADYCARDIA)




C62244   C71150   ECG Result   SICK SINUS SYNDROME
C62245   C71150   ECG Result   ECTOPIC ATRIAL RHYTHM




C62246   C71150   ECG Result   SHORT PR INTERVAL
C62247   C71150   ECG Result   PR PROLONGATION
C62248   C71150   ECG Result   ISORHYTHMIC DISSOCIATION


C62250   C71150   ECG Result   PAROXYSMAL AV BLOCK

C62253   C71150   ECG Result   INAPPROPRIATE SINUS
                               TACHYCARDIA



C62256   C71150   ECG Result   PREMATURE VENTRICULAR
                               COMPLEX
C62257   C71150   ECG Result   PREMATURE ATRIAL
                               COMPLEXES
C62258   C71150   ECG Result   DELTA WAVE



C62259   C71150   ECG Result   VENTRICULAR COUPLET



C62261   C71150   ECG Result   AV RE-ENTRANT TACHYCARDIA




C62266   C71150   ECG Result   ACCELERATED
                               IDIOVENTRICULAR RHYTHM
C62267   C71150   ECG Result   LEFT ANTERIOR FASCICULAR
                               BLOCK




C62268   C71150   ECG Result   LEFT POSTERIOR FASCICULAR
                               BLOCK




C62269   C71150   ECG Result   LEFT BUNDLE BRANCH BLOCK




C62270   C71150   ECG Result   RIGHT BUNDLE BRANCH BLOCK




C62271   C71150   ECG Result   INTRAVENTRICULAR
                               CONDUCTION DELAY,
                               NONSPECIFIC
C71026   C71150   ECG Result   ST SEGMENT ABNORMALITY


C71027   C71150   ECG Result   ST DEPRESSION


C71028   C71150   ECG Result   ST ELEVATION

C71029   C71150   ECG Result   ST ELEVATION PERICARDITIS

C71030   C71150   ECG Result   J POINT ELEVATION


C71031   C71150   ECG Result   NON-SPECIFIC ST-T CHANGES


C71032   C71150   ECG Result   NOTCHED T-WAVES
C71033   C71150   ECG Result   POOR R WAVE PROGRESSION

C71034   C71150   ECG Result   PROLONGED QT

C71035   C71150   ECG Result   ELECTRICAL ALTERNANS


C71038   C71150   ECG Result   SINOATRIAL EXIT BLOCK


C71039   C71150   ECG Result   ATRIAL ENLARGEMENT

C71040   C71150   ECG Result   LEFT ATRIAL ENLARGEMENT




C71041   C71150   ECG Result   RIGHT ATRIAL ABNORMALITY




C71042   C71150   ECG Result   ECTOPIC VENTRICULAR RHYTHM




C71043   C71150   ECG Result   ECTOPIC SUPRAVENTRICULAR
                               RHYTHM
C71044   C71150   ECG Result   2:1 AV BLOCK



C71045   C71150   ECG Result   ATRIOVENTRICULAR
                               DISSOCIATION

C71046   C71150   ECG Result   BIFASCICULAR BLOCK




C71047   C71150   ECG Result   INCOMPLETE LEFT BUNDLE
                               BRANCH BLOCK

C71048   C71150   ECG Result   INCOMPLETE RIGHT BUNDLE
                               BRANCH BLOCK




C71049   C71150   ECG Result   INCOMPLETE BUNDLE BRANCH
                               BLOCK

C71050   C71150   ECG Result   MULTIFOCAL ATRIAL
                               TACHYCARDIA



C71051   C71150   ECG Result   JUNCTIONAL RHYTHM



C71052   C71150   ECG Result   SUSTAINED VENTRICULAR
                               TACHYCARDIA
C71053   C71150   ECG Result   NON-SUSTAINED VENTRICULAR
                               TACHYCARDIA
C71054   C71150   ECG Result   BIGEMINY
C71055   C71150   ECG Result   TRIGEMINY



C71056   C71150   ECG Result   VENTRICULAR TACHYCARDIA
                               STORM

C71057   C71150   ECG Result   ADENOSINE-SENSITIVE
                               VENTRICULAR TACHYCARDIA


C71058   C71150   ECG Result   VERAPAMIL-SENSITIVE
                               VENTRICULAR TACHYCARDIA



C71059   C71150   ECG Result   VENTRICULAR ARRHYTHMIA
                               ASSOCIATED WITH BRUGADA
                               SYNDROME




C71060   C71150   ECG Result   VENTRICULAR ARRHYTHMIA
                               ASSOCIATED WITH SHORT QT
                               SYNDROME
C71061   C71150   ECG Result   FASCICULAR TACHYCARDIA




C71062   C71150   ECG Result   BUNDLE BRANCH REENTRANT
                               TACHYCARDIA
C71063   C71150   ECG Result   IDIOPATHIC RIGHT BUNDLE
                               BRANCH BLOCK VENTRICULAR
                               TACHYCARDIA




C71064   C71150   ECG Result   OUTFLOW TRACT VENTRICULAR
                               TACHYCARDIA




C71065   C71150   ECG Result   ACUTE ANTERIOR WALL MI


C71066   C71150   ECG Result   ACUTE INFERIOR WALL MI


C71067   C71150   ECG Result   ACUTE LATERAL WALL MI


C71068   C71150   ECG Result   ACUTE POSTERIOR WALL MI


C71069   C71150   ECG Result   ANTERIOR WALL MYOCARDIAL
                               INFARCTION

C71070   C71150   ECG Result   INFERIOR WALL MYOCARDIAL
                               INFARCTION

C71073   C71150   ECG Result   INTRAATRIAL CONDUCTION
                               DELAY
C71074   C71150   ECG Result   JUNCTIONAL BRADYCARDIA



C71075   C71150   ECG Result   LATERAL WALL MYOCARDIAL
                               INFARCTION

C71076   C71150   ECG Result   LEFT VENTRICULAR
                               HYPERTROPHY
C71077   C71150   ECG Result   RIGHT VENTRICULAR
                               HYPERTROPHY
C71078   C71150   ECG Result   LOW QRS VOLTAGE
C71080   C71150         ECG Result      NON Q WAVE MYOCARDIAL
                                        INFARCTION
C71081   C71150         ECG Result      POSTERIOR WALL MYOCARDIAL
                                        INFARCTION

C71082   C71150         ECG Result      SEPTAL MYOCARDIAL
                                        INFARCTION
C71083   C71150         ECG Result      T WAVE ABNORMALITY

C71084   C71150         ECG Result      VENTRICULAR HYPERTROPHY

C71085   C71150         ECG Result      T WAVE INVERSION

C71086   C71150         ECG Result      T WAVE PEAKED


C71087   C71150         ECG Result      T WAVES BIPHASIC

C71088   C71150         ECG Result      T WAVES FLAT

C71089   C71150         ECG Result      U WAVES


C71090   C71150         ECG Result      WIDE QRS TACHYCARDIA
C71094   C71150         ECG Result      Q AXIS, LEFT AXIS DEVIATION
C71095   C71150         ECG Result      Q AXIS, RIGHT AXIS DEVIATION
C71096   C71150         ECG Result      QTCB PROLONGATION >500
                                        MSEC
C71097   C71150         ECG Result      QTCF PROLONGATION >500
                                        MSEC
C71153            Yes   ECG Test Code   EGTESTCD

C39779   C71153         ECG Test Code   HRMAX



C62086   C71153         ECG Test Code   PRMEAN




C62087   C71153         ECG Test Code   QRSDUR
C62089   C71153   ECG Test Code   QTMEAN




C62090   C71153   ECG Test Code   RRMEAN




C62093   C71153   ECG Test Code   RRMIN

C62094   C71153   ECG Test Code   RRMAX

C62095   C71153   ECG Test Code   HRMEAN



C62096   C71153   ECG Test Code   HRMIN



C62112   C71153   ECG Test Code   QTCB




C62113   C71153   ECG Test Code   QTCF




C62114   C71153   ECG Test Code   QTCLC
C62115   C71153   ECG Test Code   JTMEAN




C62116   C71153   ECG Test Code   JTMIN




C62117   C71153   ECG Test Code   JTMAX




C62118   C71153   ECG Test Code   JTCB




C62119   C71153   ECG Test Code   JTCF




C62120   C71153   ECG Test Code   JTCLC




C62121   C71153   ECG Test Code   PAXIS



C62123   C71153   ECG Test Code   PWAVEDUR
C62124   C71153   ECG Test Code   PWAVEHT




C62125   C71153   ECG Test Code   PRMIN




C62131   C71153   ECG Test Code   PRMAX




C62132   C71153   ECG Test Code   QRSAXIS

C62133   C71153   ECG Test Code   QTMIN




C62135   C71153   ECG Test Code   QTMAX




C62136   C71153   ECG Test Code   RWAVEAMP


C62137   C71153   ECG Test Code   SWAVEAMP


C62144   C71153   ECG Test Code   RSAMP
C62145   C71153   ECG Test Code   STSEGDUR


C62146   C71153   ECG Test Code   TAXIS

C62147   C71153   ECG Test Code   TWAVEDUR




C62148   C71153   ECG Test Code   TWAVAREA



C62149   C71153   ECG Test Code   TWAVEHT




C62152   C71153   ECG Test Code   VRMEAN



C62153   C71153   ECG Test Code   VRMIN



C62154   C71153   ECG Test Code   VRMAX



C62155   C71153   ECG Test Code   STDVMEAN



C62156   C71153   ECG Test Code   STDVMIN



C62157   C71153   ECG Test Code   STDVMAX



C62158   C71153   ECG Test Code   STELMEAN



C62159   C71153   ECG Test Code   STELMIN
C62160   C71153         ECG Test Code   STELMAX



C62161   C71153         ECG Test Code   STDPMEAN



C62162   C71153         ECG Test Code   STDPMIN



C62163   C71153         ECG Test Code   STDPMAX



C71152            Yes   ECG Test Name   EGTEST

C39779   C71152         ECG Test Name   Summary (Max) Heart Rate



C62086   C71152         ECG Test Name   Summary (Mean) PR Duration




C62087   C71152         ECG Test Name   Summary (Mean) QRS Duration




C62089   C71152         ECG Test Name   Summary (Mean) QT Duration




C62090   C71152         ECG Test Name   Summary (Mean) RR Duration
C62093   C71152   ECG Test Name   Summary (Min) RR Duration

C62094   C71152   ECG Test Name   Summary (Max) RR Duration

C62095   C71152   ECG Test Name   Summary (Mean) Heart Rate



C62096   C71152   ECG Test Name   Summary (Min) Heart Rate



C62112   C71152   ECG Test Name   QTcB - Bazett's Correction Formula




C62113   C71152   ECG Test Name   QTcF - Fridericia's Correction
                                  Formula




C62114   C71152   ECG Test Name   QTcLC - Linear Correction Formula




C62115   C71152   ECG Test Name   Summary (Mean) JT Interval




C62116   C71152   ECG Test Name   Summary (Min) JT Interval




C62117   C71152   ECG Test Name   Summary (Max) JT Interval
C62118   C71152   ECG Test Name   JTcB - Bazett's Correction Formula




C62119   C71152   ECG Test Name   JTcF - Fridericia's Correction
                                  Formula




C62120   C71152   ECG Test Name   JTcLC - Linear Correction Formula




C62121   C71152   ECG Test Name   Summary (Mean) P Axis



C62123   C71152   ECG Test Name   Summary (Mean) P Wave Duration




C62124   C71152   ECG Test Name   Summary (Mean) P Wave Height




C62125   C71152   ECG Test Name   Summary (Min) PR Duration
C62131   C71152   ECG Test Name   Summary (Max) PR Duration




C62132   C71152   ECG Test Name   Summary (Mean) QRS Axis

C62133   C71152   ECG Test Name   Summary (Min) QT Duration




C62135   C71152   ECG Test Name   Summary (Max) QT Duration




C62136   C71152   ECG Test Name   Summary (Mean) R Wave Amplitude


C62137   C71152   ECG Test Name   Summary (Mean) S Wave Amplitude


C62144   C71152   ECG Test Name   Summary (Mean) R+S Amplitude



C62145   C71152   ECG Test Name   Summary (Mean) ST Segment
                                  Duration

C62146   C71152   ECG Test Name   Summary (Mean) T Wave Axis

C62147   C71152   ECG Test Name   Summary (Mean) T Wave Duration




C62148   C71152   ECG Test Name   Summary (Mean) T Wave Area
C62149   C71152   ECG Test Name   Summary (Mean) T Wave Height




C62152   C71152   ECG Test Name   Summary (Mean) Ventricular Rate



C62153   C71152   ECG Test Name   Summary (Min) Ventricular Rate



C62154   C71152   ECG Test Name   Summary (Max) Ventricular Rate



C62155   C71152   ECG Test Name   Summary (Mean) ST Deviation



C62156   C71152   ECG Test Name   Summary (Min) ST Deviation



C62157   C71152   ECG Test Name   Summary (Max) ST Deviation



C62158   C71152   ECG Test Name   Summary (Mean) ST Elevation



C62159   C71152   ECG Test Name   Summary (Min) ST Elevation



C62160   C71152   ECG Test Name   Summary (Max) ST Elevation



C62161   C71152   ECG Test Name   Summary (Mean) ST Depression



C62162   C71152   ECG Test Name   Summary (Min) ST Depression
C62163   C71152         ECG Test Name     Summary (Max) ST Depression



C71151            Yes   ECG Test Method   EGMETHOD

C71101   C71151         ECG Test Method   12 LEAD UNSPECIFIED


C71102   C71151         ECG Test Method   12 LEAD STANDARD




C71103   C71151         ECG Test Method   12 LEAD MASON LIKAR




C71110   C71151         ECG Test Method   12 LEAD MODIFIED MASON LIKAR




C71112   C71151         ECG Test Method   12 LEAD SINGLE PAD



C71114   C71151         ECG Test Method   12 LEAD NON-STANDARD


C71115   C71151         ECG Test Method   STANDARD LEADS FOR BICYCLE
                                          EXERCISE
C71116   C71151   ECG Test Method   12 LEAD CABRERA




C71117   C71151   ECG Test Method   STANDARD LEADS ONE
                                    INTERCOSTAL SPACE HIGHER


C71118   C71151   ECG Test Method   FRANK LEAD SYSTEM




C71119   C71151   ECG Test Method   MCFEE-PARUNGAO LEAD
                                    SYSTEM



C71120   C71151   ECG Test Method   CUBE LEAD SYSTEM



C71121   C71151   ECG Test Method   BIPOLAR UNCORRECTED XYZ
                                    LEAD SYSTEM




C71122   C71151   ECG Test Method   PSEUDO-ORTHOGONAL XYZ
                                    LEAD SYSTEM




C71123   C71151   ECG Test Method   12 LEAD EASI DOWER
                                    TRANSFORMATION
C71125   C71151         ECG Test Method   12 LEAD 1 LEAD MISSING



C71126   C71151         ECG Test Method   STANDARD 12-LEAD AND CM5-
                                          CC5-CH5




C71128   C71151         ECG Test Method   STANDARD 12-LEAD AND CC5-
                                          CM5-ML



C71130   C71151         ECG Test Method   STANDARD 12-LEAD EXTENDED
                                          RIGHT


C71131   C71151         ECG Test Method   STANDARD 12-LEAD EXTENDED
                                          LEFT

C71092   C71151         ECG Test Method   VECTORCARDIOGRAPH
                                          CORRECTED

C71093   C71151         ECG Test Method   VECTORCARDIOGRAPH
                                          UNCORRECTED

C71620            Yes   Unit              UNIT


C18063   C71620         Unit              Gy


C18064   C71620         Unit              Rad




C25301   C71620         Unit              DAYS


C25529   C71620         Unit              HOURS

C25613   C71620         Unit              %

C28251   C71620         Unit              mm
C28252   C71620   Unit   kg




C28253   C71620   Unit   mg


C28254   C71620   Unit   mL


C29844   C71620   Unit   WEEKS
C29846   C71620   Unit   MONTHS



C29848   C71620   Unit   YEARS


C41139   C71620   Unit   m


C41140   C71620   Unit   msec

C42535   C71620   Unit   sec




C42536   C71620   Unit   amp




C42538   C71620   Unit   cd
C42539   C71620   Unit   mol




C42545   C71620   Unit   Hz
C42546   C71620   Unit   Newton


C42547   C71620   Unit   Pa


C42548   C71620   Unit   Joule




C42549   C71620   Unit   Watt




C42550   C71620   Unit   Coulomb


C42551   C71620   Unit   V




C42552   C71620   Unit   Farad



C42553   C71620   Unit   Sv
C42554   C71620   Unit   ohm




C42555   C71620   Unit   Siemens




C42556   C71620   Unit   Weber



C42557   C71620   Unit   Tesla




C42558   C71620   Unit   Henry




C42559   C71620   Unit   C




C42560   C71620   Unit   lm


C42561   C71620   Unit   lx



C42562   C71620   Unit   Bq
C42566   C71620   Unit   kat




C42569   C71620   Unit   m2



C42570   C71620   Unit   m3



C42571   C71620   Unit   m/sec


C42576   C71620   Unit   kg/m3




C44277   C71620   Unit   F




C45997   C71620   Unit   pH

C48152   C71620   Unit   ug

C48154   C71620   Unit   min
C48155   C71620   Unit   g

C48460   C71620   Unit   cm2


C48461   C71620   Unit   ft2
C48466   C71620   Unit   Ci


C48473   C71620   Unit   AMPULE
C48474   C71620   Unit   BAG
C48475   C71620   Unit   BAR
C48476   C71620   Unit   BOLUS
C48477   C71620   Unit   BOTTLE
C48478   C71620   Unit   BOX
C48479   C71620   Unit   CAN
C48480   C71620   Unit   CAPSULE
C48481   C71620   Unit   CARTRIDGE
C48483   C71620   Unit   COAT
C48484   C71620   Unit   CONTAINER
C48489   C71620   Unit   CYLINDER
C48490   C71620   Unit   DISK
C48492   C71620   Unit   DRUM
C48497   C71620   Unit   grain




C48498   C71620   Unit   HOMEOPATHIC DILUTION

C48499   C71620   Unit   IMPLANT
C48500   C71620   Unit   IN
C48501   C71620   Unit   INHALATION
C48502   C71620   Unit   JAR
C48503   C71620   Unit   KALLIKREIN INHIBITOR UNIT

C48504   C71620   Unit   KIT
C48505   C71620   Unit   L


C48506   C71620   Unit   LOZENGE
C48507   C71620   Unit   uCi


C48509   C71620   Unit   umol

C48510   C71620   Unit   um

C48511   C71620   Unit   mCi



C48512   C71620   Unit   mEq

C48513   C71620   Unit   mmol
C48516   C71620   Unit   ng

C48517   C71620   Unit   nmol

C48519   C71620   Unit   oz

C48520   C71620   Unit   PACKAGE
C48521   C71620   Unit   PACKET
C48523   C71620   Unit   ppm

C48524   C71620   Unit   PATCH
C48525   C71620   Unit   PELLET
C48527   C71620   Unit   %(w/v)




C48528   C71620   Unit   %(w/w)


C48530   C71620   Unit   POUCH
C48531   C71620   Unit   LB


C48532   C71620   Unit   PRESSOR UNITS
C48536   C71620   Unit   SCOOPFUL
C48537   C71620   Unit   SPRAY
C48538   C71620   Unit   STRIP
C48539   C71620   Unit   SUPPOSITORY

C48540   C71620   Unit   SYRINGE
C48541   C71620   Unit   Tbsp



C48542   C71620   Unit   TABLET
C48543   C71620   Unit   TAMPON
C48544   C71620   Unit   tsp

C48547   C71620   Unit   TRACE
C48548   C71620   Unit   TROCHE
C48549   C71620   Unit   TUBE
C48551   C71620   Unit   VIAL
C48552   C71620   Unit   WAFER
C48553   C71620   Unit   yd

C48555   C71620   Unit   mol/L

C48571   C71620   Unit   % (v/v)
C48579   C71620   Unit   IU




C48590   C71620   Unit   QUANTITY SUFFICIENT




C49668   C71620   Unit   cm

C49670   C71620   Unit   mmHg


C49671   C71620   Unit   kg/m2

C49673   C71620   Unit   BEATS/MIN
C49674   C71620   Unit   BREATHS/MIN

C54703   C71620   Unit   CUP
C54711   C71620   Unit   atm



C62609   C71620   Unit   RING
C64387   C71620   Unit   mmol/L



C64551   C71620   Unit   pg

C64552   C71620   Unit   fg

C64553   C71620   Unit   ag

C64554   C71620   Unit   cg
C64564   C71620   Unit   dram
C64566   C71620   Unit   kg/L




C64572   C71620   Unit   g/m3




C64777   C71620   Unit   mL/min


C64783   C71620   Unit   g/dL




C65045   C71620   Unit   pmol

C65060   C71620   Unit   PUFF




C65104   C71620   Unit   mm2



C65132   C71620   Unit   tuberculin unit



C66962   C71620   Unit   mL/h


C66965   C71620   Unit   per sec

C66967   C71620   Unit   per min

C66969   C71620   Unit   mg/h
C67015   C71620   Unit   mg/dL




C67193   C71620   Unit   cal



C67194   C71620   Unit   kcal




C67264   C71620   Unit   PFU




C67273   C71620   Unit   eq




C67274   C71620   Unit   HPF

C67282   C71620   Unit   g/m2
C67306   C71620   Unit   ug/L




C67307   C71620   Unit   LPF


C67324   C71620   Unit   mV

C67326   C71620   Unit   ng/dL




C67327   C71620   Unit   ug/m3




C67328   C71620   Unit   nm


C67330   C71620   Unit   osm



C67334   C71620   Unit   psi


C67335   C71620   Unit   million IU

C67352   C71620   Unit   nCi


C67376   C71620   Unit   IU/L


C67377   C71620   Unit   IU/mL


C67379   C71620   Unit   IU/kg
C67380   C71620   Unit   IU/mg


C67388   C71620   Unit   L/min


C67394   C71620   Unit   ug/h


C67396   C71620   Unit   ug/kg


C67397   C71620   Unit   ukat/L


C67399   C71620   Unit   mg/day

C67401   C71620   Unit   mg/kg


C67402   C71620   Unit   mg/m2


C67406   C71620   Unit   umol/day



C67419   C71620   Unit   mm/h


C67420   C71620   Unit   mmol/day



C67432   C71620   Unit   nmol/L


C67434   C71620   Unit   pmol/L


C67441   C71620   Unit   RNA copies/mL


C67471   C71620   Unit   mEq/day



C67474   C71620   Unit   mEq/L
C67475   C71620   Unit   mEq/kg



C68667   C71620   Unit   deg




C68685   C71620   Unit   dmol

C68687   C71620   Unit   cmol

C68740   C71620   Unit   mmol/g

C68854   C71620   Unit   fmol

C68855   C71620   Unit   amol

C68858   C71620   Unit   m3



C68859   C71620   Unit   ft3


C68871   C71620   Unit   in2

C68875   C71620   Unit   ELISA unit




C68876   C71620   Unit   ELISA unit/dose




C68877   C71620   Unit   ELISA unit/mL




C68878   C71620   Unit   Log10 ELISA unit
C68879   C71620   Unit   Log10 ELISA unit/dose




C68891   C71620   Unit   mol/mL

C68892   C71620   Unit   mmol/kg


C68893   C71620   Unit   mol/g


C68894   C71620   Unit   mol/mg


C68895   C71620   Unit   thousand CFU

C68896   C71620   Unit   million CFU

C68897   C71620   Unit   billion CFU

C68898   C71620   Unit   CFU/g


C68899   C71620   Unit   thousand CFU/g



C68900   C71620   Unit   million CFU/g



C68901   C71620   Unit   billion CFU/g



C68902   C71620   Unit   CFU/mL


C68903   C71620   Unit   thousand CFU/mL



C68904   C71620   Unit   million CFU/mL



C68905   C71620   Unit   billion CFU/mL
C68915   C71620   Unit   Gauss




C69094   C71620   Unit   kg/cm2



C69104   C71620   Unit   g/kg


C69112   C71620   Unit   ppth
C69148   C71620   Unit   pm

C69175   C71620   Unit   uL/mL


C69188   C71620   Unit   nL

C69442   C71620   Unit   gtt
C70455   C71620   Unit   mol/mol


C70469   C71620   Unit   rpm

C70470   C71620   Unit   dyn



C70479   C71620   Unit   log10 EID 50




C70480   C71620   Unit   log EID 50/dose




C70484   C71620   Unit   log10 CCID 50
C70485   C71620   Unit   log10 CCID 50/dose




C70488   C71620   Unit   log10 TCID 50




C70489   C71620   Unit   log10 TCID 50/dose




C70492   C71620   Unit   kIU
C70493   C71620   Unit   IU/g


C70497   C71620   Unit   anti-Xa IU




C70498   C71620   Unit   anti-Xa IU/mL



C70500   C71620   Unit   AgU/mL

C70501   C71620   Unit   DAgU


C70502   C71620   Unit   DAgU/mL


C70504   C71620   Unit   AU/mL


C70505   C71620   Unit   BAU



C70506   C71620   Unit   tuberculin unit/mL


C70507   C71620   Unit   mkat
C70508   C71620   Unit   nkat

C70509   C71620   Unit   pkat

C70510   C71620   Unit   nkat/L



C70511   C71620   Unit   kBq


C70512   C71620   Unit   MBq


C70513   C71620   Unit   GBq


C70521   C71620   Unit   Bq/kg


C70522   C71620   Unit   Bq/g


C70523   C71620   Unit   Bq/ug




C70524   C71620   Unit   Bq/mg


C70525   C71620   Unit   GBq/g


C70526   C71620   Unit   GBq/ug



C70527   C71620   Unit   GBq/mg


C70528   C71620   Unit   Ci/g



C70529   C71620   Unit   Ci/kg


C70530   C71620   Unit   Ci/ug
C70531   C71620   Unit   Ci/mg


C70532   C71620   Unit   EID 50



C70533   C71620   Unit   EID 50/dose



C70534   C71620   Unit   CCID 50




C70535   C71620   Unit   CCID 50/dose


C70537   C71620   Unit   TCID 50/dose


C70562   C71620   Unit   ukat

C70565   C71620   Unit   ppb

C70566   C71620   Unit   pptr

C70570   C71620   Unit   mCi/kg


C70571   C71620   Unit   uCi/kg


C70575   C71620   Unit   Roentgen



C70578   C71620   Unit   mEq/uL

C70580   C71620   Unit   mEq/g



C70581   C71620   Unit   mEq/ug



C71165   C71620   Unit   Bq/L
C71166   C71620   Unit   Bq/uL



C71167   C71620   Unit   Bq/mL



C71168   C71620   Unit   kBq/uL



C71169   C71620   Unit   MBq/uL



C71170   C71620   Unit   Ci/L


C71171   C71620   Unit   Ci/uL



C71172   C71620   Unit   Ci/mL


C71173   C71620   Unit   uCi/L



C71174   C71620   Unit   mCi/L



C71175   C71620   Unit   uV

C71176   C71620   Unit   cycle/min



C71177   C71620   Unit   km

C71183   C71620   Unit   Mile

C71185   C71620   Unit   100 IU/mL



C71187   C71620   Unit   thousand organisms

C71188   C71620   Unit   million organisms
C71189   C71620   Unit   billion organisms

C71190   C71620   Unit   thousand organisms/g


C71191   C71620   Unit   million organisms/g


C71192   C71620   Unit   billion organisms/g


C71193   C71620   Unit   million organisms/mg


C71194   C71620   Unit   billion organisms/mg


C71195   C71620   Unit   thousand organisms/mL


C71196   C71620   Unit   million organisms/mL


C71197   C71620   Unit   billion organisms/mL


C71198   C71620   Unit   PFU/dose



C71199   C71620   Unit   PFU/mL



C71200   C71620   Unit   bel




C71201   C71620   Unit   g/cm2



C71202   C71620   Unit   kUSP

C71203   C71620   Unit   km/h


C71204   C71620   Unit   NEBULE
C71205   C71620         Unit                  ug/day




C71207   C71620         Unit                  mg/kg/min


C71209   C71620         Unit                  IU/kg/h



C71210   C71620         Unit                  ug/kg/min



C71211   C71620         Unit                  ug/min




C71253   C71620         Unit                  ft



C71321   C71620         Unit                  FINGERTIP UNIT




C71324   C71620         Unit                  SACHET


C71362   C71620         Unit                  mg/kg/h


C71480   C71620         Unit                  cycle/sec



C74456            Yes   Anatomical Location   LOC
C12220   C74456   Anatomical Location   LIP

C12230   C74456   Anatomical Location   HARD PALATE

C12246   C74456   Anatomical Location   HYPOPHARYNX

C12256   C74456   Anatomical Location   GASTRIC CARDIA


C12257   C74456   Anatomical Location   FUNDUS OF THE STOMACH


C12258   C74456   Anatomical Location   BODY OF STOMACH



C12259   C74456   Anatomical Location   ANTRUM PYLORI


C12262   C74456   Anatomical Location   GREATER CURVATURE OF THE
                                        STOMACH
C12274   C74456   Anatomical Location   MIDDLE EAR

C12275   C74456   Anatomical Location   MAXILLARY SINUS




C12276   C74456   Anatomical Location   ETHMOID SINUS
C12277   C74456   Anatomical Location   FRONTAL SINUS

C12280   C74456   Anatomical Location   SUBGLOTTIS

C12290   C74456   Anatomical Location   MANDIBLE
C12295   C74456   Anatomical Location   SKIN OF THE TRUNK

C12299   C74456   Anatomical Location   NIPPLE

C12311   C74456   Anatomical Location   CERVIX UTERI


C12314   C74456   Anatomical Location   MYOMETRIUM
C12320   C74456   Anatomical Location   PARAMETRIUM



C12341   C74456   Anatomical Location   CONJUNCTIVA
C12342   C74456   Anatomical Location   CORNEA




C12343   C74456   Anatomical Location   RETINA


C12347   C74456   Anatomical Location   ORBIT




C12352   C74456   Anatomical Location   FRONTAL LOBE

C12354   C74456   Anatomical Location   PARIETAL LOBE



C12356   C74456   Anatomical Location   BRAIN VENTRICLE


C12363   C74456   Anatomical Location   PELVIC LYMPH NODE
C12366   C74456   Anatomical Location   BONE

C12372   C74456   Anatomical Location   ARTERY

C12377   C74456   Anatomical Location   GALLBLADDER




C12378   C74456   Anatomical Location   GASTROINTESTINAL SYSTEM


C12379   C74456   Anatomical Location   LARGE INTESTINE

C12380   C74456   Anatomical Location   APPENDIX


C12382   C74456   Anatomical Location   COLON
C12386   C74456   Anatomical Location   SMALL INTESTINE




C12387   C74456   Anatomical Location   ILEUM
C12388   C74456   Anatomical Location   JEJUNUM

C12389   C74456   Anatomical Location   ESOPHAGUS




C12391   C74456   Anatomical Location   STOMACH



C12392   C74456   Anatomical Location   LIVER




C12393   C74456   Anatomical Location   PANCREAS




C12394   C74456   Anatomical Location   EAR




C12400   C74456   Anatomical Location   THYROID GLAND


C12401   C74456   Anatomical Location   EYE
C12403   C74456   Anatomical Location   FALLOPIAN TUBE
C12404   C74456   Anatomical Location   OVARY



C12405   C74456   Anatomical Location   UTERUS



C12407   C74456   Anatomical Location   VAGINA

C12408   C74456   Anatomical Location   VULVA


C12409   C74456   Anatomical Location   PENIS
C12410   C74456   Anatomical Location   PROSTATE GLAND




C12412   C74456   Anatomical Location   TESTIS

C12413   C74456   Anatomical Location   URINARY SYSTEM

C12414   C74456   Anatomical Location   BLADDER


C12415   C74456   Anatomical Location   KIDNEY




C12416   C74456   Anatomical Location   URETER

C12417   C74456   Anatomical Location   URETHRA

C12419   C74456   Anatomical Location   HEAD

C12420   C74456   Anatomical Location   LARYNX


C12421   C74456   Anatomical Location   ORAL CAVITY



C12422   C74456   Anatomical Location   TONGUE


C12423   C74456   Anatomical Location   NASOPHARYNX
C12424   C74456   Anatomical Location   NASAL CAVITY




C12425   C74456   Anatomical Location   PHARYNX


C12427   C74456   Anatomical Location   PAROTID GLAND

C12428   C74456   Anatomical Location   TRACHEA

C12429   C74456   Anatomical Location   LIMB

C12432   C74456   Anatomical Location   SPLEEN




C12433   C74456   Anatomical Location   THYMUS GLAND




C12434   C74456   Anatomical Location   BLOOD




C12435   C74456   Anatomical Location   MUSCLE TISSUE




C12439   C74456   Anatomical Location   BRAIN
C12442   C74456   Anatomical Location   MEDULLA OBLONGATA




C12447   C74456   Anatomical Location   BASAL GANGLIA




C12452   C74456   Anatomical Location   PUTAMEN




C12459   C74456   Anatomical Location   THALAMUS




C12468   C74456   Anatomical Location   LUNG




C12470   C74456   Anatomical Location   SKIN


C12502   C74456   Anatomical Location   TYMPANIC MEMBRANE




C12503   C74456   Anatomical Location   MASTOID PROCESS


C12664   C74456   Anatomical Location   ABDOMINAL CAVITY
C12666   C74456   Anatomical Location   ADRENAL GLAND




C12669   C74456   Anatomical Location   AORTA




C12674   C74456   Anatomical Location   AXILLA

C12678   C74456   Anatomical Location   BILIARY TRACT




C12679   C74456   Anatomical Location   BLOOD VESSEL


C12681   C74456   Anatomical Location   BRACHIAL ARTERY

C12682   C74456   Anatomical Location   BRACHIAL PLEXUS


C12683   C74456   Anatomical Location   BRONCHUS


C12687   C74456   Anatomical Location   CAROTID ARTERY



C12693   C74456   Anatomical Location   CERVICAL VERTEBRA


C12695   C74456   Anatomical Location   CLAVICLE

C12696   C74456   Anatomical Location   COCCYX


C12709   C74456   Anatomical Location   EPIGLOTTIS


C12711   C74456   Anatomical Location   ETHMOID BONE




C12713   C74456   Anatomical Location   EYELID
C12715   C74456   Anatomical Location   FEMORAL ARTERY

C12716   C74456   Anatomical Location   FEMORAL VEIN

C12717   C74456   Anatomical Location   FEMUR

C12718   C74456   Anatomical Location   FIBULA

C12719   C74456   Anatomical Location   GANGLION


C12724   C74456   Anatomical Location   GLOTTIS
C12726   C74456   Anatomical Location   INGUINAL REGION

C12727   C74456   Anatomical Location   HEART




C12731   C74456   Anatomical Location   HUMERUS
C12736   C74456   Anatomical Location   INTESTINE


C12743   C74456   Anatomical Location   LENS



C12744   C74456   Anatomical Location   LUMBAR VERTEBRA


C12745   C74456   Anatomical Location   LYMPH NODE




C12748   C74456   Anatomical Location   MEDIASTINUM




C12752   C74456   Anatomical Location   METATARSAL BONE


C12756   C74456   Anatomical Location   NOSE


C12761   C74456   Anatomical Location   OPTIC NERVE
C12763   C74456   Anatomical Location   PARANASAL SINUS



C12767   C74456   Anatomical Location   PELVIS


C12768   C74456   Anatomical Location   PERIPHERAL NERVE

C12770   C74456   Anatomical Location   PERITONEUM




C12782   C74456   Anatomical Location   RIB




C12783   C74456   Anatomical Location   SCAPULA

C12785   C74456   Anatomical Location   SCROTUM

C12786   C74456   Anatomical Location   LUNATE BONE

C12789   C74456   Anatomical Location   SKULL

C12793   C74456   Anatomical Location   STERNUM

C12797   C74456   Anatomical Location   TEMPORAL BONE




C12798   C74456   Anatomical Location   THORACIC VERTEBRA


C12799   C74456   Anatomical Location   THORAX

C12800   C74456   Anatomical Location   TIBIA

C12802   C74456   Anatomical Location   TONSIL


C12808   C74456   Anatomical Location   TROCHLEAR NERVE

C12811   C74456   Anatomical Location   UVEA

C12814   C74456   Anatomical Location   VEIN
C12817   C74456   Anatomical Location   VENA CAVA

C12822   C74456   Anatomical Location   VOCAL CORD



C12838   C74456   Anatomical Location   RADIAL ARTERY

C12840   C74456   Anatomical Location   PLEURAL CAVITY

C12843   C74456   Anatomical Location   CORONARY ARTERY

C12853   C74456   Anatomical Location   SACRAL VERTEBRA

C12854   C74456   Anatomical Location   SCAPHOID BONE

C12855   C74456   Anatomical Location   PISIFORM BONE

C12856   C74456   Anatomical Location   CAPITATE BONE

C12857   C74456   Anatomical Location   TRAPEZIAL BONE

C12858   C74456   Anatomical Location   TRIANGULAR BONE

C12859   C74456   Anatomical Location   TRAPEZOID BONE

C12860   C74456   Anatomical Location   HAMATE BONE
C12903   C74456   Anatomical Location   SUPRACLAVICULAR LYMPH
                                        NODE
C12904   C74456   Anatomical Location   AXILLARY LYMPH NODE


C12971   C74456   Anatomical Location   BREAST


C12998   C74456   Anatomical Location   VERTEBRAL COLUMN




C13005   C74456   Anatomical Location   PERICARDIUM


C13041   C74456   Anatomical Location   BODY


C13044   C74456   Anatomical Location   JOINT

C13046   C74456   Anatomical Location   LIGAMENT
C13050   C74456   Anatomical Location   SKELETAL MUSCLE TISSUE



C13062   C74456   Anatomical Location   BACK

C13063   C74456   Anatomical Location   NECK

C13071   C74456   Anatomical Location   FACE



C13166   C74456   Anatomical Location   MUCOSA
C13307   C74456   Anatomical Location   GASTRIC
C13308   C74456   Anatomical Location   HEPATIC
C15609   C74456   Anatomical Location   ANASTOMOSIS

C25203   C74456   Anatomical Location   SHOULDER

C25389   C74456   Anatomical Location   CHEST



C25724   C74456   Anatomical Location   HILAR
C26465   C74456   Anatomical Location   CORPUS LUTEUM




C26470   C74456   Anatomical Location   MAXILLA

C32042   C74456   Anatomical Location   ACETABULUM


C32047   C74456   Anatomical Location   ACROMIOCLAVICULAR JOINT


C32048   C74456   Anatomical Location   ACROMION
C32078   C74456   Anatomical Location   ANKLE JOINT

C32123   C74456   Anatomical Location   AORTIC ARCH



C32141   C74456   Anatomical Location   ARM


C32197   C74456   Anatomical Location   BASILIC VEIN


C32239   C74456   Anatomical Location   C1 VERTEBRA
C32240   C74456   Anatomical Location   C2 VERTEBRA
C32241   C74456   Anatomical Location   C3 VERTEBRA
C32242   C74456   Anatomical Location   C4 VERTEBRA
C32243   C74456   Anatomical Location   C5 VERTEBRA
C32244   C74456   Anatomical Location   C6 VERTEBRA
C32245   C74456   Anatomical Location   C7 VERTEBRA
C32258   C74456   Anatomical Location   CANINE TOOTH

C32286   C74456   Anatomical Location   CEPHALIC VEIN



C32298   C74456   Anatomical Location   CERVICAL LYMPH NODE
C32334   C74456   Anatomical Location   COCCYGEAL VERTEBRA

C32391   C74456   Anatomical Location   COSTAL CARTILAGE


C32414   C74456   Anatomical Location   CUBOID BONE

C32478   C74456   Anatomical Location   DORSALIS PEDIS ARTERY




C32497   C74456   Anatomical Location   ELBOW JOINT

C32514   C74456   Anatomical Location   ENDOMETRIAL CAVITY

C32577   C74456   Anatomical Location   FACET JOINT


C32608   C74456   Anatomical Location   FINGER
C32609   C74456   Anatomical Location   FINGERNAIL
C32622   C74456   Anatomical Location   FOOT

C32628   C74456   Anatomical Location   FOREARM

C32668   C74456   Anatomical Location   GASTROESOPHAGEAL
                                        JUNCTION
C32677   C74456   Anatomical Location   GINGIVA



C32682   C74456   Anatomical Location   GLENOID FOSSA

C32698   C74456   Anatomical Location   GREAT TROCHANTER

C32705   C74456   Anatomical Location   HAIR
C32712   C74456   Anatomical Location   HAND

C32720   C74456   Anatomical Location   HEAD OF THE HUMERUS
C32742   C74456   Anatomical Location   HIP JOINT

C32752   C74456   Anatomical Location   HYOID BONE



C32761   C74456   Anatomical Location   ILIAC LYMPH NODE

C32765   C74456   Anatomical Location   ILIUM

C32769   C74456   Anatomical Location   INCISOR

C32770   C74456   Anatomical Location   INCUS


C32801   C74456   Anatomical Location   INGUINAL LYMPH NODE

C32868   C74456   Anatomical Location   INTERPHALANGEAL JOINT OF
                                        THE HAND
C32884   C74456   Anatomical Location   ISCHIUM

C32888   C74456   Anatomical Location   JAW JOINT

C32898   C74456   Anatomical Location   KNEE JOINT




C32899   C74456   Anatomical Location   L1 VERTEBRA
C32900   C74456   Anatomical Location   L2 VERTEBRA

C32901   C74456   Anatomical Location   L3 VERTEBRA

C32902   C74456   Anatomical Location   L4 VERTEBRA

C32903   C74456   Anatomical Location   L5 VERTEBRA
C32906   C74456   Anatomical Location   LACRIMAL BONE



C32974   C74456   Anatomical Location   LEG

C32996   C74456   Anatomical Location   LIVER FISSURE


C33031   C74456   Anatomical Location   LYMPH NODE HILUM
C33051   C74456   Anatomical Location   MALLEUS
C33073   C74456   Anatomical Location   MEDIASTINAL LYMPH NODE




C33108   C74456   Anatomical Location   METATARSOPHALANGEAL JOINT


C33156   C74456   Anatomical Location   NAIL

C33157   C74456   Anatomical Location   NASAL BONE

C33160   C74456   Anatomical Location   NASAL SEPTUM
C33162   C74456   Anatomical Location   NAVICULAR BONE

C33178   C74456   Anatomical Location   NOSTRIL

C33200   C74456   Anatomical Location   OLECRANON

C33205   C74456   Anatomical Location   OLFACTORY MUCOSA



C33278   C74456   Anatomical Location   PAROTID GLAND LYMPH NODE

C33282   C74456   Anatomical Location   PATELLA


C33287   C74456   Anatomical Location   PELVIC BONE



C33301   C74456   Anatomical Location   PERINEUM

C33318   C74456   Anatomical Location   PHARYNGEAL TONSIL


C33343   C74456   Anatomical Location   PORTAL VEIN


C33433   C74456   Anatomical Location   PYLORIC SPHINCTER

C33507   C74456   Anatomical Location   SACROILIAC JOINT
C33508   C74456   Anatomical Location   SACRUM


C33548   C74456   Anatomical Location   SHOULDER JOINT

C33556   C74456   Anatomical Location   SINUS
C33615   C74456   Anatomical Location   STERNOCLAVICULAR JOINT
C33718   C74456   Anatomical Location   SYNOVIAL FLUID

C33720   C74456   Anatomical Location   T1 VERTEBRA

C33721   C74456   Anatomical Location   T10 VERTEBRA

C33722   C74456   Anatomical Location   T11 VERTEBRA

C33723   C74456   Anatomical Location   T12 VERTEBRA

C33724   C74456   Anatomical Location   T2 VERTEBRA

C33725   C74456   Anatomical Location   T3 VERTEBRA

C33726   C74456   Anatomical Location   T4 VERTEBRA

C33727   C74456   Anatomical Location   T5 VERTEBRA

C33728   C74456   Anatomical Location   T6 VERTEBRA

C33729   C74456   Anatomical Location   T7 VERTEBRA

C33730   C74456   Anatomical Location   T8 VERTEBRA

C33731   C74456   Anatomical Location   T9 VERTEBRA

C33737   C74456   Anatomical Location   TARSUS BONE

C33763   C74456   Anatomical Location   THIGH

C33788   C74456   Anatomical Location   TOE
C33790   C74456   Anatomical Location   TOENAIL

C33809   C74456   Anatomical Location   TRAPEZIUS MUSCLE




C33814   C74456   Anatomical Location   TROCHANTER

C33816   C74456   Anatomical Location   TRUNK
C33820   C74456   Anatomical Location   TUNICA INTIMA




C33888   C74456   Anatomical Location   VOMER


C33894   C74456   Anatomical Location   WRIST JOINT

C33895   C74456   Anatomical Location   XIPHOID PROCESS
C34082   C74456   Anatomical Location   GASTROINTESTINAL TRACT




C43362   C74456   Anatomical Location   ANUS


C49018   C74456   Anatomical Location   REGIONAL LYMPH NODE

C52730   C74456   Anatomical Location   STERNAL MANUBRIUM



C52745   C74456   Anatomical Location   PALATINE BONE




C52749   C74456   Anatomical Location   LEG SKIN
C52754   C74456   Anatomical Location   ARM SKIN
C52758   C74456   Anatomical Location   ABDOMINAL SKIN
C52759   C74456   Anatomical Location   RIB 9

C52760   C74456   Anatomical Location   RIB 8

C52761   C74456   Anatomical Location   RIB 7

C52762   C74456   Anatomical Location   RIB 6

C52763   C74456   Anatomical Location   RIB 5

C52764   C74456   Anatomical Location   RIB 4

C52765   C74456   Anatomical Location   RIB 3

C52766   C74456   Anatomical Location   RIB 2

C52767   C74456   Anatomical Location   RIB 12

C52768   C74456   Anatomical Location   RIB 11

C52769   C74456   Anatomical Location   RIB 10

C52770   C74456   Anatomical Location   RIB 1

C52771   C74456   Anatomical Location   HAND PHALANX
C52772   C74456   Anatomical Location   FOOT PHALANX
C52799   C74456   Anatomical Location   TALUS
C52810   C74456         Anatomical Location        SCIATIC NERVE



C54272   C74456         Anatomical Location        THROAT

C61563   C74456         Anatomical Location        FEMORAL NECK

C61599   C74456         Anatomical Location        MALE GENITALIA
C61600   C74456         Anatomical Location        FEMALE GENITALIA
C62432   C74456         Anatomical Location        UNCINATE PROCESS OF
                                                   PANCREAS
C62484   C74456         Anatomical Location        CHEST WALL


C63705   C74456         Anatomical Location        INFRACLAVICULAR LYMPH NODE

C63706   C74456         Anatomical Location        FACIAL BONE

C64192   C74456         Anatomical Location        WAIST
C64193   C74456         Anatomical Location        HIP

C65166   C74456         Anatomical Location        CELIAC LYMPH NODE
C66864   C74456         Anatomical Location        TOOTH CANAL

C69300   C74456         Anatomical Location        EPICONDYLE

C74558            Yes   Category for Disposition   DSCAT
                        Event

C74588   C74558         Category for Disposition   PROTOCOL MILESTONE
                        Event


C74589   C74558         Category for Disposition   OTHER EVENT
                        Event
C74590   C74558         Category for Disposition   DISPOSITION EVENT
                        Event


C76351            Yes   Skin Classification        SKINCLAS




C74569   C76351         Skin Classification        TYPE1
C74570   C76351         Skin Classification           TYPE2




C74571   C76351         Skin Classification           TYPE3



C74572   C76351         Skin Classification           TYPE4




C74573   C76351         Skin Classification           TYPE5




C74574   C76351         Skin Classification           TYPE6




C74561            Yes   Skin Type                     SKINTYP


C74591   C74561         Skin Type                     OILY


C74592   C74561         Skin Type                     DRY

C74593   C74561         Skin Type                     NORMAL

C74559            Yes   Subject Characteristic Code   SCCD




C17953   C74559         Subject Characteristic Code   EDLEVEL
C25188   C74559         Subject Characteristic Code   MARISTAT

C25193   C74559         Subject Characteristic Code   EMPJOB


C74563   C74559         Subject Characteristic Code   SKINCLAS

C74580   C74559         Subject Characteristic Code   SKINTYP

C74565   C74559         Subject Characteristic Code   JOBCLAS
C74566   C74559         Subject Characteristic Code   SALTYP


C76348            Yes   Marital Status                MARISTAT

C76240   C76348         Marital Status                ANNULLED

C51776   C76348         Marital Status                DIVORCED

C76241   C76348         Marital Status                INTERLOCUTORY

C51777   C76348         Marital Status                LEGALLY SEPARATED

C51773   C76348         Marital Status                MARRIED
C51774   C76348         Marital Status                NEVER MARRIED
C51775   C76348         Marital Status                WIDOWED
C76242   C76348         Marital Status                POLYGAMOUS
C53262   C76348         Marital Status                DOMESTIC PARTNER

C74457            Yes   Race                          RACE


C16352   C74457         Race                          BLACK OR AFRICAN AMERICAN


C41259   C74457         Race                          AMERICAN INDIAN OR ALASKA
                                                      NATIVE


C41260   C74457         Race                          ASIAN




C41219   C74457         Race                          NATIVE HAWAIIAN OR OTHER
                                                      PACIFIC ISLANDER




C41261   C74457         Race                          WHITE


C78731            Yes   Drug Accountability Test      DATEST
                        Name
C78721   C78731         Drug Accountability Test      Dispensed Amount
                        Name
C78722   C78731         Drug Accountability Test      Returned Amount
                        Name
C78732            Yes   Drug Accountability Test      DATESTCD
                        Code
C78721   C78732         Drug Accountability Test   DISPAMT
                        Code
C78722   C78732         Drug Accountability Test   RETAMT
                        Code
C78733            Yes   Specimen Condition         SPECCOND

C70717   C78733         Specimen Condition         FROZEN

C70720   C78733         Specimen Condition         HEMOLIZED


C70715   C78733         Specimen Condition         LIPEMIC

C70718   C78733         Specimen Condition         REFRIGERATED

C70719   C78733         Specimen Condition         ROOM TEMPERATURE


C78723   C78733         Specimen Condition         CALCIFIED
C78724   C78733         Specimen Condition         CLOTTED
C78725   C78733         Specimen Condition         AUTOLIZED

C78734            Yes   Specimen Type              SPECTYPE

C12472   C78734         Specimen Type              ADIPOSE TISSUE


C13188   C78734         Specimen Type              AMNIOTIC FLUID

C13190   C78734         Specimen Type              AQUEOUS HUMOR

C78729   C78734         Specimen Type              ARTERIAL BLOOD




C78739   C78734         Specimen Type              ATHEROSCLEROTIC PLAQUE

C13192   C78734         Specimen Type              BILE


C12434   C78734         Specimen Type              BLOOD




C12366   C78734         Specimen Type              BONE

C12431   C78734         Specimen Type              BONE MARROW
C13257   C78734   Specimen Type   BREAST MILK

C35708   C78734   Specimen Type   CALCULUS


C12692   C78734   Specimen Type   CEREBROSPINAL FLUID


C32293   C78734   Specimen Type   CERUMEN
C32348   C78734   Specimen Type   COLOSTRUM


C77666   C78734   Specimen Type   EMESIS

C78741   C78734   Specimen Type   EXPIRED AIR


C13233   C78734   Specimen Type   EXUDATE


C13236   C78734   Specimen Type   FLUID
C32705   C78734   Specimen Type   HAIR
C78742   C78734   Specimen Type   LOCHIA


C13273   C78734   Specimen Type   LUNG SURFACTANT




C13252   C78734   Specimen Type   LYMPH




C78743   C78734   Specimen Type   MECONIUM


C78740   C78734   Specimen Type   MENSTRUAL BLOOD


C13259   C78734   Specimen Type   MUCUS

C33156   C78734   Specimen Type   NAIL

C13356   C78734   Specimen Type   PLASMA
C50718   C78734         Specimen Type   PUS


C13275   C78734         Specimen Type   SALIVA


C13276   C78734         Specimen Type   SEBUM

C13277   C78734         Specimen Type   SEMEN




C33529   C78734         Specimen Type   SEMINAL FLUID

C13325   C78734         Specimen Type   SERUM

C33574   C78734         Specimen Type   SMEGMA

C13278   C78734         Specimen Type   SPUTUM


C13234   C78734         Specimen Type   STOOL


C13280   C78734         Specimen Type   PERSPIRATION
C12801   C78734         Specimen Type   TISSUE



C78744   C78734         Specimen Type   TRANSUDATE


C13283   C78734         Specimen Type   URINE

C78730   C78734         Specimen Type   VENOUS BLOOD




C78735            Yes   Evaluator       EVAL

C17445   C78735         Evaluator       CAREGIVER

C42708   C78735         Evaluator       CHILD
C42708   C78735         Evaluator       PARENT
C51811   C78735         Evaluator                   CLINICAL RESEARCH
                                                    COORDINATOR




C25465   C78735         Evaluator                   CLINICAL RESEARCH ASSOCIATE




C70793   C78735         Evaluator                   CLINICAL STUDY SPONSOR

C53287   C78735         Evaluator                   HEALTH CARE PROFESSIONAL


C78720   C78735         Evaluator                   INDEPENDENT ASSESSOR


C25936   C78735         Evaluator                   INVESTIGATOR



C72884   C78735         Evaluator                   FRIEND

C41189   C78735         Evaluator                   STUDY SUBJECT


C62649   C78735         Evaluator                   SPOUSE
C53262   C78735         Evaluator                   DOMESTIC PARTNER


C78726   C78735         Evaluator                   ADJUDICATION COMMITTEE


C51828   C78735         Evaluator                   GUARDIAN



C78736            Yes   Reference Range Indicator   NRIND

C78727   C78736         Reference Range Indicator   NORMAL

C78802   C78736         Reference Range Indicator   ABNORMAL

C78800   C78736         Reference Range Indicator   HIGH

C78801   C78736         Reference Range Indicator   LOW
C78737            No    Relationship Type      RELTYPE

C66832   C78737         Relationship Type      ONE
C78728   C78737         Relationship Type      MANY
C78738            Yes   Never/Current/Former   NCF
                        Classification

C70543   C78738         Never/Current/Former   NEVER
                        Classification
C25471   C78738         Never/Current/Former   CURRENT
                        Classification
C25627   C78738         Never/Current/Former   FORMER
                        Classification
CDISC Preferred Term   CDISC Synonym(s)


ACN                    Action Taken with Study
                       Treatment

DOSE INCREASED




DOSE NOT CHANGED




DOSE REDUCED




DRUG INTERRUPTED



DRUG WITHDRAWN




NOT APPLICABLE         NA
UNKNOWN                   U; Unknown




OUT                       Outcome of Event



FATAL                     Grade 5; 5




NOT RECOVERED/NOT
RESOLVED




RECOVERED/RESOLVED




RECOVERED/RESOLVED WITH
SEQUELAE




RECOVERING/RESOLVING
UNKNOWN                         U; Unknown




AGESPAN                         Age Span

ADOLESCENT (12-17 YEARS)




ADULT (18-65)


CHILDREN (2-11 YEARS)


ELDERLY (> 65)


IN UTERO




INFANT AND TODDLER (28 DAYS -
23 MONTHS)

NEWBORN (0-27 DAYS)


PRETERM NEWBORN INFANTS


AGEU                            Age Unit

DAYS
HOURS




MONTHS




WEEKS




YEARS




IECAT       Category for
            Inclusion/Exclusion



EXCLUSION
INCLUSION




SOC                           CDISC System Organ Class

BLOOD AND LYMPHATIC SYSTEM
DISORDERS

CARDIAC DISORDERS


CONGENITAL, FAMILIAL AND
GENETIC DISORDERS


EAR AND LABYRINTH
DISORDERS

ENDOCRINE DISORDERS


EYE DISORDERS



GASTROINTESTINAL DISORDERS


GENERAL DISORDERS AND
ADMINISTRATION SITE
CONDITIONS


HEPATOBILIARY DISORDERS


IMMUNE SYSTEM DISORDERS

INFECTIONS AND INFESTATIONS
INJURY, POISONING AND
PROCEDURAL COMPLICATIONS

INVESTIGATIONS




METABOLISM AND NUTRITION
DISORDERS

MUSCULOSKELETAL AND
CONNECTIVE TISSUE
DISORDERS

NEOPLASMS BENIGN,
MALIGNANT AND UNSPECIFIED
(INCL CYSTS AND POLYPS)




NERVOUS SYSTEM DISORDERS



PREGNANCY, PUERPERIUM AND
PERINATAL CONDITIONS


PSYCHIATRIC DISORDERS




RENAL AND URINARY
DISORDERS
REPRODUCTIVE SYSTEM AND
BREAST DISORDERS

RESPIRATORY, THORACIC AND
MEDIASTINAL DISORDERS


SKIN AND SUBCUTANEOUS
TISSUE DISORDERS
SOCIAL CIRCUMSTANCES


SURGICAL AND MEDICAL
PROCEDURES
VASCULAR DISORDERS



TOXGR                  Common Terminology Criteria
                       for Adverse Events




MILD                   Grade 1; 1




MODERATE               Grade 2; 2




SEVERE                 Grade 3; 3
LIFE THREATENING   Grade 4; 4




FATAL              Grade 5; 5




TCNTRL             Control Type; Type of Control




ACTIVE




NONE
PLACEBO




COUNTRY            Country




ABW                ARUBA
AFG   AFGHANISTAN




AGO   ANGOLA




AIA   ANGUILLA




ALA   ALAND ISLANDS




ALB   ALBANIA




AND   ANDORRA




ANT   NETHERLANDS ANTILLES




ARE   UNITED ARAB EMIRATES
ARG   ARGENTINA




ARM   ARMENIA




ASM   AMERICAN SAMOA




ATA   ANTARCTICA




ATF   FRENCH SOUTHERN
      TERRITORIES




ATG   ANTIGUA AND BARBUDA




AUS   AUSTRALIA




AUT   AUSTRIA
AZE   AZERBAIJAN




BDI   BURUNDI




BEL   BELGIUM




BEN   BENIN REPUBLIC




BFA   BURKINA FASO




BGD   BANGLADESH




BGR   BULGARIA




BHR   BAHRAIN
BHS   BAHAMAS




BIH   BOSNIA-HERZEGOVINA




BLR   BELARUS




BLZ   BELIZE




BMU   BERMUDA




BOL   BOLIVIA




BRA   BRAZIL




BRB   BARBADOS
BRN   BRUNEI




BTN   BHUTAN




BVT   BOUVET ISLAND




BWA   BOTSWANA




CAF   CENTRAL AFRICAN
      REPUBLIC




CAN   CANADA




CCK   COCOS (KEELING) ISLANDS




CHE   SWITZERLAND
CHL   CHILE




CHN   CHINA




CIV   COTE D'IVOIRE




CMR   CAMEROON




COD   DEMOCRATIC REPUBLIC
      OF THE CONGO




COG   CONGO




COK   COOK ISLANDS




COL   COLOMBIA
COM   COMOROS




CPV   CAPE VERDE




CRI   COSTA RICA




CUB   CUBA




CXR   CHRISTMAS ISLAND




CYM   CAYMAN ISLANDS




CYP   CYPRUS




CZE   CZECH REPUBLIC
DEU   GERMANY




DJI   DJIBOUTI




DMA   DOMINICA




DNK   DENMARK




DOM   DOMINICAN REPUBLIC



DZA   ALGERIA




ECU   ECUADOR




EGY   EGYPT




ERI   ERITREA
ESH   WESTERN SAHARA




ESP   SPAIN




EST   ESTONIA




ETH   ETHIOPIA




FIN   FINLAND




FJI   FIJI




FLK   FALKLAND ISLANDS




FRA   FRANCE
FRO   FAROE ISLANDS




FSM   MICRONESIA, FEDERATED
      STATES OF




GAB   GABON




GBR   UNITED KINGDOM




GEO   GEORGIA




GGY   GUERNSEY




GHA   GHANA




GIB   GIBRALTAR
GIN   GUINEA




GLP   GUADELOUPE




GMB   GAMBIA




GNB   GUINEA-BISSAU




GNQ   EQUATORIAL GUINEA




GRC   GREECE


GRD   GRENADA




GRL   GREENLAND




GTM   GUATEMALA
GUF   FRENCH GUIANA




GUM   GUAM




GUY   GUYANA




HKG   HKG; HONG KONG




HMD   HEARD ISLAND AND
      MCDONALD ISLANDS
HND   HONDURAS




HRV   CROATIA




HTI   HAITI




HUN   HUNGARY
IDN   INDONESIA




IND   INDIA




IOT   BRITISH INDIAN OCEAN
      TERRITORY




IRL   IRELAND




IRN   IRAN




IRQ   IRAQ




ISL   ICELAND




ISR   ISRAEL
ITA   ITALY




JAM   JAMAICA




JOR   JORDAN




JPN   JAPAN




JRE   JERSEY




KAZ   KAZAKHSTAN




KEN   KENYA




KGZ   KYRGYZSTAN
KHM   CAMBODIA




KIR   KIRIBATI




KNA   SAINT KITTS AND NEVIS




KOR   SOUTH KOREA


KWT   KUWAIT




LAO   LAO PEOPLE'S
      DEMOCRATIC REPUBLIC




LBN   LEBANON




LBR   LIBERIA




LBY   LIBYAN ARAB JAMAHIRIYA
LCA   SAINT LUCIA




LIE   LIECHTENSTEIN




LKA   SRI LANKA




LSO   LESOTHO




LTU   LITHUANIA




LUX   LUXEMBOURG




LVA   LATVIA




MAC   MACAO
MAR   MOROCCO




MCO   MONACO




MDA   MOLDOVA, REPUBLIC OF




MDG   MADAGASCAR




MDV   MALDIVES




MEX   MEXICO




MHL   MARSHALL ISLANDS




MKD   REPUBLIC OF MACEDONIA
MLI   MALI




MLT   MALTA




MMR   MYANMAR




MNE   MONTENEGRO




MNG   MONGOLIA




MNP   NORTHERN MARIANA
      ISLANDS




MOZ   MOZAMBIQUE




MRT   MAURITANIA




MSR   MONTSERRAT
MTQ   MARTINIQUE




MUS   MAURITIUS

MWI   MALAWI




MYS   MALAYSIA




MYT   MAYOTTE




NAM   NAMIBIA




NCL   NEW CALEDONIA




NER   NIGER




NFK   NORFOLK ISLAND
NGA   NIGERIA




NIC   NICARAGUA




NIU   NIUE




NLD   NETHERLANDS




NOR   NORWAY




NPL   NEPAL




NRU   NAURU




NZL   NEW ZEALAND
OMN   OMAN




PAK   PAKISTAN




PAN   PANAMA




PCN   PITCAIRN




PER   PERU




PHL   PHILIPPINES




PLW   PALAU




PNG   PAPUA NEW GUINEA
POL   POLAND




PRI   PUERTO RICO




PRK   NORTH KOREA




PRT   PORTUGAL




PRY   PARAGUAY




PSE   PALESTINIAN TERRITORY,
      OCCUPIED




PYF   FRENCH POLYNESIA




QAT   QATAR
REU   REUNION




ROU   ROMANIA




RUS   RUSSIAN FEDERATION




RWA   RWANDA




SAU   SAUDI ARABIA




SCG   SERBIA




SDN   SUDAN




SEN   SENEGAL
SGP   SINGAPORE




SGS   SOUTH GEORGIA AND THE
      SOUTH SANDWICH
      ISLANDS



SHN   SAINT HELENA




SJM   SVALBARD AND JAN
      MAYEN




SLB   SOLOMON ISLANDS




SLE   SIERRA LEONE




SLV   EL SALVADOR




SMR   SAN MARINO
SOM   SOMALIA




SPM   SAINT PIERRE AND
      MIQUELON




STP   SAO TOME AND PRINCIPE




SUR   SURINAME




SVK   SLOVAKIA




SVN   SLOVENIA




SWE   SWEDEN




SWZ   SWAZILAND
SYC   SEYCHELLES




SYR   SYRIAN ARAB REPUBLIC




TCA   TURKS AND CAICOS
      ISLANDS




TCD   CHAD




TGO   TOGO




THA   THAILAND




TJK   TAJIKISTAN




TKL   TOKELAU
TKM   TURKMENISTAN




TLS   TIMOR-LESTE




TON   TONGA

TTO   TRINIDAD AND TOBAGO




TUN   TUNISIA




TUR   TURKEY




TUV   TUVALU




TWN   TAIWAN




TZA   TANZANIA, UNITED
      REPUBLIC OF
UGA   UGANDA




UKR   UKRAINE




UMI   UNITED STATES MINOR
      OUTLYING ISLANDS



URY   URUGUAY

USA   UNITED STATES




UZB   UZBEKISTAN




VAT   VATICAN CITY STATE




VCT   SAINT VINCENT AND THE
      GRENADINES




VEN   VENEZUELA


VGB   VIRGIN ISLANDS, BRITISH
VIR   VIRGIN ISLANDS, U.S.




VNM   VIETNAM




VUT   VANUATU




WLF   WALLIS AND FUTUNA




WSM   SAMOA




YEM   YEMEN




ZAF   SOUTH AFRICA




ZMB   ZAMBIA
ZWE                ZIMBABWE




TDIGRP             Diagnosis Group




HEALTHY SUBJECTS


DICTNAM            Dictionary Name; Name of
                   Dictionary



COSTART            Coding Symbols for a
                   Thesaurus of Adverse
                   Reaction Terms
ICD                International Classification of
                   Diseases




LOINC              Logical Observation Identifiers
                   Names and Codes

MedDRA             Medical Dictionary for
                   Regulatory Activities




SNOMED             Systematized Nomenclature of
                   Medicine
WHOART                   World Health Organization
                         Adverse Reaction Terms

WHODD                    World Health Organization
                         Drug Dictionary

ND                       Not Done

NOT DONE




ETHNIC                   Patient Ethnic Group




HISPANIC OR LATINO




NOT HISPANIC OR LATINO




NOT REPORTED             Not reported




UNKNOWN                  U; Unknown
FRM                Pharmaceutical Dosage Form;
                   Dose Form




AEROSOL




AEROSOL, FOAM




AEROSOL, METERED




AEROSOL, POWDER




AEROSOL, SPRAY
BAR, CHEWABLE




BEAD




BEAD, IMPLANT, EXTENDED
RELEASE




BLOCK




CAPSULE




CAPSULE, COATED




CAPSULE, COATED PELLETS
CAPSULE, COATED, EXTENDED
RELEASE




CAPSULE, DELAYED RELEASE




CAPSULE, DELAYED RELEASE
PELLETS




CAPSULE, EXTENDED RELEASE




CAPSULE, FILM COATED,
EXTENDED RELEASE




CAPSULE, GELATIN COATED




CAPSULE, LIQUID FILLED
CEMENT




CIGARETTE




CLOTH




CONCENTRATE




CONE




CORE, EXTENDED RELEASE



CREAM
CREAM, AUGMENTED




CRYSTAL




CULTURE




DIAPHRAGM




DISC




DOUCHE




DRESSING
DRUG DELIVERY SYSTEM




ELIXIR




EMULSION




ENEMA




EXTRACT




FIBER, EXTENDED RELEASE
FILM




FILM, EXTENDED RELEASE




FILM, SOLUBLE




FOR SOLUTION




FOR SUSPENSION




FOR SUSPENSION, EXTENDED
RELEASE




GAS
GEL




GEL, DENTIFRICE




GEL, METERED




GENERATOR




GLOBULE




GRAFT
GRANULE




GRANULE, DELAYED RELEASE




GRANULE, EFFERVESCENT




GRANULE, FOR SOLUTION




GRANULE, FOR SUSPENSION




GRANULE, FOR SUSPENSION,
EXTENDED RELEASE




GUM
GUM, CHEWING




GUM, RESIN




IMPLANT




INHALANT




INJECTABLE, LIPOSOMAL




INJECTION




INJECTION, EMULSION
INJECTION, LIPID COMPLEX




INJECTION, POWDER, FOR
SOLUTION




INJECTION, POWDER, FOR
SUSPENSION




INJECTION, POWDER, FOR
SUSPENSION, EXTENDED
RELEASE




INJECTION, POWDER,
LYOPHILIZED, FOR LIPOSOMAL
SUSPENSION




INJECTION, POWDER,
LYOPHILIZED, FOR SOLUTION




INJECTION, POWDER,
LYOPHILIZED, FOR SUSPENSION
INJECTION, POWDER,
LYOPHILIZED, FOR SUSPENSION




INJECTION, POWDER,
LYOPHILIZED, FOR SUSPENSION,
EXTENDED RELEASE




INJECTION, SOLUTION




INJECTION, SOLUTION,
CONCENTRATE




INJECTION, SUSPENSION




INJECTION, SUSPENSION,
EXTENDED RELEASE




INJECTION, SUSPENSION,
SONICATED
INSERT




INSERT, EXTENDED RELEASE




INTRAUTERINE DEVICE




IRRIGANT




JELLY




KIT




LINER, DENTAL
LINIMENT




LIPSTICK




LIQUID




LIQUID, EXTENDED RELEASE




LOTION




LOTION. AUGMENTED




LOTION/SHAMPOO
LOZENGE




MOUTHWASH




NOT APPLICABLE




OIL




OINTMENT




OINTMENT, AUGMENTED
PACKING




PASTE




PASTE, DENTIFRICE




PASTILLE




PATCH




PATCH, EXTENDED RELEASE




PATCH, EXTENDED RELEASE,
ELECTRICALLY CONTROLLED
PELLET




PELLET, IMPLANTABLE




PELLETS, COATED, EXTENDED
RELEASE




PILL




PLASTER




POULTICE




POWDER
POWDER, DENTIFRICE




POWDER, FOR SOLUTION




POWDER, FOR SUSPENSION




POWDER, METERED




RING




RINSE




SALVE
SHAMPOO




SHAMPOO, SUSPENSION




SOAP




SOLUTION




SOLUTION, CONCENTRATE




SOLUTION, FOR SLUSH




SOLUTION, GEL FORMING /
DROPS
SOLUTION, GEL FORMING,
EXTENDED RELEASE




SOLUTION/ DROPS




SPONGE




SPRAY




SPRAY, METERED




SPRAY, SUSPENSION




STICK
STRIP




SUPPOSITORY




SUPPOSITORY, EXTENDED
RELEASE




SUSPENSION




SUSPENSION, EXTENDED
RELEASE




SUSPENSION/DROPS




SUTURE
SWAB




SYRUP




TABLET




TABLET, CHEWABLE




TABLET, COATED




TABLET, COATED PARTICLES




TABLET, DELAYED RELEASE
TABLET, DELAYED RELEASE
PARTICLES




TABLET, EFFERVESCENT




TABLET, EXTENDED RELEASE




TABLET, FILM COATED




TABLET, FILM COATED,
EXTENDED RELEASE




TABLET, FOR SOLUTION




TABLET, FOR SUSPENSION;
TABLET, DISPERSIBLE

TABLET, MULTILAYER
TABLET, MULTILAYER,
EXTENDED RELEASE




TABLET, ORALLY
DISINTEGRATING



TABLET, ORALLY
DISINTEGRATING, DELAYED
RELEASE




TABLET, SOLUBLE




TABLET, SUGAR COATED




TAMPON




TAPE



TINCTURE



TROCHE




UNASSIGNED
WAFER




NCOMPLT                     Completion/Reason for Non-
                            Completion
ADVERSE EVENT




COMPLETED


DEATH

LACK OF EFFICACY

LOST TO FOLLOW-UP

NON-COMPLIANCE WITH STUDY
DRUG

OTHER                       Other

PHYSICIAN DECISION


PREGNANCY




PROGRESSIVE DISEASE

PROTOCOL VIOLATION
RECOVERY


SCREEN FAILURE

STUDY TERMINATED BY
SPONSOR
TECHNICAL PROBLEMS

WITHDRAWAL BY SUBJECT


STENRF                  Relation to Reference Period

AFTER




BEFORE




DURING




DURING/AFTER




UNKNOWN                 U; Unknown




ROUTE                   Route of Administration
AURICULAR (OTIC)




BUCCAL




CONJUNCTIVAL




CUTANEOUS




DENTAL




ELECTRO-OSMOSIS




ENDOCERVICAL
ENDOSINUSIAL




ENDOTRACHEAL




ENTERAL




EPIDURAL




EXTRA-AMNIOTIC




EXTRACORPOREAL




HEMODIALYSIS
INFILTRATION




INTERSTITIAL




INTRA-ABDOMINAL




INTRA-AMNIOTIC




INTRA-ARTERIAL




INTRA-ARTICULAR




INTRABILIARY
INTRABRONCHIAL




INTRABURSAL




INTRACARDIAC




INTRACARTILAGINOUS




INTRACAUDAL




INTRACAVERNOUS




INTRACAVITARY
INTRACEREBRAL




INTRACISTERNAL




INTRACORNEAL




INTRACORONAL, DENTAL




INTRACORONARY




INTRACORPORUS CAVERNOSUM




INTRADERMAL
INTRADISCAL




INTRADUCTAL




INTRADUODENAL




INTRADURAL




INTRAEPIDERMAL




INTRAESOPHAGEAL




INTRAGASTRIC
INTRAGINGIVAL




INTRAILEAL




INTRALESIONAL




INTRALUMINAL




INTRALYMPHATIC




INTRAMEDULLARY




INTRAMENINGEAL
INTRAMUSCULAR




INTRAOCULAR




INTRAOVARIAN




INTRAPERICARDIAL




INTRAPERITONEAL




INTRAPLEURAL




INTRAPROSTATIC
INTRAPULMONARY




INTRASINAL




INTRASPINAL




INTRASYNOVIAL




INTRATENDINOUS




INTRATESTICULAR




INTRATHECAL
INTRATHORACIC




INTRATUBULAR




INTRATUMOR          Intratumor Route of
                    Administration

INTRATYMPANIC




INTRAUTERINE




INTRAVASCULAR




INTRAVENOUS




INTRAVENOUS BOLUS
INTRAVENOUS DRIP




INTRAVENTRICULAR




INTRAVESICAL




INTRAVITREAL




IONTOPHORESIS




IRRIGATION




LARYNGEAL
NASAL




NASOGASTRIC




NOT APPLICABLE




OCCLUSIVE DRESSING
TECHNIQUE

OPHTHALMIC




ORAL




OROPHARYNGEAL




OTHER
PARENTERAL




PERCUTANEOUS




PERIARTICULAR




PERIDURAL




PERINEURAL




PERIODONTAL




RECTAL
RESPIRATORY (INHALATION)




RETROBULBAR




SOFT TISSUE




SUBARACHNOID




SUBCONJUNCTIVAL




SUBCUTANEOUS




SUBLINGUAL
SUBMUCOSAL




TOPICAL




TRANSDERMAL




TRANSMUCOSAL




TRANSPLACENTAL




TRANSTRACHEAL




TRANSTYMPANIC
UNASSIGNED




UNKNOWN




URETERAL




URETHRAL




VAGINAL




AESEV        Severity/Intensity Scale for
             Adverse Events



MILD         Grade 1; 1
MODERATE   Grade 2; 2




SEVERE     Grade 3; 3




SEX        Sex



F          Female




M          Male




UNKNOWN    U; Unknown




UN         Undifferentiated

SEXPOP     Sex of Participants

BOTH
F        Female




M        Male




SIZE     Size

LARGE

MEDIUM

SMALL
DOMAIN   Domain Abbreviation




AD       Analysis Dataset




AE       Adverse Events




AU       Autopsy
BM   Bone Mineral Density (BMD)
     Data




BR   Biopsy




CM   Concomitant Meds




CO   Comments




DA   Drug Accountability




DC   Disease Characteristics




DM   Demographics
DS   Disposition




DV   Protocol Deviations




EE   Electroencephalogram




EG   Electrocardiogram




EX   Exposure




FH   Family History


HU   Healthcare Resource
     Utilization




IE   Inclusion/Exclusion
LB   Laboratory Data




MB   Microbiology




MH   Medical History




ML   Meal Data




MS   Microbiology Susceptibility




OM   Organ Measurements




PC   Pharmacokinetic
     Concentration
PE   Physical Exam




PG   Pharmacogenomics




PP   Pharmacokinetic Parameters




QS   Questionnaires




SC   Subject Characteristics




SE   Subject Element




SG   Surgery
SK   Skin Test




SL   Sleep Polysomnography Data




ST   Stress (Exercise) Test Data




SU   Substance Use




SV   Subject Visits




TA   Trial Arms




TE   TE; Trial Elements
TI             Trial Inclusion/Exclusion
               Criteria




TS             Trial Summary




TV             Trial Visits




VS             Vital Signs




TBLIND         Trial Blinding Schema

DOUBLE BLIND



OPEN LABEL


SINGLE BLIND



TINDTP         Trial Indication Type

CURE

DIAGNOSIS


MITIGATION
PREVENTION



TREATMENT


TPHASE               Trial Phase




Phase I Trial        Trial Phase 1; 1




Phase I/II Trial     Trial Phase 1-2; 1-2


Phase II Trial       Trial Phase 2; 2




Phase II/III Trial   Trial Phase 2-3; 2-3
Phase IIa Trial    Trial Phase 2A; 2A


Phase IIb Trial    Trial Phase 2B; 2B




Phase III Trial    Trial Phase 3; 3




Phase IIIaTrial    Trial Phase 3A; 3A


Phase IIIb Trial   Trial Phase 3B; 3B




Phase IV Trial     Trial Phase 4; 4




Phase V Trial      Trial Phase 5; 5

NOT APPLICABLE     NA

TSPARMCD           Trial Summary Parameter
                   Test Code

ADDON              Added on to Existing
                   Treatments

AEDICT             Adverse Event Dictionary
AGEMAX     Planned Maximum Age of
           Subjects
AGEMIN     Planned Minimum Age of
           Subjects
AGESPAN    Age Span


AGEU       Age Unit

DOSE       Dose per Administration


DRUGDICT   Drug Dictionary

LENGTH     Trial Length

MHDICT     Medical History Dictionary

PLANSUB    Planned Number of Subjects

RANDOM     Trial is Randomized




ROUTE      Route of Administration

SEXPOP     Sex of Participants

STOPRULE   Study Stop Rules

TBLIND     Trial Blinding Schema

TCNTRL     Control Type



TDIGRP     Diagnosis Group




TINDTP     Trial Indication Type

TITLE      Trial Title
TPHASE     Trial Phase Classification




TTYPE      Trial Type

TSPARM     Trial Summary Parameter
           Test Name

ADDON      Added on to Existing
           Treatments

AEDICT     Adverse Event Dictionary

AGEMAX     Planned Maximum Age of
           Subjects
AGEMIN     Planned Minimum Age of
           Subjects
AGESPAN    Age Group

AGEU       Age Unit

DOSE       Dose per Administration


DRUGDICT   Drug Dictionary

LENGTH     Trial Length

MHDICT     Medical History Dictionary



PLANSUB    Planned Number of Subjects

RANDOM     Trial is Randomized




ROUTE      Route of Administration




SEXPOP     Sex of Participants

STOPRULE   Study Stop Rules
TBLIND             Trial Blinding Schema


TCNTRL             Control Type



TDIGRP             Diagnosis Group




TINDTP             Trial Indication Type



TITLE              Trial Title



TPHASE             Trial Phase Classification




TTYPE              Trial Type



TTYPE              Trial Type

BIO-AVAILABILITY




BIO-EQUIVALENCE




EFFICACY



PHARMACODYNAMIC
PHARMACOECONOMIC




PHARMACOGENOMIC




PHARMACOKINETIC


SAFETY

VSRESU             Units for Vital Signs Results



%                  Percentage

BEATS/MIN          Beats per Minute




BREATHS/MIN        Breaths per Minute




C                  Degree Celsius




cm                 Centimeter
F          Degree Fahrenheit




g          Gram

IN         Inch




kg         Kilogram




kg/m2      Kilogram Per Square Meter

LB         Pound


m2         Square Meter



mmHg       Millimeter of Mercury


ohm        ohm




VSTESTCD   Vital Signs Test Code


BMI        Body Mass Index
BODYFAT   Adipose Tissue




BSA       Body Surface Area




DIABP     Diastolic Blood Pressure




FRMSIZE   Body Frame Size




HEIGHT    Height




HR        Heart Rate




MAP       Mean Arterial Pressure
PULSE    Pulse Rate




RESP     Respiratory Rate




SYSBP    Systolic Blood




TEMP     Temperature




WEIGHT   Weight




VSTEST   Vital Signs Test Name



BMI      Body Mass Index
BODYFAT   Adipose Tissue




BSA       Body Surface Area




DIABP     Diastolic Blood Pressure




FRMSIZE   Body Frame Size




HEIGHT    Height


HR        Heart Rate




MAP       Mean Arterial Pressure
PULSE            Pulse Rate




RESP             Respiratory Rate




SYSBP            Systolic Blood Pressure




TEMP             Temperature




WEIGHT           Weight




NY               No Yes Response




N                No




NOT APPLICABLE   NA
UNKNOWN    U; Unknown




Y          Yes




LBTESTCD   Laboratory Test Code


ANISO      Anisocytosis

POIKILO    Poikilocytes

BILI       Bilirubin

APTT       Activated Partial
           Thromboplastin Time


GLUC       Glucose
PH         pH

RBC        Erythrocytes

RETI       Reticulocytes

WBC        Leukocytes

LYM        Lymphocytes

PLAT       Platelet
BUN        Blood Urea Nitrogen

CHOL       Cholesterol

HDL        HDL Cholesterol

LDL        LDL Cholesterol

PT         Prothrombin Time
NEUT      Neutrophils

ALB       Albumin

ALP       Alkaline Phosphatase

ALT       Alanine Aminotransferase

AMYLASE   Amylase

AST       Aspartate Aminotransferase

BACT      Bacteria
BASO      Basophils
BASOLE    Basophils/Leukocytes

BILDIR    Direct Bilirubin

BILIND    Indirect Bilirubin

BLASTLE   Blasts/Leukocytes

CA        Calcium
CK        Creatine Kinase

CKBB      Creatine Kinase BB

CKMB      Creatine Kinase MB

CKMM      Creatine Kinase MM

CL        Chloride
CO2       Carbon Dioxide

COLOR     Color
CREAT     Creatinine
CRP       C Reactive Protein

ELLIPCY   Elliptocytes

EOS       Eosinophils

EOSLE     Eosinophils/Leukocytes

EPIC      Epithelial Cells

FIBRINO   Fibrinogen
HCT       Hematocrit

MCH       Ery. Mean Corpuscular
          Hemoglobin
MCHC      Ery. Mean Corpuscular HB
          Concentration

MCV       Ery. Mean Corpuscular
          Volume
RDW       Erythrocytes Distribution Width


TEARDCY   Dacryocytes
HYPO      Hypochromia


POLYCHR   Polychromasia

INR       Prothrombin Intl. Normalized
          Ratio



VLDL      VLDL Cholesterol

LIPASE    Triacylglycerol Lipase

SODIUM    Sodium
NITRITE   Nitrite
TRIG      Triglycerides

TSH       Thyrotropin

URATE     Urate
UREA      Urea
UROBIL    Urobilinogen

VITB12    Vitamin B12
LYMAT     Lymphocytes Atypical

LYMATLE   Lymphocytes
          Atypical/Leukocytes
LYMLE     Lymphocytes/Leukocytes

MACROCY   Macrocytes

MICROCY   Microcytes

MONO      Monocytes

MONOLE    Monocytes/Leukocytes

MYBLALE   Myeloblasts/Leukocytes
MYCYLE     Myelocytes/Leukocytes

NEUTLE     Neutrophils/Leukocytes


RETIRBC    Reticulocytes/Erythrocytes

PRLYMLE    Prolymphocytes/Leukocytes

NEUTB      Neutrophils Band Form

NEUTBLE    Neutrophils Band
           Form/Leukocytes
SPGRAV     Specific Gravity
MG         Magnesium

GGT        Gamma Glutamyl Transferase

HGB        Hemoglobin

HBA1C      Hemoglobin A1C

HBSAG      Hepatitis B Virus Surface
           Antigen
HCG        Choriogonadotropin Beta

K          Potassium

KETONES    Ketones
LDH        Lactate Dehydrogenase

LEUKASE    Leukocyte Esterase

PHOS       Phosphate

PROT       Protein


PSA        Prostate Specific Antigen

CREATCLR   Creatinine Clearance


HAIRYCE    Hairy Cells


BLAST      Blasts

CD19       CD19

CD3        CD3
CD4        CD4

CD8        CD8

DOHLE      Dohle Bodies


ESR        Erythrocyte Sedimentation
           Rate

HYPSEGCE   Hypersegmented Cells

LYMMCE     Lymphoma Cells

MAYHEG     May-Hegglin Anomaly

METAMY     Metamyelocytes


PAPPEN     Pappenheimer Bodies


PELGERH    Pelger Huet Anomaly

LYMPL      Plasmacytoid Lymphocytes;
           Plymphocytes


PLSPCE     Precursor Plasma Cells;
           Plasmablast

PROLYM     Prolymphocytes

PROMONO    Promonocytes

PROMY      Promyelocytes

ROULEAUX   Rouleaux Formation

SEZCE      Sezary Cells

SCKLCE     Sickle Cells

SMDGCE     Smudge Cells; Basket Cells

NEUTVAC    Vacuolated Neutrophils

BLASTLM    Leukemic Blasts;
           Lymphocytes; Lymphoblasts;
           Immunoblastic
MONOBL     Monoblasts

MYBLA      Myeloblasts

ACANTRBC   Acanthocytes/Erythrocytes

BTECERBC   Bite Cells/Erythrocytes



CD19LY     CD19/Lymphocytes

CD3LY      CD3/Lymphocytes

CD4CD8     CD4/CD8

CD4LY      CD4/Lymphocytes

CD8LY      CD8/Lymphocytes

HRYCELY    Hairy Cells/Lymphocytes


BLSTLMLY   Leukemic Blasts/Lymphocytes


MLIGCEBC   Malignant Cells, NOS/Blood
           Cells

METAMYLE   Metamyelocytes/Leukocytes



MONOBLLE   Monoblasts/Leukocytes

RBCNURBC   Nucleated
           Erythrocytes/Erythrocytes

LYMPLLY    Plasmacytoid
           Lymphocytes/Lymphocytes



POIKRBC    Poikilocytes/Erythrocytes


PLSPCELY   Precursor Plasma
           Cells/Lymphocytes
PROLYMLY   Prolymphocytes/Lymphocytes


PROMONLE   Promonocytes/Leukocytes

PROMYLE    Promyelocytes/Leukocytes


LYMRCTLY   Reactive
           Lymphocytes/Lymphocytes



SEZCELY    Sezary Cells/Lymphocytes


SCKCERBC   Sickle Cells/Erythrocytes


AUERRODS   Auer Rods



HELMETCE   Helmet Cells


LGUNSCE    Large Unstained Cells



MLIGCE     Malignant Cells, NOS

PLSMCE     Mature Plasma Cells;
           Plasmacytes
MYCY       Myelocytes

SPERM      Spermatozoa

YEAST      Yeast Cells

CYAMORPH   Amorphous Crystals


AMORPHSD   Amorphous Sediment

BICARB     Bicarbonate; HCO3

CYBILI     Bilirubin Crystals

CYCACAR    Calcium Carbonate Crystals
CYCAOXA    Calcium Oxalate Crystals

CYCAPHOS   Calcium Phosphate Crystals

CYCHOL     Cholesterol Crystals

CRYSTALS   Crystals

CYCYSTIN   Cystine Crystals

FOLICAC    Folic Acid; Vitamin B9
CARNITF    Carnitine, Free

FRUCT      Fructosamine; Glycated
           Serum Protein
IRON       Iron; FE
CYLEUC     Leucine Crystals

CYMSU      Monosodium Urate Crystals

CARNIT     Carnitine

CYTYRO     Tyrosine Crystals

CYURIAC    Uric Acid Crystals

ANIONG     Anion Gap


OCCBLD     Occult Blood

AMPHET     Amphetamine

BARB       Barbiturate

CANNAB     Cannabinoids

COCAINE    Cocaine

EPIROCE    Round Epithelial Cells

ACANT      Acanthocytes

BITECE     Bite Cells


BURRCE     Burr Cells; Keratocytes
CABOT     Cabot Rings


CRENCE    Crenated Cells; Echinocytes



HOWJOL    Howell-Jolly Bodies



RBCNUC    Nucleated Erythrocytes


SCHISTO   Schistocytes

SPHERO    Spherocytes

STOMCY    Stomatocytes


HEINZ     Heinz Bodies; Heinz-Erhlich
          Bodies

HASAB     Hepatitis A Virus Surface
          Antibody
HBSAB     Hepatitis B Virus Surface
          Antibody
HCSAB     Hepatitis C Virus Surface
          Antibody
HIV1AB    HIV-1 Antibody

HIV12AB   HIV-1/2 Antibody

HIV2AB    HIV-2 Antibody

RPR       Rapid Plasma Reagin


RF        Rheumatoid Factor

IBCT      Total Iron Binding Capacity

IBCU      Unsaturated Iron Binding
          Capacity
MUCTHR    Mucous Threads

TURB      Turbidity
HAVPCR    HAV PCR Viral Load

HBVPCR    HBV PCR Viral Load
HCVPCR     HCV PCR Viral Load

HIVPCR     HIV PCR Viral Load

PLATGNT    Giant Platelets

PLATLRG    Large Platelets

MPV        Mean Platelet Volume

ALDOLASE   Aldolase

AFP        Alpha Fetoprotein

APOA1      Apolipoprotein A1

APOB       Apolipoprotein B

BNP        Brain Natriuretic Peptide; B-
           Type Natriuretic Peptide
CPEPTIDE   C-peptide

FERRITIN   Ferritin
GLOBUL     Globulin

GLUTAM     Glutamate
HAPTOG     Haptoglobin

HOMOCY     Homocysteine

NTELOP     N-telopeptide

OSTEOC     Osteocalcin

SHBG       Sex Hormone Binding
           Globulin; Sex Hormone
           Binding Protein
TBG        Thyroxine Binding Globulin

T3         Triiodothyronine

T3UP       Triiodothyronine Uptake

TROPONI    Troponin I

TROPONT    Troponin T

TNF        Tumor Necrosis Factor

BUNCREAT   BUN/Creatinine Ratio
CYHIPPAC   Hippuric Acid Crystals

CYSULFA    Sulfa Crystals

CYTRPHOS   Triple Phosphate Crystals

CYUNCLA    Unclassified Crystals

CYAMMBIU   Ammonium Biurate Crystals

CYAMMOX    Ammonium Oxalate Crystals

ALBCREAT   Albumin/Creatinine Ratio;
           Microalbumin/Creatinine Ratio

CSBACT     Bacterial Casts

CASTS      Casts

CSCELL     Cellular Casts


CSGRANC    Granular Coarse Casts

CSFAT      Fatty Casts

FGRANCS    Fine Granular Casts

CSGRAN     Granular Casts

CSGRANF    Granular Fine Casts

CSHYAL     Hyaline Casts

CSMIX      Mixed Casts

CSRBC      RBC Casts

EPISQCE    Squamous Epithelial Cells

EPISQTCE   Squamous Transitional
           Epithelial Cells; Epithelial Cells

EPITUCE    Tubular Epithelial Cells

CSUNCLA    Unclassified Casts

CSWAX      Waxy Casts

CSWBC      WBC Casts
CSEPI      Epithelial Casts

ACTH       Adrenocorticotropic Hormone

CORTISOL   Cortisol
ESTRDIOL   Estradiol
FSH        Follicle Stimulating Hormone

PTHFG      Parathyroid Hormone,
           Fragmented
TESTOSFR   Testosterone, Free

T4FR       Thyroxin, Free; Free T4

T3FR       Triiodothyronine, Free; Free
           T3
INSULIN    Insulin
PTHI       Parathyroid Hormone, Intact

LH         Luteinizing Hormone

PROGEST    Progesterone

SOMATRO    Somatotropin; Growth
           Hormone;
TESTOS     Testosterone

T4         Thyroxine

OPIATE     Opiate

LYMMCELY   Lymphoma Cells/Lymphocytes


PLSMCELY   Mature Plasma
           Cells/Lymphocytes

CYACIDU    Acid Urate Crystals

ADSDNA     Anti-Double Stranded DNA

ANA        Antinuclear Antibodies


NCTD5P     5 Prime Nucleotidase, 5'-
           Ribonucleotide
           Phosphohydrolase
SIXMAM     6-Monoacetylmorphine

ACH        Acetylcholine
ADPNCTN    Adiponectin

ALBGLOB    Albumin/Globulin Ratio

ALDSTRN    Aldosterone

ALPCREAT   Alkaline
           Phosphatase/Creatinine

GSTAL      Alpha Glutathione-S-
           Transferase
AMMONIA    Ammonia, NH3
ANDSTNDL   Androstenediol

ANDSTNDN   Androstenedione, 4-
           Androstenedione
ANGTNS1    Angiotensin I

ANGTNS2    Angiotensin II

ANGTNSGN   Angiotensinogen, Angiotensin
           Precursor
ANTIDPRS   Antidepressants

ADH        Antidiuretic Hormone,
           Vasopressin
ANP        Atrial Natriuretic Peptide,
           Atriopeptin
BNZDZPN    Benzodiazepine

BILEAC     Bile Acid, Bile Salts, Bile
           Acids, Bile Salt
BTECERBC   Bite Cells/Erythrocytes



CLCTONN    Calcitonin

CLCTRIOL   Calcitriol

CACREAT    Calcium/Creatinine

CLCREAT    Chloride/Creatinine

CCK        Cholecystokinin,
           Pancreozymin
CODEINE    Codeine

CRTRONE    Corticosterone
CRH        Corticotropin Releasing
           Hormone, Corticotropin
           Releasing Factor
CKBBCK     Creatine Kinase BB/Total
           Creatine Kinase

CKMBCK     Creatine Kinase MB/Total
           Creatine Kinase

CKMMCK     Creatine Kinase MM/Total
           Creatine Kinase

DHEA       Dehydroepiandrosterone,
           Dehydroisoandrosterone
DPD        Deoxypyridinoline

DPDCREAT   Deoxypyridinoline/Creatinine

DIHYDCDN   Dihydrocodeine

DHT        Dihydrotestosterone,
           Androstanalone
DOPAMINE   Dopamine

EPIN       Epinephrine, Adrenaline

EPO        Erythropoietin, Hematopoietin

ESTRIOL    Estriol, Oestriol

ESTRONE    Estrone, Oestrone

ETHANOL    Ethanol, Alcohol

GGTCREAT   Gamma Glutamyl
           Transferase/Creatinine

GASTRIN    Gastrin

GLUCAGON   Glucagon

GLUCCRT    Glucose/Creatinine

GLDH       Glutamate Dehydrogenase

GSTCREAT   Glutathione-S-
           Transferase/Creatinine

GNRH       Gonadotropin Releasing
           Hormone, Luteinising
           Hormone Releasing Hormone
GRWHIH     Growth Hormone Inhibiting
           Hormone, Somatostatin
GRWH       Growth Hormone,
           Somatotropin
GRWHRH     Growth Hormone Releasing
           Hormone, Somatocrinin
HVA        Homovanillic Acid

HYDCDN     Hydrocodone

HYDMRPHN   Hydromorphone

IGF1       Insulin-like Growth Factor-1

IGF2       Insulin-like Growth Factor-2

INTLK1     Interleukin 1

INTLK10    Interleukin 10

INTLK11    Interleukin 11

INTLK12    Interleukin 12

INTLK13    Interleukin 13

INTLK14    Interleukin 14

INTLK15    Interleukin 15

INTLK16    Interleukin 16

INTLK17    Interleukin 17

INTLK18    Interleukin 18

INTLK19    Interleukin 19

INTLK2     Interleukin 2

INTLK20    Interleukin 20

INTLK21    Interleukin 21

INTLK22    Interleukin 22

INTLK23    Interleukin 23

INTLK24    Interleukin 24

INTLK25    Interleukin 25
INTLK26    Interleukin 26

INTLK27    Interleukin 27

INTLK28    Interleukin 28

INTLK29    Interleukin 29

INTLK3     Interleukin 3

INTLK30    Interleukin 30

INTLK31    Interleukin 31

INTLK32    Interleukin 32

INTLK33    Interleukin 33

INTLK4     Interleukin 4

INTLK5     Interleukin 5

INTLK6     Interleukin 6

INTLK7     Interleukin 7

INTLK8     Interleukin 8

INTLK9     Interleukin 9

LDH1       LDH Isoenzyme 1

LDH2       LDH Isoenzyme 2

LDH3       LDH Isoenzyme 3

LDH4       LDH Isoenzyme 4

LDH5       LDH Isoenzyme 5

LDHCREAT   Lactate
           Dehydrogenase/Creatinine
LACTICAC   Lactic Acid, 2-
           hydroxypropanoic acid,
           Lactate
LGLUCLE    Large Unstained
           Cells/Leukocytes

LDH1LDH    LDH Isoenzyme 1/LDH
LDH2LDH    LDH Isoenzyme 2/LDH


LDH3LDH    LDH Isoenzyme 3/LDH


LDH4LDH    LDH Isoenzyme 4/LDH


LDH5LDH    LDH Isoenzyme 5/LDH


LEPTIN     Leptin

MGCREAT    Magnesium/Creatinine

MLATONIN   Melatonin

METHDN     Methadone

METHQLDN   Methaqualone

MORPHINE   Morphine

GSTMU      Mu Glutathione-S-Transferase

GSTMUCRT   Mu Glutathione-S-
           Transferase/Creatinine

MGB        Myoglobin
NAG        N-Acetyl Glucosamide, N-
           Acetyl Glucosamine
NAGCREAT   N-Acetyl
           Glucosamide/Creatinine
NPY        Neuropeptide Y

NOREPIN    Norepinephrine, Noradrenaline

OSMLTY     Osmolality

OXYCDN     Oxycodone, Oxycontin

OXYTOCIN   Oxytocin, Oxytoxin

PCP        Phencyclidine,
           Phenylcyclohexylpiperidine
PHENTHZ    Phenothiazine,
           Dibenzothiazine
PHOSCRT    Phosphate/Creatinine

KCREAT     Potassium/Creatinine
PROLCTN    Prolactin

PROPOX     Propoxyphene

PROTCRT    Protein/Creatinine

PSDEPHD    Pseudoephedrine

LYMRCT     Reactive Lymphocytes


RENIN      Renin, Angiotensinogenase
SECRETIN   Secretin

SRTONIN    Serotonin

NACREAT    Sodium/Creatinine

SDH        Sorbitol Dehydrogenase

THRMPTN    Thrombopoietin

TRH        Thyrotropin Releasing
           Hormone, Thyrotropin
           Releasing Factor
VMA        Vanillyl Mandelic Acid,
           Vanilmandelic Acid
VITA       Vitamin A, Retinol
VITB1      Thiamine, Vitamin B1
VITB17     Vitamin B17, Amygdalin
VITB2      Riboflavin, Vitamin B2
VITB3      Niacin, Vitamin B3
VITB5      Vitamin B5, Pantothenic Acid

VITB6      Vitamin B6, Pyridoxine

VITB7      Vitamin B7, Biotin

VITC       Vitamin C, Ascorbic Acid
VITD2      Vitamin D2, Ergocalciferol

VITD3      Vitamin D3, Cholecalciferol

VITE       Vitamin E, Tocopherol
VITK       Vitamin K, Naphthoquinone
VOLUME     Volume
LBTEST     Laboratory Test Name


ANISO      Anisocytosis
POIKILO   Poikilocytes

BILI      Bilirubin

APTT      Activated Partial
          Thromboplastin Time


GLUC      Glucose
PH        pH

RBC       Erythrocytes

RETI      Reticulocytes

WBC       Leukocytes

LYM       Lymphocytes

PLAT      Platelet
BUN       Blood Urea Nitrogen

CHOL      Cholesterol

HDL       HDL Cholesterol

LDL       LDL Cholesterol

PT        Prothrombin Time


NEUT      Neutrophils

ALB       Albumin

ALP       Alkaline Phosphatase

ALT       Alanine Aminotransferase

AMYLASE   Amylase

AST       Aspartate Aminotransferase

BACT      Bacteria
BASO      Basophils
BASOLE    Basophils/Leukocytes

BILDIR    Direct Bilirubin

BILIND    Indirect Bilirubin
BLASTLE   Blasts/Leukocytes

CA        Calcium
CK        Creatine Kinase

CKBB      Creatine Kinase BB

CKMB      Creatine Kinase MB

CKMM      Creatine Kinase MM

CL        Chloride
CO2       Carbon Dioxide

COLOR     Color
CREAT     Creatinine
CRP       C Reactive Protein

ELLIPCY   Elliptocytes

EOS       Eosinophils

EOSLE     Eosinophils/Leukocytes

EPIC      Epithelial Cells

FIBRINO   Fibrinogen
HCT       Hematocrit

MCH       Ery. Mean Corpuscular
          Hemoglobin
MCHC      Ery. Mean Corpuscular HB
          Concentration

MCV       Ery. Mean Corpuscular
          Volume
RDW       Erythrocytes Distribution Width


TEARDCY   Dacryocytes
HYPO      Hypochromia


POLYCHR   Polychromasia

INR       Prothrombin Intl. Normalized
          Ratio
VLDL      VLDL Cholesterol

LIPASE    Triacylglycerol Lipase

SODIUM    Sodium
NITRITE   Nitrite
TRIG      Triglycerides

TSH       Thyrotropin

URATE     Urate
UREA      Urea
UROBIL    Urobilinogen

VITB12    Vitamin B12
LYMAT     Lymphocytes Atypical

LYMATLE   Lymphocytes
          Atypical/Leukocytes
LYMLE     Lymphocytes/Leukocytes

MACROCY   Macrocytes

MICROCY   Microcytes

MONO      Monocytes

MONOLE    Monocytes/Leukocytes

MYBLALE   Myeloblasts/Leukocytes

MYCYLE    Myelocytes/Leukocytes

NEUTLE    Neutrophils/Leukocytes


RETIRBC   Reticulocytes/Erythrocytes

PRLYMLE   Prolymphocytes/Leukocytes

NEUTB     Neutrophils Band Form

NEUTBLE   Neutrophils Band
          Form/Leukocytes
SPGRAV    Specific Gravity
MG        Magnesium

GGT       Gamma Glutamyl Transferase

HGB       Hemoglobin
HBA1C      Hemoglobin A1C

HBSAG      Hepatitis B Virus Surface
           Antigen
HCG        Choriogonadotropin Beta

K          Potassium

KETONES    Ketones
LDH        Lactate Dehydrogenase

LEUKASE    Leukocyte Esterase

PHOS       Phosphate

PROT       Protein


PSA        Prostate Specific Antigen

CREATCLR   Creatinine Clearance


HAIRYCE    Hairy Cells


BLAST      Blasts

CD19       CD19

CD3        CD3

CD4        CD4

CD8        CD8

DOHLE      Dohle Bodies


ESR        Erythrocyte Sedimentation
           Rate

HYPSEGCE   Hypersegmented Cells

LYMMCE     Lymphoma Cells

MAYHEG     May-Hegglin Anomaly

METAMY     Metamyelocytes
PAPPEN     Pappenheimer Bodies


PELGERH    Pelger Huet Anomaly

LYMPL      Plasmacytoid Lymphocytes;
           Plymphocytes


PLSPCE     Precursor Plasma Cells;
           Plasmablast

PROLYM     Prolymphocytes

PROMONO    Promonocytes

PROMY      Promyelocytes

ROULEAUX   Rouleaux Formation

SEZCE      Sezary Cells

SCKLCE     Sickle Cells

SMDGCE     Smudge Cells; Basket Cells

NEUTVAC    Vacuolated Neutrophils

BLASTLM    Leukemic Blasts;
           Lymphocytes; Lymphoblasts;
           Immunoblastic

MONOBL     Monoblasts

MYBLA      Myeloblasts

ACANTRBC   Acanthocytes/Erythrocytes

BTECERBC   Bite Cells/Erythrocytes



CD19LY     CD19/Lymphocytes

CD3LY      CD3/Lymphocytes

CD4CD8     CD4/CD8

CD4LY      CD4/Lymphocytes

CD8LY      CD8/Lymphocytes
HRYCELY    Hairy Cells/Lymphocytes


BLSTLMLY   Leukemic Blasts/Lymphocytes


MLIGCEBC   Malignant Cells, NOS/Blood
           Cells

METAMYLE   Metamyelocytes/Leukocytes



MONOBLLE   Monoblasts/Leukocytes

RBCNURBC   Nucleated
           Erythrocytes/Erythrocytes

LYMPLLY    Plasmacytoid
           Lymphocytes/Lymphocytes



POIKRBC    Poikilocytes/Erythrocytes


PLSPCELY   Precursor Plasma
           Cells/Lymphocytes


PROLYMLY   Prolymphocytes/Lymphocytes


PROMONLE   Promonocytes/Leukocytes

PROMYLE    Promyelocytes/Leukocytes


LYMRCTLY   Reactive
           Lymphocytes/Lymphocytes



SEZCELY    Sezary Cells/Lymphocytes


SCKCERBC   Sickle Cells/Erythrocytes
AUERRODS   Auer Rods



HELMETCE   Helmet Cells


LGUNSCE    Large Unstained Cells



MLIGCE     Malignant Cells, NOS

PLSMCE     Mature Plasma Cells;
           Plasmacytes
MYCY       Myelocytes

SPERM      Spermatozoa

YEAST      Yeast Cells

CYAMORPH   Amorphous Crystals


AMORPHSD   Amorphous Sediment

BICARB     Bicarbonate; HCO3

CYBILI     Bilirubin Crystals

CYCACAR    Calcium Carbonate Crystals

CYCAOXA    Calcium Oxalate Crystals

CYCAPHOS   Calcium Phosphate Crystals

CYCHOL     Cholesterol Crystals

CRYSTALS   Crystals

CYCYSTIN   Cystine Crystals

FOLICAC    Folic Acid; Vitamin B9
CARNITF    Carnitine, Free

FRUCT      Fructosamine; Glycated
           Serum Protein
IRON       Iron; FE
CYLEUC     Leucine Crystals

CYMSU      Monosodium Urate Crystals
CARNIT    Carnitine

CYTYRO    Tyrosine Crystals

CYURIAC   Uric Acid Crystals

ANIONG    Anion Gap


OCCBLD    Occult Blood

AMPHET    Amphetamine

BARB      Barbiturate

CANNAB    Cannabinoids

COCAINE   Cocaine

EPIROCE   Round Epithelial Cells

ACANT     Acanthocytes

BITECE    Bite Cells


BURRCE    Burr Cells; Keratocytes



CABOT     Cabot Rings


CRENCE    Crenated Cells; Echinocytes



HOWJOL    Howell-Jolly Bodies



RBCNUC    Nucleated Erythrocytes


SCHISTO   Schistocytes

SPHERO    Spherocytes

STOMCY    Stomatocytes
HEINZ      Heinz Bodies; Heinz-Erhlich
           Bodies

HASAB      Hepatitis A Virus Surface
           Antibody
HBSAB      Hepatitis B Virus Surface
           Antibody
HCSAB      Hepatitis C Virus Surface
           Antibody
HIV1AB     HIV-1 Antibody

HIV12AB    HIV-1/2 Antibody

HIV2AB     HIV-2 Antibody

RPR        Rapid Plasma Reagin


RF         Rheumatoid Factor

IBCT       Total Iron Binding Capacity

IBCU       Unsaturated Iron Binding
           Capacity
MUCTHR     Mucous Threads

TURB       Turbidity
HAVPCR     HAV PCR Viral Load

HBVPCR     HBV PCR Viral Load

HCVPCR     HCV PCR Viral Load

HIVPCR     HIV PCR Viral Load

PLATGNT    Giant Platelets

PLATLRG    Large Platelets

MPV        Mean Platelet Volume

ALDOLASE   Aldolase

AFP        Alpha Fetoprotein

APOA1      Apolipoprotein A1

APOB       Apolipoprotein B

BNP        Brain Natriuretic Peptide; B-
           Type Natriuretic Peptide
CPEPTIDE   C-peptide

FERRITIN   Ferritin
GLOBUL     Globulin

GLUTAM     Glutamate
HAPTOG     Haptoglobin

HOMOCY     Homocysteine

NTELOP     N-telopeptide

OSTEOC     Osteocalcin

SHBG       Sex Hormone Binding
           Globulin; Sex Hormone
           Binding Protein
TBG        Thyroxine Binding Globulin

T3         Triiodothyronine

T3UP       Triiodothyronine Uptake

TROPONI    Troponin I

TROPONT    Troponin T

TNF        Tumor Necrosis Factor

BUNCREAT   BUN/Creatinine Ratio


CYHIPPAC   Hippuric Acid Crystals

CYSULFA    Sulfa Crystals

CYTRPHOS   Triple Phosphate Crystals

CYUNCLA    Unclassified Crystals

CYAMMBIU   Ammonium Biurate Crystals

CYAMMOX    Ammonium Oxalate Crystals

ALBCREAT   Albumin/Creatinine Ratio;
           Microalbumin/Creatinine Ratio

CSBACT     Bacterial Casts

CASTS      Casts
CSCELL     Cellular Casts


CSGRANC    Granular Coarse Casts

CSFAT      Fatty Casts

FGRANCS    Fine Granular Casts

CSGRAN     Granular Casts

CSGRANF    Granular Fine Casts

CSHYAL     Hyaline Casts

CSMIX      Mixed Casts

CSRBC      RBC Casts

EPISQCE    Squamous Epithelial Cells

EPISQTCE   Squamous Transitional
           Epithelial Cells; Epithelial Cells

EPITUCE    Tubular Epithelial Cells

CSUNCLA    Unclassified Casts

CSWAX      Waxy Casts

CSWBC      WBC Casts

CSEPI      Epithelial Casts

ACTH       Adrenocorticotropic Hormone

CORTISOL   Cortisol
ESTRDIOL   Estradiol
FSH        Follicle Stimulating Hormone

PTHFG      Parathyroid Hormone,
           Fragmented
TESTOSFR   Testosterone, Free

T4FR       Thyroxin, Free; Free T4

T3FR       Triiodothyronine, Free; Free
           T3
INSULIN    Insulin
PTHI       Parathyroid Hormone, Intact
LH         Luteinizing Hormone

PROGEST    Progesterone

SOMATRO    Somatotropin; Growth
           Hormone;
TESTOS     Testosterone

T4         Thyroxine

OPIATE     Opiate

LYMMCELY   Lymphoma Cells/Lymphocytes


PLSMCELY   Mature Plasma
           Cells/Lymphocytes

CYACIDU    Acid Urate Crystals

ADSDNA     Anti-Double Stranded DNA

ANA        Antinuclear Antibodies


NCTD5P     5 Prime Nucleotidase, 5'-
           Ribonucleotide
           Phosphohydrolase
SIXMAM     6-Monoacetylmorphine

ACH        Acetylcholine

ADPNCTN    Adiponectin

ALBGLOB    Albumin/Globulin Ratio

ALDSTRN    Aldosterone

ALPCREAT   Alkaline
           Phosphatase/Creatinine

GSTAL      Alpha Glutathione-S-
           Transferase
AMMONIA    Ammonia, NH3
ANDSTNDL   Androstenediol

ANDSTNDN   Androstenedione, 4-
           Androstenedione
ANGTNS1    Angiotensin I

ANGTNS2    Angiotensin II
ANGTNSGN   Angiotensinogen, Angiotensin
           Precursor
ANTIDPRS   Antidepressants

ADH        Antidiuretic Hormone,
           Vasopressin
ANP        Atrial Natriuretic Peptide,
           Atriopeptin
BNZDZPN    Benzodiazepine

BILEAC     Bile Acid, Bile Salts, Bile
           Acids, Bile Salt
BTECERBC   Bite Cells/Erythrocytes



CLCTONN    Calcitonin

CLCTRIOL   Calcitriol

CACREAT    Calcium/Creatinine

CLCREAT    Chloride/Creatinine

CCK        Cholecystokinin,
           Pancreozymin
CODEINE    Codeine

CRTRONE    Corticosterone

CRH        Corticotropin Releasing
           Hormone, Corticotropin
           Releasing Factor
CKBBCK     Creatine Kinase BB/Total
           Creatine Kinase

CKMBCK     Creatine Kinase MB/Total
           Creatine Kinase

CKMMCK     Creatine Kinase MM/Total
           Creatine Kinase

DHEA       Dehydroepiandrosterone,
           Dehydroisoandrosterone
DPD        Deoxypyridinoline

DPDCREAT   Deoxypyridinoline/Creatinine

DIHYDCDN   Dihydrocodeine

DHT        Dihydrotestosterone,
           Androstanalone
DOPAMINE   Dopamine

EPIN       Epinephrine, Adrenaline

EPO        Erythropoietin, Hematopoietin

ESTRIOL    Estriol, Oestriol

ESTRONE    Estrone, Oestrone

ETHANOL    Ethanol, Alcohol

GGTCREAT   Gamma Glutamyl
           Transferase/Creatinine

GASTRIN    Gastrin

GLUCAGON   Glucagon

GLUCCRT    Glucose/Creatinine

GLDH       Glutamate Dehydrogenase

GSTCREAT   Glutathione-S-
           Transferase/Creatinine

GNRH       Gonadotropin Releasing
           Hormone, Luteinising
           Hormone Releasing Hormone

GRWHIH     Growth Hormone Inhibiting
           Hormone, Somatostatin
GRWH       Growth Hormone,
           Somatotropin
GRWHRH     Growth Hormone Releasing
           Hormone, Somatocrinin
HVA        Homovanillic Acid

HYDCDN     Hydrocodone

HYDMRPHN   Hydromorphone

IGF1       Insulin-like Growth Factor-1

IGF2       Insulin-like Growth Factor-2

INTLK1     Interleukin 1

INTLK10    Interleukin 10

INTLK11    Interleukin 11
INTLK12   Interleukin 12

INTLK13   Interleukin 13

INTLK14   Interleukin 14

INTLK15   Interleukin 15

INTLK16   Interleukin 16

INTLK17   Interleukin 17

INTLK18   Interleukin 18

INTLK19   Interleukin 19

INTLK2    Interleukin 2

INTLK20   Interleukin 20

INTLK21   Interleukin 21

INTLK22   Interleukin 22

INTLK23   Interleukin 23

INTLK24   Interleukin 24

INTLK25   Interleukin 25

INTLK26   Interleukin 26

INTLK27   Interleukin 27

INTLK28   Interleukin 28

INTLK29   Interleukin 29

INTLK3    Interleukin 3

INTLK30   Interleukin 30

INTLK31   Interleukin 31

INTLK32   Interleukin 32

INTLK33   Interleukin 33

INTLK4    Interleukin 4

INTLK5    Interleukin 5
INTLK6     Interleukin 6

INTLK7     Interleukin 7

INTLK8     Interleukin 8

INTLK9     Interleukin 9

LDH1       LDH Isoenzyme 1

LDH2       LDH Isoenzyme 2

LDH3       LDH Isoenzyme 3

LDH4       LDH Isoenzyme 4

LDH5       LDH Isoenzyme 5

LDHCREAT   Lactate
           Dehydrogenase/Creatinine
LACTICAC   Lactic Acid, 2-
           hydroxypropanoic acid,
           Lactate
LGLUCLE    Large Unstained
           Cells/Leukocytes

LDH1LDH    LDH Isoenzyme 1/LDH


LDH2LDH    LDH Isoenzyme 2/LDH


LDH3LDH    LDH Isoenzyme 3/LDH


LDH4LDH    LDH Isoenzyme 4/LDH


LDH5LDH    LDH Isoenzyme 5/LDH


LEPTIN     Leptin

MGCREAT    Magnesium/Creatinine

MLATONIN   Melatonin

METHDN     Methadone

METHQLDN   Methaqualone
MORPHINE   Morphine

GSTMU      Mu Glutathione-S-Transferase

GSTMUCRT   Mu Glutathione-S-
           Transferase/Creatinine

MGB        Myoglobin
NAG        N-Acetyl Glucosamide, N-
           Acetyl Glucosamine
NAGCREAT   N-Acetyl
           Glucosamide/Creatinine
NPY        Neuropeptide Y

NOREPIN    Norepinephrine, Noradrenaline

OSMLTY     Osmolality

OXYCDN     Oxycodone, Oxycontin

OXYTOCIN   Oxytocin, Oxytoxin

PCP        Phencyclidine,
           Phenylcyclohexylpiperidine
PHENTHZ    Phenothiazine,
           Dibenzothiazine
PHOSCRT    Phosphate/Creatinine

KCREAT     Potassium/Creatinine

PROLCTN    Prolactin

PROPOX     Propoxyphene

PROTCRT    Protein/Creatinine

PSDEPHD    Pseudoephedrine

LYMRCT     Reactive Lymphocytes


RENIN      Renin, Angiotensinogenase
SECRETIN   Secretin

SRTONIN    Serotonin

NACREAT    Sodium/Creatinine

SDH        Sorbitol Dehydrogenase

THRMPTN    Thrombopoietin
TRH          Thyrotropin Releasing
             Hormone, Thyrotropin
             Releasing Factor
VMA          Vanillyl Mandelic Acid,
             Vanilmandelic Acid
VITA         Vitamin A, Retinol
VITB1        Thiamine, Vitamin B1
VITB17       Vitamin B17, Amygdalin
VITB2        Riboflavin, Vitamin B2
VITB3        Niacin, Vitamin B3
VITB5        Vitamin B5, Pantothenic Acid

VITB6        Vitamin B6, Pyridoxine

VITB7        Vitamin B7, Biotin

VITC         Vitamin C, Ascorbic Acid
VITD2        Vitamin D2, Ergocalciferol

VITD3        Vitamin D3, Cholecalciferol

VITE         Vitamin E, Tocopherol
VITK         Vitamin K, Naphthoquinone
VOLUME       Volume
FREQ         Frequency

OTHER        Other

UNKNOWN      U; Unknown
CONTINUOUS   Continuous


BID          Twice per day
BIS          Twice per week
QM           Every Month
PRN          As needed
Q10H         Every 10 hours
Q11H         Every 11 hours
Q12H         Every 12 hours
Q13H         Every 13 hours
Q14H         Every 14 hours
Q15H         Every 15 hours
Q16H         Every 16 hours
Q17H         Every 17 hours
Q18H         Every 18 hours
Q19H         Every 19 hours
QH           Every hour
Q20H         Every 20 hours
Q21H         Every 21 hours
Q22H         Every 22 hours
Q23H         Every 23 hours
Q24H                      Every 24 hours
Q2H                       Every 2 hours
Q3H                       Every 3 hours
Q4H                       Every 4 hours
Q5H                       Every 5 hours
Q6H                       Every 6 hours
Q7H                       Every 7 hours
Q8H                       Every 8 hours
Q9H                       Every 9 hours
QOD                       Every other day
TID                       3 times per day
TIS                       Three times a week
Q4S                       Every 4 weeks
QID                       4 times per day
QIS                       4 times per week
Q3D                       Every 3 days
Q4D                       Every 4 days
Q3S                       Every 3 weeks
Q2M                       Every two months
Q3M                       Every 3 months
Q4M                       Every 4 months
ONCE                      Once
QS                        Every week
Q5D                       Every 5 days
Q2S                       Every 2 weeks.
BIM                       Twice per month
INTERMITTENT              Intermittent
POSITION                  Position


SITTING                   Sitting

PRONE                     Prone

STANDING                  Standing

SUPINE                    Supine

TRENDELENBURG             Trendelenburg


REVERSE TRENDELENBURG     Reverse Trendelenburg

RIGHT LATERAL DECUBITUS   Right lateral decubitus

LEFT LATERAL DECUBITUS    Left lateral decubitus
FOWLERS                   Fowlers
SEMI-FOWLERS              Semi-Fowlers


EGSTRESC                  ECG Result

SINUS TACHYCARDIA         Sinus tachycardia

SINUS BRADYCARDIA         Sinus bradycardia

VENTRICULAR ARRHYTHMIA    Ventricular arrhythmia
ASSOCIATED WITH LONG QT   associated with long QT
SYNDROME                  syndrome




PRE-EXCITATION            Pre-excitation




AV NODE RE-ENTRY          AV node re-entry




JUNCTIONAL TACHYCARDIA    Junctional tachycardia




SUPRAVENTRICULAR          Supraventricular tachycardia
TACHYCARDIA
WOLFF-PARKINSON-WHITE     Wolff-Parkinson-White
SYNDROME                  syndrome
ATRIAL TACHYCARDIA         Atrial tachycardia




ATRIAL FIBRILLATION        Atrial fibrillation




3RD DEGREE AV BLOCK        3rd degree AV block

TORSADES DE POINTES        Torsades de pointes




VENTRICULAR FIBRILLATION   Ventricular fibrillation




VENTRICULAR FLUTTER        Ventricular flutter




VENTRICULAR TACHYCARDIA    Ventricular tachycardia

ATRIAL FLUTTER             Atrial flutter


R ON T PHENOMENON          R on T phenomenon
1ST DEGREE AV BLOCK        1st degree AV block



2ND DEGREE AV BLOCK        2nd degree AV block


VENTRICULAR TACHYCARDIA,   Ventricular tachycardia,
MONOMORPHIC                monomorphic


VENTRICULAR TACHYCARDIA,   Ventricular tachycardia,
POLYMORPHIC                polymorphic


SINUS ARRHYTHMIA           Sinus arrhythmia




WANDERING ATRIAL           Wandering atrial pacemaker
PACEMAKER



SINUS ARREST/PAUSE         Sinus arrest/pause


SINUS NODE DYSFUNCTION     Sinus node dysfunction
(BRADYCARDIA)              (bradycardia)




SICK SINUS SYNDROME        Sick sinus syndrome
ECTOPIC ATRIAL RHYTHM       Ectopic atrial rhythm




SHORT PR INTERVAL           Short PR interval
PR PROLONGATION             PR prolongation
ISORHYTHMIC DISSOCIATION    Isorhythmic dissociation


PAROXYSMAL AV BLOCK         Paroxysmal AV block

INAPPROPRIATE SINUS         Inappropriate sinus
TACHYCARDIA                 tachycardia



PREMATURE VENTRICULAR       PVC
COMPLEX
PREMATURE ATRIAL            Premature atrial complexes
COMPLEXES
DELTA WAVE                  Delta wave



VENTRICULAR COUPLET         Ventricular couplet



AV RE-ENTRANT TACHYCARDIA   AV re-entrant tachycardia




ACCELERATED                 Accelerated idioventricular
IDIOVENTRICULAR RHYTHM      rhythm
LEFT ANTERIOR FASCICULAR    Left anterior fascicular block
BLOCK




LEFT POSTERIOR FASCICULAR   Left posterior fascicular block
BLOCK




LEFT BUNDLE BRANCH BLOCK    Left bundle branch block




RIGHT BUNDLE BRANCH BLOCK   Right Bundle Branch Block




INTRAVENTRICULAR            Intraventricular conduction
CONDUCTION DELAY,           delay, nonspecific
NONSPECIFIC
ST SEGMENT ABNORMALITY         ST segment abnormality


ST DEPRESSION                  ST depression


ST ELEVATION                   ST elevation

ST ELEVATION PERICARDITIS      ST elevation pericarditis

J POINT ELEVATION              J point elevation


NON-SPECIFIC ST-T CHANGES      Non-specific ST-T changes


NOTCHED T-WAVES                Notched T-waves
POOR R WAVE PROGRESSION        Poor R Wave Progression

PROLONGED QT                   Prolonged QT

ELECTRICAL ALTERNANS           Electrical alternans


SINOATRIAL EXIT BLOCK          Sinoatrial exit block


ATRIAL ENLARGEMENT             Atrial Enlargement

LEFT ATRIAL ENLARGEMENT        P-mitrale




RIGHT ATRIAL ABNORMALITY       P-pulmonale




ECTOPIC VENTRICULAR RHYTHM Ectopic ventricular rhythm




ECTOPIC SUPRAVENTRICULAR       Ectopic supraventricular
RHYTHM                         rhythm
2:1 AV BLOCK                2:1 AV block



ATRIOVENTRICULAR            Atrioventricular dissociation
DISSOCIATION

BIFASCICULAR BLOCK          Bifascicular block




INCOMPLETE LEFT BUNDLE      Incomplete left bundle branch
BRANCH BLOCK                block

INCOMPLETE RIGHT BUNDLE     Incomplete right bundle
BRANCH BLOCK                branch block




INCOMPLETE BUNDLE BRANCH    Incomplete bundle branch
BLOCK                       block

MULTIFOCAL ATRIAL           Multifocal atrial tachycardia
TACHYCARDIA



JUNCTIONAL RHYTHM           Junctional rhythm



SUSTAINED VENTRICULAR       Sustained ventricular
TACHYCARDIA                 tachycardia
NON-SUSTAINED VENTRICULAR   Non-sustained ventricular
TACHYCARDIA                 tachycardia
BIGEMINY                    Bigeminy
TRIGEMINY                  Trigeminy



VENTRICULAR TACHYCARDIA    Ventricular tachycardia storm
STORM

ADENOSINE-SENSITIVE        Adenosine-sensitive
VENTRICULAR TACHYCARDIA    ventricular tachycardia


VERAPAMIL-SENSITIVE        Verapamil-sensitive ventricular
VENTRICULAR TACHYCARDIA    tachycardia



VENTRICULAR ARRHYTHMIA     Ventricular arrhythmia
ASSOCIATED WITH BRUGADA    associated with Brugada
SYNDROME                   syndrome




VENTRICULAR ARRHYTHMIA     Ventricular arrhythmia
ASSOCIATED WITH SHORT QT   associated with short QT
SYNDROME                   syndrome
FASCICULAR TACHYCARDIA     Fascicular tachycardia




BUNDLE BRANCH REENTRANT    Bundle branch reentrant
TACHYCARDIA                tachycardia
IDIOPATHIC RIGHT BUNDLE        Idiopathic right bundle branch
BRANCH BLOCK VENTRICULAR       block ventricular tachycardia
TACHYCARDIA




OUTFLOW TRACT VENTRICULAR Outflow tract ventricular
TACHYCARDIA               tachycardia




ACUTE ANTERIOR WALL MI         Acute Anterior Wall
                               Myocardial Infarction

ACUTE INFERIOR WALL MI         Acute Inferior Wall Myocardial
                               Infarction

ACUTE LATERAL WALL MI          Acute Lateral Wall Myocardial
                               Infarction

ACUTE POSTERIOR WALL MI        Acute Posterior Wall
                               Myocardial Infarction

ANTERIOR WALL MYOCARDIAL       Anterior Wall Myocardial
INFARCTION                     Infarction

INFERIOR WALL MYOCARDIAL       Inferior Wall Myocardial
INFARCTION                     Infarction

INTRAATRIAL CONDUCTION         Intraatrial Conduction Delay
DELAY
JUNCTIONAL BRADYCARDIA         Junctional bradycardia



LATERAL WALL MYOCARDIAL        Lateral Wall Myocardial
INFARCTION                     Infarction

LEFT VENTRICULAR               Left Ventricular Hypertrophy
HYPERTROPHY
RIGHT VENTRICULAR              Right ventricular Hypertrophy
HYPERTROPHY
LOW QRS VOLTAGE                Low QRS voltage
NON Q WAVE MYOCARDIAL          Non Q Wave Myocardial
INFARCTION                     Infarction
POSTERIOR WALL MYOCARDIAL      Posterior Wall Myocardial
INFARCTION                     Infarction

SEPTAL MYOCARDIAL              Septal myocardial infarction
INFARCTION
T WAVE ABNORMALITY             T wave abnormality

VENTRICULAR HYPERTROPHY        Ventricular Hypertrophy

T WAVE INVERSION               T Wave Inversion

T WAVE PEAKED                  T wave peaked


T WAVES BIPHASIC               T waves biphasic

T WAVES FLAT                   T waves flat

U WAVES                        U waves


WIDE QRS TACHYCARDIA           Wide QRS tachycardia
Q AXIS, LEFT AXIS DEVIATION    Q Axis, Left axis deviation
Q AXIS, RIGHT AXIS DEVIATION   Q Axis, Right axis deviation
QTCB PROLONGATION >500         QTcB prolongation >500 msec
MSEC
QTCF PROLONGATION >500         QTcF prolongation >500 msec
MSEC
EGTESTCD                       ECG Test Code

HRMAX                          Summary (Max) Heart Rate



PRMEAN                         Summary (Mean) PR Duration




QRSDUR                         Summary (Mean) QRS
                               Duration
QTMEAN   Summary (Mean) QT Duration




RRMEAN   Summary (Mean) RR Duration




RRMIN    Summary (Min) RR Duration

RRMAX    Summary (Max) RR Duration

HRMEAN   Summary (Mean) Heart Rate



HRMIN    Summary (Min) Heart Rate



QTCB     QTcB - Bazett's Correction
         Formula




QTCF     QTcF - Fridericia's Correction
         Formula




QTCLC    QTcLC - Linear Correction
         Formula
JTMEAN     Summary (Mean) JT Interval




JTMIN      Summary (Min) JT Interval




JTMAX      Summary (Max) JT Interval




JTCB       JTcB - Bazett's Correction
           Formula




JTCF       JTcF - Fridericia's Correction
           Formula




JTCLC      JTcLC - Linear Correction
           Formula




PAXIS      Summary (Mean) P Axis



PWAVEDUR   Summary (Mean) P Wave
           Duration
PWAVEHT    Summary (Mean) P Wave
           Height




PRMIN      Summary (Min) PR Duration




PRMAX      Summary (Max) PR Duration




QRSAXIS    Summary (Mean) QRS Axis

QTMIN      Summary (Min) QT Duration




QTMAX      Summary (Max) QT Duration




RWAVEAMP   Summary (Mean) R Wave
           Amplitude

SWAVEAMP   Summary (Mean) S Wave
           Amplitude

RSAMP      Summary (Mean) R+S
           Amplitude
STSEGDUR   Summary (Mean) ST Segment
           Duration

TAXIS      Summary (Mean) T Wave
           Axis
TWAVEDUR   Summary (Mean) T Wave
           Duration



TWAVAREA   Summary (Mean) T Wave
           Area


TWAVEHT    Summary (Mean) T Wave
           Height



VRMEAN     Summary (Mean) Ventricular
           Rate


VRMIN      Summary (Min) Ventricular
           Rate


VRMAX      Summary (Max) Ventricular
           Rate


STDVMEAN   Summary (Mean) ST
           Deviation


STDVMIN    Summary (Min) ST Deviation



STDVMAX    Summary (Max) ST Deviation



STELMEAN   Summary (Mean) ST
           Elevation


STELMIN    Summary (Min) ST Elevation
STELMAX    Summary (Max) ST Elevation



STDPMEAN   Summary (Mean) ST
           Depression


STDPMIN    Summary (Min) ST
           Depression


STDPMAX    Summary (Max) ST
           Depression


EGTEST     ECG Test Name

HRMAX      Summary (Max) Heart Rate



PRMEAN     Summary (Mean) PR Duration




QRSDUR     Summary (Mean) QRS
           Duration




QTMEAN     Summary (Mean) QT Duration




RRMEAN     Summary (Mean) RR Duration
RRMIN    Summary (Min) RR Duration

RRMAX    Summary (Max) RR Duration

HRMEAN   Summary (Mean) Heart Rate



HRMIN    Summary (Min) Heart Rate



QTCB     QTcB - Bazett's Correction
         Formula




QTCF     QTcF - Fridericia's Correction
         Formula




QTCLC    QTcLC - Linear Correction
         Formula




JTMEAN   Summary (Mean) JT Interval




JTMIN    Summary (Min) JT Interval




JTMAX    Summary (Max) JT Interval
JTCB       JTcB - Bazett's Correction
           Formula




JTCF       JTcF - Fridericia's Correction
           Formula




JTCLC      JTcLC - Linear Correction
           Formula




PAXIS      Summary (Mean) P Axis



PWAVEDUR   Summary (Mean) P Wave
           Duration



PWAVEHT    Summary (Mean) P Wave
           Height




PRMIN      Summary (Min) PR Duration
PRMAX      Summary (Max) PR Duration




QRSAXIS    Summary (Mean) QRS Axis

QTMIN      Summary (Min) QT Duration




QTMAX      Summary (Max) QT Duration




RWAVEAMP   Summary (Mean) R Wave
           Amplitude

SWAVEAMP   Summary (Mean) S Wave
           Amplitude

RSAMP      Summary (Mean) R+S
           Amplitude


STSEGDUR   Summary (Mean) ST Segment
           Duration

TAXIS      Summary (Mean) T Wave
           Axis
TWAVEDUR   Summary (Mean) T Wave
           Duration



TWAVAREA   Summary (Mean) T Wave
           Area
TWAVEHT    Summary (Mean) T Wave
           Height



VRMEAN     Summary (Mean) Ventricular
           Rate


VRMIN      Summary (Min) Ventricular
           Rate


VRMAX      Summary (Max) Ventricular
           Rate


STDVMEAN   Summary (Mean) ST
           Deviation


STDVMIN    Summary (Min) ST Deviation



STDVMAX    Summary (Max) ST Deviation



STELMEAN   Summary (Mean) ST
           Elevation


STELMIN    Summary (Min) ST Elevation



STELMAX    Summary (Max) ST Elevation



STDPMEAN   Summary (Mean) ST
           Depression


STDPMIN    Summary (Min) ST
           Depression
STDPMAX                        Summary (Max) ST
                               Depression


EGMETHOD                       ECG Test Method

12 LEAD UNSPECIFIED            12 Lead Unspecified


12 LEAD STANDARD               12 Lead Standard




12 LEAD MASON LIKAR            12 Lead Mason Likar




12 LEAD MODIFIED MASON LIKAR 12 Lead Modified Mason Likar




12 LEAD SINGLE PAD             12 Lead Single Pad



12 LEAD NON-STANDARD           12 Lead Non-Standard


STANDARD LEADS FOR BICYCLE Standard leads for bicycle
EXERCISE                   exercise. Limb leads on the
                           back (shoulder and on the
                           hips)
12 LEAD CABRERA            12 Lead Cabrera




STANDARD LEADS ONE         Standard leads one intercostal
INTERCOSTAL SPACE HIGHER   space higher


FRANK LEAD SYSTEM          Frank lead system




MCFEE-PARUNGAO LEAD        McFee-Parungao lead system
SYSTEM



CUBE LEAD SYSTEM           Cube lead system



BIPOLAR UNCORRECTED XYZ    Bipolar uncorrected XYZ lead
LEAD SYSTEM                system




PSEUDO-ORTHOGONAL XYZ      Pseudo-orthogonal XYZ lead
LEAD SYSTEM                system




12 LEAD EASI DOWER         12 Lead EASI Dower
TRANSFORMATION             Transformation
12 LEAD 1 LEAD MISSING      12 Lead 1 Lead Missing



STANDARD 12-LEAD AND CM5-   Standard 12-lead and CM5-
CC5-CH5                     CC5-CH5




STANDARD 12-LEAD AND CC5-   Standard 12-lead and CC5-
CM5-ML                      CM5-ML



STANDARD 12-LEAD EXTENDED   Standard 12-lead extended to
RIGHT                       the right by V5R, V4R, V3R


STANDARD 12-LEAD EXTENDED   Standard 12-lead extended to
LEFT                        the left by V7, V8, V9

VECTORCARDIOGRAPH           Vectorcardiograph Corrected
CORRECTED

VECTORCARDIOGRAPH           Vectorcardiograph
UNCORRECTED                 Uncorrected

UNIT                        Unit


Gy                          Gray


Rad                         Rad




DAYS                        Day


HOURS                       Hour

%                           Percentage

mm                          Millimeter
kg       Kilogram




mg       Milligram


mL       Milliliter


WEEKS    Week
MONTHS   Month



YEARS    Year


m        Meter


msec     Millisecond

sec      Second




amp      Ampere




cd       Candela
mol       Mole




Hz        Hertz
Newton    Newton


Pa        Pascal


Joule     Joule




Watt      Watt




Coulomb   Coulomb


V         Volt




Farad     Farad



Sv        Sievert
ohm       Ohm




Siemens   Siemens




Weber     Weber



Tesla     Tesla




Henry     Henry




C         Degree Celsius




lm        Lumen


lx        Lux



Bq        Becquerel
kat     Katal




m2      Square Meter



m3      Cubic Meter



m/sec   Meter Per Second


kg/m3   Kilogram per Cubic Meter; g/L;
        Gram per Liter; ug/uL;
        Microgram per Microliter;
        Milligram per Milliliter




F       Degree Fahrenheit




pH      pH

ug      Microgram

min     Minute Unit of Time
g       Gram

cm2     Square Centimeter


ft2     Square Foot
Ci                          Curie


AMPULE                      Ampule Dosing Unit
BAG                         Bag Dosing Unit
BAR                         Bar Dosing Unit
BOLUS                       Bolus Dosing Unit
BOTTLE                      Bottle Dosing Unit
BOX                         Box Dosing Unit
CAN                         Can Dosing Unit
CAPSULE                     Capsule Dosing Unit
CARTRIDGE                   Cartridge Dosing Unit
COAT                        Coat Dosing Unit
CONTAINER                   Container Dosing Unit
CYLINDER                    Cylinder Dosing Unit
DISK                        Disk Dosing Unit
DRUM                        Drum Dosing Unit
grain                       Grain




HOMEOPATHIC DILUTION        Homeopathic Dilution Unit

IMPLANT                     Implant Dosing Unit
IN                          Inch
INHALATION                  Inhalation Dosing Unit
JAR                         Jar Dosing Unit
KALLIKREIN INHIBITOR UNIT   Kallikrein Inhibitor Unit

KIT                         Kit Dosing Unit
L                           Liter


LOZENGE                     Lozenge Dosing Unit
uCi                         Microcurie


umol                        Micromole

um                          Micron

mCi                         Millicurie



mEq                         Milliequivalent

mmol                        Millimole
ng              Nanogram

nmol            Nanomole

oz              Ounce

PACKAGE         Package Dosing Unit
PACKET          Packet Dosing Unit
ppm             Part per Million

PATCH           Patch Dosing Unit
PELLET          Pellet Dosing Unit
%(w/v)          Percent Weight per Volume




%(w/w)          Percent Weight per Weight


POUCH           Pouch Dosing Unit
LB              Pound


PRESSOR UNITS   Pressor Unit
SCOOPFUL        Scoopful Dosing Unit
SPRAY           Spray Dosing Unit
STRIP           Strip Dosing Unit
SUPPOSITORY     Suppository Dosing Unit

SYRINGE         Syringe Dosing Unit
Tbsp            Tablespoon Dosing Unit



TABLET          Tablet Dosing Unit
TAMPON          Tampon Dosing Unit
tsp             Teaspoon Dosing Unit

TRACE           Trace Dosing Unit
TROCHE          Troche Dosing Unit
TUBE            Tube Dosing Unit
VIAL            Vial Dosing Unit
WAFER           Wafer Dosing Unit
yd              Yard

mol/L           Mole per Liter

% (v/v)         Percent Volume per Volume
IU                    International Unit




QUANTITY SUFFICIENT   Quantity Sufficient




cm                    Centimeter

mmHg                  Millimeter of Mercury


kg/m2                 Kilogram per Square Meter

BEATS/MIN             Beats per Minute
BREATHS/MIN           Breaths per Minute

CUP                   Cup Dosing Unit
atm                   Atmosphere



RING                  Ring Dosing Unit
mmol/L                Millimole per Liter; umol/mL;
                      Micromole per Milliliter;
                      mol/m3; Mole per Cubic Meter

pg                    Picogram

fg                    Femtogram

ag                    Attogram

cg                    Centigram
dram                  Dram
kg/L              Kilogram per Liter; g/mL;
                  Gram per Milliliter




g/m3              Gram per Cubic Meter; ug/mL;
                  Microgram per Milliliter; mg/L;
                  Milligram per Liter



mL/min            Milliliters per Minute


g/dL              Gram per Deciliter




pmol              Picomole

PUFF              Puff




mm2               Square Millimeter



tuberculin unit   Tuberculin Unit



mL/h              Milliliters per Hour


per sec           Per Second

per min           Per Minute

mg/h              Milligram per Hour
mg/dL   Milligram per Deciliter




cal     Calorie



kcal    Kilogram-Calorie




PFU     Plaque Forming Unit




eq      Equivalent Weight




HPF     High Power Field

g/m2    Gram per Square Meter
ug/L         Microgram per Liter; mg/m3;
             Milligram per Cubic Meter;
             ng/mL; Nanogram per Milliliter



LPF          Low Power Field


mV           Millivolt

ng/dL        Nanogram per Deciliter




ug/m3        Microgram per Cubic Meter




nm           Nanometer


osm          Osmole



psi          Pounds per Square Inch


million IU   Million International Units

nCi          Nanocurie


IU/L         International Unit per Liter


IU/mL        International Unit per Milliliter;
             kIU/L; Kilo International Unit
             per Liter
IU/kg        International Unit per Kilogram
IU/mg           International Unit per Milligram


L/min           Liters per Minute


ug/h            Micrograms per Hour


ug/kg           Microgram per Kilogram


ukat/L          Microkatal per Liter


mg/day          Milligram per Day

mg/kg           Milligram per Kilogram


mg/m2           Milligram per Square Meter


umol/day        Micromoles per Day



mm/h            Millimeter per Hour


mmol/day        Millimole per 24 Hours



nmol/L          Nanomole per Liter


pmol/L          Picomole per Liter


RNA copies/mL   RNA Copies per Milliliter


mEq/day         Milliequivalents per Day



mEq/L           Milliequivalent Per Liter
mEq/kg             Milliequivalent Per Kilogram



deg                Degree Unit of Plane Angle




dmol               Decimole

cmol               Centimole

mmol/g             Millimole per Gram

fmol               Femtomole

amol               Attomole

m3                 Standard Cubic Meter



ft3                Standard Cubic Foot


in2                Square Inch

ELISA unit         Enzyme-Linked
                   Immunosorbent Assay Unit




ELISA unit/dose    Enzyme-Linked
                   Immunosorbent Assay Unit
                   per Dose


ELISA unit/mL      Enzyme-Linked
                   Immunosorbent Assay Unit
                   per Milliliter


Log10 ELISA unit   Log10 Enzyme-Linked
                   Immunosorbent Assay Unit
Log10 ELISA unit/dose   Log10 Enzyme-Linked
                        Immunosorbent Assay Unit
                        per Dose


mol/mL                  Mole per Milliliter

mmol/kg                 Millimole per Kilogram


mol/g                   Mole per Gram


mol/mg                  Mole per Milligram


thousand CFU            Thousand Colony Forming
                        Units
million CFU             Million Colony Forming Units

billion CFU             Billion Colony Forming Units

CFU/g                   Colony Forming Unit per Gram


thousand CFU/g          Thousand Colony Forming
                        Units per Gram


million CFU/g           Million Colony Forming Units
                        per Gram


billion CFU/g           Billion Colony Forming Units
                        per Gram


CFU/mL                  Colony Forming Unit per
                        Milliliter

thousand CFU/mL         Thousand Colony Forming
                        Units per Milliliter


million CFU/mL          Million Colony Forming Units
                        per Milliliter


billion CFU/mL          Billion Colony Forming Units
                        per Milliliter
Gauss             Gauss




kg/cm2            Kilogram per Square
                  Centimeter


g/kg              Gram per Kilogram; mg/g;
                  Milligram per Gram

ppth              Part per Thousand
pm                Picometer

uL/mL             Microliter per Milliliter


nL                Nanoliter

gtt               Drop
mol/mol           Mole per Mole


rpm               Revolution per Minute

dyn               Dyne



log10 EID 50      Log10 50 Percent Embryo
                  Infective Dose




log EID 50/dose   Log10 50 Percent Embryo
                  Infective Dose per Dose



log10 CCID 50     Log10 50 Percent Cell Culture
                  Infective Dose
log10 CCID 50/dose   Log10 50 Percent Cell Culture
                     Infective Dose per Dose



log10 TCID 50        Log10 50 Percent Tissue
                     Culture Infective Dose




log10 TCID 50/dose   Log10 50 Percent Tissue
                     Culture Infective Dose per
                     Dose


kIU                  Kilo International Unit
IU/g                 International Unit per Gram


anti-Xa IU           Anti-Xa Activity International
                     Unit




anti-Xa IU/mL        Anti-Xa Activity International
                     Unit per Milliliter


AgU/mL               Antigen Unit per Milliliter

DAgU                 D Antigen Unit


DAgU/mL              D Antigen Unit per Milliliter


AU/mL                Allergy Unit per Milliliter


BAU                  Bioequivalent Allergy Unit



tuberculin unit/mL   Tuberculin Unit per Milliliter


mkat                 Millikatal
nkat     Nanokatal

pkat     Picokatal

nkat/L   Nanokatal per Liter



kBq      Kilobecquerel


MBq      Megabecquerel


GBq      Gigabecquerel


Bq/kg    Becquerel per Kilogram


Bq/g     Becquerel per Gram


Bq/ug    Becquerel per Microgram;
         kBq/mg; Kilobecquerel per
         Milligram; MBq/g;
         Megabecquerel per Gram


Bq/mg    Becquerel per Milligram;
         kBq/g; Kilobecquerel per
         Gram
GBq/g    Gigabecquerel per Gram;
         kBq/ug; Kilobecquerel per
         Microgram
GBq/ug   Gigabecquerel per Microgram;
         MBq/ug; Megabecquerel per
         Microgram

GBq/mg   Gigabecquerel per Milligram;
         MBq/mg; Megabecquerel per
         Milligram
Ci/g     Curie per Gram; uCi/ug;
         Microcurie per Microgram;
         mCi/mg; Millicurie per
         Milligram
Ci/kg    Curie per Kilogram; uCi/mg;
         Microcurie per Milligram;
         mCi/g; Millicurie per Gram
Ci/ug    Curie per Microgram
Ci/mg          Curie per Milligram; mCi/ug;
               Millicurie per Microgram

EID 50         50 Percent Embryo Infective
               Dose


EID 50/dose    50 Percent Embryo Infective
               Dose per Dose


CCID 50        50 Percent Cell Culture
               Infective Dose




CCID 50/dose   50 Percent Cell Culture
               Infective Dose per Dose

TCID 50/dose   50 Percent Tissue Culture
               Infective Dose per Dose

ukat           Microkatal

ppb            Part per Billion

pptr           Parts per Trillion

mCi/kg         Millicurie per Kilogram; uCi/g;
               Microcurie per Gram

uCi/kg         Microcurie per Kilogram


Roentgen       Roentgen



mEq/uL         Milliequivalent Per Microliter

mEq/g          Milliequivalent Per Gram



mEq/ug         Milliequivalent Per Microgram



Bq/L           Becquerel per Liter
Bq/uL                Becquerel per Microliter;
                     kBq/mL; Kilobecquerel per
                     Milliliter; MBq/L;
                     Megabecquerel per Liter
Bq/mL                Becquerel per Milliliter; kBq/L;
                     Kilobecquerel per Liter


kBq/uL               Kilobecquerel per Microliter;
                     GBq/L; Gigabecquerel per
                     Liter; MBq/mL;
                     Megabecquerel per Milliliter
MBq/uL               Megabecquerel per Microliter;
                     GBq/mL; Gigabecquerel per
                     Milliliter

Ci/L                 Curie per Liter; uCi/uL;
                     Microcurie per Microliter

Ci/uL                Curie per Microliter



Ci/mL                Curie per Milliliter


uCi/L                Microcurie per Liter



mCi/L                Millicurie per Liter; uCi/mL;
                     Microcurie per Milliliter


uV                   Microvolt

cycle/min            Cycle per Minute



km                   Kilometer

Mile                 International Mile

100 IU/mL            100 International units/Milliliter



thousand organisms   Thousand Organisms

million organisms    Million Organisms
billion organisms       Billion Organisms

thousand organisms/g    Thousand Organisms per
                        Gram

million organisms/g     Million Organisms per Gram


billion organisms/g     Billion Organisms per Gram


million organisms/mg    Million Organisms per
                        Milligram

billion organisms/mg    Billion Organisms per
                        Milligram

thousand organisms/mL   Thousand Organisms per
                        Milliliter

million organisms/mL    Million Organisms per Milliliter


billion organisms/mL    Billion Organisms per Milliliter


PFU/dose                Plaque Forming Unit per Dose



PFU/mL                  Plaque Forming Unit per
                        Milliliter


bel                     Bel




g/cm2                   Gram per Square Centimeter



kUSP                    Kilo United States
                        Pharmacopoeia Unit
km/h                    Kilometer Per Hour


NEBULE                  Nebule
ug/day           Microgram per Day




mg/kg/min        Milligram per Kilogram per
                 Minute

IU/kg/h          International units per
                 Kilogram per Hour


ug/kg/min        Microgram per Kilogram per
                 Minute; Gamma per Kilogram
                 per Minute; gamma/kg/min

ug/min           Micrograms per Minute




ft               Foot



FINGERTIP UNIT   Fingertip Unit




SACHET           Sachet dosing unit


mg/kg/h          Milligram per Kilogram per
                 Hour

cycle/sec        Cycle per Second



LOC              Anatomical Location
LIP                        Lip

HARD PALATE                Hard Palate

HYPOPHARYNX                Hypopharynx

GASTRIC CARDIA             Gastric Cardia


FUNDUS OF THE STOMACH      Fundus of the Stomach


BODY OF STOMACH            Body of Stomach



ANTRUM PYLORI              Antrum Pylori


GREATER CURVATURE OF THE   Greater Curvature of the
STOMACH                    Stomach
MIDDLE EAR                 Middle Ear

MAXILLARY SINUS            Maxillary Sinus




ETHMOID SINUS              Ethmoid Sinus
FRONTAL SINUS              Frontal Sinus

SUBGLOTTIS                 Subglottis

MANDIBLE                   Mandible
SKIN OF THE TRUNK          Skin of the Trunk

NIPPLE                     Nipple

CERVIX UTERI               Cervix Uteri


MYOMETRIUM                 Myometrium
PARAMETRIUM                Parametrium



CONJUNCTIVA                Conjunctiva
CORNEA                    Cornea




RETINA                    Retina


ORBIT                     Orbit




FRONTAL LOBE              Frontal Lobe

PARIETAL LOBE             Parietal Lobe



BRAIN VENTRICLE           Brain Ventricle


PELVIC LYMPH NODE         Pelvic Lymph Node
BONE                      Bone

ARTERY                    Artery

GALLBLADDER               Gallbladder




GASTROINTESTINAL SYSTEM   Gastrointestinal System


LARGE INTESTINE           Large Intestine

APPENDIX                  Appendix


COLON                     Colon
SMALL INTESTINE   Small Intestine




ILEUM             Ileum
JEJUNUM           Jejunum

ESOPHAGUS         Esophagus




STOMACH           Stomach



LIVER             Liver




PANCREAS          Pancreas




EAR               Ear




THYROID GLAND     Thyroid Gland


EYE               Eye
FALLOPIAN TUBE    Fallopian Tube
OVARY            Ovary



UTERUS           Uterus



VAGINA           Vagina

VULVA            Vulva


PENIS            Penis
PROSTATE GLAND   Prostate Gland




TESTIS           Testis

URINARY SYSTEM   Urinary System

BLADDER          Bladder


KIDNEY           Kidney




URETER           Ureter

URETHRA          Urethra

HEAD             Head

LARYNX           Larynx


ORAL CAVITY      Oral Cavity



TONGUE           Tongue


NASOPHARYNX      Nasopharynx
NASAL CAVITY    Nasal Cavity




PHARYNX         Pharynx


PAROTID GLAND   Parotid Gland

TRACHEA         Trachea

LIMB            Limb

SPLEEN          Spleen




THYMUS GLAND    Thymus Gland




BLOOD           Blood




MUSCLE TISSUE   Muscle Tissue




BRAIN           Brain
MEDULLA OBLONGATA   Medulla Oblongata




BASAL GANGLIA       Basal Ganglia




PUTAMEN             Putamen




THALAMUS            Thalamus




LUNG                Lung




SKIN                Skin


TYMPANIC MEMBRANE   Tympanic Membrane




MASTOID PROCESS     Mastoid Process


ABDOMINAL CAVITY    Abdominal Cavity
ADRENAL GLAND       Adrenal Gland




AORTA               Aorta




AXILLA              Axilla

BILIARY TRACT       Biliary Tract




BLOOD VESSEL        Blood Vessel


BRACHIAL ARTERY     Brachial Artery

BRACHIAL PLEXUS     Brachial Plexus


BRONCHUS            Bronchus


CAROTID ARTERY      Carotid Artery



CERVICAL VERTEBRA   Cervical Vertebra


CLAVICLE            Clavicle

COCCYX              Coccyx


EPIGLOTTIS          Epiglottis


ETHMOID BONE        Ethmoid Bone




EYELID              Eyelid
FEMORAL ARTERY    Femoral Artery

FEMORAL VEIN      Femoral Vein

FEMUR             Femur

FIBULA            Fibula

GANGLION          Ganglion


GLOTTIS           Glottis
INGUINAL REGION   Inguinal Region

HEART             Heart




HUMERUS           Humerus
INTESTINE         Intestine


LENS              Lens



LUMBAR VERTEBRA   Lumbar Vertebra


LYMPH NODE        Lymph Node




MEDIASTINUM       Mediastinum




METATARSAL BONE   Metatarsal Bone


NOSE              Nose


OPTIC NERVE       Optic Nerve
PARANASAL SINUS     Paranasal Sinus



PELVIS              Pelvis


PERIPHERAL NERVE    Peripheral Nerve

PERITONEUM          Peritoneum




RIB                 Rib




SCAPULA             Scapula

SCROTUM             Scrotum

LUNATE BONE         Lunate Bone

SKULL               Skull

STERNUM             Sternum

TEMPORAL BONE       Temporal Bone




THORACIC VERTEBRA   Thoracic Vertebra


THORAX              Thorax

TIBIA               Tibia

TONSIL              Tonsil


TROCHLEAR NERVE     Trochlear Nerve

UVEA                Uvea

VEIN                Vein
VENA CAVA               Vena Cava

VOCAL CORD              Vocal Cord



RADIAL ARTERY           Radial Artery

PLEURAL CAVITY          Pleural Cavity

CORONARY ARTERY         Coronary Artery

SACRAL VERTEBRA         Sacral Vertebra

SCAPHOID BONE           Scaphoid Bone

PISIFORM BONE           Pisiform Bone

CAPITATE BONE           Capitate Bone

TRAPEZIAL BONE          Trapezial Bone

TRIANGULAR BONE         Triangular Bone

TRAPEZOID BONE          Trapezoid Bone

HAMATE BONE             Hamate Bone
SUPRACLAVICULAR LYMPH   Supraclavicular Lymph Node
NODE
AXILLARY LYMPH NODE     Axillary Lymph Node


BREAST                  Breast


VERTEBRAL COLUMN        Vertebral Column




PERICARDIUM             Pericardium


BODY                    Body


JOINT                   Joint

LIGAMENT                Ligament
SKELETAL MUSCLE TISSUE    Skeletal Muscle Tissue



BACK                      Back

NECK                      Neck

FACE                      Face



MUCOSA                    Mucosa
GASTRIC                   Gastric
HEPATIC                   Hepatic
ANASTOMOSIS               Anastomosis

SHOULDER                  Shoulder

CHEST                     Chest



HILAR                     Hilar
CORPUS LUTEUM             Corpus Luteum




MAXILLA                   Maxilla

ACETABULUM                Acetabulum


ACROMIOCLAVICULAR JOINT   Acromioclavicular Joint


ACROMION                  Acromion
ANKLE JOINT               Ankle Joint

AORTIC ARCH               Aortic Arch



ARM                       Arm


BASILIC VEIN              Basilic Vein


C1 VERTEBRA               C1 Vertebra
C2 VERTEBRA               C2 Vertebra
C3 VERTEBRA                  C3 Vertebra
C4 VERTEBRA                  C4 Vertebra
C5 VERTEBRA                  C5 Vertebra
C6 VERTEBRA                  C6 Vertebra
C7 VERTEBRA                  C7 Vertebra
CANINE TOOTH                 Canine Tooth

CEPHALIC VEIN                Cephalic Vein



CERVICAL LYMPH NODE          Cervical Lymph Node
COCCYGEAL VERTEBRA           Coccygeal Vertebra

COSTAL CARTILAGE             Costal Cartilage


CUBOID BONE                  Cuboid Bone

DORSALIS PEDIS ARTERY        Dorsalis Pedis Artery




ELBOW JOINT                  Elbow Joint

ENDOMETRIAL CAVITY           Endometrial Cavity

FACET JOINT                  Facet Joint


FINGER                       Finger
FINGERNAIL                   Fingernail
FOOT                         Foot

FOREARM                      Forearm

GASTROESOPHAGEAL JUNCTION Gastroesophageal Junction

GINGIVA                      Gingiva



GLENOID FOSSA                Glenoid Fossa

GREAT TROCHANTER             Great Trochanter

HAIR                         Hair
HAND                         Hand

HEAD OF THE HUMERUS          Head of the Humerus
HIP JOINT                  Hip Joint

HYOID BONE                 Hyoid Bone



ILIAC LYMPH NODE           Iliac Lymph Node

ILIUM                      Ilium

INCISOR                    Incisor

INCUS                      Incus


INGUINAL LYMPH NODE        Inguinal Lymph Node

INTERPHALANGEAL JOINT OF   Interphalangeal Joint of the
THE HAND                   Hand
ISCHIUM                    Ischium

JAW JOINT                  Jaw Joint

KNEE JOINT                 Knee Joint




L1 VERTEBRA                L1 Vertebra
L2 VERTEBRA                L2 Vertebra

L3 VERTEBRA                L3 Vertebra

L4 VERTEBRA                L4 Vertebra

L5 VERTEBRA                L5 Vertebra
LACRIMAL BONE              Lacrimal Bone



LEG                        Leg

LIVER FISSURE              Liver Fissure


LYMPH NODE HILUM           Lymph Node Hilum
MALLEUS                    Malleus
MEDIASTINAL LYMPH NODE        Mediastinal Lymph Node




METATARSOPHALANGEAL JOINT Metatarsophalangeal Joint


NAIL                          Nail

NASAL BONE                    Nasal Bone

NASAL SEPTUM                  Nasal Septum
NAVICULAR BONE                Navicular Bone

NOSTRIL                       Nostril

OLECRANON                     Olecranon

OLFACTORY MUCOSA              Olfactory Mucosa



PAROTID GLAND LYMPH NODE      Parotid Gland Lymph Node

PATELLA                       Patella


PELVIC BONE                   Pelvic Bone



PERINEUM                      Perineum

PHARYNGEAL TONSIL             Pharyngeal Tonsil


PORTAL VEIN                   Portal Vein


PYLORIC SPHINCTER             Pyloric Sphincter

SACROILIAC JOINT              Sacroiliac Joint
SACRUM                        Sacrum


SHOULDER JOINT                Shoulder Joint

SINUS                         Sinus
STERNOCLAVICULAR JOINT        Sternoclavicular Joint
SYNOVIAL FLUID     Synovial Fluid

T1 VERTEBRA        T1 Vertebra

T10 VERTEBRA       T10 Vertebra

T11 VERTEBRA       T11 Vertebra

T12 VERTEBRA       T12 Vertebra

T2 VERTEBRA        T2 Vertebra

T3 VERTEBRA        T3 Vertebra

T4 VERTEBRA        T4 Vertebra

T5 VERTEBRA        T5 Vertebra

T6 VERTEBRA        T6 Vertebra

T7 VERTEBRA        T7 Vertebra

T8 VERTEBRA        T8 Vertebra

T9 VERTEBRA        T9 Vertebra

TARSUS BONE        Tarsus Bone

THIGH              Thigh

TOE                Toe
TOENAIL            Toenail

TRAPEZIUS MUSCLE   Trapezius Muscle




TROCHANTER         Trochanter

TRUNK              Trunk
TUNICA INTIMA      Tunica Intima




VOMER              Vomer


WRIST JOINT        Wrist Joint

XIPHOID PROCESS    Xiphoid Process
GASTROINTESTINAL TRACT   Gastrointestinal Tract




ANUS                     Anus


REGIONAL LYMPH NODE      Regional Lymph Node

STERNAL MANUBRIUM        Sternal Manubrium



PALATINE BONE            Palatine Bone




LEG SKIN                 Leg Skin
ARM SKIN                 Arm Skin
ABDOMINAL SKIN           Abdominal Skin
RIB 9                    Rib 9

RIB 8                    Rib 8

RIB 7                    Rib 7

RIB 6                    Rib 6

RIB 5                    Rib 5

RIB 4                    Rib 4

RIB 3                    Rib 3

RIB 2                    Rib 2

RIB 12                   Rib 12

RIB 11                   Rib 11

RIB 10                   Rib 10

RIB 1                    Rib 1

HAND PHALANX             Hand Phalanx
FOOT PHALANX             Foot Phalanx
TALUS                    Talus
SCIATIC NERVE                 Sciatic Nerve



THROAT                        Throat

FEMORAL NECK                  Femoral Neck

MALE GENITALIA                Male Genitalia
FEMALE GENITALIA              Female Genitalia
UNCINATE PROCESS OF           Uncinate Process of Pancreas
PANCREAS
CHEST WALL                    Chest Wall


INFRACLAVICULAR LYMPH NODE Infraclavicular Lymph Node

FACIAL BONE                   Facial Bone

WAIST                         Waist
HIP                           Hip

CELIAC LYMPH NODE             Celiac Lymph Node
TOOTH CANAL                   Tooth Canal

EPICONDYLE                    Epicondyle

DSCAT                         Category for Disposition Event


PROTOCOL MILESTONE            Protocol Milestone



OTHER EVENT                   Other Event

DISPOSITION EVENT             Disposition Event



SKINCLAS                      Skin Classification




TYPE1
TYPE2




TYPE3



TYPE4




TYPE5




TYPE6




SKINTYP    Skin Type


OILY


DRY

NORMAL

SCCD       Subject Characteristic Code




EDLEVEL    Education Level
MARISTAT   Marital Status

EMPJOB     Employee Job


SKINCLAS   Skin Classification

SKINTYP    Skin Type

JOBCLAS    Employee Job Class
SALTYP                      Employee Salary Type


MARISTAT                    Marital Status

ANNULLED

DIVORCED

INTERLOCUTORY

LEGALLY SEPARATED

MARRIED
NEVER MARRIED
WIDOWED
POLYGAMOUS
DOMESTIC PARTNER

RACE                        Race


BLACK OR AFRICAN AMERICAN


AMERICAN INDIAN OR ALASKA
NATIVE


ASIAN




NATIVE HAWAIIAN OR OTHER
PACIFIC ISLANDER




WHITE


DATEST                      Drug Accountability Test
                            Name
DISPAMT                     Dispensed Amount

RETAMT                      Returned Amount

DATESTCD                    Drug Accountability Test Code
DISPAMT                  Dispensed Amount

RETAMT                   Returned Amount

SPECCOND                 Specimen Condition

FROZEN                   Frozen Specimen

HEMOLIZED                Hemolysis in Specimen


LIPEMIC                  Lipemic Specimen

REFRIGERATED             Refrigerated Specimen

ROOM TEMPERATURE         Specimen at Room
                         Temperature

CALCIFIED                Calcified Specimen
CLOTTED                  Clotted Specimen
AUTOLIZED                Autolized Specimen

SPECTYPE                 Specimen Type

ADIPOSE TISSUE


AMNIOTIC FLUID

AQUEOUS HUMOR

ARTERIAL BLOOD




ATHEROSCLEROTIC PLAQUE

BILE


BLOOD




BONE

BONE MARROW
BREAST MILK

CALCULUS


CEREBROSPINAL FLUID


CERUMEN
COLOSTRUM


EMESIS                Vomit

EXPIRED AIR


EXUDATE


FLUID
HAIR
LOCHIA


LUNG SURFACTANT       Surfactant




LYMPH




MECONIUM


MENSTRUAL BLOOD


MUCUS

NAIL

PLASMA
PUS


SALIVA


SEBUM

SEMEN           Seminal Plasma




SEMINAL FLUID

SERUM

SMEGMA

SPUTUM


STOOL           Feces


PERSPIRATION    Sweat
TISSUE



TRANSUDATE


URINE

VENOUS BLOOD




EVAL            Evaluator

CAREGIVER

CHILD
PARENT
CLINICAL RESEARCH
COORDINATOR




CLINICAL RESEARCH ASSOCIATE Research Associate




CLINICAL STUDY SPONSOR        Study Sponsor, Sponsor

HEALTH CARE PROFESSIONAL


INDEPENDENT ASSESSOR


INVESTIGATOR



FRIEND

STUDY SUBJECT


SPOUSE
DOMESTIC PARTNER


ADJUDICATION COMMITTEE


GUARDIAN



NRIND                         Reference Range Indicator

NORMAL

ABNORMAL

HIGH

LOW
RELTYPE   Relationship Type

ONE
MANY
NCF       Never/Current/Former
          Classification

NEVER

CURRENT

FORMER    Previous
CDISC Definition                                                NCI Preferred Term


The reason that changes were made to the therapy under          CDISC SDTM Action Taken with
study. (NCI)                                                    Study Treatment Terminology

An indication that a medication schedule was modified by        Dose Increased
addition; either by changing the frequency, strength or
amount. (NCI)




An indication that a medication schedule was maintained.        Dose Not Changed
(NCI)




An indication that a medication schedule was modified by        Dose Reduced
subtraction, either by changing the frequency, strength or
amount. (NCI)




An indication that a medication schedule was modified by        Drug Interrupted
temporarily terminating a prescribed regimen of medication.
(NCI)
An indication that a medication schedule was modified           Drug Withdrawn
through termination of a prescribed regimen of medication.
(NCI)




Determination of a value is not relevant in the current context. Not Applicable
(NCI)
Not known, not observed, not recorded, or refused. (NCI)         Unknown




A condition or event that is attributed to the adverse event and CDISC SDTM Adverse Event
is the result or conclusion of the adverse event. (NCI)          Outcome Terminology

The termination of life as a result of an adverse event. (NCI)   Death Related to Adverse Event




One of the possible results of an adverse event outcome that Not Recovered or Not Resolved
indicates that the event has not improved or recuperated.
(NCI)




One of the possible results of an adverse event outcome that Recovered or Resolved
indicates that the event has improved or recuperated. (NCI)




One of the possible results of an adverse event outcome          Recovered or Resolved with
where the subject recuperated but retained pathological          Sequelae
conditions resulting from the prior disease or injury. (NCI)




One of the possible results of an adverse event outcome that Recovering or Resolving
indicates that the event is improving. (NCI)
Not known, not observed, not recorded, or refused. (NCI)       Unknown




Subgroups of populations based on age. (NCI)                   CDISC SDTM Age Group
                                                               Terminology
A juvenile between the onset of puberty and maturity; in the   Adolescent
state of development between puberty and maturity. (NCI)




A person from 18 years to 65 years of age. (NCI)               Adult 18-65 Years Old


A person from 2 years to 11 years of age. (NCI)                Children 2-11 Years Old


An age group comprised by people 65 years of age and older. Elderly
(NCI)

The period of time during which the embryo or foetus is        In Utero
present in the uterus of the female. Also describes the
location of the embryo or foetus as being in the uterus in
contrast to outside the uterus (ex utero). (NCI)

A person from 28 days to 23 months of age. (NCI)               Infant And Toddler


An infant during the first month after birth. (NCI)            Newborn


An infant born prior to completion of the normal gestation     Preterm Newborn Infant
period. (NCI)

Those units of time that are routinely used to express the age CDISC SDTM Age Unit
of a person. (NCI)                                               Terminology
The time for Earth to make a complete rotation on its axis;      Day
ordinarily divided into twenty-four hours. This also refers to a
specific day. (NCI)
A unit measure of time equal to 3,600 seconds or 60 minutes. Hour
It is approximately 1/24 of a median day. (NCI)




One of the 12 divisions of a year as determined by a calendar. Month
It corresponds to the unit of time of approximately to one cycle
of the moon's phases, about 30 days or 4 weeks. (NCI)




Any period of seven consecutive days. (NCI)                    Week




The period of time that it takes for Earth to make a complete Year
revolution around the sun, approximately 365 days; a specific
one year period. (NCI)




A collection of criteria on which subjects are evaluated and   CDISC SDTM Category of
that must be met by all study subjects. (NCI)                  Inclusion And Or Exclusion
                                                               Terminology

List of characteristics in a protocol, any one of which may    Exclusion
exclude a potential subject from participation in a study.
(CDISC glossary)
The criteria in a protocol that prospective subjects must meet Inclusion
to be eligible for participation in a study. NOTE: Exclusion
and inclusion criteria define the study population. See also
exclusion criteria. (CDISC glossary)




Terms at the highest level of the CDISC system organ class         CDISC SDTM System Organ
terminology.                                                       Class Terminology
Any deviation from the normal structure or function of the         Hematopoietic and Lymphoid
blood or lymphatic system that is manifested by a                  System Disorder
characteristic set of symptoms and signs. (NCI)
Any deviation from the normal structure or function of the         Heart Disorder
cardiac system that is manifested by a characteristic set of
symptoms and signs. (NCI)
A class of disorders that encompasses conditions resulting         Congenital, Familial and Genetic
from a congenital, familial hereditary trait or genetic            Disorder Class
abnormality as is manifested by a characterstic set of
symptoms and signs. (NCI)
Any deviation from the normal structure or function of the ear     Ear and Labyrinth Disorder Class
or labyrinth that is manifested by a characteristic set of
symptoms and signs. (NCI)
Any deviation from the normal structure or function of the         Endocrine Disorder
endocrine system that is manifested by a characteristic set of
symptoms and signs. (NCI)
Any deviation from the normal structure or function of the eye     Eye Disorder
that is manifested by a characteristic set of symptoms and
signs. (NCI)
Diseases of the digestive tract (oral cavity to anus) and          Gastrointestinal Disorder
associated organs (salivary glands, liver, pancreas). (NCI)

A class of disorders that encompasses conditions of a general      General Disorders and
kind that result from a disease, the treatment of disease or       Administration Site Conditions
administration of treatment at a particular site and are           Class
manifested by a characteristic set of symptoms and signs.
(NCI)
Any deviation from the normal structure or function of the liver   Liver and Biliary Tract Disorder
or biliary tract that is manifested by a characteristic set of
symptoms and signs. (NCI)
A disorder resulting from an abnormality in the immune             Immune System Disorder
system. -- 2003 (NCI)
A disorder resulting from the presence and activity of a           Infectious Disorder
microbial, viral, or parasitic agent. It can be transmitted by
direct or indirect contact. -- 2003 (NCI)
A class of disorders that encompasses conditions resulting         Injury, Poisoning and Procedural
from an injury, poisoning or procedure. (NCI)                      Complication Class

The act or process of a systematic and thorough examination; Investigation
research, study; the process of inquiring into or following up,
intended to develop facts. (NCI)

A class of disorders that encompasses conditions occurring         Metabolism and Nutrition
as a result of metabolic dysfunction or deviation from the         Disorder Class
normal nutritional requirements. (NCI)
Any deviation from the normal structure or function of the         Connective and Soft Tissue
musculoskeletal or connective tissue that is manifested by a       Disorder
characteristic set of symptoms and signs. (NCI)

An abnormal tissue growth resulted from uncontrolled cell          Neoplasm
proliferation. Benign neoplastic cells resemble normal cells
without exhibiting significant cytologic atypia, while malignant
ones exhibit overt signs such as dysplastic features, atypical
mitotic figures, necrosis, nuclear pleomorphism, and
anaplasia. Representative examples of benign neoplasms
include papillomas, cystadenomas, and lipomas; malignant
neoplasms include carcinomas, sarcomas, lymphomas, and
leukemias. -- 2004 (NCI)



Any deviation from the normal structure or function of the         Nervous System Disorder
nervous system that is manifested by a characteristic set of
symptoms and signs. (NCI)
A class of conditions associated with pregnancy, puerperium        Pregnancy, Puerperium and
and perinatal status. (NCI)                                        Perinatal Condition Class


Any deviation from the normal structure or function of the       Psychiatric Disorder
brain and a psychiatric condition, that results in an impairment
of an individual's normal cognitive, emotional, or behavioral
functioning, and is caused by physiological or psychosocial
factors. (NCI)
Disorders of any part of the urologic system. (NCI)              Urinary System Disorder

Any deviation from the normal structure or function of the         Reproductive System and Breast
reproductive system or breast that is manifested by a              Disorder Class
characteristic set of symptoms and signs. (NCI)
Any deviation from the normal structure or function of the         Respiratory and Thoracic
respiratory system including the thorax and mediastinum that       Disorder
is manifested by a characteristic set of symptoms and signs.
(NCI)
Any deviation from the normal structure or function of the skin    Skin Disorder
or subcutaneous tissue that is manifested by a characteristic
set of symptoms and signs.(NCI)
A set of concepts that results from or is influenced by criteria   Social Circumstances
or activities associated with the social environment of a
person. (NCI)
A particular course of action intended to achieve a result.        Procedure
(NCI)
Any deviation from the normal structure or function of the         Vascular Disorder
vascular system that is manifested by a characteristic set of
symptoms and signs. (NCI)
A standard terminology developed to report adverse events          CDISC SDTM Common
occurring in cancer clinical trials. Common terminology            Terminology Criteria for Adverse
criteria for adverse events (CTCAE) are used in study              Event Grade Terminology
adverse event summaries and Investigational New Drug
reports to the Food and Drug Administration. The CTCAE
contain a grading scale for each adverse event term
representing the severity of the event. (NCI)




A type of adverse event that is usually transient and may          Mild Adverse Event
require only minimal treatment or therapeutic intervention.
The event does not generally interfere with usual activities of
daily living.




A type of adverse event that is usually alleviated with       Moderate Adverse Event
additional specific therapeutic intervention. The event
interferes with usual activities of daily living, causing
discomfort but poses no significant or permanent risk of harm
to the research participant.



A type of adverse event that requires intensive therapeutic        Severe Adverse Event
intervention. The event interrupts usual activities of daily
living, or significantly affects clinical status. The event
possesses a significant risk of harm to the research
participant and hospitalization may be required.
An adverse event, and/or its immediate sequelae, which is             Life Threatening or Disabling
associated with an imminent risk of death or which is                 Adverse Event
associated with physical or mental disabilities that affect or
limit the ability of a person to perform activities of daily living
(eating, ambulation, toileting, etc.) See NCI Common
Terminology Criteria for Adverse Events.


The termination of life as a result of an adverse event. (NCI)        Death Related to Adverse Event




Comparator against which the study treatment is evaluated             CDISC SDTM Control Type
(e.g., concurrent (placebo, no treatment, dose-response,              Terminology
active), external (historical, published literature).



A type of control, which has a demonstrated effect,                   Active Control
administered as a comparator, to subjects in a clinical trial.
[From ICH E10].


No person or thing, nobody, not any. (NCI)                            None
Use of an inactive compound identical in appearance to drug           Placebo Control
or treatment being tested in experimental research, which
may or may not be known to the physician and/or subject,
administered to distinguish between drug action and
suggestive effect of the drug or treatment under study. The
effects of the active drug or treatment are compared to the
effects of the placebo. (NCI)

A collective generic term that refers here to a wide variety of       CDISC SDTM Country
dependencies, areas of special sovereignty, uninhabited               Terminology
islands, and other entities in addition to the traditional
countries or independent states. (NCI)

Island in the Caribbean Sea, north of Venezuela.                      Aruba
A country in Southern Asia, north and west of Pakistan, east   Afghanistan
of Iran.




A country in Southern Africa, bordering the South Atlantic     Angola
Ocean, between Namibia and Democratic Republic of the
Congo.



An island in the Caribbean Sea, east of Puerto Rico.           Anguilla




An archipelago in the Baltic Sea at the entrance to the Gulf of Aland Islands
Bothnia between Sweden and Finland.




A country in Southeastern Europe, bordering the Adriatic Sea Albania
and Ionian Sea, between Greece and Serbia and Montenegro.




A country in Southwestern Europe, between France and           Andorra
Spain.




A country in the Caribbean, comprising two island groups in Netherlands Antilles
the Caribbean Sea - one includes Curacao and Bonaire north
of Venezuela; the other is east of the Virgin Islands.



A country in the Middle East, bordering the Gulf of Oman and United Arab Emirates
the Persian Gulf, between Oman and Saudi Arabia.
A country in Southern South America, bordering the South       Argentina
Atlantic Ocean, between Chile and Uruguay.




A country in Southwestern Asia, east of Turkey.                Armenia




A group of islands in the South Pacific Ocean, about half way American Samoa
between Hawaii and New Zealand.




The continent lying mostly south of the Antarctic Circle.      Antarctica




Islands in the southern Indian Ocean, south of Africa, about   French Southern Territories
equidistant between Africa, Antarctica, and Australia.




Islands between the Caribbean Sea and the North Atlantic       Antigua and Barbuda
Ocean, east-southeast of Puerto Rico.




The continent between the Indian Ocean and the South           Australia
Pacific Ocean.




A country in Central Europe, north of Italy and Slovenia.      Austria
A country in Southwestern Asia, bordering the Caspian Sea,     Azerbaijan
between Iran and Russia.




A country in Central Africa, east of Democratic Republic of the Burundi
Congo.




A country in Western Europe, bordering the North Sea,          Belgium
between France and the Netherlands.




A country in Western Africa, bordering the North Atlantic      Benin Republic
Ocean, between Nigeria and Togo.




A country in Western Africa, north of Ghana.                   Burkina Faso




A country in Southern Asia, bordering the Bay of Bengal,       Bangladesh
between Burma and India.




A country in Southeastern Europe, bordering the Black Sea,     Bulgaria
between Romania and Turkey.




An archipelago in the Persian Gulf, east of Saudi Arabia.      Bahrain
A chain of islands in the North Atlantic Ocean, southeast of   Bahamas
Florida.




A country in Southeastern Europe, bordering the Adriatic Sea Bosnia-Herzegovina
and Croatia.




A country in Eastern Europe, east of Poland.                   Belarus




A country in Central America, bordering the Caribbean Sea,     Belize
between Guatemala and Mexico.




No Definition                                                  Bermuda




A country in Central South America, southwest of Brazil.       Bolivia




A country in Eastern South America, bordering the Atlantic     Brazil
Ocean.




An island between the Caribbean Sea and the North Atlantic     Barbados
Ocean, northeast of Venezuela.
A country in Southeastern Asia, bordering the South China      Brunei Darussalam
Sea and Malaysia.




A country in Southern Asia, between China and India.           Bhutan




An island in the South Atlantic Ocean, south-southwest of the Bouvet Island
Cape of Good Hope (South Africa).




A country in Southern Africa, north of South Africa.           Botswana




A country in Central Africa, north of Democratic Republic of   Central African Republic
the Congo.




A country in Northern North America, bordering the North       Canada
Atlantic Ocean on the east, North Pacific Ocean on the west,
and the Arctic Ocean on the north, north of the conterminous
US.


A group of islands in the Indian Ocean, south of Indonesia,    Cocos (Keeling) Islands
about halfway from Australia to Sri Lanka.




A country in Central Europe, east of France, north of Italy.   Switzerland
A country in Southern South America, bordering the South      Chile
Atlantic Ocean and South Pacific Ocean, between Argentina
and Peru.



A country in Eastern Asia, bordering the East China Sea,  China
Korea Bay, Yellow Sea, and South China Sea, between North
Korea and Vietnam.



A country in Western Africa, bordering the North Atlantic     Cote d'Ivoire
Ocean, between Ghana and Liberia.




A country in Western Africa, bordering the Bight of Biafra,   Cameroon
between Equatorial Guinea and Nigeria.




A country in Central Africa, northeast of Angola.             Democratic Republic of the
                                                              Congo




A country in Western Africa, bordering the South Atlantic     Congo
Ocean, between Angola and Gabon.




A group of islands in the South Pacific Ocean, about one-half Cook Islands
of the way from Hawaii to New Zealand.




A country in Northern South America, bordering the            Colombia
Caribbean Sea, between Panama and Venezuela, and
bordering the North Pacific Ocean, between Ecuador and
Panama.
A group of islands in the Mozambique Channel, about two-   Comoros
thirds of the way between northern Madagascar and northern
Mozambique.



A group of islands in the North Atlantic Ocean, west of        Cape Verde
Senegal.




A country in Central America, bordering both the Caribbean     Costa Rica
Sea and the North Pacific Ocean, between Nicaragua and
Panama.



An island between the Caribbean Sea and the North Atlantic     Cuba
Ocean, 150 km south of Key West, Florida.




An Australian-administered island in the eastern Indian Ocean Christmas Island
south of Java, Indonesia.




An island group in the Caribbean Sea, nearly one-half of the   Cayman Islands
way from Cuba to Honduras.




An island in the Mediterranean Sea, south of Turkey.           Cyprus




A country in Central Europe, southeast of Germany.             Czech Republic
A country in Central Europe, bordering the Baltic Sea and the Germany
North Sea, between the Netherlands and Poland, south of
Denmark.



A country in Eastern Africa, bordering the Gulf of Aden and   Djibouti
the Red Sea, between Eritrea and Somalia.




An island between the Caribbean Sea and the North Atlantic Dominica
Ocean, about one-half of the way from Puerto Rico to Trinidad
and Tobago.



A country in Northern Europe, bordering the Baltic Sea and    Denmark
the North Sea, on a peninsula north of Germany (Jutland);
also includes two major islands (Sjaelland and Fyn).



A country comprising the eastern two-thirds of the island of Dominican Republic
Hispaniola, between the Caribbean Sea and the North Atlantic
Ocean, east of Haiti.
A country in Northern Africa, bordering the Mediterranean     Algeria
Sea, between Morocco and Tunisia.




A country in Western South America, bordering the Pacific     Ecuador
Ocean at the Equator, between Colombia and Peru.




A country in Northern Africa, bordering the Mediterranean     Egypt
Sea, between Libya and the Gaza Strip.




A country in Eastern Africa, bordering the Red Sea, between   Eritrea
Djibouti and Sudan.
A country in Northern Africa, bordering the North Atlantic     Western Sahara
Ocean, between Mauritania and Morocco.




A country in Southwestern Europe, bordering the Bay of         Spain
Biscay, Mediterranean Sea, North Atlantic Ocean, and
Pyrenees Mountains, southwest of France.



A country in Eastern Europe, bordering the Baltic Sea and      Estonia
Gulf of Finland, between Latvia and Russia.




A country in Eastern Africa, west of Somalia.                  Ethiopia




A country in Northern Europe, bordering the Baltic Sea, Gulf Finland
of Bothnia, and Gulf of Finland, between Sweden and Russia.




An island group in the South Pacific Ocean, about two-thirds   Fiji
of the way from Hawaii to New Zealand.




Islands in the South Atlantic Ocean, east of southern          Falkland Islands
Argentina.




A country in Western Europe, bordering the Bay of Biscay and France
English Channel, between Belgium and Spain, southeast of
the UK; bordering the Mediterranean Sea, between Italy and
Spain.
An island group between the Norwegian Sea and the North        Faroe Islands
Atlantic Ocean, about one-half of the way from Iceland to
Norway.



An island group in the North Pacific Ocean, about three-       Federated States of Micronesia
quarters of the way from Hawaii to Indonesia.




A country in Western Africa, bordering the Atlantic Ocean at   Gabon
the Equator, between Republic of the Congo and Equatorial
Guinea.



A country in Western Europe, comprising islands, including   United Kingdom
the northern one-sixth of the island of Ireland, between the
North Atlantic Ocean and the North Sea, northwest of France.



A country in Southwestern Asia, bordering the Black Sea,       Georgia
between Turkey and Russia.




The island of Guernsey and the other Channel Islands           Guernsey
represent the last remnants of the medieval Dukedom of
Normandy, which held sway in both France and England.
Guernsey is a British crown dependency, but is not part of the
UK.

A country in Western Africa, bordering the Gulf of Guinea,     Ghana
between Cote d'Ivoire and Togo.




A dependency in Southwestern Europe, bordering the Strait of Gibraltar
Gibraltar, on the southern coast of Spain.
A country in Western Africa, bordering the North Atlantic     Guinea
Ocean, between Guinea-Bissau and Sierra Leone.




Islands in the eastern Caribbean Sea, southeast of Puerto     Guadeloupe
Rico.




A country in Western Africa, bordering the North Atlantic     Gambia
Ocean and Senegal.




A country in Western Africa, bordering the North Atlantic     Guinea-Bissau
Ocean, between Guinea and Senegal.




A country in Western Africa, bordering the Bight of Biafra,   Equatorial Guinea
between Cameroon and Gabon; composed of a mainland
portion and five inhabited islands.



A country in Southern Europe, bordering the Aegean Sea,    Greece
Ionian Sea, and the Mediterranean Sea, between Albania and
Turkey.
An island between the Caribbean Sea and Atlantic Ocean,    Grenada
north of Trinidad and Tobago.




An island between the Arctic Ocean and the North Atlantic     Greenland
Ocean, northeast of Canada.




A country in Central America, bordering the Caribbean Sea,  Guatemala
between Honduras and Belize and bordering the North Pacific
Ocean, between El Salvador and Mexico.
A country in Northern South America, bordering the North        French Guiana
Atlantic Ocean, between Brazil and Suriname.




Island in the North Pacific Ocean, about three-quarters of the Guam
way from Hawaii to the Philippines.




A country in Northern South America, bordering the North        Guyana
Atlantic Ocean, between Suriname and Venezuela.




A special administrative region of China, bordering the South   Hong Kong
China Sea and China.




Islands in the Indian Ocean, about two-thirds of the way from   Heard Island and McDonald
Madagascar to Antarctica.                                       Islands
A country in Central America, bordering the Caribbean Sea,      Honduras
between Guatemala and Nicaragua and bordering the North
Pacific Ocean, between El Salvador and Nicaragua.



A country in Southeastern Europe, bordering the Adriatic Sea, Croatia
between Bosnia and Herzegovina and Slovenia.




A country comprising the western one-third of the island of  Haiti
Hispaniola, between the Caribbean Sea and the North Atlantic
Ocean, west of the Dominican Republic.



A country in Central Europe, northwest of Romania.              Hungary
A country in Southeastern Asia, comprising the archipelago     Indonesia
between the Indian Ocean and the Pacific Ocean.




A country in Southern Asia, bordering the Arabian Sea and      India
the Bay of Bengal, between Burma and Pakistan.




An archipelago in the Indian Ocean, about one-half the way     British Indian Ocean Territory
from Africa to Indonesia.




A country in Western Europe, occupying five-sixths of the      Ireland
island of Ireland in the North Atlantic Ocean, west of Great
Britain.



A country in the Middle East, bordering the Gulf of Oman, the Iran
Persian Gulf, and the Caspian Sea, between Iraq and
Pakistan.



A country in the Middle East, bordering the Persian Gulf,      Iraq
between Iran and Kuwait.




A country in Northern Europe, island between the Greenland     Iceland
Sea and the North Atlantic Ocean, northwest of the UK.




A country in the Middle East, bordering the Mediterranean      Israel
Sea, between Egypt and Lebanon.
A country in Southern Europe, occupying a peninsula          Italy
extending into the central Mediterranean Sea, northeast of
Tunisia.



An island in the Caribbean Sea, south of Cuba.               Jamaica




A country in the Middle East, northwest of Saudi Arabia.     Jordan




A country in Eastern Asia, occupying an island chain between Japan
the North Pacific Ocean and the Sea of Japan, east of the
Korean Peninsula.



Jersey and the other Channel Islands represent the last      Jersey
remnants of the medieval Dukedom of Normandy that held
sway in both France and England. Jersey is a British crown
dependency, but is not part of the UK.


A country in Central Asia, northwest of China.               Kazakhstan




A country in Eastern Africa, bordering the Indian Ocean,     Kenya
between Somalia and Tanzania.




A country in Central Asia, west of China.                    Kyrgyzstan
A country in Southeastern Asia, bordering the Gulf of             Cambodia
Thailand, between Thailand, Vietnam, and Laos.




A group of 33 coral atolls in the Pacific Ocean, straddling the   Kiribati
equator; the capital Tarawa is about one-half of the way from
Hawaii to Australia.



Islands in the Caribbean Sea, about one-third of the way from Saint Kitts and Nevis
Puerto Rico to Trinidad and Tobago.




A country in Eastern Asia, occupying the southern half of the South Korea
Korean Peninsula, bordering the Sea of Japan and the Yellow
Sea.
A country in the Middle East, bordering the Persian Gulf,     Kuwait
between Iraq and Saudi Arabia.




A country in Southeastern Asia, northeast of Thailand, west of Lao People's Democratic
Vietnam.                                                       Republic




A country in the Middle East, bordering the Mediterranean         Lebanon
Sea, between Israel and Syria.




A country in Western Africa, bordering the North Atlantic         Liberia
Ocean, between Cote d'Ivoire and Sierra Leone.




A country in Northern Africa, bordering the Mediterranean         Libyan Arab Jamahiriya
Sea, between Egypt and Tunisia.
A country in the Caribbean, occupying an island between the     Saint Lucia
Caribbean Sea and North Atlantic Ocean, north of Trinidad
and Tobago.



A country in Central Europe, between Austria and                Liechtenstein
Switzerland.




A country in Southern Asia, occupying an island in the Indian   Sri Lanka
Ocean, south of India.




A country in Southern Africa, an enclave of South Africa.       Lesotho




A country in Eastern Europe, bordering the Baltic Sea,          Lithuania
between Latvia and Russia.




A country in Western Europe, between France, Belgium, and Luxembourg
Germany.




A country in Eastern Europe, bordering the Baltic Sea,          Latvia
between Estonia and Lithuania.




A country in Eastern Asia, bordering the South China Sea and Macao
China.
A country in Northern Africa, bordering the North Atlantic      Morocco
Ocean and the Mediterranean Sea, between Algeria and
Western Sahara.



A country in Western Europe, bordering the Mediterranean        Monaco
Sea on the southern coast of France, near the border with
Italy.



A country in Eastern Europe, northeast of Romania.              Moldova




A country in Southern Africa, occupying an island in the Indian Madagascar
Ocean, east of Mozambique.




A country in Southern Asia, occupying a group of atolls in the Maldives
Indian Ocean, south-southwest of India.




A country in Central America, bordering the Caribbean Sea       Mexico
and the Gulf of Mexico, between Belize and the US and
bordering the North Pacific Ocean, between Guatemala and
the US.


A group of atolls and reefs in the North Pacific Ocean, about   Marshall Islands
one-half of the way from Hawaii to Australia.




A country in Southeastern Europe, north of Greece.              Republic of Macedonia
A country in Western Africa, southwest of Algeria.           Mali




A country in Southern Europe, occupying islands in the       Malta
Mediterranean Sea, south of Sicily (Italy).




A country in Southeastern Asia, bordering the Andaman Sea    Myanmar
and the Bay of Bengal, between Bangladesh and Thailand.




A republic in Southeastern Europe, bordering the Adriatic Montenegro
Sea, between Albania and Bosnia and Herzegovina. Formerly
part of Serbia and Montenegro (Federation Republic of
Yugoslavia).


A country in Northern Asia, between China and Russia.        Mongolia




A country in the Pacific, comprising islands in the North     Northern Mariana Islands
Pacific Ocean, about three-quarters of the way from Hawaii to
the Philippines.



A country in Southern Africa, bordering the Mozambique       Mozambique
Channel, between South Africa and Tanzania.




A country in Northern Africa, bordering the North Atlantic   Mauritania
Ocean, between Senegal and Western Sahara.




A country in the Caribbean, occupying an island in the       Montserrat
Caribbean Sea, southeast of Puerto Rico.
An island in the Caribbean Sea, north of Trinidad and Tobago. Martinique




A country in Southern Africa, occupying an island in the Indian Mauritius
Ocean, east of Madagascar.
A country in Southern Africa, east of Zambia.                  Malawi




A country in Southeastern Asia, occupying a peninsula and      Malaysia
the northern one-third of the island of Borneo, bordering
Indonesia and the South China Sea, south of Vietnam.



A country in Southern Africa, occupying an island in the       Mayotte
Mozambique Channel, about one-half of the way from
northern Madagascar to northern Mozambique.



A country in Southern Africa, bordering the South Atlantic     Namibia
Ocean, between Angola and South Africa.




A country in the Pacific, comprised of islands in the South    New Caledonia
Pacific Ocean, east of Australia.




A country in Western Africa, southeast of Algeria.             Niger




A country in the Pacific, occupying an island in the South     Norfolk Island
Pacific Ocean, east of Australia.
A country in Western Africa, bordering the Gulf of Guinea,    Nigeria
between Benin and Cameroon.




A country in Central America, bordering both the Caribbean    Nicaragua
Sea and the North Pacific Ocean, between Costa Rica and
Honduras.



A country in the Pacific, occupying an island in the South    Niue
Pacific Ocean, east of Tonga.




A country in Western Europe, bordering the North Sea,         Netherlands
between Belgium and Germany.




A country in Northern Europe, bordering the North Sea and     Norway
the North Atlantic Ocean, west of Sweden.




A country in Southern Asia, between China and India.          Nepal




A country in Oceania, occupying an island in the South Pacific Nauru
Ocean, south of the Marshall Islands.




A country in the Pacific, comprised of islands in the South   New Zealand
Pacific Ocean, southeast of Australia.
A country in the Middle East, bordering the Arabian Sea, Gulf Oman
of Oman, and Persian Gulf, between Yemen and the United
Arab Emirates.



A country in Southern Asia, bordering the Arabian Sea,           Pakistan
between India on the east and Iran and Afghanistan on the
west and China in the north.



A country in Central America, bordering both the Caribbean       Panama
Sea and the North Pacific Ocean, between Colombia and
Costa Rica.



A country in the Pacific, comprised of islands in the South      Pitcairn Island
Pacific Ocean, about midway between Peru and New
Zealand.



A country in Western South America, bordering the South          Peru
Pacific Ocean, between Chile and Ecuador.




A country in Southeastern Asia, comprised of an archipelago Philippines
between the Philippine Sea and the South China Sea, east of
Vietnam.



A country in the Pacific, comprising a group of islands in the   Palau
North Pacific Ocean, southeast of the Philippines.




A country in Southeastern Asia, comprising a group of islands Papua New Guinea
and including the eastern half of the island of New Guinea,
between the Coral Sea and the South Pacific Ocean, east of
Indonesia.
A country in Central Europe, east of Germany.                   Poland




An island between the Caribbean Sea and the North Atlantic      Puerto Rico
Ocean, east of the Dominican Republic.




A country in Eastern Asia, occupying the northern half of the   North Korea
Korean Peninsula, bordering the Korea Bay and the Sea of
Japan, between China and South Korea.



A country in Southwestern Europe, bordering the North           Portugal
Atlantic Ocean, west of Spain.




A country in Central South America, northeast of Argentina.     Paraguay




A collective name for the West Bank and the Gaza Strip, two     Palestinian Territory, Occupied
territories in Palestine.




An archipelago in the South Pacific Ocean, about one-half of    French Polynesia
the way from South America to Australia.




A country in the Middle East, occupying a peninsula bordering Qatar
the Persian Gulf and Saudi Arabia.
An Southern Africa, occupying an island in the Indian Ocean,   Reunion
east of Madagascar.




A country in Southeastern Europe, bordering the Black Sea,     Romania
between Bulgaria and Ukraine.




A country in Northern Asia (that part west of the Urals is   Russia
sometimes included with Europe), bordering the Arctic Ocean,
between Europe and the North Pacific Ocean.



A country in Central Africa, east of Democratic Republic of the Rwanda
Congo.




A country in the Middle East, bordering the Persian Gulf and   Saudi Arabia
the Red Sea, north of Yemen.




A republic in Southeastern Europe, bordering the Adriatic Serbia
Sea, between Albania and Bosnia and Herzegovina. Formerly
part of Serbia and Montenegro (Federation Republic of
Yugoslavia).


A country in Northern Africa, bordering the Red Sea, between Sudan
Egypt and Eritrea.




A country in Western Africa, bordering the North Atlantic      Senegal
Ocean, between Guinea-Bissau and Mauritania.
A country in Southeastern Asia, comprised of islands between Singapore
Malaysia and Indonesia.




A group of islands in the South Atlantic Ocean, east of the tip South Georgia and the South
of South America.                                               Sandwich Islands




Islands in the South Atlantic Ocean, about midway between      Saint Helena
South America and Africa.




Islands between the Arctic Ocean, Barents Sea, Greenland       Svalbard and Jan Mayen
Sea, and Norwegian Sea, northeast of Iceland and north of
Norway.



A group of islands in the South Pacific Ocean, east of Papua   Solomon Islands
New Guinea.




A country in Western Africa, bordering the North Atlantic      Sierra Leone
Ocean, between Guinea and Liberia.




A country in Central America, bordering the North Pacific      El Salvador
Ocean, between Guatemala and Honduras.




A country in Southern Europe, an enclave in central Italy.     San Marino
A country in Eastern Africa, bordering the Gulf of Aden and     Somalia
the Indian Ocean, east of Ethiopia.




A country in Northern North America, comprised of islands in    Saint Pierre and Miquelon
the North Atlantic Ocean, south of Newfoundland (Canada).




A country in Western Africa, comprised of islands in the Gulf   Sao Tome and Principe
of Guinea, straddling the Equator, west of Gabon.




A country in Northern South America, bordering the North        Suriname
Atlantic Ocean, between French Guiana and Guyana.




A country in Central Europe, south of Poland.                   Slovakia




A country in Central Europe, bordering the Adriatic Sea,        Slovenia
between Austria and Croatia.




A country in Northern Europe, bordering the Baltic Sea, Gulf    Sweden
of Bothnia, Kattegat, and Skagerrak, between Finland and
Norway.



A country in Southern Africa, between Mozambique and            Swaziland
South Africa.
A country in Eastern Africa, comprised of a group of islands in Seychelles
the Indian Ocean, northeast of Madagascar.




A country in the Middle East, bordering the Mediterranean      Syria
Sea, between Lebanon and Turkey.




Two island groups in the North Atlantic Ocean, southeast of    Turks and Caicos Islands
The Bahamas.




A country in Central Africa, south of Libya.                   Chad




A country in Western Africa, bordering the Bight of Benin,     Togo
between Benin and Ghana.




A country in Southeastern Asia, bordering the Andaman Sea      Thailand
and the Gulf of Thailand, southeast of Burma.




A country in Central Asia, west of China.                      Tajikistan




A group of three atolls in the South Pacific Ocean, about one- Tokelau
half of the way from Hawaii to New Zealand.
A country in Central Asia, bordering the Caspian Sea,          Turkmenistan
between Iran and Kazakhstan.




A country in Southeastern Asia, northwest of Australia in the Timor-Leste
Lesser Sunda Islands at the eastern end of the Indonesian
archipelago. East Timor includes the eastern half of the island
of Timor, the Oecussi (Ambeno) region on the northwest
portion of the island of Timor, and the islands of Pulau Atauro
and Pulau Jaco.


An archipelago in the South Pacific Ocean, about two-thirds of Tonga
the way from Hawaii to New Zealand.
Islands between the Caribbean Sea and the North Atlantic       Trinidad and Tobago
Ocean, northeast of Venezuela.




A country in Northern Africa, bordering the Mediterranean      Tunisia
Sea, between Algeria and Libya.




A country in southeastern Europe and southwestern Asia (that Turkey
portion of Turkey west of the Bosporus is geographically part
of Europe), bordering the Black Sea, between Bulgaria and
Georgia, and bordering the Aegean Sea and the
Mediterranean Sea, between Greece and Syria.

An island group consisting of nine coral atolls in the South   Tuvalu
Pacific Ocean, about one-half of the way from Hawaii to
Australia.



A group of islands bordering the East China Sea, Philippine    Taiwan
Sea, South China Sea, and Taiwan Strait, north of the
Philippines, off the southeastern coast of China.



A country in Eastern Africa, bordering the Indian Ocean,       Tanzania
between Kenya and Mozambique.
A country in Eastern Africa, west of Kenya.                     Uganda




A country in Eastern Europe, bordering the Black Sea,           Ukraine
between Poland and Russia.




The U.S. Minor Outlying Islands consist of Baker Island,     United States Minor Outlying
Howland Island, Jarvis Island, Johnston Atoll, Kingman Reef, Islands
Midway Island, Navassa Island, Palmyra Atoll, and Wake
Island (Wake Atoll).
A country in Southern South America, bordering the South        Uruguay
Atlantic Ocean, between Argentina and Brazil.
A country in North America, bordering both the North Atlantic   United States
Ocean and the North Pacific Ocean, between Canada and
Mexico.



A country in Central Asia, north of Afghanistan.                Uzbekistan




An enclave of Rome (Italy).                                     Holy See




A country in the Caribbean, comprised of islands in the         Saint Vincent and the
Caribbean Sea, north of Trinidad and Tobago.                    Grenadines




A country in Northern South America, bordering the              Venezuela
Caribbean Sea and the North Atlantic Ocean, between
Colombia and Guyana.
Islands between the Caribbean Sea and the North Atlantic        British Virgin Islands
Ocean, east of Puerto Rico.
Islands between the Caribbean Sea and the North Atlantic      United States Virgin Islands
Ocean, east of Puerto Rico.




A country in Southeastern Asia, bordering the Gulf of         Vietnam
Thailand, Gulf of Tonkin, and South China Sea, alongside
China, Laos, and Cambodia.



A group of islands in the South Pacific Ocean, about three-   Vanuatu
quarters of the way from Hawaii to Australia.




Islands in the South Pacific Ocean, about two-thirds of the   Wallis and Futuna Islands
way from Hawaii to New Zealand.




A group of islands in the South Pacific Ocean, about one-half Samoa
of the way from Hawaii to New Zealand.




A country in the Middle East, bordering the Arabian Sea, Gulf Yemen
of Aden, and Red Sea, between Oman and Saudi Arabia.




A country in Southern Africa, at the southern tip of the      South Africa
continent of Africa.




A country in Southern Africa, east of Angola.                 Zambia
A country in Southern Africa, between South Africa and            Zimbabwe
Zambia.




A grouping of individuals on the basis of a shared procedure      CDISC SDTM Diagnosis Group
or disease, or lack thereof (e.g. healthy volunteers, type 2      Terminology
diabetic subjects, subjects with renal cell cancer).
Standardized naming systems are available that define the
groups within which a subject should be placed. (NCI)

An individual who is or becomes a participant in a research       Healthy Subject
study and has no significant health-related issues. (NCI)

A name given to a reference source that lists words and gives CDISC SDTM Dictionary Name
their meaning. (NCI)                                          Terminology



A terminology developed and used by the Food and Drug             Thesaurus of Adverse Reaction
Administration (FDA) for the coding, filing and retrieving of     Term Coding Symbols
post marketing adverse reaction reports. (NCI)
A system of categories to which morbid entries are assigned       International Classification of
according to established criteria. Included is the entire range   Diseases
of conditions in a manageable number of categories, grouped
to facilitate mortality reporting. It is produced by the World
Health Organization (from ICD-10, p1). The Clinical
Modifications, produced by the United States Dept. of Health
and Human Services, are larger extensions used for morbidity
and general epidemiological purposes, primarily in the U.S.
(MSH2005_2004_10_12)
Published by the The Regenstrief Institute, the Logical           Logical Observation Identifiers
Observation Identifiers Names and Codes covers clinical and       Names and Codes
clinical laboratory terminology. (NCI)
MedDRA is an international medical terminology designed to        MedDRA
support the classification, retrieval, presentation, and
communication of medical information throughout the medical
product regulatory cycle. MedDRA was developed under the
auspices of the International Conference on Harmonisation of
Technical Requirements for Registration of Pharmaceuticals
for Human Use (ICH). The MedDRA Maintenance and
Support Services Organization (MSSO) holds a contract with
the International Federation of Pharmaceutical Manufacturers
Associations (IFPMA) to maintain and support the
implementation of the terminology. (NCI)

A multiaxial, hierarchical classification system for diseases in Systematized Nomenclature of
man developed by the College of American Pathologists.           Medicine
(NCI)
A terminology implemented by the World Health Organization       World Health Organization
to describe adverse reactions to a prescribed medication or      Adverse Reaction Terminology
treatment regimen. (NCI)
A reference source of drugs and drug associated information      World Health Organization Drug
maintained by the World Health Organization. (NCI)               Dictionary

Indicates a task, process or examination that has either not     CDISC SDTM Not Done
been initiated or completed. (NCI)                               Terminology
Indicates a task, process or examination that has either not     Not Done
been initiated or completed. (NCI)




A social group characterized by a distinctive social and         CDISC SDTM Patient Ethnic
cultural tradition maintained from generation to generation, a   Group Terminology
common history and origin and a sense of identification with
the group; members of the group have distinctive features in
their way of life, shared experiences and often a common
genetic heritage; these features may be reflected in their
experience of health and disease. (NCI)
A person of Mexican, Puerto Rican, Cuban, Central or South       Hispanic or Latino
American or other Spanish culture or origin, regardless of
race. (NCI)




A person not of Cuban, Mexican, Puerto Rican, South or           Not Hispanic or Latino
Central American, or other Spanish culture or origin,
regardless of race. An arbitrary ethnic classification. (NCI)




Not provided or available                                        Not Stated




Not known, not observed, not recorded, or refused. (NCI)         Unknown
The form of the completed pharmaceutical product, e.g.              CDISC SDTM Pharmaceutical
tablet, capsule, injection, elixir, suppository. Dosage form can Dosage Form Terminology
have a significant effect on the onset, duration and intensity of
the pharmacological action of a drug. A pharmaceutical
dosage form controls the rate at which the drug is released
into the biological fluids. This release rate affects its intrinsic
absorption pattern and therefore, the bioavailability of the
drug.
A product that is packaged under pressure and contains              Aerosol Dosage Form
therapeutically active ingredients that are released upon
activation of an appropriate valve system; it is intended for
topical application to the skin as well as local application into
the nose (nasal aerosols), mouth (lingual aerosols), or lungs
(inhalation aerosols). (FDA)




A dosage form containing one or more active ingredients,          Aerosol Foam Dosage Form
surfactants, aqueous or non-aqueous liquids, and the
propellants; if the propellant is in the internal (discontinuous)
phase (i.e., of the oil-in-water type), a stable foam is
discharged, and if the propellant is in the external
(continuous) phase (i.e., of the water-in-oil type), a spray or a
quick-breaking foam is discharged. (FDA)
A pressurized dosage form consisting of metered dose valves Metered Aerosol Dosage Form
which allow for the delivery of a uniform quantity of spray upon
each activation. (NCI)




A product that is packaged under pressure and contains            Powder Aerosol Dosage Form
therapeutically active ingredients, in the form of a powder, that
are released upon activation of an appropriate valve system.
(NCI)



An aerosol product which utilizes a compressed gas as the         Aerosol Spray Dosage Form
propellant to provide the force necessary to expel the product
as a wet spray; it is applicable to solutions of medicinal agents
in aqueous solvents. (NCI)
A solid dosage form usually in the form of a rectangle that is    Chewable Bar Dosage Form
meant to be chewed. (NCI)




A solid dosage form in the shape of a small ball. (NCI)           Bead Dosage Form




A small sterile solid mass consisting of a highly purified drug   Extended Release Bead Implant
intended for implantation in the body which would allow at        Dosage Form
least a reduction in dosing frequency as compared to that
drug presented as a conventional dosage form. (NCI)



Solid dosage form, usually in the shape of a square or            Block Dosage Form
rectangle. (NCI)




A solid pharmaceutical dosage form that contains medicinal        Capsule Dosage Form
agent within either a hard or soft soluble container or shell,
usually used for the oral administration of medicine. The
shells are made of a suitable form of gelatin or other
substance. (NCI)


A solid dosage form in which the drug is enclosed within          Coated Capsule Dosage Form
either a hard or soft soluble container or "shell" made from a
suitable form of gelatin; additionally, the capsule is covered in
a designated coating. (NCI)



A solid dosage form in which the drug is enclosed within          Coated Pellets in Capsule
either a hard or soft soluble container or "shell" made from a    Dosage Form
suitable form of gelatin; the drug itself is in the form of
granules to which varying amounts of coating have been
applied. (NCI)
A solid dosage form in which the drug is enclosed within            Extended Release Coated
either a hard or soft soluble container or "shell" made from a      Capsule Dosage Form
suitable form of gelatin; additionally, the capsule is covered in
a designated coating, and which releases a drug (or drugs) in
such a manner to allow at least a reduction in dosing
frequency as compared to that drug (or drugs) presented as a
conventional dosage form. (NCI)
A solid dosage form in which the drug is enclosed within            Delayed Release Capsule
either a hard or soft soluble container made from a suitable        Dosage Form
form of gelatin, and which releases a drug (or drugs) at a time
other than promptly after administration. Enteric-coated
articles are delayed release dosage forms. (NCI)


A solid dosage form in which the drug is enclosed within            Delayed Release Pellets in
either a hard or soft soluble container or "shell" made from a      Capsule Dosage Form
suitable form of gelatin; the drug itself is in the form of
granules to which enteric coating has been applied, thus
delaying release of the drug until its passage into the
intestines. (NCI)

A solid dosage form in which the drug is enclosed within        Extended Release Capsule
either a hard or soft soluble container made from a suitable    Dosage Form
form of gelatin, and which releases a drug (or drugs) in such a
manner to allow a reduction in dosing frequency as compared
to that drug (or drugs) presented as a conventional dosage
form. (NCI)

A solid dosage form in which the drug is enclosed within            Extended Release Film Coated
either a hard or soft soluble container or "shell" made from a      Capsule Dosage Form
suitable form of gelatin; additionally, the capsule is covered in
a designated film coating, and which releases a drug (or
drugs) in such a manner to allow at least a reduction in dosing
frequency as compared to that drug (or drugs) presented as a
conventional dosage form. (NCI)
A solid dosage form in which the drug is enclosed within            Gelatin Coated Capsule Dosage
either a hard or soft soluble container made from a suitable        Form
form of gelatin; through a banding process, the capsule is
coated with additional layers of gelatin so as to form a
complete seal. (NCI)


A solid dosage form in which the drug is enclosed within a          Liquid Filled Capsule Dosage
soluble, gelatin shell which is plasticized by the addition of a    Form
polyol, such as sorbitol or glycerin, and is therefore of a
somewhat thicker consistency than that of a hard shell
capsule; typically, the active ingredients are dissolved or
suspended in a liquid vehicle. (NCI)
A substance that serves to produce solid union between two       Cement Dosage Form
surfaces. (NCI)




A narrow tube filled with material that is capable to burn with Cigarette Dosage Form
release of therapeutically-active substance(s) during the
process of smoking. Cigarette is a very efficient drug-delivery
inhaler system for fast-acting substances.(FDA)



A large piece of relatively flat, absorbent material that contains Cloth Dosage Form
a drug. It is typically used for applying medication or for
cleansing. (FDA)




A liquid preparation of increased strength and reduced           Concentrate Dosage Form
volume which is usually diluted prior to administration. (NCI)




A solid dosage form bounded by a circular base and the           Cone Dosage Form
surface formed by line segments joining every point of the
boundary of the base to a common vertex. A cone (usually
containing antibiotics) is normally placed below the gingiva
after a dental extraction. (NCI)


An ocular system placed in the eye from which the drug           Extended Release Core Dosage
diffuses through a membrane at a constant rate over a            Form
specified period. (NCI)
A semisolid emulsion of either the oil-in-water or the water-in- Cream Dosage Form
oil type, ordinarily intended for topical use. (NCI)
A cream dosage form that enhances drug delivery.               Augmented Cream Dosage
Augmentation does not refer to the strength of the drug in the Form
dosage form. NOTE: CDER has decided to refrain from
expanding the use of this dosage form due to difficulties in
setting specific criteria that must be met to be considered
augmented. (FDA)

A naturally produced angular solid of definite form in which the Crystal Dosage Form
ultimate units from which it is built up are systematically
arranged; they are usually evenly spaced on a regular space
lattice.



The propagation of microorganisms or of living tissue cells in   Culture Dosage Form
special media conducive to their growth. (NCI)




A device usually dome-shaped, worn during copulation over        Diaphragm Dosage Form
the cervical mouth for prevention of conception or infection.
(NCI)




A circular plate-like organ or structure. (FDA)                  Disc Dosage Form




A liquid preparation, intended for the irrigative cleansing of the Douche Dosage Form
vagina, that is prepared from powders, liquid solutions, or
liquid concentrates and contains one or more chemical
substances dissolved in a suitable solvent or mutually
miscible solvents. (NCI)


The application of various materials for protecting a            Dressing Dosage Form
wound.(FDA)
Modern technology, distributed with or as a part of a drug       Drug Delivery System
product that allows for the uniform release or targeting of
drugs to the body. (FDA)




A clear, pleasantly flavored, sweetened hydroalcoholic liquid    Elixir Dosage Form
containing dissolved medicinal agents; it is intended for oral
use. (NCI)




A dosage form consisting of a two-phase system comprised Emulsion Dosage Form
of at least two immiscible liquids (1), one of which is dispersed
as droplets (internal or dispersed phase) within the other liquid
(external or continuous phase), generally stabilized with one
or more emulsifying agents. Note 1: A liquid is pourable; it
flows and conforms to its container at room temperature. It
displays Newtonian or pseudoplastic flow behavior. Note 2:
Emulsion is used as a dosage form term unless a more
specific term is applicable, e.g. cream, lotion, ointment. (NCI)


A rectal preparation for therapeutic, diagnostic, or nutritive   Enema Dosage Form
purposes. (NCI)




A concentrated preparation of vegetable or animal drugs          Extract Dosage Form
obtained by removal of the active constituents of the
respective drugs with a suitable menstrua, evaporation of all
or nearly all of the solvent, and adjustment of the residual
masses or powders to the prescribed standards. (NCI)


A slender and elongated solid thread-like substance that      Extended Release Fiber Dosage
delivers drug in such a manner to allow a reduction in dosing Form
frequency as compared to that drug (or drugs) presented as a
conventional dosage form. (FDA)
A thin layer or coating. (NCI)                                   Film Dosage Form




A drug delivery system in the form of a film that releases the   Extended Release Film Dosage
drug over an extended period in such a way as to maintain        Form
constant drug levels in the blood or target tissue. (NCI)




A thin layer or coating which is susceptible to being dissolved Soluble Film Dosage Form
when in contact with a liquid. (NCI)




A product, usually a solid, intended for solution prior to       Dosage Form For Solution
administration. (FDA)




A product, usually a solid, intended for suspension prior to     Dosage Form For Suspension
administration. (FDA)




A product, usually a solid, intended for suspension prior to  Extended Release Dosage Form
administration; once the suspension is administered, the drug For Suspension
will be released at a constant rate over a specified period.
(FDA)



Any elastic aeriform fluid in which the molecules are            Gas Dosage Form
separated from one another and have free paths. (NCI)
A semisolid (1) dosage form that contains a gelling agent to     Gel Dosage Form
provide stiffness to a solution or a colloidal dispersion (2). A
gel may contain suspended particles. Note 1: A semisolid is
not pourable; it does not flow or conform to its container at
room temperature. It does not flow at low shear stress and
generally exhibits plastic flow behavior. Note 2: A colloidal
dispersion is a system in which particles of colloidal
dimension (i.e., typically between 1 nm and 1 micrometer) are
distributed uniformly throughout a liquid. (NCI)

A combination of a dentifrice (formulation intended to clean      Dentifrice Gel Dosage Form
and/or polish the teeth, and which may contain certain
additional agents), and a gel. It is used with a toothbrush for
the purpose of cleaning and polishing the teeth. (NCI)



A gel preparation, with metered dose valves, which allow for      Metered Gel Dosage Form
the delivery of a uniform quantity of gel upon each activation.
(FDA)




An apparatus for the formation of vapor or gas from a liquid or Generator Dosage Form
solid by heat or chemical action. The term GENERATOR also
applies to radioactive columns from which radionuclides are
provided. (NCI)



Also called pellets or pilules, are made of pure sucrose,        Globule Dosage Form
lactose, or other polysaccharides. They are formed into small
globular masses of various sizes, and are medicated by
placing them in a vial and adding the liquid drug attenuation in
the proportion not less than one percent (v/w). After shaking,
the medicated globules are dried at temperatures not to
exceed 40 degrees Centigrade. (NCI)

A slip of skin or of other tissue for implantation. (NCI)         Graft Dosage Form
A small particle or grain. (NCI)                                 Granule Dosage Form




A small medicinal particle or grain to which an enteric or other Delayed Release Granule
coating has been applied, thus delaying release of the drug      Dosage Form
until its passage into the intestines. (NCI)




A small particle or grain containing a medicinal agent in a dry Effervescent Granule Dosage
mixture usually composed of sodium bicarbonate, citric acid, Form
and tartaric acid which, when in contact with water, has the
capability to release gas, resulting in effervescence. (NCI)



A small medicinal particle or grain made available in its more   Granule For Solution Dosage
stable dry form, to be reconstituted with solvent just before    Form
dispensing; the granules are so prepared to contain not only
the medicinal agent, but the colorants, flavorants, and any
other desired pharmaceutic ingredient. (NCI)


A small medicinal particle or grain made available in its more   Granule For Suspension Dosage
stable dry form, to be reconstituted with solvent just before    Form
dispensing to form a suspension; the granules are so
prepared to contain not only the medicinal agent, but the
colorants, flavorants, and any other desired pharmaceutic
ingredient. (NCI)

A small medicinal particle or grain made available in its more Extended Release Granule For
stable dry form, to be reconstituted with solvent just before  Suspension Dosage Form
dispensing to form a suspension; the extended release
system achieves slow release of the drug over an extended
period of time and maintains constant drug levels in the blood
or target tissue. (NCI)

A mucilaginous excretion from various plants. (NCI)              Gum Dosage Form
A sweetened and flavored insoluble plastic material of various Chewing Gum Dosage Form
shapes which when chewed, releases a drug substance into
the oral cavity. (NCI)




Natural mixture of gum and resin, usually obtained as              Resin Gum Dosage Form
exudations from plants. (NCI)




A material containing drug intended to be inserted securely        Implant Dosage Form
and deeply in a living site for growth, slow release, or
formation of an organic union. (NCI)




A special class of inhalations consisting of a drug or             Inhalant Dosage Form
combination of drugs, that by virtue of their high vapor
pressure, can be carried by an air current into the nasal
passage where they exert their effect; the container from
which the inhalant generally is administered is known as an
inhaler. (NCI)

An injection, which either consists of or forms liposomes (a       Liposomal Injection Dosage
lipid bilayer vesicle usually composed of phospholipids which      Form
is used to encapsulate an active drug substance). (FDA)




A sterile preparation intended for parenteral use; five distinct   Injectable Dosage Form
classes of injections exist as defined by the USP. (NCI)




An emulsion consisting of a sterile, pyrogen-free preparation      Emulsion for Injection Dosage
intended to be administered parenterally.(FDA)                     Form
[definition pending](FDA)                                        Injectable Lipid Complex Dosage
                                                                 Form




A sterile preparation intended for reconstitution to form a      Powder For Injectable Solution
solution for parenteral use. (NCI)                               Dosage Form




A sterile preparation intended for reconstitution to form a      Powder For Injectable
suspension for parenteral use. (NCI)                             Suspension Dosage Form




A dried preparation intended for reconstitution to form a    Powder For Injectable Extended
suspension for parenteral use which has been formulated in a Release Suspension Dosage
manner to allow at least a reduction in dosing frequency as  Form
compared to that drug presented as a conventional dosage
form (e.g., as a solution).(FDA)


A sterile freeze dried preparation intended for reconstitution   Lyophilized Powder For
for parenteral use which has been formulated in a manner         Injectable Liposomal Suspension
that would allow liposomes (a lipid bilayer vesicle usually      Dosage Form
composed of phospholipids which is used to encapsulate an
active drug substance, either within a lipid bilayer or in an
aqueous space) to be formed upon reconstitution. (NCI)

A dosage form intended for the solution prepared by              Lyophilized Powder For
lyophilization ('freeze drying'), a process which involves the   Injectable Solution Dosage Form
removal of water from products in the frozen state at
extremely low pressures; this is intended for subsequent
addition of liquid to create a solution that conforms in all
respects to the requirements for Injections. (NCI)

A liquid preparation, intended for parenteral use, that contains Lyophilized Powder For
solids suspended in a suitable fluid medium and conforms in Injectable Suspension Dosage
all respects to the requirements for Sterile Suspensions; the Form
medicinal agents intended for the suspension are prepared by
lyophilization ("freeze drying"), a process which involves the
removal of water from products in the frozen state at
extremely low pressures. (NCI)
A sterile freeze dried preparation intended for reconstitution Lyophilized Powder For
for parenteral use which has been formulated in a manner to Extended Release Injectable
allow at least a reduction in dosing frequency as compared to Suspension Dosage Form
that drug presented as a conventional dosage form (e.g., as a
solution). (NCI)


A liquid preparation containing one or more drug substances Injectable Solution Dosage Form
dissolved in a suitable solvent or mixture of mutually miscible
solvents that is suitable for injection. (NCI)




A sterile preparation for parenteral use which, upon the           Concentrate for Injectable
addition of suitable solvents, yields a solution conforming in all Solution Dosage Form
respects to the requirements for Injections. (NCI)




A liquid preparation, suitable for injection, which consists of    Injectable Suspension Dosage
solid particles dispersed throughout a liquid phase in which       Form
the particles are not soluble. It can also consist of an oil phase
dispersed throughout an aqueous phase, or vice-versa. (NCI)



A sterile preparation intended for parenteral use which has       Injectable Extended Release
been formulated in a manner to allow at least a reduction in      Suspension Dosage Form
dosing frequency as compared to that drug presented as a
conventional dosage form (e.g., as a solution or a prompt
drug-releasing, conventional solid dosage form). (NCI)


A liquid parenteral pharmaceutical dosage form structured as      Injectable Liposomal Suspension
a multilamellar composition of concentric phospholipid            Dosage Form
spheres that encapsulate the drug (drug delivery systems)
separated by layers of water. Drug release is facilitated and
controlled by in vivo erosion of the liposomes. To further
increase the in vivo circulation time, liposomes in some
preparations are covalently derivatized with PEG to produce
PEGylated or stealth liposomes. Covalent attachment of
drugs to the outer surface of liposomes can potentially serve
as a delayed-release product. (NCI)
A liquid preparation, suitable for injection, which consists of   Injectable Sonicated Suspension
solid particles dispersed throughout a liquid phase in which      Dosage Form
the particles are not soluble. In addition, the product is
sonicated while a gas is bubbled through the suspension, and
this results in the formation of microspheres by the solid
particles. (NCI)
A specially formulated and shaped non-encapsulated solid         Insert Dosage Form
preparation intended to be placed into a non-rectal orifice of
the body, where drug is released, generally for localized
effects. (FDA)



A specially formulated and shaped solid preparation (e.g.,     Extended Release Insert Dosage
ring, tablet, or stick) intended to be placed in the vagina by Form
special inserters, where the medication is released, generally
for localized effects; the extended release preparation is
designed to allow a reduction in dosing frequency. (NCI)


A device inserted and left in the uterus to prevent effective    Intrauterine Device Dosage Form
conception. (NCI)




A sterile solution intended to bathe or flush open wounds or     Irrigant Dosage Form
body cavities; they're used topically, never parenterally. (NCI)




A class of gels--semisolid systems which consist of               Jelly Dosage Form
suspensions made up of either small inorganic particles or
large organic molecules interpenetrated by a liquid--in which
the structural coherent matrix contains a high portion of liquid,
usually water. (NCI)


A packaged collection of related material. (NCI)                 Kit Dosage Form




A material applied to the inside of the dental cavity, for       Dental Liner Dosage Form
protection or insulation of the surface.(FDA)
A solution or mixture of various substances in oil, alcoholic     Liniment Dosage Form
solutions of soap, or emulsions intended for external
application. (NCI)




A waxy solid, usually colored cosmetic, in stick form for the     Lipstick Dosage Form
lips. (NCI)




A dosage form consisting of a pure chemical in its liquid state. Liquid Dosage Form
This dosage form term should not be applied to solutions.
Note: A liquid is pourable; it flows and conforms to its
container at room temperature. It displays Newtonian or
pseudoplastic flow behavior.(FDA)


A liquid that delivers a drug in such a manner to allow a         Extended Release Liquid
reduction in dosing frequency as compared to that drug (or        Dosage Form
drugs) presented as a conventional dosage form. (FDA)




An emulsion, liquid (1) dosage form. This dosage form is          Lotion Dosage Form
generally for external application to the skin (2). Note 1: A
liquid is pourable; it flows and conforms to its container at
room temperature. It displays Newtonian or pseudoplastic
flow behavior. Note 2: Previously the definition of a lotion was:
The term lotion has been used to categorize many topical
suspensions, solutions, and emulsions intended for
application to the skin. The current definition of a lotion is
restricted to an emulsion. (FDA)
A lotion dosage form that enhances drug delivery.                 Augmented Lotion Dosage Form
Augmentation does not refer to the strength of the drug in the
dosage form. NOTE: CDER has decided to refrain from
expanding the use of this dosage form due to difficulties in
setting specific criteria that must be met to be considered
augmented. (FDA)

A lotion dosage form which has a soap or detergent that is        Lotion Shampoo Dosage Form
usually used to clean the hair and scalp; it is often used as a
vehicle for dermatologic agents. (FDA)
A solid preparation containing one or more medicaments,         Lozenge Dosage Form
usually in a flavored, sweetened base which is intended to
dissolve or disintegrate slowly in the mouth. A lollipop is a
lozenge on a stick.(FDA)



An aqueous solution which is most often used for its            Mouthwash Dosage Form
deodorant, refreshing, or antiseptic effect. (NCI)




The use of a dosage form term is not relevant or appropriate. Dosage Form Not Applicable
(NCI)




An unctuous, combustible substance which is liquid, or easily Oil Dosage Form
liquefiable, on warming, and is soluble in ether but insoluble in
water. Such substances, depending on their origin, are
classified as animal, mineral, or vegetable oils. (NCI)



A suspension or emulsion, semisolid (1) dosage form, usually Ointment Dosage Form
containing < 20% water and volatiles (2) and > 50%
hydrocarbons, waxes, or polyols as the vehicle. This dosage
form is generally for external application to the skin or mucous
membranes. Note 1: A semisolid is not pourable; it does not
flow or conform to its container at room temperature. It does
not flow at low shear stress and generally exhibits plastic flow
behavior. Note 2: Percent water and volatiles are measured
by a loss on drying test in which the sample is heated at 105
degrees C until constant weight is achieved. (NCI)

An ointment dosage form that enhances drug delivery.           Augmented Ointment Dosage
Augmentation does not refer to the strength of the drug in the Form
dosage form. NOTE: CDER has decided to refrain from
expanding the use of this dosage form due to difficulties in
setting specific criteria that must be met to be considered
augmented. (FDA)
A material, usually covered by or impregnated with a drug,      Packing Dosage Form
that is inserted into a body cavity or between the tooth enamel
and the gingival margin.(FDA)




A semisolid dosage form, containing a large proportion (20 - Paste Dosage Form
50%) of solids finely dispersed in a fatty vehicle. This dosage
form is generally for external application to the skin or mucous
membranes. Note: A semisolid is not pourable; it does not
flow or conform to its container at room temperature. It does
not flow at low shear stress and generally exhibits plastic flow
behavior. (NCI)
A paste formulation intended to clean and/or polish the teeth, Dentifrice Paste Dosage Form
and which may contain certain additional agents. (NCI)




An aromatic preparation, often with a pleasing flavor, usually   Pastille Dosage Form
intended to dissolve in the mouth. (FDA)




A drug delivery system that often contains an adhesive           Patch Dosage Form
backing that is usually applied to an external site on the body.
Its ingredients either passively diffuse from, or are actively
transported from, some portion of the patch. Depending upon
the patch, the ingredients are either delivered to the outer
surface of the body or into the body. A patch is sometimes
synonymous with the terms Extended Release Film and
System. (NCI)
A drug delivery system in the form of a patch that releases the Extended Release Patch Dosage
drug in such a manner that a reduction in dosing frequency       Form
compared to that drug presented as a conventional dosage
form (e.g., a solution or a prompt drug-releasing, conventional
solid dosage form). (NCI)


A drug delivery system in the form of a patch which is           Electrically Controlled Extended
controlled by an electric current that releases the drug in such Release Patch Dosage Form
a manner that a reduction in dosing frequency compared to
that drug presented as a conventional dosage form (e.g., a
solution or a prompt drug-releasing, conventional solid
dosage form). (NCI)
A small sterile solid mass consisting of a highly purified drug Pellet Dosage Form
(with or without excipients) made by the formation of granules,
or by compression and molding. (NCI)




A small sterile solid mass consisting of a highly purified drug Implantable Pellet Dosage Form
(with or without excipients) made by the formation of granules,
or by compression and molding; they are intended for
implantation in the body (usually subcutaneously) for the
purpose of providing continuous release of the drug over long
periods of time. (NCI)

A solid dosage form in which the drug itself is in the form of Extended Release Coated
granules to which varying amounts of coating have been         Pellets Dosage Form
applied, and which releases a drug (or drugs) in such a
manner to allow a reduction in dosing frequency as compared
to that drug (or drugs) presented as a conventional dosage
form. (NCI)

A dose of medicine in the form of a small pellet. (NCI)          Pill Dosage Form




Substance intended for external application made of such         Plaster Dosage Form
materials and of such consistency as to adhere to the skin
and attach to a dressing; plasters are intended to afford
protection and support and/or to furnish an occlusion and
macerating action and to bring medication into close contact
with the skin. (NCI)

A soft, moist mass of meal, herbs, seed, etc., usually applied   Poultice Dosage Form
hot in cloth that consists of gruel-like consistency. (NCI)




An intimate mixture of dry, finely divided drugs and/or          Powder Dosage Form
chemicals that may be intended for internal or external use.
(NCI)
A powder formulation intended to clean and/or polish the      Dentifrice Powder Dosage Form
teeth, and which may contain certain additional agents. (NCI)




An intimate mixture of dry, finely divided drugs and/or          Powder for Solution Dosage
chemicals, which, upon the addition of suitable vehicles,        Form
yields a solution. (NCI)




An intimate mixture of dry, finely divided drugs and/or          Powder for Suspension Dosage
chemicals, which, upon the addition of suitable vehicles,        Form
yields a suspension (a liquid preparation containing the solid
particles dispersed in the liquid vehicle). (NCI)



A powder dosage form that is situated inside a container that    Metered Powder Dosage Form
has a mechanism to deliver a specified quantity. (NCI)




A small circular object with a vacant circular center that is   Ring Dosage Form
usually intended to be placed in the body by special inserters,
where the medication is released, generally for localized
effects. (FDA)



A liquid used to cleanse by flushing. (NCI)                      Rinse Dosage Form




A thick ointment or cerate (a fat or wax based preparation with Salve Dosage Form
a consistency between an ointment and a plaster). (NCI)
A liquid soap or detergent used to clean the hair and scalp     Shampoo Dosage Form
and is often used as a vehicle for dermatologic agents. (NCI)




A liquid soap or detergent containing one or more solid,        Shampoo Suspension Dosage
insoluble substances dispersed in a liquid vehicle that is used Form
to clean the hair and scalp and is often used as a vehicle for
dermatologic agents. (NCI)



Any compound of one or more fatty acids, or their equivalents, Soap Dosage Form
with an alkali; soap is detergent and is much employed in
liniments, enemas, and in making pills. It is also a mild
aperient, antacid and antiseptic. (NCI)



A clear, homogeneous liquid dosage form that contains one       Solution Dosage Form
or more chemical substances dissolved in a solvent or
mixture of mutually miscible solvents. Note: A liquid is
pourable; it flows and conforms to its container at room
temperature. It displays Newtonian or pseudoplastic flow
behavior. (NCI)

A liquid preparation (i.e., a substance that flows readily in its Concentrate for Solution Dosage
natural state) that contains a drug dissolved in a suitable       Form
solvent or mixture of mutually miscible solvents; the drug has
been strengthened by the evaporation of its non-active parts.
(NCI)


A solution for the preparation of an iced saline slush, which is Solution For Slush Dosage Form
administered by irrigation and used to induce regional
hypothermia (in conditions such as certain open heart and
kidney surgical procedures) by its direct application. (NCI)



A solution, which after usually being administered in a drop-   Gel Forming Drops Solution
wise fashion, forms a gel. (FDA)                                Dosage Form
A solution that forms a gel when it comes in contact with          Extended Release Gel Forming
ocular fluid, and which allows at least a reduction in dosing      Solution Dosage Form
frequency




A solution which is usually administered in a drop-wise            Drops Solution Dosage Form
fashion. (FDA)




A porous, interlacing, absorbent material that contains a drug. Sponge Dosage Form
It is typically used for applying or introducing medication, or
for cleansing. A sponge usually retains its shape.(FDA)




A liquid minutely divided as by a jet of air or steam. (NCI)       Spray Dosage Form




A non-pressurized dosage form consisting of valves which           Metered Spray Dosage Form
allow the dispensing of a specified quantity of spray upon
each activation. (NCI)




A liquid preparation containing solid particles dispersed in a     Spray Suspension Dosage Form
liquid vehicle and in the form of coarse droplets or as finely
divided solids to be applied locally, most usually to the nasal-
pharyngeal tract, or topically to the skin. (NCI)



A dosage form prepared in a relatively long and slender often Stick Dosage Form
cylindrical form. (NCI)
A long narrow piece of material.                                    Strip Dosage Form




A solid body of various weights and shapes, adapted for             Suppository Dosage Form
introduction into the rectal, vaginal, or urethral orifice of the
human body; they usually melt, soften, or dissolve at body
temperature. (NCI)



A drug delivery system in the form of a suppository that allows Extended Release Suppository
at least a reduction in dosing frequency. (NCI)                 Dosage Form




A liquid dosage form that contains solid particles dispersed in Suspension Dosage Form
a liquid vehicle. Note: A liquid is pourable; it flows and
conforms to its container at room temperature. It displays
Newtonian or pseudoplastic flow behavior.(FDA)



A liquid preparation consisting of solid particles dispersed  Extended Release Suspension
throughout a liquid phase in which the particles are not      Dosage Form
soluble; the suspension has been formulated in a manner to
allow at least a reduction in dosing frequency as compared to
that drug presented as a conventional dosage form (e.g., as a
solution or a prompt drug-releasing, conventional solid
dosage form). (NCI)
A suspension which is usually administered in a dropwise      Drops Suspension Dosage Form
fashion. (FDA)




A strand or fiber used to hold wound edges in apposition            Suture Dosage Form
during healing. (NCI)
A small piece of relatively flat absorbent material that contains Swab Dosage Form
a drug. A swab may also be attached to one end of a small
stick. A swab is typically used for applying medication or for
cleansing. (NCI)



An oral solution containing high concentrations of sucrose or     Syrup Dosage Form
other sugars; the term has also been used to include any
other liquid dosage form prepared in a sweet and viscid
vehicle, including oral suspensions. (NCI)



A solid dosage form containing medicinal substances with or       Tablet Dosage Form
without suitable diluents. (NCI)




A solid dosage form containing medicinal substances with or       Chewable Tablet Dosage Form
without suitable diluents that is intended to be chewed,
producing a pleasant tasting residue in the oral cavity that is
easily swallowed and does not leave a bitter or unpleasant
after-taste. (NCI)


A solid dosage form that contains medicinal substances with       Coated Tablet Dosage Form
or without suitable diluents and is covered with a designated
coating. (NCI)




A solid dosage form containing a conglomerate of medicinal        Tablet Coated Particles Dosage
particles that have each been covered with a coating. (FDA)       Form




A solid dosage form which releases a drug (or drugs) at a         Delayed Release Tablet Dosage
time other than promptly after administration. Enteric-coated     Form
articles are delayed release dosage forms. (NCI)
A solid dosage form containing a conglomerate of medicinal        Delayed Release Particles Tablet
particles that have been covered with a coating which             Dosage Form
releases a drug (or drugs) at a time other than promptly after
administration. Enteric-coated articles are delayed release
dosage forms. (NCI)


A solid dosage form containing mixtures of acids (e.g., citric    Effervescent Tablet Dosage
acid, tartaric acid) and sodium bicarbonate, which release        Form
carbon dioxide when dissolved in water; it is intended to be
dissolved or dispersed in water before administration.(FDA)



A solid dosage form containing a drug which allows at least a Extended Release Tablet
reduction in dosing frequency as compared to that drug        Dosage Form
presented in conventional dosage form. (NCI)




A solid dosage form that contains medicinal substances with Film Coated Tablet Dosage
or without suitable diluents and is coated with a thin layer of a Form
water-insoluble or water-soluble polymer. (NCI)




A solid dosage form that contains medicinal substances with Film Coated Extended Release
or without suitable diluents and is coated with a thin layer of a Tablet Dosage Form
water-insoluble or water-soluble polymer; the tablet is
formulated in such manner as to make the contained
medicament available over an extended period of time
following ingestion. (NCI)

A tablet that forms a solution when placed in a liquid. (FDA)     Tablet For Solution Dosage
                                                                  Form




A tablet that forms a suspension when placed in a liquid          Tablet For Suspension Dosage
(formerly referred to as a Dispersible Tablet).                   Form

A solid dosage form containing medicinal substances that          Multilayered Tablet Dosage Form
have been compressed to form a multiple-layered tablet or a
tablet-within-a-tablet, the inner tablet being the core and the
outer portion being the shell. (NCI)
A solid dosage form containing medicinal substances that            Multilayered Extended Release
have been compressed to form a multiple-layered tablet or a         Tablet Dosage Form
tablet-within-a-tablet, the inner tablet being the core and the
outer portion being the shell, which, additionally, is covered in
a designated coating; the tablet is formulated in such manner
as to allow at least a reduction in dosing frequency as
compared to that drug presented as a conventional dosage
form. (NCI)
A solid dosage form containing medicinal substances which           Orally Disintegrating Tablet
disintegrates rapidly, usually within a matter of seconds, when     Dosage Form
placed upon the tongue. (NCI)


A solid dosage form containing medicinal substances which       Tablet Orally Disintegrating
disintegrates rapidly, usually within a matter of seconds, when Delayed Release Dosage Form
placed upon the tongue, but which releases a drug (or drugs)
at a time other than promptly after administration. (FDA)



A solid dosage form that contains medicinal substances with         Soluble Tablet Dosage Form
or without suitable diluents and possesses the ability to
dissolve in fluids. (NCI)

A solid dosage form that contains medicinal substances with Sugar Coated Tablet Dosage
or without suitable diluents and is coated with a colored or an Form
uncolored water-soluble sugar. (NCI)


A plug made of cotton, sponge, or oakum variously used in           Tampon Dosage Form
surgery to plug the nose, vagina, etc., for the control of
hemorrhage or the absorption of secretions. (NCI)


A narrow woven fabric, or a narrow extruded synthetic (such         Tape Dosage Form
as plastic), usually with an adhesive on one or both sides.
(NCI)
An alcoholic or hydroalcoholic solution prepared from               Tincture Dosage Form
vegetable materials or from chemical substances. (NCI)


A discoid-shaped solid containing the medicinal agent in a     Troche Dosage Form
suitably flavored base; troches are placed in the mouth where
they slowly dissolve, liberating the active ingredients. (NCI)



A dosage form has yet to be assigned. (NCI)                         Unassigned Dosage Form
A thin slice of material containing a medicinal agent. (NCI)      Wafer Dosage Form




The reason that a subject was discontinued from a clinical     CDISC SDTM Reason for Non-
trial.                                                         Completion Terminology
Any untoward medical occurrence in a patient or clinical       Adverse Event
investigation subject administered a pharmaceutical product
and which does not necessarily have a causal relationship
with this treatment. An adverse event (AE) can therefore be
any unintended sign (including an abnormal laboratory
finding), symptom, or disease temporally associated with the
use of a medicinal (investigational) product, whether or not
related to the medicinal (investigational) product. NOTE: For
further information, see the ICH Guideline for Clinical Safety
Data Management: Definitions and Standards for Expedited
Reporting. [Modified from ICH E2A] Synonyms: side effect,
adverse experience. See also serious adverse event, serious
adverse experience. (CDISC glossary)

To possess every necessary or normal part or component or         Complete
step; having come or been brought to a conclusion. (NCI)

The absence of life or state of being dead. (NCI)                 Death

The lack of expected or desired effect related to a therapy.      Lack of Efficacy
(NCI)
The loss or lack of continuation of follow-up after a study has   Lost To Follow-up
officially closed. See Follow-up. (NCI)
An indication that a subject has not agreed with or followed      Non-Compliance With Study
the instructions related to the study medication. (NCI)           Drug

Different than the one(s) previously specified or mentioned.   Other
(NCI)
A position, opinion or judgment reached after consideration by Physician Decision
a physician with reference to subject. (NCI)

Pregnancy is the state or condition of having a developing    Pregnancy
embryo or fetus in the body (uterus), after union of an ovum
and spermatozoon, during the period from conception to birth.
(NCI)

A disease process that is increasing in scope or severity.        Progressive Disease
(NCI)
An event or decision that stands in contrast to the guidelines    Protocol Violation
set out by the protocol. (NCI)
A healing process and/or an outcome implying relative health.      Recovery
The term is typically used in the context of direct and indirect
effects of sickness or injury. (NCI)
The potential subject who does not meet one or more criteria       Trial Screen Failure
required for participation in a trial.
An indication that a clinical study was stopped by its sponsor.    Study Terminated By Sponsor
(NCI)
A problem with some technical aspect of a clinical study,          Technical Problem
usually related to an instrument. (NCI)
An indication that a study participant has removed itself from     Withdrawal by Subject
the study. (NCI)

The name of a code list that contains terms that reference         CDISC SDTM Relation to
timepoints within and without a defined time period.               Reference Period Terminology
The time period following a point or another period of time.       Status Post
(NCI)




Earlier in time or order. (NCI)                                    Prior




At some point in a given period of time. (NCI)                     During




Within a certain period of time or after a certain point or period During Or After
in time. (NCI)




Not known, not observed, not recorded, or refused. (NCI)           Unknown




The course by which a substance was administered in order          CDISC SDTM Route of
to reach the site of action in the body.                           Administration Terminology
Administration to or by way of the ear.(FDA)                  Auricular Route of Administration




Administration directed toward the cheek, generally from      Buccal Route of Administration
within the mouth.(FDA)




Administration to the conjunctiva, the delicate membrane that Conjunctival Route of
lines the eyelids and covers the exposed surface of the       Administration
eyeball.(FDA)




Administration to the skin.(FDA)                              Cutaneous Route of
                                                              Administration




Administration to a tooth or teeth.(FDA)                      Dental Route of Administration




Administration of through the diffusion of substance through a Electro-osmosis Route of
membrane in an electric field.(FDA)                            Administration




Administration within the canal of the cervix uteri.          Endocervical Route of
Synonymous with the term intracervical.(FDA)                  Administration
Administration within the nasal sinuses of the head.(FDA)    Endosinusial Route of
                                                             Administration




Administration directly into the trachea. Synonymous with the Endotracheal Route of
term intratracheal.(FDA)                                      Administration




Administration directly into the intestines.(FDA)            Enteral Route of Administration




Administration upon or over the dura mater.(FDA)             Epidural Route of Administration




Administration to the outside of the membrane enveloping the Extraamniotic Route of
fetus.(FDA)                                                  Administration




Administration outside of the body.(FDA)                     Extracorporeal Circulation Route
                                                             of Administration




Administration through hemodialysate fluid.(FDA)             Administration Via Hemodialysis
Administration that results in substances passing into tissue     Infiltration Route of
spaces or into cells.(FDA)                                        Administration




Administration to or in the interstices of a tissue.(FDA)         Interstitial Route of
                                                                  Administration




Administration within the abdomen.(FDA)                           Intraabdominal Route of
                                                                  Administration




Administration within the amnion.(FDA)                            Intraamniotic Route of
                                                                  Administration




Administration within an artery or arteries.(FDA)                 Intraarterial Route of
                                                                  Administration




Administration within a joint.(FDA)                               Intraarticular Route of
                                                                  Administration




Administration within the bile, bile ducts or gallbladder.(FDA)   Intrabiliary Route of
                                                                  Administration
Administration within a bronchus.(FDA)                           Intrabronchial Route of
                                                                 Administration




Administration within a bursa.(FDA)                              Intrabursal Route of
                                                                 Administration




Administration within the heart.(FDA)                            Intracardiac Route of
                                                                 Administration




Administration within a cartilage; endochondral.(FDA)            Intracartilaginous Route of
                                                                 Administration




Administration within the cauda equina.(FDA)                     Intracaudal Route of
                                                                 Administration




Administration within a pathologic cavity, such as occurs in     Intracavernous Route of
the lung in tuberculosis.(FDA)                                   Administration




Administration within a non-pathologic cavity, such as that of   Intracavitary Route of
the cervix, uterus, or penis, or such as that is formed as the   Administration
result of a wound.(FDA)
Administration within the cerebrum.(FDA)                        Intracerebral Route of
                                                                Administration




Administration within the cisterna magna                        Intracisternal Route of
cerebellomedularis.(FDA)                                        Administration




Administration within the cornea (the transparent structure      Intracorneal Route of
forming the anterior part of the fibrous tunic of the eye).(FDA) Administration




Administration of a drug within a portion of a tooth which is   Intracoronal Dental Route of
covered by enamel and which is separated from the roots by      Administration
a slightly constricted region known as the neck.(FDA)




Administration within the coronary arteries.(FDA)               Intracoronary Route of
                                                                Administration




Administration within the dilatable spaces of the corporus      Intracorporus Cavernosum
cavernosa of the penis.(FDA)                                    Route of Administration




Administration within the dermis.(FDA)                          Intradermal Route of
                                                                Administration
Administration within a disc.(FDA)                Intradiscal Route of
                                                  Administration




Administration within the duct of a gland.(FDA)   Intraductal Route of
                                                  Administration




Administration within the duodenum.(FDA)          Intraduodenal Route of
                                                  Administration




Administration within or beneath the dura.(FDA)   Intradural Route of
                                                  Administration




Administration within the epidermis.(FDA)         Intraepidermal Route of
                                                  Administration




Administration within the esophagus.(FDA)         Intraesophageal Route of
                                                  Administration




Administration within the stomach.(FDA)           Intragastric Route of
                                                  Administration
Administration within the gingivae.(FDA)                           Intragingival Route of
                                                                   Administration




Administration within the distal portion of the small intestine,   Intraileal Route of Administration
from the jejunum to the cecum.(FDA)




Administration within or introduced directly into a localized      Intralesional Route of
lesion.(FDA)                                                       Administration




Administration within the lumen of a tube.(FDA)                    Intraluminal Route of
                                                                   Administration




Administration within the lymph.(FDA)                              Intralymphatic Route of
                                                                   Administration




Administration within the marrow cavity of a bone.(FDA)            Intramedullary Route of
                                                                   Administration




Administration within the meninges (the three membranes            Intrameningeal Route of
that envelope the brain and spinal cord).(FDA)                     Administration
Administration within a muscle. (FDA)               Intramuscular Route of
                                                    Administration




Administration within the eye.(FDA)                 Intraocular Route of
                                                    Administration




Administration within the ovary.(FDA)               Intraovarian Route of
                                                    Administration




Administration within the pericardium.(FDA)         Intrapericardial Route of
                                                    Administration




Administration within the peritoneal cavity.(FDA)   Intraperitoneal Route of
                                                    Administration




Administration within the pleura.(FDA)              Intrapleural Route of
                                                    Administration




Administration within the prostate gland.(FDA)      Intraprostatic Route of
                                                    Administration
Administration within the lungs or its bronchi.(FDA)             Intrapulmonary Route of
                                                                 Administration




Administration within the nasal or periorbital sinuses.(FDA)     Intrasinal Route of Administration




Administration within the vertebral column.(FDA)                 Intraspinal Route of
                                                                 Administration




Administration within the synovial cavity of a joint.(FDA)       Intrasynovial Route of
                                                                 Administration




Administration within a tendon.(FDA)                             Intratendinous Route of
                                                                 Administration




Administration within the testicle.(FDA)                         Intratesticular Route of
                                                                 Administration




Administration within the cerebrospinal fluid at any level of the Intrathecal Route of
cerebrospinal axis, including injection into the cerebral         Administration
ventricles.(FDA)
Administration within the thorax (internal to the ribs);          Endothoracic Route of
synonymous with the term endothoracic.(FDA)                       Administration




Administration within the tubules of an organ.(FDA)               Intratubular Route of
                                                                  Administration




Administration within a tumor.(FDA)                               Intratumoral Route of
                                                                  Administration

Administration within the auris media.(FDA)                       Intratympanic Route of
                                                                  Administration




Administration within the uterus.(FDA)                            Intrauterine Route of
                                                                  Administration




Administration within a vessel or vessels.(FDA)                   Intravascular Route of
                                                                  Administration




Administration within or into a vein or veins.(FDA)               Intravenous Route of
                                                                  Administration




Administration within or into a vein or veins all at once.(FDA)   Intravenous Bolus
Administration within or into a vein or veins over a sustained   Intravenous Drip
period of time.(FDA)




Administration within a ventricle.(FDA)                          Intraventricular Route of
                                                                 Administration




Administration within the bladder.(FDA)                          Intravesical Route of
                                                                 Administration




Administration within the vitreous body of the eye.(FDA)         Intravitreal Route of
                                                                 Administration




Administration by means of an electric current where ions of     Iontophoresis Route of
soluble salts migrate into the tissues of the body.(FDA)         Administration




Administration to bathe or flush open wounds or body             Irrigation-Route of Administration
cavities.(FDA)




Administration directly upon the larynx.(FDA)                    Laryngeal Route of
                                                                 Administration
Administration to the nose; administered by way of the       Nasal Route of Administration
nose.(FDA)




Administration through the nose and into the stomach, usually Nasogastric Route of
by means of a tube.(FDA)                                      Administration




Routes of administration are not applicable.(FDA)            Route of Administration Not
                                                             Applicable




Administration by the topical route which is then covered by a Occlusive Dressing Technique
dressing which occludes the area.(FDA)

Administration to the external eye.(FDA)                     Ophthalmic Route of
                                                             Administration




Administration to or by way of the mouth.(FDA)               Oral Route of Administration




Administration directly to the mouth and pharynx.(FDA)       Oropharyngeal Route of
                                                             Administration




Administration is different from others on this list.(FDA)   Other Route of Administration
Administration by injection, infusion, or implantation.(FDA)    Parenteral Route of
                                                                Administration




Administration through the skin.(FDA)                           Percutaneous Route of
                                                                Administration




Administration around a joint.(FDA)                             Periarticular Route of
                                                                Administration




Administration to the outside of the dura mater of the spinal   Peridural Route of Administration
cord.(FDA)




Administration surrounding a nerve or nerves.(FDA)              Perineural Route of
                                                                Administration




Administration around a tooth.(FDA)                             Periodontal Route of
                                                                Administration




Administration to the rectum.(FDA)                              Rectal Route of Administration
Administration within the respiratory tract by inhaling orally or   Inhalation Route of
nasally for local or systemic effect.(FDA)                          Administration




Administration behind the pons or behind the eyeball.(FDA)          Retrobulbar Route of
                                                                    Administration




Administration into any soft tissue.(FDA)                           Soft Tissue Route Of
                                                                    Administration




Administration beneath the arachnoid.(FDA)                          Subarachnoid Route of
                                                                    Administration




Administration beneath the conjunctiva.(FDA)                        Subconjunctival Route of
                                                                    Administration




Administration beneath the skin; hypodermic. Synonymous             Subcutaneous Route of
with the term SUBDERMAL.(FDA)                                       Administration




Administration beneath the tongue.(FDA)                             Sublingual Route of
                                                                    Administration
Administration beneath the mucous membrane.(FDA)                  Submucosal Route of
                                                                  Administration




Administration to a particular spot on the outer surface of the   Topical Route of Administration
body. The E2B term TRANSMAMMARY is a subset of the
term TOPICAL.(FDA)


Administration through the dermal layer of the skin to the        Transdermal Route of
systemic circulation by diffusion.(FDA)                           Administration




Administration across the mucosa.(FDA)                            Mucosal Route of Administration




Administration through or across the placenta.(FDA)               Transplacental Route of
                                                                  Administration




Administration through the wall of the trachea.(FDA)              Transtracheal Route of
                                                                  Administration




Administration across or through the tympanic cavity.(FDA)        Transtympanic Route of
                                                                  Administration
Route of administration has not yet been assigned.(FDA)           Unassigned Route of
                                                                  Administration




Route of administration is unknown.(FDA)                          Unknown Route of
                                                                  Administration




Administration into the ureter.(FDA)                              Ureteral Route of Administration




Administration into the urethra.(FDA)                             Intraurethral Route of
                                                                  Administration




Administration into the vagina.(FDA)                              Vaginal Route of Administration




A scale that defines the degree or state of disease existing in CDISC SDTM Severity Intensity
a patient as a result of the occurrence of an adverse event.    Scale for Adverse Event
(NCI)                                                           Terminology

A type of adverse event that is usually transient and may         Mild Adverse Event
require only minimal treatment or therapeutic intervention.
The event does not generally interfere with usual activities of
daily living.
A type of adverse event that is usually alleviated with       Moderate Adverse Event
additional specific therapeutic intervention. The event
interferes with usual activities of daily living, causing
discomfort but poses no significant or permanent risk of harm
to the research participant.



A type of adverse event that requires intensive therapeutic       Severe Adverse Event
intervention. The event interrupts usual activities of daily
living, or significantly affects clinical status. The event
possesses a significant risk of harm to the research
participant and hospitalization may be required.

The assemblage of physical properties or qualities by which  CDISC SDTM Sex of Individual
male is distinguished from female; the physical difference   Terminology
between male and female; the distinguishing peculiarity of
male or female. (NCI)
A person who belongs to the sex that normally produces ova. Female
The term is used to indicate biological sex distinctions, or
cultural gender role distinctions, or both. (NCI)




A person who belongs to the sex that normally produces            Male
sperm. The term is used to indicate biological sex
distinctions, cultural gender role distinctions, or both. (NCI)




Not known, not observed, not recorded, or refused. (NCI)          Unknown




A person (one of unisexual specimens) who is born with         Intersex
genitalia and/or secondary sexual characteristics of
indeterminate sex, or which combine features of both sexes. CDISC SDTM Sex of Study
The specific sex, either male, female, or mixed of the subject
group being studied. (NCI)                                     Group Terminology
One and the other; relating to or being two in conjunction.    Both
(NCI)
A person who belongs to the sex that normally produces ova. Female
The term is used to indicate biological sex distinctions, or
cultural gender role distinctions, or both. (NCI)



A person who belongs to the sex that normally produces            Male
sperm. The term is used to indicate biological sex
distinctions, cultural gender role distinctions, or both. (NCI)



The physical magnitude of something. (NCI)                        CDISC SDTM Size Terminology

Of considerable or relatively great size, extent, or capacity.    Large
(NCI)
Mid-way between small and large in number, quantity,              Medium
magnitude or extent. (NCI)
Limited in number, quantity, magnitude or extent. (NCI)           Small
A unique, 2-character domain code used in the regulatory          CDISC SDTM Submission
submission process. The domain abbreviation is used               Domain Abbreviation
consistently throughout the submission, i.e. in the dataset       Terminology
name, as the value of the domain variable within the dataset,
and as a prefix for most variable names in the dataset.
(CDISC Glossary)
Datasets used for statistical analysis and reporting by the       Analysis Dataset Domain
sponsor. These are submitted in addition to the data
tabulation datasets.




Adverse events may be captured either as free text or a pre-      Adverse Event Domain
specified list of terms.




Additional data about deaths, specific to findings from           Autopsy Domain
autopsies.
Findings resulting from evaluations of bone mineral density.      Bone Mineral Density Data
                                                                  Domain




Findings resulting from biopsies.                                 Biopsy Domain




Case report form (CRF) data that captures the Concomitant         Concomitant Medication Domain
and Prior Medications/Therapies used by the subject.
Examples are the Concomitant Medications/Therapies given
on an as needed basis and the usual Background
Medications/Therapies given for a condition.


The Comments dataset accommodates two sources of             Comment Domain
comments: 1) those collected alongside other data on topical
case report form (CRF) pages such as Adverse Events and 2)
those collected on a separate page specifically dedicated to
comments.


Data regarding the accountability of study drug, such as       Drug Accountability Domain
information on the receipt, dispensing, return, and packaging.




Data related to the characteristics of a specific disease state   Disease Characteristics Domain
under study for a subject.




The Demographics domain includes a set of essential               Demographics Domain
standard variables that describe each subject in a clinical
study. It is the parent domain for all other observations for
human clinical subjects
A subject domain utilized for the submission of information       Disposition Domain
encompassing and representing data, vocabulary or records
related to disposition. (NCI)




The intent of the domain is to capture protocol violations and    Protocol Deviations Domain
deviations during the course of the study and will store only
those criteria violation by or deviated from by the subject and
not a response to each violation or deviation.



Findings resulting from electroencephalogram (EEG) tests.         Electroencephalogram Domain




Findings related to the collection of ECG data, including         Electrocardiogram Domain
position of the subject, method of evaluation, all cycle
measurements and all findings from the ECG including an
overall interpretation if collected or derived.



The Exposure domain model records the details of a subject's Exposure Domain
exposure to protocol-specified study treatment. Study
treatment may be any intervention that is prospectively
defined as a test material within a study, and is typically but
not always supplied to the subject.


A subject domain utilized for the submission of information       Family History Domain
encompassing and representing data, vocabulary or records
related to family history. (NCI)
Healthcare resource utilization data such as subject visits to    Healthcare Resource Utilization
physicians, hospitalizations, and nursing home stays.             Domain




The intent of the domain model is to only collect those criteria Inclusion Exclusion Domain
that cause the subject to be in violation of the
inclusion/exclusion criteria not a response to each criterion.
Laboratory test findings including, but is not limited to       Laboratory Data Domain
hematology, clinical chemistry and urinalysis data. This
domain does not include microbiology or pharmacokinetic
data, which are stored in separate domains.



Microbiology specimen findings, including gram stain results,   Microbiology Specimen Domain
and organisms found.




The medical history dataset includes the subject's prior history Medical History Domain
at the start of the trial. Examples of subject medical history
information could include general medical history,
gynecological history, and primary diagnosis.

Information regarding the subject's meal consumption, such      Meal Data Domain
as fluid intake, amounts, form (solid or liquid state),
frequency, etc., typically used for pharmacokinetic analysis.




This includes microbiology susceptibility test results, plus    Microbiology Susceptibility
results of any other organism-related tests.                    Domain




Findings from organ measurement evaluations.                    Organ Measurement Domain




Concentrations of drugs/metabolites in fluids or tissues as a   Pharmacokinetic Concentration
function of time.                                               Domain
Findings collected during a physical examination of the            Physical Exam Domain
subject. It has findings that are discovered that are related to
body systems. Does not include vital signs measurements,
which are stored in the vital signs domain.



Pharmacogenomics findings that initially focus on genotype         Pharmacogenomics Domain
and gene expression data.




Pharmacokinetic parameters derived from pharmacokinetic            Pharmacokinetic Parameters
concentration-time (PC) data.                                      Domain




Questionnaire data may include, but are not limited to the         Questionnaire Domain
following: subject reported outcomes, validated or non-
validated questionnaires, and validated or non-validated
diaries (i.e. data with a common topicality).



The subject characteristics domain is for data not collected in Subject Characteristics Domain
other domains that is subject-related. Examples: subject
initials, other race details, eye color, childbearing status, etc.




The subject element table describes the actual order of            Subject Element Domain
elements followed by the subject, together with the start
date/time and end date/time for each element.




Surgical information.                                              Surgery Domain
Findings from diagnostic skin tests.                               Skin Test Domain




Findings from diagnostic sleep tests (polysomnography).            Sleep Polysomnography Domain




Findings from exercise stress tests.                               Stress Exercise Test Data
                                                                   Domain




The intent of the domain is to capture substance use               Substance Use Domain
information that may be used to assess the efficacy and/or
safety of therapies that look to mitigate the effects of chronic
substance use.



The subject visits table describes the actual start and end        Subject Visits Domain
data/time for each visit of each individual subject.




The trial arms table describes each planned arm in the trial.      Trial Arms Domain
An arm is described as an ordered sequence of elements.




The trial elements table describes the element code that is        Trial Elements Domain
unique for each element, the element description, and the
rules for starting and ending an element.
The trial summary information domain is not subject oriented. Trial Inclusion and Exclusion
It contains one record for each of the inclusion and exclusion Criteria Domain
criteria for the trial.




The trial summary information domain is not subject oriented. Trial Summary Domain
It contains one record for each trial summary characteristic.




The trial visits table describes the planned order and number    Trial Visits Domain
of visits in the study within each arm.




Measurements including but not limited to blood pressure,        Vital Signs Domain
temperature, respiration, body surface area, BMI, height and
weight.




The name of a code list that contains terms to define the type   CDISC SDTM Trial Blinding
of blinding for the trial. (NCI)                                 Schema Terminology
A study in which neither the subject nor the investigator nor    Double Blind Study
the research team interacting with the subject or data during
the trial knows what treatment a subject is receiving. (CDISC
glossary)
A trial in which subjects and investigators know which product   Open Label Study
each subject is receiving; opposite of a blinded or double-
blind study. (CDISC glossary)
A study in which one party, either the investigator or the       Single Blind Study
subject, does not know which medication or placebo is
administered to the subject; also called singlemasked study.
(CDISC glossary)
The name of a code list that contains terms to define the type   CDISC SDTM Trial Indication
of trial, e.g. cure or prevention. (NCI)                         Type Terminology
A type of study protocol designed to evaluate intervention(s)    Cure Study
aimed to cure a disease or condition. (NCI)
A type of study protocol designed to evaluate intervention(s)    Diagnosis Study
aimed at identifying a disease or condition. (NCI)

A type of study designed to identify actions necessary to        Adverse Effect Mitigation Study
eliminate or reduce the risk to human life or well-being as a
result of a particular medication or treatment regimen. (NCI)
A type of study designed to identify actions necessary to         Prevention Study
permanently eliminate or reduce the long-term risk to human
life as a result of a particular medication or treatment regimen.

A type of study protocol designed to evaluate intervention(s)    Treatment Study
for treatment of disease, syndrome or condition.

Clinical trials are broken into three or four phases: Phase I     CDISC SDTM Trial Phase
tests a new drug or treatment for safety in a small group;        Terminology
Phase II expands the study to a larger group of people; Phase
III expands the study to an even larger group of people to
measure whether the treatment actually benefits patients, and
whether its benefits exceed its risks; and Phase IV takes
place after the drug or treatment has been licensed and
marketed. (NCI)
The initial introduction of an investigational new drug into      Phase I Trial
humans. Phase 1 studies are typically closely monitored and
may be conducted in patients or normal volunteer subjects.
NOTE: These studies are designed to determine the
metabolism and pharmacologic actions of the drug in
humans, the side effects associated with increasing doses,
and, if possible, to gain early evidence on effectiveness.
During Phase 1, sufficient information about the drug's
pharmacokinetics and pharmacological effects should be
obtained to permit the design of well-controlled, scientifically
valid, Phase 2 studies. The total number of subjects and
patients included in Phase I studies varies with the drug, but is
generally in the range of 20 to 80. Phase 1 studies also
include studies of drug metabolism, structure-activity
relationships, and mechanism of action in humans, as well as
studies in which investigational drugs are used as research
tools to explore biological phenomena or disease processes.
[After FDA CDER Handbook, ICH E8] (CDISC glossary)




A class of clinical study that combines elements characteristic Phase I/II Trial
of traditional Phase I and Phase II trials. See also Phase I,
Phase II.
Phase 2. Controlled clinical studies conducted to evaluate the Phase II Trial
effectiveness of the drug for a particular indication or
indications in patients with the disease or condition under
study and to determine the common short-term side effects
and risks associated with the drug. NOTE: Phase 2 studies
are typically well controlled, closely monitored, and conducted
in a relatively small number of patients, usually involving no
more than several hundred subjects. [After FDA CDER
Handbook, ICH E8] (CDISC glossary)
A class of clinical study that combines elements characteristic Phase II/III Trial
of traditional Phase II and Phase III trials.
A clinical research protocol generally refered to as a pilot or       Phase IIa Trial
feasibility trial that aims to prove the concept of the new
intervention in question. (NCI)
A clinical research protocol generally refered to as a well-          Phase IIb Trial
controlled and pivotal trial that aims to prove the mechanism
of action of the new intervention in question. A pivotal study
will generally be well-controlled, randomized, of adequate
size, and whenever possible, double-blind. (NCI)

Phase 3. Studies are expanded controlled and uncontrolled      Phase III Trial
trials. They are performed after preliminary evidence
suggesting effectiveness of the drug has been obtained, and
are intended to gather the additional information about
effectiveness and safety that is needed to confirm efficacy
and evaluate the overall benefit-risk relationship of the drug
and to provide an adequate basis for physician labeling.
NOTE: Phase 3 studies usually include from several hundred
to several thousand subjects. [After FDA CDER Handbook,
ICH E8] (CDISC glossary)

A classification typically assigned retrospectively to a Phase III    Phase IIIa Trial
trial upon determination by regulatory authorities of a need for
a Phase III B trial.
A subcategory of Phase III trials done near the time of               Phase IIIb Trial
approval to elicit additional findings. NOTE: Dossier review
may continue while associated Phase IIIB trials are
conducted. These trials may be required as a condition of
regulatory authority approval.
Phase 4. Postmarketing (Phase 4) studies to delineate                 Phase IV Trial
additional information about the drug's risks, benefits, and
optimal use that may be requested by regulatory authorities in
conjunction with marketing approval. NOTE: These studies
could include, but would not be limited to, studying different
doses or schedules of administration than were used in Phase
2 studies, use of the drug in other patient populations or other
stages of the disease, or use of the drug over a longer period
of time. [After FDA CDER Handbook, ICH E8] (CDISC
glossary)
Postmarketing surveillance is sometimes referred to as Phase          Phase V Trial
V.
Determination of a value is not relevant in the current context.      Not Applicable
(NCI)
Individual characteristics of a clinical trial, e.g. description of   CDISC SDTM Trial Summary
trial design, trial blinding schema, and primary objective of         Parameter Terminology by Code
trial. (NCI)
The addition of a therapeutic product to the existing regimen         Test Product Added to Existing
in a clinical trial, where both entities remain as discrete           Treatment
products.
A reference source that provides meanings of words related            Adverse Event Dictionary
to adverse events. (NCI)
The anticipated maximum age of the subjects to be entered in       Planned Maximum Age of
a clinical trial. (NCI)                                            Subjects
The anticipated minimum age of the subjects to be entered in       Planned Minimum Age of
a clinical trial. (NCI)                                            Subjects
Subgroups of populations based on age. (NCI)                       Age Group


Those units of time that are routinely used to express the age     Age Unit
of a person. (NCI)
The amount of drug administered to a patient or test subject       Dose
at one time or the total quantity administered. [AMA Manual of
Style] (CDISC Glossary)
A reference source that provides meanings of words related         Drug Dictionary
to drugs. (NCI)
The anticipated length of a clinical trial measured as a unit of   Trial Length
time. (NCI)
A reference source that provides meanings of words related         Medical History Dictionary
to medical history. (NCI)
The number of subjects entered in a clinical trial. (NCI)          Planned Subject Number

The process of assigning trial subjects to treatment or control    Randomization
groups using an element of chance to determine the
assignments in order to reduce bias. NOTE: Unequal
randomization is used to allocate subjects into groups at a
differential rate; for example, three subjects may be assigned
to a treatment group for every one assigned to the control
group. [ICH E6 1.48] See also balanced study. (CDISC
glossary)
The course by which a substance was administered in order          Route of Administration
to reach the site of action in the body.
The specific sex, either male, female, or mixed of the subject     Sex of Study Group
group being studied. (NCI)
The rule, regulation and/or condition that determines the point    Study Stop Rules
in time when a clinical trial will be terminated. (NCI)
The name of a code list that contains terms to define the type     Trial Blinding Schema
of blinding for the trial. (NCI)
Comparator against which the study treatment is evaluated          Control Type
(e.g., concurrent (placebo, no treatment, dose-response,
active), external (historical, published literature).

A grouping of individuals on the basis of a shared procedure       Diagnosis Group
or disease, or lack thereof (e.g. healthy volunteers, type 2
diabetic subjects, subjects with renal cell cancer).
Standardized naming systems are available that define the
groups within which a subject should be placed. (NCI)

The name of a code list that contains terms to define the type Trial Indication Type
of trial, e.g. cure or prevention. (NCI)
The name of a clinical trial. (NCI)                            Trial Title
Clinical trials are broken into three or four phases: Phase I     Trial Phase
tests a new drug or treatment for safety in a small group;
Phase II expands the study to a larger group of people; Phase
III expands the study to an even larger group of people to
measure whether the treatment actually benefits patients, and
whether its benefits exceed its risks; and Phase IV takes
place after the drug or treatment has been licensed and
marketed. (NCI)
The type of clinical trial performed e.g. efficacy, safety. (NCI) Trial Type

Individual characteristics of a clinical trial, e.g. description of   CDISC SDTM Trial Summary
trial design, trial blinding schema, and primary objective of         Parameter Terminology by Name
trial. (NCI)
The addition of a therapeutic product to the existing regimen         Test Product Added to Existing
in a clinical trial, where both entities remain as discrete           Treatment
products.
A reference source that provides meanings of words related            Adverse Event Dictionary
to adverse events. (NCI)
The anticipated maximum age of the subjects to be entered in          Planned Maximum Age of
a clinical trial. (NCI)                                               Subjects
The anticipated minimum age of the subjects to be entered in          Planned Minimum Age of
a clinical trial. (NCI)                                               Subjects
Subgroups of populations based on age. (NCI)                          Age Group

Those units of time that are routinely used to express the age        Age Unit
of a person. (NCI)
The amount of drug administered to a patient or test subject          Dose
at one time or the total quantity administered. [AMA Manual of
Style] (CDISC Glossary)
A reference source that provides meanings of words related            Drug Dictionary
to drugs. (NCI)
The anticipated length of a clinical trial measured as a unit of      Trial Length
time. (NCI)
A reference source that provides meanings of words related            Medical History Dictionary
to medical history. (NCI)

The number of subjects entered in a clinical trial. (NCI)             Planned Subject Number

The process of assigning trial subjects to treatment or control Randomization
groups using an element of chance to determine the
assignments in order to reduce bias. NOTE: Unequal
randomization is used to allocate subjects into groups at a
differential rate; for example, threewas administered assigned Route of Administration
The course by which a substance subjects may be in order
to reach the site of action in the body.



The specific sex, either male, female, or mixed of the subject Sex of Study Group
group being studied. (NCI)
The rule, regulation and/or condition that determines the point Study Stop Rules
in time when a clinical trial will be terminated. (NCI)
The name of a code list that contains terms to define the type Trial Blinding Schema
of blinding for the trial. (NCI)

Comparator against which the study treatment is evaluated           Control Type
(e.g., concurrent (placebo, no treatment, dose-response,
active), external (historical, published literature).

A grouping of individuals on the basis of a shared procedure Diagnosis Group
or disease, or lack thereof (e.g. healthy volunteers, type 2
diabetic subjects, subjects with renal cell cancer).
Standardized naming systems are available that define the
The name of which list that contains terms to define
groups within a code a subject should be placed. (NCI)the type Trial Indication Type
of trial, e.g. cure or prevention. (NCI)

The name of a clinical trial. (NCI)                                 Trial Title



Clinical trials are broken into three or four phases: Phase I Trial Phase
tests a new drug or treatment for safety in a small group;
Phase II expands the study to a larger group of people; Phase
III expands the study to an even larger group of people to
measure whether the treatment actually benefits patients, and
whether its benefits exceed its risks; and Phase IV takes
place after the drug or treatment has been licensed and
marketed. (NCI)


The type of clinical trial performed e.g. efficacy, safety. (NCI)   Trial Type



                                                                CDISC SDTM Trial Type
The type of clinical trial performed e.g. efficacy, safety. (NCI)
                                                                Terminology
A study of the degree to which or rate at which a drug or other Bioavailability Study
substance is absorbed or becomes available at the site of
physiological activity after administration. (NCI)

A study most often used to compare the efficacy of different       Therapeutic Equivalency Study
formulations to treat a given disease. It is the testing of an old
versus a new formulation in healthy volunteers or subjects
with the disease under study and usually in one dose. (NCI)

A study of the relative therapeutic efficacy of treatment of a      Efficacy Study
disease. Usually this is a Phase II or III study. (NCI)

A study of the biochemical and physiological effect of a drug       Pharmacodynamic Study
and the mechanism of drug action and the relationship
between drug concentration and effect. (NCI)
A study that assesses the value associated with a given drug Pharmacoeconomic Study
in therapeutic and economic terms. This type of study is
multidisciplinary in nature and takes into consideration the
social and economic costs (resource utilization costs including
direct, indirect, and intangible costs) of drug therapy in
addition to its direct therapeutic benefits. Analyses relate the
difference in therapeutic benefits to the difference in costs
between treatment alternatives. (NCI)

A study of identification and analysis of genomic variations    Pharmacogenomic Study
that affect the efficacy of a drug. Pharmacogenomic studies
can potentially be predictive of an individual's drug-response
or adverse reactions or susceptibility to iatrogenic disorders,
and may also reveal new targets that can help in the design of
new drugs. (NCI)

A study of the process by which a drug is absorbed,              Pharmacokinetic Study
distributed, metabolized, and eliminated by the body. (NCI)

A study of the relative safety of treatment of a disease.        Safety Study
Usually this is a Phase I or II trial. (NCI)
The unit used to record and describe the result of a test        CDISC SDTM Unit for Vital Sign
investigating a vital sign. (NCI)                                Result Terminology

A fraction or ratio with 100 understood as the denominator.      Percentage
(NCI)
The number of heartbeats measured per minute time. (NCI)         Beats per Minute




The number of breaths (inhalation and exhalation) taken per      Breaths per Minute
minute time. (NCI)



A unit of temperature of the temperature scale designed so          Degree Celsius
that the freezing point of water is 0 degrees and the boiling
point is 100 degrees at standard atmospheric pressure. The
current official definition of the Celsius sets 0.01 C to be at the
triple point of water and a degree to be 1/273.16 of the
difference in temperature between the triple point of water and
absolute zero. One degree Celsius represents the same
temperature difference as one Kelvin. (NCI)

A basic unit of length in the former CGS version of metric       Centimeter
system, equal to one hundredth of a meter or approximately
0.393 700 787 inch. (NCI)
The Fahrenheit temperature scale is named after the German Degree Fahrenheit
physicist Gabriel Fahrenheit (1686-1736), who proposed it in
1724. In this scale, the freezing point of water is 32 degrees
Fahrenheit and the boiling point is 212 degrees, placing the
boiling and melting points of water 180 degrees apart. In this
scale a degree Fahrenheit is 5/9ths of a kelvin (or of a degree
Celsius), and minus 40 degrees Fahrenheit is equal to minus
40 degrees Celsius. (NCI)



A metric unit of mass equal to one one thousandth of a               Gram
kilogram. (NCI)
A traditional unit of length equal to 2.54 centimeters. (NCI)        Inch




The basic SI unit of mass. It is defined as the mass of an           Kilogram
international prototype in the form of a platinum-iridium
cylinder kept at Sevres in France. It is the only basic unit still
defined in terms of a material object, and also the only one
with a prefix [kilo] already in place. A kilogram is equal to
1,000 grams and 2.204 622 6 pounds. (NCI)
The SI derived unit of spread rate of a substance by mass,           Kilogram Per Square Meter
used also as a measure of area density. (NCI)
A traditional unit of mass. By international agreement, one          Pound
avoirdupois pound is equal to exactly 0.453 592 37 kilogram,
16 ounces, or 1.215 28 troy pounds. (NCI)
The SI unit of area measurement equal to a square whose              Square Meter
sides are one meter long. Square meter is equal to 10,000
square centimeters; 0.01 ares; 1.196 square yards; 10.76
square feet; 1550 square inches. (NCI)
A unit of pressure equal to 0.001316 atmosphere and equal to         Millimeter of Mercury
the pressure indicated by one millimeter rise of mercury in a
barometer at the Earth's surface. (NCI)
A unit of electrical resistance equal to the resistance between      Ohm
two points on a conductor when a potential difference of one
volt between them produces a current of one ampere. Ohm is
also used to measure impedance and reactance for complex
resistance. A measurement in ohms is the reciprocal of a
measurement in siemens. (NCI)

The name given to the test that analyzes a particular set of         CDISC SDTM Vital Sign
vital signs including temperature, respiratory rate, heart beat      Terminology by Code
(pulse), and blood pressure. (NCI)
A general indicator of the body fat an individual is carrying        Body Mass Index
based upon the ratio of weight to height. (NCI)
A specialized form of connective tissue consisting primarily of Adipose Tissue
adipocytes (fat cells), surrounded by a meshwork of collagen
fibers.




A measure of the 2-dimensional extent of the body surface      Body Surface Area
(i.e., the skin). Body surface area (BSA) can be calculated by
mathematical formula or from a chart that relates height to
weight. BSA is often an important factor in dosing. (NCI)



The blood pressure after the contraction of the heart while the Diastolic Blood Pressure
chambers of the heart refill with blood. (NCI)




The categorization of a person's body frame into small,        Body Frame Size
medium and large based on the measurement of wrist
circumference or the breadth of the elbow. (NCI)




The vertical measurement or distance from the base to the      Height
top of an object; the vertical dimension of extension. (NCI)




The number of heartbeats per unit of time, usually expressed Heart Rate
as beats per minute. (NCI)




The mean pressure of the blood within the arterial circulation. Mean Arterial Pressure
The arterial pressure may be directly measured by insertion of
an intra-arterial catheter connected to a transducer. The
mean arterial pressure (MAP) can be calculated by
subsequent analysis of the waveform. MAP can be
approximated without an invasive procedure using the
following formula: diastolic pressure plus 1/3 of the pulse
pressure, where pulse pressure is systolic pressure - diastolic
pressure. (NCI)
The rate of the pulse as observed in an artery, expressed as      Pulse Rate
beats per minute. It can be measured at several anatomical
sites, including the wrist, neck, temple, groin, behind the
knees, or on top of the foot. (NCI)



The rate of breathing (inhalation and exhalation) measured      Respiratory Rate
within in a unit time, usually expressed as breaths per minute.
(NCI)




The blood pressure during the contraction of the left ventricle Systolic Blood Pressure
of the heart.




The property of a body or region of space that determines            Temperature
whether or not there will be a net flow of heat into it or out of it
from a neighboring body or region and in which direction (if
any) the heat will flow, perceptible by living organism as a
somatic sensation of cold or heat. It is a measure of the
average translational kinetic energy associated with the
disordered microscopic motion of atoms and molecules.
Temperature is measured in one of the three standard
temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI)

The vertical force exerted by a mass as a result of gravity.      Weight
(NCI)




The name given to the test that analyzes a particular set of      CDISC SDTM Vital Sign
vital signs including temperature, respiratory rate, heart beat   Terminology by Name
(pulse), and blood pressure. (NCI)
A general indicator of the body fat an individual is carrying     Body Mass Index
based upon the ratio of weight to height. (NCI)
A specialized form of connective tissue consisting primarily of Adipose Tissue
adipocytes (fat cells), surrounded by a meshwork of collagen
fibers.




A measure of the 2-dimensional extent of the body surface      Body Surface Area
(i.e., the skin). Body surface area (BSA) can be calculated by
mathematical formula or from a chart that relates height to
weight. BSA is often an important factor in dosing. (NCI)



The blood pressure after the contraction of the heart while the Diastolic Blood Pressure
chambers of the heart refill with blood. (NCI)




The categorization of a person's body frame into small,        Body Frame Size
medium and large based on the measurement of wrist
circumference or the breadth of the elbow. (NCI)




The vertical measurement or distance from the base to the      Height
top of an object; the vertical dimension of extension. (NCI)

The number of heartbeats per unit of time, usually expressed Heart Rate
as beats per minute. (NCI)




The mean pressure of the blood within the arterial circulation. Mean Arterial Pressure
The arterial pressure may be directly measured by insertion of
an intra-arterial catheter connected to a transducer. The
mean arterial pressure (MAP) can be calculated by
subsequent analysis of the waveform. MAP can be
approximated without an invasive procedure using the
following formula: diastolic pressure plus 1/3 of the pulse
pressure, where pulse pressure is systolic pressure - diastolic
pressure. (NCI)
The rate of the pulse as observed in an artery, expressed as      Pulse Rate
beats per minute. It can be measured at several anatomical
sites, including the wrist, neck, temple, groin, behind the
knees, or on top of the foot. (NCI)



The rate of breathing (inhalation and exhalation) measured      Respiratory Rate
within in a unit time, usually expressed as breaths per minute.
(NCI)




The blood pressure during the contraction of the left ventricle Systolic Blood Pressure
of the heart.




The property of a body or region of space that determines            Temperature
whether or not there will be a net flow of heat into it or out of it
from a neighboring body or region and in which direction (if
any) the heat will flow, perceptible by living organism as a
somatic sensation of cold or heat. It is a measure of the
average translational kinetic energy associated with the
disordered microscopic motion of atoms and molecules.
Temperature is measured in one of the three standard
temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI)

The vertical force exerted by a mass as a result of gravity.      Weight
(NCI)




A term that is used to indicate a question with permissible       CDISC SDTM Yes No Unknown
values of yes/no/unknown/not applicable.                          or Not Applicable Response
                                                                  Terminology


The non-affirmative response to a question. (NCI)                 No




Determination of a value is not relevant in the current context. Not Applicable
(NCI)
Not known, not observed, not recorded, or refused. (NCI)            Unknown




The affirmative response to a question. (NCI)                       Yes




Terminology used for Laboratory Tests of the CDISC                  CDISC SDTM Laboratory Test
Standard Data Tabulation Model.                                     Terminology by Code

A measurement of the inequality in the size of the red blood        Anisocytosis
cells in a whole blood specimen.
A measurement of the odd-shaped erythrocytes in a whole        Poikilocytosis
blood specimen.
A measurement of the total bilirubin in a biological specimen. Total Bilirubin

A measurement of the length of time that it takes for clotting      Partial Thromboplastin Time
to occur when reagents are added to a plasma specimen. The
test is partial due to the absence of tissue factor (Factor III)
from the reaction mixture.
A measurement of the glucose in a biological specimen.              Plasma Glucose Measurement
A measure of the acidity or alkalinity of a fluid on a scale of 0   pH
to 14.
A count of the total erythrocytes per unit of a biological          Erythrocyte Count
specimen.
A count of the reticulocytes per unit of a biological specimen.     Reticulocyte Count

A count of the leukocytes per unit of a biological specimen.        Leukocyte Count

A count of the lymphocytes per unit of a biological specimen.       Lymphocyte Count

A count of the platelets per unit of a biological specimen.    Platelet Count
A measurement of the urea nitrogen in a blood specimen.        Blood Urea Nitrogen
                                                               Measurement
A measurement of the cholesterol in a biological specimen.     Serum Total Cholesterol
                                                               Measurement
A measurement of the high density lipoprotein cholesterol in a Serum HDL Cholesterol
biological specimen.                                           Measurement
A measurement of the low density lipoprotein cholesterol in a Serum LDL Cholesterol
biological specimen.                                           Measurement
A blood clotting measurement that evaluates the extrinsic      Prothrombin Time
pathway of coagulation and is expressed in units of time or
percent activity.
A count of the neutrophils per unit of a biological specimen.    Absolute Neutrophil Count

A measurement of the albumin protein in a biological             Albumin Measurement
specimen.
A measurement of the alkaline phosphatase in a biological        Alkaline Phosphatase
specimen.                                                        Measurement
A measurement of the alanine aminotransferase in a               Alanine Aminotransferase
biological specimen.                                             Measurement
A measurement of the pancreatic enzyme amylase in a              Amylase Measurement
biological specimen.
A measurement of the aspartate aminotransferase in a             Aspartate Aminotransferase
biological specimen.                                             Measurement
A measurement of the bacteria in a biological specimen.          Bacterial Count
A count of the basophils per unit of a biological specimen.      Total Basophil Count
A relative measure (ratio or percentage) of the basophils to     Basophil To Leukocyte Ratio
leukocytes in a biological specimen.
A measurement of the conjugated or water-soluble bilirubin in    Direct Bilirubin Measurement
a biological specimen.
A measurement of the unconjugated or non-water-soluble           Indirect Bilirubin Measurement
bilirubin in a biological specimen.
A relative measure (ratio or percentage) of the blasts to        Blast To Leukocyte Ratio
leukocytes in a biological specimen.
A measurement of the calcium in a biological specimen.           Calcium Measurement
A measurement of the total creatine kinase in a biological       Creatine Kinase Measurement
specimen.
A measurement of the homozygous B-type creatine kinase in        Creatine Kinase BB
a biological specimen.                                           Measurement
A measurement of the heterozygous MB-type creatine kinase        Creatine Kinase MB
in a biological specimen.                                        Measurement
A measurement of the homozygous M-type creatine kinase in        Creatine Kinase MM
a biological specimen.                                           Measurement
A measurement of the chloride in a biological specimen.          Chloride Measurement
A measurement of the carbon dioxide gas in a biological          Carbon Dioxide Measurement
specimen.
A measurement of the color of a biological specimen.             Color Assessment
A measurement of the creatinine in a biological specimen.        Creatinine Measurement
A measurement of the C reactive protein in a biological          C-Reactive Protein
specimen.                                                        Measurement
A count of the elliptocytes per unit of a biological specimen.   Elliptocyte Count

A count of the eosinophils per unit of a biological specimen.    Eosinophil Count

A relative measure (ratio or percentage) of the eosinophils to   Eosinophil To Leukocyte Ratio
leukocytes in a biological specimen.
A measurement of the epithelial cells in a biological specimen. Epithelial Cell Count

A measurement of the fibrinogen in a biological specimen.        Fibrinogen Measurement
The percentage of a whole blood specimen that is composed        Hematocrit
of red blood cells (erythrocytes).
A quantitative measurement of the mean amount of                 Erythrocyte Mean Corpuscular
hemoglobin per erythrocyte in a biological specimen.             Hemoglobin
A quantitative measurement of the mean amount of                   Erythrocyte Mean Corpuscular
hemoglobin per erythrocytes in a specified volume of a             Hemoglobin Concentration
biological specimen.
A quantitative measurement of the mean volume of                   Erythrocyte Mean Corpuscular
erythrocytes in a biological specimen.                             Volume
A value derived from mean corpuscular volume and the               Erythrocyte Distribution Width
standard deviation of the red blood cell volume in a whole         Measurement
blood specimen.
A count of dacryocytes in unit of a biological specimen.           Dacryocyte Analysis
An observation which indicates that the hemoglobin                 Hypochromia
concentration in a red blood cell specimen has fallen below a
specified level.
A measurement of the blue-staining characteristic of newly         Polychromasia
generated erythrocytes.
A ratio that represents the prothrombin time for a plasma          International Normalized Ratio of
specimen, divided by the result for a control plasma               Prothrombin Time
specimen, further standardized for the International Sensitivity
Index of the tissue factor (thromboplastin) used in the test.

A measurement of the very low density lipoprotein cholesterol      Serum VLDL Cholesterol
in a biological specimen.                                          Measurement
A measurement of the pancreatic lipase in a biological             Triacylglycerol Lipase
specimen.                                                          Measurement
A measurement of the sodium in a biological specimen.              Sodium Measurement
A measurement of the nitrite in a urine specimen.                  Nitrite Measurement
A measurement of the triglycerides in a biological specimen.       Triglyceride Measurement

A measurement of the thyrotropin in a biological specimen.         Thyrotropin Measurement

A measurement of the urate in a biological specimen.               Urate Measurement
A measurement of the urea in a biological specimen.                Urea Measurement
A measurement of the urobilinogen in a biological specimen.        Urobilinogen Measurement

A measurement of the Vitamin B12 in a serum specimen.              Vitamin B12 Measurement
A count of the atypical lymphocytes per unit of a biological       Atypical Lymphocyte Count
specimen.
A relative measure (ratio or percentage) of the atypical           Atypical Lymphocyte To
lymphocytes to leukocytes in a biological specimen.                Leukocyte Ratio
A relative measure (ratio or percentage) of the lymphocytes to     Lymphocyte To Leukocyte Ratio
leukocytes in a biological specimen.
A count of the macrocytes per unit of a biological specimen.       Macrocyte Count

A count of the microcytes per unit of a biological specimen.       Microcyte Count

A count of the monocytes per unit of a biological specimen.        Monocyte Count

A relative measure (ratio or percentage) of the monocytes to Monocyte To Leukocyte Ratio
leukocytes in a biological specimen.
A relative measure (ratio or percentage) of the myeloblasts to Myeloblast To Leukocyte Ratio
leukocytes in a biological specimen.
A relative measure (ratio or percentage) of the myelocytes to     Myelocyte To Leukocyte Ratio
leukocytes in a biological specimen.
The determination of the ratio of neutrophils compared to         Neutrophil To Leukocyte Ratio
leukocytes in a blood sample. The measurement may be
expressed as a ratio or percentage.
A relative measure (ratio or percentage) of reticulocytes to      Reticulocyte To Erythrocyte Ratio
erythrocytes in a biological specimen.
A relative measure (ratio or percentage) of prolymphocytes to     Prolymphocyte To Leukocyte
leukocytes in a biological specimen.                              Ratio
A count of the banded neutrophils per unit of a biological        Neutrophil Band Form Count
specimen.
A relative measure (ratio or percentage) of the banded            Neutrophil Band Form To
neutrophils to leukocytes in a biological specimen.               Leukocyte Ratio
A ratio of the density of a fluid to the density of water.        Specific Gravity
A measurement of the magnesium in a biological specimen.          Magnesium Measurement

A measurement of the gamma glutamyl transpeptidase in a           Gamma Glutamyl
biological specimen.                                              Transpeptidase Measurement
A measurement of the hemoglobin in a biological specimen.         Hemoglobin Measurement

A measurement of the glycosylated hemoglobin in a biological      Glycosylated Hemoglobin
specimen.                                                         Measurement
A measurement of the surface antigen reaction of a biological     Hepatitis B Virus Surface Antigen
specimen to the Hepatitis B virus.                                Measurement
A measurement of the Choriogonadotropin Beta in a                 Choriogonadotropin Beta
biological specimen.                                              Measurement
A measurement of the potassium in a biological specimen.          Potassium Measurement

A measurement of the ketones in a biological specimen.            Ketone Measurement
A measurement of the lactate dehydrogenase in a biological        Lactate Dehydrogenase
specimen.                                                         Measurement
A measurement of the enzyme which indicates the presence          Leukocyte Esterase
of white blood cells in a biological specimen.                    Measurement
A measurement of the phosphate in a biological specimen.          Phosphate Measurement

A measurement of a group of complex organic                       Total Protein Measurement
macromolecules composed of one or more alpha-L-amino
acid chains in a biological specimen.
A measurement of the prostate specific antigen in a biological    Prostate Specific Antigen
specimen.                                                         Measurement
A measurement of the volume of serum or plasma that would         Creatinine Clearance
be cleared of creatinine by excretion of urine for a specified
unit of time (e.g. one minute).
A measurement of the hairy cells (b-cell lymphocytes with         Hairy Cell Count
hairy projections from the cytoplasm) in a biological specimen.

A measurement of the blast cells in a biological specimen.        Blast Count

A count of the CD19 B cells per unit of a biological specimen. CD19 Expressing B Cell Count

A count of the CD3 T cells per unit of a biological specimen.     CD3 Expressing T Cell Count
A count of the CD4 T cells per unit of a biological specimen.      CD4 Expressing T Cell Count

A count of the CD8 T cells per unit of a biological specimen.      CD8 Expressing T Cell Count

A measurement of the Dohle bodie (blue-gray, basophilic,           Dohle Body Measurement
leukocyte inclusions located in the peripheral cytoplasm of
neutrophils) in a biological specimen.
The distance (e.g. millimeters) that red blood cells settle in     Erythrocyte Sedimentation Rate
unclotted blood over a specified unit of time (e.g. one hour).     Measurement

A measurement of the hypersegmented (more than five                Hypersegmented Neutrophil
lobes) neutrophils in a biological specimen.                       Measurement
A measurement of the malignant lymphocytes in a biological         Lymphoma Cell Count
specimen.
A measurement of the amount of May-Hegglin anomaly                 May-Hegglin Anomaly
present in a blood sample.                                         Measurement
A measurement of the metamyelocytes (small, myelocytic             Metamyelocyte Count
neutrophils with an indented nucleus) in a biological
specimen.
A measurement of the Pappenheimer Bodies (violet or blue           Pappenheimer Body Count
staining, ferritin granules usually found along the periphery of
the red blood cells) in a biological specimen.
A measurement of the amount of Pelger Huet anomaly                 Pelger Huet Anomaly
present in a biological specimen.                                  Measurement
A measurement of the plasmacytoid lymphocytes                      Plasmacytoid Lymphocyte Count
(lymphocytes with peripherally clumped chromatin and often
deep blue cytoplasm, and that appear similar to plasma cells)
in a biological specimen.
A measurement of the precursor (blast stage) plasma cells          Precursor Plasma Cell Count
(antibody secreting cells derived from B cells via antigen
stimulation) in a biological specimen.
A measurement of the prolymphocytes in a biological                Prolymphocyte Count
specimen.
A measurement of the promonocytes per unit of a biological         Promonocyte Count
specimen.
A measurement of the promyelocytes (immature myelocytes)           Promyelocyte Count
in a biological specimen.
A measurement of the number of stacking red blood cells            Rouleaux Formation Count
within a biological specimen.
A measurement of the Sezary cells (atypical lymphocytes with       Sezary Cell Count
cerebriform nuclei) in a biological specimen.
A measurement of the sickle cells (sickle shaped red blood         Sickle Cell Count
cells) in a biological specimen.
A measurement of the smudge cells (the nuclear remnant of a        Smudge Cell Count
ruptured white blood cell) in a biological specimen.
A measurement of the neutrophils containing small vacuoles         Vacuolated Neutrophil Count
in a biological specimen.
A measurement of the leukemic blasts (lymphoblasts that            Leukemic Blast Count
remain in an immature state even when outside the bone
marrow) in a biological specimen.
A measurement of the monoblast cells per unit of a biological       Monoblast Count
specimen.
A measurement of the myeloblast cells per unit of a biological      Myeloblast Count
specimen.
A relative measurement (ratio or percentage) of acanthocytes        Acanthocyte to Erythrocyte Ratio
to all erythrocytes in a biological specimen.                       Measurement
A relative measurement (ratio or percentage) of bite cells          Bite Cell to Erythrocyte Ratio
(erthrocytes with the appearance of a bite having been              Measurement
removed, due to oxidative hemolysis) to all erythrocytes in a
biological specimen .
A relative measurement (ratio or percentage) of CD19 B cells        CD19 B Cell to Lymphocyte
to all lymphocytes in a biological specimen.                        Ratio Measurement
A relative measurement (ratio or percentage) of CD3 T cells         CD3 T Cell to Lymphocyte Ratio
to all lymphocytes in a biological specimen.                        Measurement
A relative measurement (ratio or percentage) of CD4 T cells         CD4 T Cell to CD8 T Cell Ratio
to the CD8 T cells in a biological specimen.                        Measurement
A relative measurement (ratio or percentage) of CD4 T cells         CD4 T Cell to Lymphocyte Ratio
to all lymphocytes in a biological specimen.                        Measurement
A relative measurement (ratio or percentage) of CD8 T cells         CD8 T Cell to Lymphocyte Ratio
to all lymphocytes in a biological specimen.                        Measurement
A relative measurement (ratio or percentage) of the hairy cells     Hairy Cell to Lymphocyte Ratio
(b-cell lymphocytes with hairy projections from the cytoplasm)      Measurement
to all lymphocytes in a biological specimen .
A relative measurement (ratio or percentage) of the leukemic        Leukemic Blast to Lymphocyte
blasts (immature lymphoblasts) to mature lymphocytes in a           Ratio Measurement
biological specimen.
A relative measurement (ratio or percentage) of the malignant       Malignant Cell to Blood Cell
cells of all types to all blood cells in a biological specimen.     Ratio Measurement

A relative measurement (ratio or percentage) of the                 Metamyelocyte to Leukocyte
metamyelocytes (small, myelocytic neutrophils with an               Ratio Measurement
indented nucleus) to all leukocytes in a biological specimen.

A relative measurement (ratio or percentage) of monoblast           Monoblast to Leukocyte Ratio
cells to all leukocytes in a biological specimen.                   Measurement
A relative measurement (ratio or percentage) of the nucleated       Nucleated Red Blood Cell to
erythrocytes (large, immature nucleated erythrocytes) to all        Erythrocyte Ratio Measurement
erythrocytes in a biological specimen.
A relative measurement (ratio or percentage) of the                 Plasmacytoid Lymphocyte to
plasmacytoid lymphocytes (lymphocytes with peripherally             Lymphocyte Ratio Measurement
clumped chromatin and often deep blue cytoplasm, and that
appear similar to plasma cells) to all lymphocytes in a
biological specimen.
A relative measurement (ratio or percentage) of the                 Poikilocyte to Erythrocyte Ratio
poikilocytes irregularly shaped erythrocytes) to all erythrocytes   Measurement
in a biological specimen.
A relative measurement (ratio or percentage) of the precursor       Precursor Plasma Cell to
(blast stage) plasma cells (antibody secreting cells derived        Lymphocyte Ratio Measurement
from B cells via antigen stimulation) to all lymphocytes in a
biological specimen.
A relative measurement (ratio or percentage) of the              Prolymphocyte to Lymphocyte
prolymphocytes to all lymphocytes in a biological specimen.      Ratio Measurement

A relative measurement (ratio or percentage) of the              Promonocyte to Lymphocyte
promonocytes to all leukocytes in a biological specimen.         Ratio Measurement
A relative measurement (ratio or percentage) of the              Promyelocyte to Lymphocyte
promyelocytes (immature myelocytes) to all leukocytes in a       Ratio Measurement
biological specimen.
A relative measurement (ratio or percentage) of the reactive     Reactive Lymphocyte to
lymphocytes (lymphocytes with peripherally clumped               Lymphocyte Ratio Measurement
chromatin and often deep blue cytoplasm and that appear
similar to plasma cells) to all lymphocytes in a biological
specimen.
A relative measurement (ratio or percentage of the Sezary        Sezary Cell to Lymphocyte Ratio
cells (atypical lymphocytes with cerebriform nuclei) to all      Measurement
lymphocytes in a biological specimen.
A relative measurement (ratio or percentage) of the sickle       Sickle Cell to Erythrocyte Ratio
cells (sickle shaped red blood cells) to all erythrocytes in a   Measurement
biological specimen.
A measurement of the Auer rods (elongated needle structures      Auer Rod Measurement
that are found in the cytoplasm of leukemic blasts and are
formed by clumps of azurophilic granular material) in a
biological specimen.
A measurement of the Helmet cells (specialized Keratocytes       Helmet Cell Count
with two projections on either end that are tapered and
hornlike) in a biological specimen.
A measurement of the large, peroxidase-negative cells which      Large Unstained Cell Count
cannot be further characterized (i.e. as large lymphocytes,
virocytes, or stem cells) present in a biological specimen.

A measurement of the malignant cells of all types in a           Malignant Cell Count
biological specimen.
A measurement of the mature plasma cells (plasmacytes) in a      Mature Plasma Cell Count
biological specimen.
A measurement of the myelocytes per unit of a biological         Myelocyte Count
specimen.
A measurement of the spermatozoa cells present in a              Spermatozoa Cell Count
biological specimen.
A measurement of the yeast cells present in a biological         Yeast Cell Measurement
specimen.
A measurement of the amorphous (Note: phosphate or urate,        Amorphous Crystal
depending on pH) crystals present in a biological specimen.      Measurement

A measurement of the amorphous sediment present in a             Amorphous Sediment
biological specimen.                                             Measurement
A measurement of the bicarbonate in a biological specimen        Bicarbonate Measurement

A measurement of the bilirubin crystals present in a biological Bilirubin Crystal Measurement
specimen.
A measurement of the calcium carbonate crystals present in a Calcium Carbonate Crystal
biological specimen.                                            Measurement
A measurement of the calcium oxalate crystals present in a        Calcium Oxalate Crystal
biological specimen.                                              Measurement
A measurement of the calcium phosphate crystals present in        Calcium Phosphate Crystal
a biological specimen.                                            Measurement
A measurement of the cholesterol crystals present in a            Cholesterol Crystal
biological specimen.                                              Measurement
A statement that indicates crystals were looked for and not       Crystal Present Or Absent
found in a biological specimen.
A measurement of the cystine crystals present in a biological     Cystine Crystal Measurement
specimen.
A measurement of the folic acid in a biological specimen.         Folic Acid Measurement
A measurement of the free carnitine in a biological specimen.     Free Carnitine Measurement

A measurement of the fructosamine in a biological specimen. Fructosamine Measurement

A measurement of the iron in a biological specimen.               Iron Measurement
A measurement of the leucine crystals present in a biological     Leucine Crystal Measurement
specimen.
A measurement of the monosodium urate crystals present in         Monosodium Urate Crystal
a biological specimen.                                            Measurement
A measurement of the total carnitine in a biological specimen.    Total Carnitine Measurement

A measurement of the triple phosphate crystals present in a       Tyrosine Crystal Measurement
biological specimen.
A measurement of the uric acid crystals present in a biological   Uric Acid Crystal Measurement
specimen.
A computed estimate of the unmeasured anions (those other         Anion Gap Measurement
than the chloride and bicarbonate anions) in a biological
specimen.
A measurement of the blood in body products such as a stool       Occult Blood Measurement
sample, not detectable on gross examination.
A measurement of any amphetamine class drug present in a          Amphetamine Drug Class
biological specimen.                                              Measurement
A measurement of any barbiturate class drug present in a          Barbiturate Drug Class
biological specimen.                                              Measurement
A measurement of any cannabinoid class drug present in a          Cannabinoid Drug Class
biological specimen.                                              Measurement
A measurement of the cocaine present in a biological              Cocaine Measurement
specimen.
A measurement of the round epithelial cells present in a urine    Round Epithelial Cell Count
specimen.
A measurement of the acanthocytes per unit of a biological        Acanthocyte Count
specimen.
A measurement of the bite cells (erthrocytes with the             Bite Cell Count
appearance of a bite having been removed, due to oxidative
hemolysis) in a biological specimen .
A measurement of the Burr cells (erythrocytes characterized       Burr Cell Count
by the presence of small, blunt projections evenly distributed
across the cell surface) in a biological specimen.
A measurement of the Cabot rings (red-purple staining,           Cabot Ring Count
threadlike, ring or figure 8 shaped filaments in an erythrocyte)
in a biological specimen.
A measurement of the Burr cells (erythrocytes characterized Crenated Cell Measurement
by the presence of multiple small, sharp projections evenly
distributed across the cell surface) in a biological specimen.

A measurement of the Howell-Jolly bodies (spherical, blue-       Howell-Jolly Body Measurement
black condensed DNA inclusions within the body of a red
blood cell that appear under Wright-stain) in a biological
specimen.
A measurement of the nucleated erythrocytes (large,              Nucleated Red Blood Cell Count
immature nucleated erythrocytes) in a biological specimen.

A measurement of the schistocytes (fragmented red blood          Schistocyte Count
cells) in a biological specimen.
A measurement of the spherocytes (small, sphere-shaped red       Spherocyte Count
blood cells) in a biological specimen.
A measurement of the stomatocytes (red blood cells with an       Stomatocyte Count
oval or rectangular area of central pallor, producing the
appearance of a cell mouth) in a biological specimen.
A measurement of the Heinz bodies (small round inclusions        Heinz-Ehrlich Body
within the body of a red blood cell) in a biological specimen.   Measurement

A measurement of the surface antibody reaction of a              Hepatitis A Surface Antibody
biological specimen to the Hepatitis A virus.                    Measurement
A measurement of the surface antibody reaction of a              Hepatitis B Surface Antibody
biological specimen to the Hepatitis B virus.                    Measurement
A measurement of the surface antibody reaction of a              Hepatitis C Surface Antibody
biological specimen to the Hepatitis C virus.                    Measurement
A measurement of the antibody reaction of a biological           HIV-1 Antibody Measurement
specimen to the HIV-1 virus.
A measurement of the antibody reaction of a biological           HIV-1 HIV-2 Antibody
specimen to the either the HIV-1 or HIV-2 virus.                 Measurement
A measurement of the antibody reaction of a biological           HIV-2 Antibody Measurement
specimen to the HIV-2 virus.
A measurement of the antibodies produced by cellular             Rapid Plasma Reagin
damage caused by Treponema pallidum (syphilis) in a              Measurement
biological specimen.
A measurement of the rheumatoid factor antibody in a             Rheumatoid Factor
biological specimen.                                             Measurement
A measurement of the amount of iron needed to fully saturate     Total Iron Binding Capacity
the transferrin in a serum specimen.
A measurement of the binding capacity of unsaturated iron in     Unsaturated Iron Binding
a biological specimen.                                           Capacity Measurement
A measurement of the mucous threads present in a biological      Mucous Thread Measurement
specimen.
A measurement of the opacity of a biological specimen.           Turbidity Measurement
A measurement of the hepatitis A viral load in a biological      Hepatitis A Viral Load PCR
specimen using polymerase chain reaction.                        Measurement
A measurement of the hepatitis B viral load in a sample using    Hepatitis B Viral Load PCR
polymerase chain reaction.                                       Measurement
A measurement of the hepatitis C viral load in a sample using   Hepatitis C Viral Load PCR
polymerase chain reaction.                                      Measurement
A measurement of the HIV viral load in a specimen using         HIV Viral Load PCR
polymerase chain reaction.                                      Measurement
A measurement of the giant (larger than 7um in diameter)        Giant Platelet Count
platelets in a biological specimen.
A measurement of the large (between 4 um and 7um in             Large Platelet Count
diameter) platelets in a biological specimen.
A measurement of the average size of the platelets present in   Mean Platelet Volume
a blood sample.                                                 Measurement
A measurement of the aldolase enzyme in a biological            Aldolase Measurement
specimen.
A measurement of the alpha fetoprotein in a biological          Alpha-fetoprotein Measurement
specimen.
A measurement of the apolipoprotein A1 in the high density      Apolipoprotein A1 Measurement
lipoproteins of a biological specimen.
A measurement of the apolipoprotein B in the low density        Apolipoprotein B Measurement
lipoproteins of a biological specimen.
A measurement of the brain (B-type) natriuretic peptide in a    Brain Natriuretic Peptide
biological specimen.                                            Measurement
A measurement of the C (connecting) peptide of insulin in a     C-peptide Measurement
biological specimen.
A measurement of the ferritin in a biological specimen.         Ferritin Measurement
A measurement of the globulin protein in a biological           Globulin Protein Measurement
specimen.
A measurement of the glutamate in a biological specimen.        Glutamate Measurement
A measurement of the haptoglobin protein in a biological        Haptoglobin Protein
specimen.                                                       Measurement
A measurement of the homocysteine amino acid in a               Homocysteine Acid
biological specimen.                                            Measurement
A measurement of the N-telopeptide in a biological specimen.    N-telopeptide Measurement

A measurement of the osteocalcin in a biological specimen.      Osteocalcin Measurement

A measurement of the sex hormone binding (globulin) protein Sex Hormone Binding Protein
in a biological specimen.                                   Measurement

A measurement of the thyroxine binding globulin protein in a    Thyroxine Binding Globulin
biological specimen.                                            Protein Measurement
A measurement of the total (free and bound) triiodothyronine    Triiodothyronine Measurement
in a biological specimen.
A measurement of the binding of triiodothyonine to thyroxine    Triiodothyronine Uptake
binding globulin protein in a biological specimen.              Measurement
A measurement of the actin binding troponin in a biological     Troponin I Measurement
specimen.
A measurement of the tropomyosin binding troponin in a          Troponin T Measurement
biological specimen.
A measurement of the total tumor necrosis factor (cachexin)     Tumor Necrosis Factor
cytokine in a biological specimen.                              Measurement
A relative measurement (ratio or percentage) (ratio) of the     Blood Urea Nitrogen To
blood urea nitrogen (BUN) to the creatinine in a blood          Creatinine Ratio Measurement
specimen.
A measurement of the hippuric acid crystals present in a urine   Hippuric Acid Crystal
specimen.                                                        Measurement
A measurement of the sulfa crystals present in a urine           Sulfa Crystal Measurement
specimen.
A measurement of the triple phosphate crystals present in a      Triple Phosphate Crystal
urine specimen.                                                  Measurement
A measurement of the unclassifiable crystals present in a        Unclassified Crystal
urine specimen.                                                  Measurement
A measurement of the ammonium biurate crystals present in        Urine Ammonium Biurate Crystal
a biological specimen.                                           Measurement
A measurement of the ammonium oxalate crystals present in        Urine Ammonium Oxalate
a urine specimen.                                                Crystal Measurement
A relative measurement (ratio or percentage) of the albumin      Albumin To Creatinine Protein
to the creatinine in a urine specimen.                           Ratio Measurement

A measurement of the bacterial casts present in a urine          Bacterial Cast Measurement
specimen.
A statement that indicates casts were looked for and not         Cast Present Or Absent
found in a biological specimen.
A measurement of the cellular (white blood cell, red blood cell, Cellular Cast Measurement
epithelial and bacterial) casts present in a urine specimen.

A measurement of the coarse granular casts present in a       Coarse Granular Cast
urine specimen.                                               Measurement
A measurement of the fatty casts present in a urine specimen. Fatty Cast Measurement

A measurement of the fine granular casts present in a urine      Fine Granular Cast
specimen.                                                        Measurement
A measurement of the granular (course and fine) casts            Granular Cast Measurement
present in a urine specimen.
A measurement of the fine granular casts present in a urine      Granular Fine Cast
specimen.                                                        Measurement
A measurement of the hyaline casts present in a urine            Hyaline Cast Measurement
specimen.
A measurement of the mixed (the cast contains a mixture of       Mixed Cast Count
cell types) casts present in a urine specimen.
A measurement of the red blood cell casts present in a urine     Red Blood Cell Cast
specimen.                                                        Measurement
A measurement of the squamous epithelial cells present in a      Squamous Epithelial Cell Count
urine specimen.
A measurement of the squamous transitional epithelial cells      Squamous Transitional Epithelial
present in a urine specimen.                                     Cell Count

A measurement of the tubular epithelial cells present in a       Tubular Epithelial Cell Count
urine specimen.
A measurement of the unclassifiable casts present in a urine     Unclassified Cast Measurement
specimen.
A measurement of the waxy casts present in a urine               Waxy Cell Cast Measurement
specimen.
A measurement of the white blood cell casts present in a         White Blood Cell Cast
urine specimen.                                                  Measurement
A measurement of the epithelial cell casts present in a urine   Epithelial-Cast Measurement
specimen.
A measurement of the adrenocorticotropic hormone in a           Adrenocorticotropic Hormone
biological specimen.                                            Measurement
A measurement of the cortisol in a biological specimen.         Cortisol Measurement
A measurement of the estradiol in a biological specimen.        Estradiol Measurement
A measurement of the follicle stimulating hormone (FSH) in a    Follicle Stimulating Hormone
biological specimen.                                            Measurement
A measurement of the fragmented parathyroid hormone in a        Fragmented Parathyroid
biological specimen.                                            Hormone Measurement
A measurement of the free testosterone in a biological          Free Testosterone Measurement
specimen.
A measurement of the free thyroxine in a biological specimen.   Free Thyroxine Measurement

A measurement of the free triiodothyronine in a biological      Free Triiodothyronine
specimen.                                                       Measurement
A measurement of the insulin in a biological specimen.          Insulin Measurement
A measurement of the intact parathyroid hormone in a            Intact Parathyroid Hormone
biological specimen.                                            Measurement
A measurement of the luteinizing hormone in a biological        Luteinizing Hormone
specimen.                                                       Measurement
A measurement of the progesterone hormone in a biological       Progesterone Measurement
specimen.
A measurement of the somatotropin (growth) hormone in a         Somatotropin Measurement
biological specimen.
A measurement of the total (free and bound) testosterone in a   Total Testosterone
biological specimen.                                            Measurement
A measurement of the total (free and bound) thyroxine in a      Total Thyroxine Measurement
biological specimen.
A measurement of any opiate class drug present in a             Opiate Measurement
biological specimen.
A relative measurement (ratio or percentage) of the malignant   Lymphoma Cell to Lymphocyte
lymphocytes to all lymphocytes in a biological specimen.        Ratio Measurement

A relative measurement (ratio or percentage) of the mature      Mature Plasma Cell to
plasma cells (plasmacytes) to all lymphocytes in a biological   Lymphocyte Ratio Measurement
specimen.
A measurement of the ammonium acid urate crystals present       Acid Urate Crystal Measurement
in a biological specimen.
A measurement of the anti-double stranded DNA antibody in       Anti-Double Stranded DNA
a biological specimen.                                          Measurement
A measurement of the antinuclear antibodies (antibodies that    Antinuclear Antibody
attack the body's own tissue) in a biological specimen.         Measurement

A measurement of the 5'-nucleotidase in a biological            5 Prime Nucleotidase
specimen.                                                       Measurement

A measurement of the 6-monoacetylmorphine present in a          6-Monoacetylmorphine
biological specimen.                                            Measurement
A measurement of the acetylcholine hormone in a biological      Acetylcholine Measurement
specimen.
A measurement of the adiponectin hormone in a biological          Adiponectin Measurement
specimen.
The ratio of albumin to globulin in a blood specimen.             Albumin to Globulin Ratio
                                                                  Measurement
A measurement of the aldosterone hormone in a biological          Aldosterone Measurement
specimen.
A relative measurement (ratio or percentage) of the alkaline      Alkaline Phosphatase to
phosphatase to creatinine in a biological specimen.               Creatinine Ratio Measurement

A measurement of the alpha form of glutathione S-transferase      Alpha Glutathione-S-Transferase
in a biological specimen.                                         Measurement
A measurement of the ammonia in a biological specimen.            Ammonia Measurement
A measurement of the androstenediol metabolite in a               Androstenediol Metabolite
biological specimen.                                              Measurement
A measurement of the androstenedione hormone in a                 Androstenedione Measurement
biological specimen.
A measurement of the angiotensin I hormone in a biological        Angiotensin I Measurement
specimen.
A measurement of the angiotensin II hormone in a biological       Angiotensin II Measurement
specimen.
A measurement of the angiotensinogen hormone in a                 Angiotensinogen Measurement
biological specimen.
A measurement of any antidepressant class drug present in a       Antidepressant Measurement
biological specimen.
A measurement of the antidiuretic hormone in a biological         Antidiuretic Hormone Measurement
specimen.
A measurement of the atrial natriuretic peptide in a biological   Atrial Natriuretic Peptide
specimen.                                                         Measurement
A measurement of any benzodiazepine class drug present in         Benzodiazepine Measurement
a biological specimen.
A measurement of the total bile acids in a biological             Bile Acid Measurement
specimen.
A relative measurement of the bite cells (erythrocytes with the   Bite Cell To Erythrocyte Ratio
appearance of a bite having been removed, due to oxidative        Measurement
hemolysis) to all erythrocytes in a biological specimen.

A measurement of the calcitonin hormone in a biological           Calcitonin Measurement
specimen.
A measurement of the calcitriol hormone in a biological           Calcitriol Measurement
specimen.
A relative measurement (ratio or percentage) of the calcium to    Calcium to Creatinine Ratio
creatinine in a biological specimen.                              Measurement
A relative measurement (ratio or percentage) of the chloride      Chloride to Creatinine Ratio
to creatinine in a biological specimen.                           Measurement
A measurement of the cholecystokinin hormone in a biological      Cholecystokinin Measurement
specimen.
A measurement of the codeine present in a biological              Codeine Measurement
specimen.
A measurement of corticosterone in a biological specimen.         Corticosterone Measurement
A measurement of the corticotropin releasing hormone in a      Corticotropin Releasing Hormone
biological specimen.                                           Measurement

A relative measurement (ratio or percentage) of the BB-type    Creatine Kinase BB to Total
creatine kinase to total creatine kinase in a biological       Creatine Kinase Ratio
specimen.                                                      Measurement
A relative measurement (ratio or percentage) of the MB-type    Creatine Kinase MB to Total
creatine kinase to total creatine kinase in a biological       Creatine Kinase Ratio
specimen.                                                      Measurement
A relative measurement (ratio or percentage) of the MM-type    Creatine Kinase MM to Total
creatine kinase to total creatine kinase in a biological       Creatine Kinase Ratio
specimen.                                                      Measurement
A measurement of the dehydroepiandrosterone hormone in a       Dehydroepiandrosterone
biological specimen.                                           Measurement
A measurement of the deoxypyridinoline in a biological         Deoxypyridinoline Measurement
specimen.
A relative measurement (ratio or percentage) of the            Deoxypyridinoline to Creatinine
deoxypyridinoline to creatinine in a biological specimen.      Ratio Measurement
A measurement of the dihydrocodeine present in a biological    Dihydrocodeine Measurement
specimen.
A measurement of the dihydrotestosterone hormone in a          Dihydrotestosterone Measurement
biological specimen.
A measurement of the dopamine hormone in a biological          Dopamine Measurement
specimen.
A measurement of the epinephrine hormone in a biological       Epinephrine Measurement
specimen.
A measurement of the erythropoietin hormone in a biological    Erythropoietin Measurement
specimen.
A measurement of the estriol hormone in a biological           Estriol Measurement
specimen.
A measurement of the estrone hormone in a biological           Estrone Measurement
specimen.
A measurement of the ethanol present in a biological           Ethanol Measurement
specimen.
A relative measurement (ratio or percentage) of the gamma      Gamma Glutamyl Transferase to
glutamyl transferase to creatinine in a biological specimen.   Creatinine Ratio Measurement

A measurement of the gastrin hormone in a biological           Gastrin Measurement
specimen.
A measurement of the glucagon hormone in a biological          Glucagon Measurement
specimen.
A relative measurement (ratio or percentage) of the glucose    Glucose to Creatinine Ratio
to creatinine in a biological specimen.                        Measurement
A measurement of the glutamate dehydrogenase in a              Glutamate Dehydrogenase
biological specimen.                                           Measurement
A relative measurement (ratio or percentage) of the            Glutathione-S-Transferase to
glutathione S-transferase to creatinine in a biological        Creatinine Ratio Measurement
specimen.
A measurement of the gonadotropin releasing hormone in a       Gonadotropin Releasing Hormone
biological specimen.                                           Measurement
A measurement of the growth hormone inhibiting hormone in      Growth Hormone Inhibiting Hormone
a biological specimen.                                         Measurement
A measurement of the growth hormone in a biological            Growth Hormone Measurement
specimen.
A measurement of the growth hormone releasing hormone in       Growth Hormone Releasing
a biological specimen.                                         Hormone Measurement
A measurement of the homovanillic acid metabolite in a         Homovanillic Acid Measurement
biological specimen.
A measurement of the hydrocodone present in a biological       Hydrocodone Measurement
specimen.
A measurement of the hydromorphone present in a biological     Hydromorphone Measurement
specimen.
A measurement of the insulin-like growth factor-1 in a         Insulin Like Growth Factor-1
biological specimen.                                           Measurement
A measurement of the insulin-like growth factor-2 in a         Insulin Like Growth Factor-2
biological specimen.                                           Measurement
A measurement of the interleukin 1 in a biological specimen.   Interleukin 1 Measurement

A measurement of the interleukin 10 in a biological specimen. Interleukin 10 Measurement

A measurement of the interleukin 11 in a biological specimen. Interleukin 11 Measurement

A measurement of the interleukin 12 in a biological specimen. Interleukin 12 Measurement

A measurement of the interleukin 13 in a biological specimen. Interleukin 13 Measurement

A measurement of the interleukin 14 in a biological specimen. Interleukin 14 Measurement

A measurement of the interleukin 15 in a biological specimen. Interleukin 15 Measurement

A measurement of the interleukin 16 in a biological specimen. Interleukin 16 Measurement

A measurement of the interleukin 17 in a biological specimen. Interleukin 17 Measurement

A measurement of the interleukin 18 in a biological specimen. Interleukin 18 Measurement

A measurement of the interleukin 19 in a biological specimen. Interleukin 19 Measurement

A measurement of the interleukin 2 in a biological specimen.   Interleukin 2 Measurement

A measurement of the interleukin 20 in a biological specimen. Interleukin 20 Measurement

A measurement of the interleukin 21 in a biological specimen. Interleukin 21 Measurement

A measurement of the interleukin 22 in a biological specimen. Interleukin 22 Measurement

A measurement of the interleukin 23 in a biological specimen. Interleukin 23 Measurement

A measurement of the interleukin 24 in a biological specimen. Interleukin 24 Measurement

A measurement of the interleukin 25 in a biological specimen. Interleukin 25 Measurement
A measurement of the interleukin 26 in a biological specimen. Interleukin 26 Measurement

A measurement of the interleukin 27 in a biological specimen. Interleukin 27 Measurement

A measurement of the interleukin 28 in a biological specimen. Interleukin 28 Measurement

A measurement of the interleukin 29 in a biological specimen. Interleukin 29 Measurement

A measurement of the interleukin 3 in a biological specimen.   Interleukin 3 Measurement

A measurement of the interleukin 30 in a biological specimen. Interleukin 30 Measurement

A measurement of the interleukin 31 in a biological specimen. Interleukin 31 Measurement

A measurement of the interleukin 32 in a biological specimen. Interleukin 32 Measurement

A measurement of the interleukin 33 in a biological specimen. Interleukin 33 Measurement

A measurement of the interleukin 4 in a biological specimen.   Interleukin 4 Measurement

A measurement of the interleukin 5 in a biological specimen.   Interleukin 5 Measurement

A measurement of the interleukin 6 in a biological specimen.   Interleukin 6 Measurement

A measurement of the interleukin 7 in a biological specimen.   Interleukin 7 Measurement

A measurement of the interleukin 8 in a biological specimen.   Interleukin 8 Measurement

A measurement of the interleukin 9 in a biological specimen.   Interleukin 9 Measurement

A measurement of the lactate dehydrogenase isoenzyme 1 in      Lactate Dehydrogenase Isoenzyme
a biological specimen.                                         1 Measurement
A measurement of the lactate dehydrogenase isoenzyme 2 in      Lactate Dehydrogenase Isoenzyme
a biological specimen.                                         2 Measurement
A measurement of the lactate dehydrogenase isoenzyme 3 in      Lactate Dehydrogenase Isoenzyme
a biological specimen.                                         3 Measurement
A measurement of the lactate dehydrogenase isoenzyme 4 in      Lactate Dehydrogenase Isoenzyme
a biological specimen.                                         4 Measurement
A measurement of the lactate dehydrogenase isoenzyme 5 in      Lactate Dehydrogenase Isoenzyme
a biological specimen.                                         5 Measurement
A relative measurement (ratio or percentage) of the lactate    Lactate Dehydrogenase to
dehydrogenase to creatinine in a biological specimen.          Creatinine Ratio Measurement
A measurement of the lactic acid in a biological specimen.     Lactic Acid Measurement


A relative measure (ratio or percentage) of the large          Large Unstained Cells to
unstained cells to leukocytes in a biological specimen.        Leukocytes Ratio Measurement

A relative measurement (ratio or percentage) of the lactate LDH Isoenzyme 1 to LDH Ratio
dehydrogenase isoenzyme 1 to total lactate dehydrogenase in Measurement
a biological specimen.
A relative measurement (ratio or percentage) of the lactate     LDH Isoenzyme 2 to LDH Ratio
dehydrogenase isoenzyme 2 to total lactate dehydrogenase in     Measurement
a biological specimen.
A relative measurement (ratio or percentage) of the lactate     LDH Isoenzyme 3 to LDH Ratio
dehydrogenase isoenzyme 3 to total lactate dehydrogenase in     Measurement
a biological specimen.
A relative measurement (ratio or percentage) of the lactate     LDH Isoenzyme 4 to LDH Ratio
dehydrogenase isoenzyme 4 to total lactate dehydrogenase in     Measurement
a biological specimen.
A relative measurement (ratio or percentage) of the lactate     LDH Isoenzyme 5 to LDH Ratio
dehydrogenase isoenzyme 5 to total lactate dehydrogenase in     Measurement
a biological specimen.
A measurement of the leptin hormone in a biological             Leptin Measurement
specimen.
A relative measurement (ratio or percentage) of the             Magnesium to Creatinine Ratio
magnesium to creatinine in a biological specimen.               Measurement
A measurement of the melatonin hormone in a biological          Melatonin Measurement
specimen.
A measurement of the methadone present in a biological          Methadone Measurement
specimen.
A measurement of the methaqualone present in a biological       Methaqualone Measurement
specimen.
A measurement of the morphine present in a biological           Morphine Measurement
specimen.
A measurement of the mu form of glutathione S-transferase in    Mu Glutathione-S-Transferase
a biological specimen.                                          Measurement
A relative measurement (ratio or percentage) of the mu          Mu Glutathione-S-Transferase to
gamma glutamyl transpeptidase to creatinine in a biological     Creatinine Ratio Measurement
specimen.
A measurement of myoglobin in a biological specimen.            Myoglobin Measurement
A measurement of N-acetyl glucosamide in a biological           N-Acetyl Glucosamide
specimen.                                                       Measurement
A relative measurement (ratio or percentage) of the N-acetyl    N-Acetyl Glucosamide to
glucosamide to creatinine in a biological specimen.             Creatinine Ratio Measurement
A measurement of the neuropeptide Y in a biological             Neuropeptide Y Measurement
specimen.
A measurement of the norepinephrine hormone in a biological     Noradrenaline Measurement
specimen.
A measurement of the osmoles of solute per unit of biological   Osmolality Measurement
specimen.
A measurement of the oxycodone present in a biological          Oxycodone Measurement
specimen.
A measurement of the oxytocin hormone in a biological           Oxytocin Measurement
specimen.
A measurement of the phencyclidine present in a biological      Phencyclidine Measurement
specimen.
A measurement of the phenothiazine present in a biological      Phenothiazine Measurement
specimen.
A relative measurement (ratio or percentage) of the             Phosphate to Creatinine Ratio
phosphate to creatinine in a biological specimen.               Measurement
A relative measurement (ratio or percentage) of the             Potassium to Creatinine Ratio
potassium to creatinine in a biological specimen.               Measurement
A measurement of the prolactin hormone in a biological           Prolactin Measurement
specimen.
A measurement of the propoxyphene present in a biological        Propoxyphene Measurement
specimen.
A relative measurement (ratio or percentage) of the protein to   Protein to Creatinine Ratio
creatinine in a biological specimen.                             Measurement
A measurement of the pseudoephedrine present in a                Pseudoephedrine Measurement
biological specimen.
A measurement of the reactive lymphocytes (lymphocytes           Reactive Lymphocyte Count
which have become large due to an antigen reaction) in a         Measurement
biological specimen.
A measurement of the renin in a biological specimen.             Renin Measurement
A measurement of the secretin hormone in a biological            Secretin Measurement
specimen.
A measurement of the serotonin hormone in a biological           Serotonin Measurement
specimen.
A relative measurement (ratio or percentage) of the sodium to    Sodium to Creatinine Ratio
creatinine in a biological specimen.                             Measurement
A measurement of the sorbitol dehydrogenase in a biological      Sorbitol Dehydrogenase
specimen.                                                        Measurement
A measurement of the thrombopoietin hormone in a biological      Thrombopoietin Measurement
specimen.
A measurement of the thyrotropin releasing hormone in a          Thyrotropin Releasing Hormone
biological specimen.                                             Measurement

A measurement of the vanillyl mandelic acid metabolite in a      Vanillyl Mandelic Acid Measurement
biological specimen.
A measurement of the Vitamin A in a biological specimen.         Vitamin A Measurement
A measurement of the thiamine in a biological specimen.          Vitamin B1 Measurement
A measurement of the Vitamin B17 in a serum specimen.            Vitamin B17 Measurement
A measurement of the riboflavin in a biological specimen.        Vitamin B2 Measurement
A measurement of the niacin in a biological specimen.            Vitamin B3 Measurement
A measurement of the Vitamin B5 in a biological specimen.        Vitamin B5 Measurement

A measurement of the Vitamin B6 in a biological specimen.        Vitamin B6 Measurement

A measurement of the Vitamin B7 in a biological specimen.        Vitamin B7 Measurement

A measurement of the Vitamin C in a biological specimen.         Vitamin C Measurement
A measurement of the Vitamin D2 in a biological specimen.        Vitamin D2 Measurement

A measurement of the Vitamin D3 in a biological specimen.        Vitamin D3 Measurement

A measurement of the Vitamin E in a biological specimen.         Vitamin E Measurement
A measurement of the Vitamin K in a biological specimen.         Vitamin K Measurement
A measurement of the volume of a biological specimen.            Volume Measurement
Terminology used for Laboratory Tests of the CDISC               CDISC SDTM Laboratory Test
Standard Data Tabulation Model.                                  Terminology by Name

A measurement of the inequality in the size of the red blood     Anisocytosis
cells in a whole blood specimen.
A measurement of the odd-shaped erythrocytes in a whole        Poikilocytosis
blood specimen.
A measurement of the total bilirubin in a biological specimen. Total Bilirubin

A measurement of the length of time that it takes for clotting      Partial Thromboplastin Time
to occur when reagents are added to a plasma specimen. The
test is partial due to the absence of tissue factor (Factor III)
from the reaction mixture.
A measurement of the glucose in a biological specimen.              Plasma Glucose Measurement
A measure of the acidity or alkalinity of a fluid on a scale of 0   pH
to 14.
A count of the total erythrocytes per unit of a biological          Erythrocyte Count
specimen.
A count of the reticulocytes per unit of a biological specimen.     Reticulocyte Count

A count of the leukocytes per unit of a biological specimen.        Leukocyte Count

A count of the lymphocytes per unit of a biological specimen.       Lymphocyte Count

A count of the platelets per unit of a biological specimen.    Platelet Count
A measurement of the urea nitrogen in a blood specimen.        Blood Urea Nitrogen
                                                               Measurement
A measurement of the cholesterol in a biological specimen.     Serum Total Cholesterol
                                                               Measurement
A measurement of the high density lipoprotein cholesterol in a Serum HDL Cholesterol
biological specimen.                                           Measurement
A measurement of the low density lipoprotein cholesterol in a Serum LDL Cholesterol
biological specimen.                                           Measurement
A blood clotting measurement that evaluates the extrinsic      Prothrombin Time
pathway of coagulation and is expressed in units of time or
percent activity.
A count of the neutrophils per unit of a biological specimen.  Absolute Neutrophil Count

A measurement of the albumin protein in a biological                Albumin Measurement
specimen.
A measurement of the alkaline phosphatase in a biological           Alkaline Phosphatase
specimen.                                                           Measurement
A measurement of the alanine aminotransferase in a                  Alanine Aminotransferase
biological specimen.                                                Measurement
A measurement of the pancreatic enzyme amylase in a                 Amylase Measurement
biological specimen.
A measurement of the aspartate aminotransferase in a                Aspartate Aminotransferase
biological specimen.                                                Measurement
A measurement of the bacteria in a biological specimen.             Bacterial Count
A count of the basophils per unit of a biological specimen.         Total Basophil Count
A relative measure (ratio or percentage) of the basophils to        Basophil To Leukocyte Ratio
leukocytes in a biological specimen.
A measurement of the conjugated or water-soluble bilirubin in       Direct Bilirubin Measurement
a biological specimen.
A measurement of the unconjugated or non-water-soluble              Indirect Bilirubin Measurement
bilirubin in a biological specimen.
A relative measure (ratio or percentage) of the blasts to          Blast To Leukocyte Ratio
leukocytes in a biological specimen.
A measurement of the calcium in a biological specimen.             Calcium Measurement
A measurement of the total creatine kinase in a biological         Creatine Kinase Measurement
specimen.
A measurement of the homozygous B-type creatine kinase in          Creatine Kinase BB
a biological specimen.                                             Measurement
A measurement of the heterozygous MB-type creatine kinase          Creatine Kinase MB
in a biological specimen.                                          Measurement
A measurement of the homozygous M-type creatine kinase in          Creatine Kinase MM
a biological specimen.                                             Measurement
A measurement of the chloride in a biological specimen.            Chloride Measurement
A measurement of the carbon dioxide gas in a biological            Carbon Dioxide Measurement
specimen.
A measurement of the color of a biological specimen.               Color Assessment
A measurement of the creatinine in a biological specimen.          Creatinine Measurement
A measurement of the C reactive protein in a biological            C-Reactive Protein
specimen.                                                          Measurement
A count of the elliptocytes per unit of a biological specimen.     Elliptocyte Count

A count of the eosinophils per unit of a biological specimen.      Eosinophil Count

A relative measure (ratio or percentage) of the eosinophils to Eosinophil To Leukocyte Ratio
leukocytes in a biological specimen.
A measurement of the epithelial cells in a biological specimen. Epithelial Cell Count

A measurement of the fibrinogen in a biological specimen.          Fibrinogen Measurement
The percentage of a whole blood specimen that is composed          Hematocrit
of red blood cells (erythrocytes).
A quantitative measurement of the mean amount of                   Erythrocyte Mean Corpuscular
hemoglobin per erythrocyte in a biological specimen.               Hemoglobin
A quantitative measurement of the mean amount of                   Erythrocyte Mean Corpuscular
hemoglobin per erythrocytes in a specified volume of a             Hemoglobin Concentration
biological specimen.
A quantitative measurement of the mean volume of                   Erythrocyte Mean Corpuscular
erythrocytes in a biological specimen.                             Volume
A value derived from mean corpuscular volume and the               Erythrocyte Distribution Width
standard deviation of the red blood cell volume in a whole         Measurement
blood specimen.
A count of dacryocytes in unit of a biological specimen.           Dacryocyte Analysis
An observation which indicates that the hemoglobin                 Hypochromia
concentration in a red blood cell specimen has fallen below a
specified level.
A measurement of the blue-staining characteristic of newly         Polychromasia
generated erythrocytes.
A ratio that represents the prothrombin time for a plasma          International Normalized Ratio of
specimen, divided by the result for a control plasma               Prothrombin Time
specimen, further standardized for the International Sensitivity
Index of the tissue factor (thromboplastin) used in the test.
A measurement of the very low density lipoprotein cholesterol    Serum VLDL Cholesterol
in a biological specimen.                                        Measurement
A measurement of the pancreatic lipase in a biological           Triacylglycerol Lipase
specimen.                                                        Measurement
A measurement of the sodium in a biological specimen.            Sodium Measurement
A measurement of the nitrite in a urine specimen.                Nitrite Measurement
A measurement of the triglycerides in a biological specimen.     Triglyceride Measurement

A measurement of the thyrotropin in a biological specimen.       Thyrotropin Measurement

A measurement of the urate in a biological specimen.             Urate Measurement
A measurement of the urea in a biological specimen.              Urea Measurement
A measurement of the urobilinogen in a biological specimen.      Urobilinogen Measurement

A measurement of the Vitamin B12 in a serum specimen.            Vitamin B12 Measurement
A count of the atypical lymphocytes per unit of a biological     Atypical Lymphocyte Count
specimen.
A relative measure (ratio or percentage) of the atypical         Atypical Lymphocyte To
lymphocytes to leukocytes in a biological specimen.              Leukocyte Ratio
A relative measure (ratio or percentage) of the lymphocytes to   Lymphocyte To Leukocyte Ratio
leukocytes in a biological specimen.
A count of the macrocytes per unit of a biological specimen.     Macrocyte Count

A count of the microcytes per unit of a biological specimen.     Microcyte Count

A count of the monocytes per unit of a biological specimen.      Monocyte Count

A relative measure (ratio or percentage) of the monocytes to     Monocyte To Leukocyte Ratio
leukocytes in a biological specimen.
A relative measure (ratio or percentage) of the myeloblasts to   Myeloblast To Leukocyte Ratio
leukocytes in a biological specimen.
A relative measure (ratio or percentage) of the myelocytes to    Myelocyte To Leukocyte Ratio
leukocytes in a biological specimen.
The determination of the ratio of neutrophils compared to        Neutrophil To Leukocyte Ratio
leukocytes in a blood sample. The measurement may be
expressed as a ratio or percentage.
A relative measure (ratio or percentage) of reticulocytes to     Reticulocyte To Erythrocyte Ratio
erythrocytes in a biological specimen.
A relative measure (ratio or percentage) of prolymphocytes to    Prolymphocyte To Leukocyte
leukocytes in a biological specimen.                             Ratio
A count of the banded neutrophils per unit of a biological       Neutrophil Band Form Count
specimen.
A relative measure (ratio or percentage) of the banded           Neutrophil Band Form To
neutrophils to leukocytes in a biological specimen.              Leukocyte Ratio
A ratio of the density of a fluid to the density of water.       Specific Gravity
A measurement of the magnesium in a biological specimen.         Magnesium Measurement

A measurement of the gamma glutamyl transpeptidase in a          Gamma Glutamyl
biological specimen.                                             Transpeptidase Measurement
A measurement of the hemoglobin in a biological specimen.        Hemoglobin Measurement
A measurement of the glycosylated hemoglobin in a biological      Glycosylated Hemoglobin
specimen.                                                         Measurement
A measurement of the surface antigen reaction of a biological     Hepatitis B Virus Surface Antigen
specimen to the Hepatitis B virus.                                Measurement
A measurement of the Choriogonadotropin Beta in a                 Choriogonadotropin Beta
biological specimen.                                              Measurement
A measurement of the potassium in a biological specimen.          Potassium Measurement

A measurement of the ketones in a biological specimen.            Ketone Measurement
A measurement of the lactate dehydrogenase in a biological        Lactate Dehydrogenase
specimen.                                                         Measurement
A measurement of the enzyme which indicates the presence          Leukocyte Esterase
of white blood cells in a biological specimen.                    Measurement
A measurement of the phosphate in a biological specimen.          Phosphate Measurement

A measurement of a group of complex organic                       Total Protein Measurement
macromolecules composed of one or more alpha-L-amino
acid chains in a biological specimen.
A measurement of the prostate specific antigen in a biological    Prostate Specific Antigen
specimen.                                                         Measurement
A measurement of the volume of serum or plasma that would         Creatinine Clearance
be cleared of creatinine by excretion of urine for a specified
unit of time (e.g. one minute).
A measurement of the hairy cells (b-cell lymphocytes with         Hairy Cell Count
hairy projections from the cytoplasm) in a biological specimen.

A measurement of the blast cells in a biological specimen.        Blast Count

A count of the CD19 B cells per unit of a biological specimen. CD19 Expressing B Cell Count

A count of the CD3 T cells per unit of a biological specimen.     CD3 Expressing T Cell Count

A count of the CD4 T cells per unit of a biological specimen.     CD4 Expressing T Cell Count

A count of the CD8 T cells per unit of a biological specimen.     CD8 Expressing T Cell Count

A measurement of the Dohle bodie (blue-gray, basophilic,          Dohle Body Measurement
leukocyte inclusions located in the peripheral cytoplasm of
neutrophils) in a biological specimen.
The distance (e.g. millimeters) that red blood cells settle in    Erythrocyte Sedimentation Rate
unclotted blood over a specified unit of time (e.g. one hour).    Measurement

A measurement of the hypersegmented (more than five               Hypersegmented Neutrophil
lobes) neutrophils in a biological specimen.                      Measurement
A measurement of the malignant lymphocytes in a biological        Lymphoma Cell Count
specimen.
A measurement of the amount of May-Hegglin anomaly                May-Hegglin Anomaly
present in a blood sample.                                        Measurement
A measurement of the metamyelocytes (small, myelocytic            Metamyelocyte Count
neutrophils with an indented nucleus) in a biological
specimen.
A measurement of the Pappenheimer Bodies (violet or blue           Pappenheimer Body Count
staining, ferritin granules usually found along the periphery of
the red blood cells) in a biological specimen.
A measurement of the amount of Pelger Huet anomaly                 Pelger Huet Anomaly
present in a biological specimen.                                  Measurement
A measurement of the plasmacytoid lymphocytes                      Plasmacytoid Lymphocyte Count
(lymphocytes with peripherally clumped chromatin and often
deep blue cytoplasm, and that appear similar to plasma cells)
in a biological specimen.
A measurement of the precursor (blast stage) plasma cells          Precursor Plasma Cell Count
(antibody secreting cells derived from B cells via antigen
stimulation) in a biological specimen.
A measurement of the prolymphocytes in a biological                Prolymphocyte Count
specimen.
A measurement of the promonocytes per unit of a biological         Promonocyte Count
specimen.
A measurement of the promyelocytes (immature myelocytes)           Promyelocyte Count
in a biological specimen.
A measurement of the number of stacking red blood cells            Rouleaux Formation Count
within a biological specimen.
A measurement of the Sezary cells (atypical lymphocytes with       Sezary Cell Count
cerebriform nuclei) in a biological specimen.
A measurement of the sickle cells (sickle shaped red blood         Sickle Cell Count
cells) in a biological specimen.
A measurement of the smudge cells (the nuclear remnant of a        Smudge Cell Count
ruptured white blood cell) in a biological specimen.
A measurement of the neutrophils containing small vacuoles         Vacuolated Neutrophil Count
in a biological specimen.
A measurement of the leukemic blasts (lymphoblasts that            Leukemic Blast Count
remain in an immature state even when outside the bone
marrow) in a biological specimen.

A measurement of the monoblast cells per unit of a biological      Monoblast Count
specimen.
A measurement of the myeloblast cells per unit of a biological     Myeloblast Count
specimen.
A relative measurement (ratio or percentage) of acanthocytes       Acanthocyte to Erythrocyte Ratio
to all erythrocytes in a biological specimen.                      Measurement
A relative measurement (ratio or percentage) of bite cells         Bite Cell to Erythrocyte Ratio
(erthrocytes with the appearance of a bite having been             Measurement
removed, due to oxidative hemolysis) to all erythrocytes in a
biological specimen .
A relative measurement (ratio or percentage) of CD19 B cells       CD19 B Cell to Lymphocyte
to all lymphocytes in a biological specimen.                       Ratio Measurement
A relative measurement (ratio or percentage) of CD3 T cells        CD3 T Cell to Lymphocyte Ratio
to all lymphocytes in a biological specimen.                       Measurement
A relative measurement (ratio or percentage) of CD4 T cells        CD4 T Cell to CD8 T Cell Ratio
to the CD8 T cells in a biological specimen.                       Measurement
A relative measurement (ratio or percentage) of CD4 T cells        CD4 T Cell to Lymphocyte Ratio
to all lymphocytes in a biological specimen.                       Measurement
A relative measurement (ratio or percentage) of CD8 T cells        CD8 T Cell to Lymphocyte Ratio
to all lymphocytes in a biological specimen.                       Measurement
A relative measurement (ratio or percentage) of the hairy cells     Hairy Cell to Lymphocyte Ratio
(b-cell lymphocytes with hairy projections from the cytoplasm)      Measurement
to all lymphocytes in a biological specimen .
A relative measurement (ratio or percentage) of the leukemic        Leukemic Blast to Lymphocyte
blasts (immature lymphoblasts) to mature lymphocytes in a           Ratio Measurement
biological specimen.
A relative measurement (ratio or percentage) of the malignant       Malignant Cell to Blood Cell
cells of all types to all blood cells in a biological specimen.     Ratio Measurement

A relative measurement (ratio or percentage) of the                 Metamyelocyte to Leukocyte
metamyelocytes (small, myelocytic neutrophils with an               Ratio Measurement
indented nucleus) to all leukocytes in a biological specimen.

A relative measurement (ratio or percentage) of monoblast           Monoblast to Leukocyte Ratio
cells to all leukocytes in a biological specimen.                   Measurement
A relative measurement (ratio or percentage) of the nucleated       Nucleated Red Blood Cell to
erythrocytes (large, immature nucleated erythrocytes) to all        Erythrocyte Ratio Measurement
erythrocytes in a biological specimen.
A relative measurement (ratio or percentage) of the                 Plasmacytoid Lymphocyte to
plasmacytoid lymphocytes (lymphocytes with peripherally             Lymphocyte Ratio Measurement
clumped chromatin and often deep blue cytoplasm, and that
appear similar to plasma cells) to all lymphocytes in a
biological specimen.
A relative measurement (ratio or percentage) of the                 Poikilocyte to Erythrocyte Ratio
poikilocytes irregularly shaped erythrocytes) to all erythrocytes   Measurement
in a biological specimen.
A relative measurement (ratio or percentage) of the precursor       Precursor Plasma Cell to
(blast stage) plasma cells (antibody secreting cells derived        Lymphocyte Ratio Measurement
from B cells via antigen stimulation) to all lymphocytes in a
biological specimen.
A relative measurement (ratio or percentage) of the                 Prolymphocyte to Lymphocyte
prolymphocytes to all lymphocytes in a biological specimen.         Ratio Measurement

A relative measurement (ratio or percentage) of the                 Promonocyte to Lymphocyte
promonocytes to all leukocytes in a biological specimen.            Ratio Measurement
A relative measurement (ratio or percentage) of the                 Promyelocyte to Lymphocyte
promyelocytes (immature myelocytes) to all leukocytes in a          Ratio Measurement
biological specimen.
A relative measurement (ratio or percentage) of the reactive        Reactive Lymphocyte to
lymphocytes (lymphocytes with peripherally clumped                  Lymphocyte Ratio Measurement
chromatin and often deep blue cytoplasm and that appear
similar to plasma cells) to all lymphocytes in a biological
specimen.
A relative measurement (ratio or percentage of the Sezary           Sezary Cell to Lymphocyte Ratio
cells (atypical lymphocytes with cerebriform nuclei) to all         Measurement
lymphocytes in a biological specimen.
A relative measurement (ratio or percentage) of the sickle          Sickle Cell to Erythrocyte Ratio
cells (sickle shaped red blood cells) to all erythrocytes in a      Measurement
biological specimen.
A measurement of the Auer rods (elongated needle structures Auer Rod Measurement
that are found in the cytoplasm of leukemic blasts and are
formed by clumps of azurophilic granular material) in a
biological specimen.
A measurement of the Helmet cells (specialized Keratocytes Helmet Cell Count
with two projections on either end that are tapered and
hornlike) in a biological specimen.
A measurement of the large, peroxidase-negative cells which Large Unstained Cell Count
cannot be further characterized (i.e. as large lymphocytes,
virocytes, or stem cells) present in a biological specimen.

A measurement of the malignant cells of all types in a            Malignant Cell Count
biological specimen.
A measurement of the mature plasma cells (plasmacytes) in a       Mature Plasma Cell Count
biological specimen.
A measurement of the myelocytes per unit of a biological          Myelocyte Count
specimen.
A measurement of the spermatozoa cells present in a               Spermatozoa Cell Count
biological specimen.
A measurement of the yeast cells present in a biological          Yeast Cell Measurement
specimen.
A measurement of the amorphous (Note: phosphate or urate,         Amorphous Crystal
depending on pH) crystals present in a biological specimen.       Measurement

A measurement of the amorphous sediment present in a              Amorphous Sediment
biological specimen.                                              Measurement
A measurement of the bicarbonate in a biological specimen         Bicarbonate Measurement

A measurement of the bilirubin crystals present in a biological   Bilirubin Crystal Measurement
specimen.
A measurement of the calcium carbonate crystals present in a      Calcium Carbonate Crystal
biological specimen.                                              Measurement
A measurement of the calcium oxalate crystals present in a        Calcium Oxalate Crystal
biological specimen.                                              Measurement
A measurement of the calcium phosphate crystals present in        Calcium Phosphate Crystal
a biological specimen.                                            Measurement
A measurement of the cholesterol crystals present in a            Cholesterol Crystal
biological specimen.                                              Measurement
A statement that indicates crystals were looked for and not       Crystal Present Or Absent
found in a biological specimen.
A measurement of the cystine crystals present in a biological     Cystine Crystal Measurement
specimen.
A measurement of the folic acid in a biological specimen.         Folic Acid Measurement
A measurement of the free carnitine in a biological specimen.     Free Carnitine Measurement

A measurement of the fructosamine in a biological specimen. Fructosamine Measurement

A measurement of the iron in a biological specimen.               Iron Measurement
A measurement of the leucine crystals present in a biological     Leucine Crystal Measurement
specimen.
A measurement of the monosodium urate crystals present in         Monosodium Urate Crystal
a biological specimen.                                            Measurement
A measurement of the total carnitine in a biological specimen. Total Carnitine Measurement

A measurement of the triple phosphate crystals present in a       Tyrosine Crystal Measurement
biological specimen.
A measurement of the uric acid crystals present in a biological   Uric Acid Crystal Measurement
specimen.
A computed estimate of the unmeasured anions (those other         Anion Gap Measurement
than the chloride and bicarbonate anions) in a biological
specimen.
A measurement of the blood in body products such as a stool       Occult Blood Measurement
sample, not detectable on gross examination.
A measurement of any amphetamine class drug present in a          Amphetamine Drug Class
biological specimen.                                              Measurement
A measurement of any barbiturate class drug present in a          Barbiturate Drug Class
biological specimen.                                              Measurement
A measurement of any cannabinoid class drug present in a          Cannabinoid Drug Class
biological specimen.                                              Measurement
A measurement of the cocaine present in a biological              Cocaine Measurement
specimen.
A measurement of the round epithelial cells present in a urine    Round Epithelial Cell Count
specimen.
A measurement of the acanthocytes per unit of a biological        Acanthocyte Count
specimen.
A measurement of the bite cells (erthrocytes with the             Bite Cell Count
appearance of a bite having been removed, due to oxidative
hemolysis) in a biological specimen .
A measurement of the Burr cells (erythrocytes characterized       Burr Cell Count
by the presence of small, blunt projections evenly distributed
across the cell surface) in a biological specimen.

A measurement of the Cabot rings (red-purple staining,           Cabot Ring Count
threadlike, ring or figure 8 shaped filaments in an erythrocyte)
in a biological specimen.
A measurement of the Burr cells (erythrocytes characterized Crenated Cell Measurement
by the presence of multiple small, sharp projections evenly
distributed across the cell surface) in a biological specimen.

A measurement of the Howell-Jolly bodies (spherical, blue-        Howell-Jolly Body Measurement
black condensed DNA inclusions within the body of a red
blood cell that appear under Wright-stain) in a biological
specimen.
A measurement of the nucleated erythrocytes (large,               Nucleated Red Blood Cell Count
immature nucleated erythrocytes) in a biological specimen.

A measurement of the schistocytes (fragmented red blood    Schistocyte Count
cells) in a biological specimen.
A measurement of the spherocytes (small, sphere-shaped red Spherocyte Count
blood cells) in a biological specimen.
A measurement of the stomatocytes (red blood cells with an Stomatocyte Count
oval or rectangular area of central pallor, producing the
appearance of a cell mouth) in a biological specimen.
A measurement of the Heinz bodies (small round inclusions        Heinz-Ehrlich Body
within the body of a red blood cell) in a biological specimen.   Measurement

A measurement of the surface antibody reaction of a              Hepatitis A Surface Antibody
biological specimen to the Hepatitis A virus.                    Measurement
A measurement of the surface antibody reaction of a              Hepatitis B Surface Antibody
biological specimen to the Hepatitis B virus.                    Measurement
A measurement of the surface antibody reaction of a              Hepatitis C Surface Antibody
biological specimen to the Hepatitis C virus.                    Measurement
A measurement of the antibody reaction of a biological           HIV-1 Antibody Measurement
specimen to the HIV-1 virus.
A measurement of the antibody reaction of a biological           HIV-1 HIV-2 Antibody
specimen to the either the HIV-1 or HIV-2 virus.                 Measurement
A measurement of the antibody reaction of a biological           HIV-2 Antibody Measurement
specimen to the HIV-2 virus.
A measurement of the antibodies produced by cellular             Rapid Plasma Reagin
damage caused by Treponema pallidum (syphilis) in a              Measurement
biological specimen.
A measurement of the rheumatoid factor antibody in a             Rheumatoid Factor
biological specimen.                                             Measurement
A measurement of the amount of iron needed to fully saturate     Total Iron Binding Capacity
the transferrin in a serum specimen.
A measurement of the binding capacity of unsaturated iron in     Unsaturated Iron Binding
a biological specimen.                                           Capacity Measurement
A measurement of the mucous threads present in a biological      Mucous Thread Measurement
specimen.
A measurement of the opacity of a biological specimen.           Turbidity Measurement
A measurement of the hepatitis A viral load in a biological      Hepatitis A Viral Load PCR
specimen using polymerase chain reaction.                        Measurement
A measurement of the hepatitis B viral load in a sample using    Hepatitis B Viral Load PCR
polymerase chain reaction.                                       Measurement
A measurement of the hepatitis C viral load in a sample using    Hepatitis C Viral Load PCR
polymerase chain reaction.                                       Measurement
A measurement of the HIV viral load in a specimen using          HIV Viral Load PCR
polymerase chain reaction.                                       Measurement
A measurement of the giant (larger than 7um in diameter)         Giant Platelet Count
platelets in a biological specimen.
A measurement of the large (between 4 um and 7um in              Large Platelet Count
diameter) platelets in a biological specimen.
A measurement of the average size of the platelets present in    Mean Platelet Volume
a blood sample.                                                  Measurement
A measurement of the aldolase enzyme in a biological             Aldolase Measurement
specimen.
A measurement of the alpha fetoprotein in a biological           Alpha-fetoprotein Measurement
specimen.
A measurement of the apolipoprotein A1 in the high density       Apolipoprotein A1 Measurement
lipoproteins of a biological specimen.
A measurement of the apolipoprotein B in the low density         Apolipoprotein B Measurement
lipoproteins of a biological specimen.
A measurement of the brain (B-type) natriuretic peptide in a     Brain Natriuretic Peptide
biological specimen.                                             Measurement
A measurement of the C (connecting) peptide of insulin in a      C-peptide Measurement
biological specimen.
A measurement of the ferritin in a biological specimen.          Ferritin Measurement
A measurement of the globulin protein in a biological            Globulin Protein Measurement
specimen.
A measurement of the glutamate in a biological specimen.         Glutamate Measurement
A measurement of the haptoglobin protein in a biological         Haptoglobin Protein
specimen.                                                        Measurement
A measurement of the homocysteine amino acid in a                Homocysteine Acid
biological specimen.                                             Measurement
A measurement of the N-telopeptide in a biological specimen.     N-telopeptide Measurement

A measurement of the osteocalcin in a biological specimen.       Osteocalcin Measurement

A measurement of the sex hormone binding (globulin) protein Sex Hormone Binding Protein
in a biological specimen.                                   Measurement

A measurement of the thyroxine binding globulin protein in a     Thyroxine Binding Globulin
biological specimen.                                             Protein Measurement
A measurement of the total (free and bound) triiodothyronine     Triiodothyronine Measurement
in a biological specimen.
A measurement of the binding of triiodothyonine to thyroxine     Triiodothyronine Uptake
binding globulin protein in a biological specimen.               Measurement
A measurement of the actin binding troponin in a biological      Troponin I Measurement
specimen.
A measurement of the tropomyosin binding troponin in a           Troponin T Measurement
biological specimen.
A measurement of the total tumor necrosis factor (cachexin)      Tumor Necrosis Factor
cytokine in a biological specimen.                               Measurement
A relative measurement (ratio or percentage) (ratio) of the      Blood Urea Nitrogen To
blood urea nitrogen (BUN) to the creatinine in a blood           Creatinine Ratio Measurement
specimen.
A measurement of the hippuric acid crystals present in a urine   Hippuric Acid Crystal
specimen.                                                        Measurement
A measurement of the sulfa crystals present in a urine           Sulfa Crystal Measurement
specimen.
A measurement of the triple phosphate crystals present in a      Triple Phosphate Crystal
urine specimen.                                                  Measurement
A measurement of the unclassifiable crystals present in a        Unclassified Crystal
urine specimen.                                                  Measurement
A measurement of the ammonium biurate crystals present in        Urine Ammonium Biurate Crystal
a biological specimen.                                           Measurement
A measurement of the ammonium oxalate crystals present in        Urine Ammonium Oxalate
a urine specimen.                                                Crystal Measurement
A relative measurement (ratio or percentage) of the albumin      Albumin To Creatinine Protein
to the creatinine in a urine specimen.                           Ratio Measurement

A measurement of the bacterial casts present in a urine          Bacterial Cast Measurement
specimen.
A statement that indicates casts were looked for and not         Cast Present Or Absent
found in a biological specimen.
A measurement of the cellular (white blood cell, red blood cell, Cellular Cast Measurement
epithelial and bacterial) casts present in a urine specimen.

A measurement of the coarse granular casts present in a       Coarse Granular Cast
urine specimen.                                               Measurement
A measurement of the fatty casts present in a urine specimen. Fatty Cast Measurement

A measurement of the fine granular casts present in a urine     Fine Granular Cast
specimen.                                                       Measurement
A measurement of the granular (course and fine) casts           Granular Cast Measurement
present in a urine specimen.
A measurement of the fine granular casts present in a urine     Granular Fine Cast
specimen.                                                       Measurement
A measurement of the hyaline casts present in a urine           Hyaline Cast Measurement
specimen.
A measurement of the mixed (the cast contains a mixture of      Mixed Cast Count
cell types) casts present in a urine specimen.
A measurement of the red blood cell casts present in a urine    Red Blood Cell Cast
specimen.                                                       Measurement
A measurement of the squamous epithelial cells present in a     Squamous Epithelial Cell Count
urine specimen.
A measurement of the squamous transitional epithelial cells     Squamous Transitional Epithelial
present in a urine specimen.                                    Cell Count

A measurement of the tubular epithelial cells present in a      Tubular Epithelial Cell Count
urine specimen.
A measurement of the unclassifiable casts present in a urine    Unclassified Cast Measurement
specimen.
A measurement of the waxy casts present in a urine              Waxy Cell Cast Measurement
specimen.
A measurement of the white blood cell casts present in a        White Blood Cell Cast
urine specimen.                                                 Measurement
A measurement of the epithelial cell casts present in a urine   Epithelial-Cast Measurement
specimen.
A measurement of the adrenocorticotropic hormone in a           Adrenocorticotropic Hormone
biological specimen.                                            Measurement
A measurement of the cortisol in a biological specimen.         Cortisol Measurement
A measurement of the estradiol in a biological specimen.        Estradiol Measurement
A measurement of the follicle stimulating hormone (FSH) in a    Follicle Stimulating Hormone
biological specimen.                                            Measurement
A measurement of the fragmented parathyroid hormone in a        Fragmented Parathyroid
biological specimen.                                            Hormone Measurement
A measurement of the free testosterone in a biological          Free Testosterone Measurement
specimen.
A measurement of the free thyroxine in a biological specimen.   Free Thyroxine Measurement

A measurement of the free triiodothyronine in a biological      Free Triiodothyronine
specimen.                                                       Measurement
A measurement of the insulin in a biological specimen.          Insulin Measurement
A measurement of the intact parathyroid hormone in a            Intact Parathyroid Hormone
biological specimen.                                            Measurement
A measurement of the luteinizing hormone in a biological        Luteinizing Hormone
specimen.                                                       Measurement
A measurement of the progesterone hormone in a biological       Progesterone Measurement
specimen.
A measurement of the somatotropin (growth) hormone in a         Somatotropin Measurement
biological specimen.
A measurement of the total (free and bound) testosterone in a   Total Testosterone
biological specimen.                                            Measurement
A measurement of the total (free and bound) thyroxine in a      Total Thyroxine Measurement
biological specimen.
A measurement of any opiate class drug present in a             Opiate Measurement
biological specimen.
A relative measurement (ratio or percentage) of the malignant   Lymphoma Cell to Lymphocyte
lymphocytes to all lymphocytes in a biological specimen.        Ratio Measurement

A relative measurement (ratio or percentage) of the mature      Mature Plasma Cell to
plasma cells (plasmacytes) to all lymphocytes in a biological   Lymphocyte Ratio Measurement
specimen.
A measurement of the ammonium acid urate crystals present       Acid Urate Crystal Measurement
in a biological specimen.
A measurement of the anti-double stranded DNA antibody in       Anti-Double Stranded DNA
a biological specimen.                                          Measurement
A measurement of the antinuclear antibodies (antibodies that    Antinuclear Antibody
attack the body's own tissue) in a biological specimen.         Measurement

A measurement of the 5'-nucleotidase in a biological            5 Prime Nucleotidase
specimen.                                                       Measurement

A measurement of the 6-monoacetylmorphine present in a          6-Monoacetylmorphine
biological specimen.                                            Measurement
A measurement of the acetylcholine hormone in a biological      Acetylcholine Measurement
specimen.
A measurement of the adiponectin hormone in a biological        Adiponectin Measurement
specimen.
The ratio of albumin to globulin in a blood specimen.           Albumin to Globulin Ratio
                                                                Measurement
A measurement of the aldosterone hormone in a biological        Aldosterone Measurement
specimen.
A relative measurement (ratio or percentage) of the alkaline    Alkaline Phosphatase to
phosphatase to creatinine in a biological specimen.             Creatinine Ratio Measurement

A measurement of the alpha form of glutathione S-transferase    Alpha Glutathione-S-Transferase
in a biological specimen.                                       Measurement
A measurement of the ammonia in a biological specimen.          Ammonia Measurement
A measurement of the androstenediol metabolite in a             Androstenediol Metabolite
biological specimen.                                            Measurement
A measurement of the androstenedione hormone in a               Androstenedione Measurement
biological specimen.
A measurement of the angiotensin I hormone in a biological      Angiotensin I Measurement
specimen.
A measurement of the angiotensin II hormone in a biological     Angiotensin II Measurement
specimen.
A measurement of the angiotensinogen hormone in a                 Angiotensinogen Measurement
biological specimen.
A measurement of any antidepressant class drug present in a       Antidepressant Measurement
biological specimen.
A measurement of the antidiuretic hormone in a biological         Antidiuretic Hormone Measurement
specimen.
A measurement of the atrial natriuretic peptide in a biological   Atrial Natriuretic Peptide
specimen.                                                         Measurement
A measurement of any benzodiazepine class drug present in         Benzodiazepine Measurement
a biological specimen.
A measurement of the total bile acids in a biological             Bile Acid Measurement
specimen.
A relative measurement of the bite cells (erythrocytes with the   Bite Cell To Erythrocyte Ratio
appearance of a bite having been removed, due to oxidative        Measurement
hemolysis) to all erythrocytes in a biological specimen.

A measurement of the calcitonin hormone in a biological           Calcitonin Measurement
specimen.
A measurement of the calcitriol hormone in a biological           Calcitriol Measurement
specimen.
A relative measurement (ratio or percentage) of the calcium to    Calcium to Creatinine Ratio
creatinine in a biological specimen.                              Measurement
A relative measurement (ratio or percentage) of the chloride      Chloride to Creatinine Ratio
to creatinine in a biological specimen.                           Measurement
A measurement of the cholecystokinin hormone in a biological      Cholecystokinin Measurement
specimen.
A measurement of the codeine present in a biological              Codeine Measurement
specimen.
A measurement of corticosterone in a biological specimen.         Corticosterone Measurement

A measurement of the corticotropin releasing hormone in a         Corticotropin Releasing Hormone
biological specimen.                                              Measurement

A relative measurement (ratio or percentage) of the BB-type       Creatine Kinase BB to Total
creatine kinase to total creatine kinase in a biological          Creatine Kinase Ratio
specimen.                                                         Measurement
A relative measurement (ratio or percentage) of the MB-type       Creatine Kinase MB to Total
creatine kinase to total creatine kinase in a biological          Creatine Kinase Ratio
specimen.                                                         Measurement
A relative measurement (ratio or percentage) of the MM-type       Creatine Kinase MM to Total
creatine kinase to total creatine kinase in a biological          Creatine Kinase Ratio
specimen.                                                         Measurement
A measurement of the dehydroepiandrosterone hormone in a          Dehydroepiandrosterone
biological specimen.                                              Measurement
A measurement of the deoxypyridinoline in a biological            Deoxypyridinoline Measurement
specimen.
A relative measurement (ratio or percentage) of the               Deoxypyridinoline to Creatinine
deoxypyridinoline to creatinine in a biological specimen.         Ratio Measurement
A measurement of the dihydrocodeine present in a biological       Dihydrocodeine Measurement
specimen.
A measurement of the dihydrotestosterone hormone in a             Dihydrotestosterone Measurement
biological specimen.
A measurement of the dopamine hormone in a biological          Dopamine Measurement
specimen.
A measurement of the epinephrine hormone in a biological       Epinephrine Measurement
specimen.
A measurement of the erythropoietin hormone in a biological    Erythropoietin Measurement
specimen.
A measurement of the estriol hormone in a biological           Estriol Measurement
specimen.
A measurement of the estrone hormone in a biological           Estrone Measurement
specimen.
A measurement of the ethanol present in a biological           Ethanol Measurement
specimen.
A relative measurement (ratio or percentage) of the gamma      Gamma Glutamyl Transferase to
glutamyl transferase to creatinine in a biological specimen.   Creatinine Ratio Measurement

A measurement of the gastrin hormone in a biological           Gastrin Measurement
specimen.
A measurement of the glucagon hormone in a biological          Glucagon Measurement
specimen.
A relative measurement (ratio or percentage) of the glucose    Glucose to Creatinine Ratio
to creatinine in a biological specimen.                        Measurement
A measurement of the glutamate dehydrogenase in a              Glutamate Dehydrogenase
biological specimen.                                           Measurement
A relative measurement (ratio or percentage) of the            Glutathione-S-Transferase to
glutathione S-transferase to creatinine in a biological        Creatinine Ratio Measurement
specimen.
A measurement of the gonadotropin releasing hormone in a       Gonadotropin Releasing Hormone
biological specimen.                                           Measurement



A measurement of the growth hormone inhibiting hormone in      Growth Hormone Inhibiting Hormone
a biological specimen.                                         Measurement
A measurement of the growth hormone in a biological            Growth Hormone Measurement
specimen.
A measurement of the growth hormone releasing hormone in       Growth Hormone Releasing
a biological specimen.                                         Hormone Measurement
A measurement of the homovanillic acid metabolite in a         Homovanillic Acid Measurement
biological specimen.
A measurement of the hydrocodone present in a biological       Hydrocodone Measurement
specimen.
A measurement of the hydromorphone present in a biological     Hydromorphone Measurement
specimen.
A measurement of the insulin-like growth factor-1 in a         Insulin Like Growth Factor-1
biological specimen.                                           Measurement
A measurement of the insulin-like growth factor-2 in a         Insulin Like Growth Factor-2
biological specimen.                                           Measurement
A measurement of the interleukin 1 in a biological specimen.   Interleukin 1 Measurement

A measurement of the interleukin 10 in a biological specimen. Interleukin 10 Measurement

A measurement of the interleukin 11 in a biological specimen. Interleukin 11 Measurement
A measurement of the interleukin 12 in a biological specimen. Interleukin 12 Measurement

A measurement of the interleukin 13 in a biological specimen. Interleukin 13 Measurement

A measurement of the interleukin 14 in a biological specimen. Interleukin 14 Measurement

A measurement of the interleukin 15 in a biological specimen. Interleukin 15 Measurement

A measurement of the interleukin 16 in a biological specimen. Interleukin 16 Measurement

A measurement of the interleukin 17 in a biological specimen. Interleukin 17 Measurement

A measurement of the interleukin 18 in a biological specimen. Interleukin 18 Measurement

A measurement of the interleukin 19 in a biological specimen. Interleukin 19 Measurement

A measurement of the interleukin 2 in a biological specimen.   Interleukin 2 Measurement

A measurement of the interleukin 20 in a biological specimen. Interleukin 20 Measurement

A measurement of the interleukin 21 in a biological specimen. Interleukin 21 Measurement

A measurement of the interleukin 22 in a biological specimen. Interleukin 22 Measurement

A measurement of the interleukin 23 in a biological specimen. Interleukin 23 Measurement

A measurement of the interleukin 24 in a biological specimen. Interleukin 24 Measurement

A measurement of the interleukin 25 in a biological specimen. Interleukin 25 Measurement

A measurement of the interleukin 26 in a biological specimen. Interleukin 26 Measurement

A measurement of the interleukin 27 in a biological specimen. Interleukin 27 Measurement

A measurement of the interleukin 28 in a biological specimen. Interleukin 28 Measurement

A measurement of the interleukin 29 in a biological specimen. Interleukin 29 Measurement

A measurement of the interleukin 3 in a biological specimen.   Interleukin 3 Measurement

A measurement of the interleukin 30 in a biological specimen. Interleukin 30 Measurement

A measurement of the interleukin 31 in a biological specimen. Interleukin 31 Measurement

A measurement of the interleukin 32 in a biological specimen. Interleukin 32 Measurement

A measurement of the interleukin 33 in a biological specimen. Interleukin 33 Measurement

A measurement of the interleukin 4 in a biological specimen.   Interleukin 4 Measurement

A measurement of the interleukin 5 in a biological specimen.   Interleukin 5 Measurement
A measurement of the interleukin 6 in a biological specimen.   Interleukin 6 Measurement

A measurement of the interleukin 7 in a biological specimen.   Interleukin 7 Measurement

A measurement of the interleukin 8 in a biological specimen.   Interleukin 8 Measurement

A measurement of the interleukin 9 in a biological specimen.   Interleukin 9 Measurement

A measurement of the lactate dehydrogenase isoenzyme 1 in      Lactate Dehydrogenase Isoenzyme
a biological specimen.                                         1 Measurement
A measurement of the lactate dehydrogenase isoenzyme 2 in      Lactate Dehydrogenase Isoenzyme
a biological specimen.                                         2 Measurement
A measurement of the lactate dehydrogenase isoenzyme 3 in      Lactate Dehydrogenase Isoenzyme
a biological specimen.                                         3 Measurement
A measurement of the lactate dehydrogenase isoenzyme 4 in      Lactate Dehydrogenase Isoenzyme
a biological specimen.                                         4 Measurement
A measurement of the lactate dehydrogenase isoenzyme 5 in      Lactate Dehydrogenase Isoenzyme
a biological specimen.                                         5 Measurement
A relative measurement (ratio or percentage) of the lactate    Lactate Dehydrogenase to
dehydrogenase to creatinine in a biological specimen.          Creatinine Ratio Measurement
A measurement of the lactic acid in a biological specimen.     Lactic Acid Measurement


A relative measure (ratio or percentage) of the large          Large Unstained Cells to
unstained cells to leukocytes in a biological specimen.        Leukocytes Ratio Measurement

A relative measurement (ratio or percentage) of the lactate    LDH Isoenzyme 1 to LDH Ratio
dehydrogenase isoenzyme 1 to total lactate dehydrogenase in    Measurement
a biological specimen.
A relative measurement (ratio or percentage) of the lactate    LDH Isoenzyme 2 to LDH Ratio
dehydrogenase isoenzyme 2 to total lactate dehydrogenase in    Measurement
a biological specimen.
A relative measurement (ratio or percentage) of the lactate    LDH Isoenzyme 3 to LDH Ratio
dehydrogenase isoenzyme 3 to total lactate dehydrogenase in    Measurement
a biological specimen.
A relative measurement (ratio or percentage) of the lactate    LDH Isoenzyme 4 to LDH Ratio
dehydrogenase isoenzyme 4 to total lactate dehydrogenase in    Measurement
a biological specimen.
A relative measurement (ratio or percentage) of the lactate    LDH Isoenzyme 5 to LDH Ratio
dehydrogenase isoenzyme 5 to total lactate dehydrogenase in    Measurement
a biological specimen.
A measurement of the leptin hormone in a biological            Leptin Measurement
specimen.
A relative measurement (ratio or percentage) of the            Magnesium to Creatinine Ratio
magnesium to creatinine in a biological specimen.              Measurement
A measurement of the melatonin hormone in a biological         Melatonin Measurement
specimen.
A measurement of the methadone present in a biological         Methadone Measurement
specimen.
A measurement of the methaqualone present in a biological      Methaqualone Measurement
specimen.
A measurement of the morphine present in a biological            Morphine Measurement
specimen.
A measurement of the mu form of glutathione S-transferase in     Mu Glutathione-S-Transferase
a biological specimen.                                           Measurement
A relative measurement (ratio or percentage) of the mu           Mu Glutathione-S-Transferase to
gamma glutamyl transpeptidase to creatinine in a biological      Creatinine Ratio Measurement
specimen.
A measurement of myoglobin in a biological specimen.             Myoglobin Measurement
A measurement of N-acetyl glucosamide in a biological            N-Acetyl Glucosamide
specimen.                                                        Measurement
A relative measurement (ratio or percentage) of the N-acetyl     N-Acetyl Glucosamide to
glucosamide to creatinine in a biological specimen.              Creatinine Ratio Measurement
A measurement of the neuropeptide Y in a biological              Neuropeptide Y Measurement
specimen.
A measurement of the norepinephrine hormone in a biological      Noradrenaline Measurement
specimen.
A measurement of the osmoles of solute per unit of biological    Osmolality Measurement
specimen.
A measurement of the oxycodone present in a biological           Oxycodone Measurement
specimen.
A measurement of the oxytocin hormone in a biological            Oxytocin Measurement
specimen.
A measurement of the phencyclidine present in a biological       Phencyclidine Measurement
specimen.
A measurement of the phenothiazine present in a biological       Phenothiazine Measurement
specimen.
A relative measurement (ratio or percentage) of the              Phosphate to Creatinine Ratio
phosphate to creatinine in a biological specimen.                Measurement
A relative measurement (ratio or percentage) of the              Potassium to Creatinine Ratio
potassium to creatinine in a biological specimen.                Measurement
A measurement of the prolactin hormone in a biological           Prolactin Measurement
specimen.
A measurement of the propoxyphene present in a biological        Propoxyphene Measurement
specimen.
A relative measurement (ratio or percentage) of the protein to   Protein to Creatinine Ratio
creatinine in a biological specimen.                             Measurement
A measurement of the pseudoephedrine present in a                Pseudoephedrine Measurement
biological specimen.
A measurement of the reactive lymphocytes (lymphocytes           Reactive Lymphocyte Count
which have become large due to an antigen reaction) in a         Measurement
biological specimen.
A measurement of the renin in a biological specimen.             Renin Measurement
A measurement of the secretin hormone in a biological            Secretin Measurement
specimen.
A measurement of the serotonin hormone in a biological           Serotonin Measurement
specimen.
A relative measurement (ratio or percentage) of the sodium to    Sodium to Creatinine Ratio
creatinine in a biological specimen.                             Measurement
A measurement of the sorbitol dehydrogenase in a biological      Sorbitol Dehydrogenase
specimen.                                                        Measurement
A measurement of the thrombopoietin hormone in a biological      Thrombopoietin Measurement
specimen.
A measurement of the thyrotropin releasing hormone in a          Thyrotropin Releasing Hormone
biological specimen.                                             Measurement

A measurement of the vanillyl mandelic acid metabolite in a      Vanillyl Mandelic Acid Measurement
biological specimen.
A measurement of the Vitamin A in a biological specimen.         Vitamin A Measurement
A measurement of the thiamine in a biological specimen.          Vitamin B1 Measurement
A measurement of the Vitamin B17 in a serum specimen.            Vitamin B17 Measurement
A measurement of the riboflavin in a biological specimen.        Vitamin B2 Measurement
A measurement of the niacin in a biological specimen.            Vitamin B3 Measurement
A measurement of the Vitamin B5 in a biological specimen.        Vitamin B5 Measurement

A measurement of the Vitamin B6 in a biological specimen.        Vitamin B6 Measurement

A measurement of the Vitamin B7 in a biological specimen.        Vitamin B7 Measurement

A measurement of the Vitamin C in a biological specimen.         Vitamin C Measurement
A measurement of the Vitamin D2 in a biological specimen.        Vitamin D2 Measurement

A measurement of the Vitamin D3 in a biological specimen.        Vitamin D3 Measurement

A measurement of the Vitamin E in a biological specimen.         Vitamin E Measurement
A measurement of the Vitamin K in a biological specimen.         Vitamin K Measurement
A measurement of the volume of a biological specimen.            Volume Measurement
The terminology that includes terms pertaining to frequency      CDISC SDTM Frequency
within CDISC.                                                    Terminology
Different than the one(s) previously specified or mentioned.     Other
(NCI)
Not known, not observed, not recorded, or refused. (NCI)         Unknown
Remain in force or carry on without letup; keep or maintain in   Continue
unaltered condition; exist in time or space without stop or
interruption. (NCI)
Two times per day, at unspecified times. (NCI)                   Twice Daily
Two times per week. (NCI)                                        Twice Weekly
Every month. (NCI)                                               Monthly
As needed. (NCI)                                                 As Necessary
Every ten hours. (NCI)                                           Every Ten Hours
Every eleven hours. (NCI)                                        Every Eleven Hours
Every twelve hours. (NCI)                                        Every Twelve Hours
Every thirteen hours. (NCI)                                      Every Thirteen Hours
Every fourteen hours. (NCI)                                      Every Fourteen Hours
Every fifteen hours. (NCI)                                       Every Fifteen Hours
Every sixteen hours. (NCI)                                       Every Sixteen Hours
Every seventeen hours. (NCI)                                     Every Seventeen Hours
Every eighteen hours. (NCI)                                      Every Eighteen Hours
Every nineteen hours. (NCI)                                      Every Nineteen Hours
Every hour. (NCI)                                                Every Hour
Every twenty hours. (NCI)                                        Every Twenty Hours
Every twenty-one hours. (NCI)                                    Every Twenty-One Hours
Every twenty-two hours. (NCI)                                    Every Twenty-Two Hours
Every twenty-three hours. (NCI)                                  Every Twenty-Three Hours
Every twenty-four hours. (NCI)                                  Every Twenty-Four Hours
Every two hours. (NCI)                                          Every Two Hours
Every three hours. (NCI)                                        Every Three Hours
Every four hours. (NCI)                                         Every Four Hours
Every five hours. (NCI)                                         Every Five Hours
Every six hours. (NCI)                                          Every Six Hours
Every seven hours. (NCI)                                        Every Seven Hours
Every eight hours. (NCI)                                        Every Eight Hours
Every nine hours. (NCI)                                         Every Nine Hours
Every other day. (NCI)                                          Every Other Day
Three times per day. (NCI)                                      Three Times Daily
Three times per week. (NCI)                                     Three Times Weekly
Every four weeks. (NCI)                                         Every Four Weeks
Four times per day. (NCI)                                       Four Times Daily
Four times per week. (NCI)                                      Four Times Weekly
Every three days. (NCI)                                         Every Three Days
Every four days. (NCI)                                          Every Four Days
Every three weeks. (NCI)                                        Every Three Weeks
Every two months. (NCI)                                         Every Two Months
Every three months. (NCI)                                       Every Three Months
Every four months. (NCI)                                        Every Four Months
A one time intervention. (NCI)                                  Once
Every week. (NCI)                                               Weekly
Every five days. (NCI)                                          Every Five Days
Every two weeks. (NCI)                                          Every Two Weeks
Twice per month. (NCI)                                          Twice Per Month
Periodically stoping and starting. (NCI)                        Intermittent
Terminology codelist used with Body Position within CDISC.      CDISC SDTM Body Position
                                                                Terminology

The state or act of one who sits; the posture of one who        Sitting
occupies a seat. (NCI)
An anterior recumbent body position whereby the person lies     Prone Position
on its stomach and faces downward. (NCI)
The act of assuming or maintaining an erect upright position.   Standing
(NCI)
A posterior recumbent body position whereby the person lies     Supine Position
on its back and faces upward. (NCI)
A supine position with the person inclined at an angle of 45    Trendelenburg
degrees so that the pelvis is higher than the head. (NCI)

A supine position with the person inclined at an angle of 45    Reverse Trendelenburg
degrees so that the head is higher than the pelvis. (NCI)
A recumbent right lateral side position. (NCI)                  Right Lateral Decubitus Position

A recumbent left lateral side position. (NCI)                 Left Lateral Decubitus Position
A semi-sitting position whereby the head of an adjustable bed Fowler's Position
is elevated to the desired height, about 60-90 cm, to produce
angulation of the body, usually 45 degrees to 60 degrees.
Knees may or may not be bent. (NCI)
A semi-sitting or semi-reclined body position whereby the            Semi-Fowler's Position
head is elevated on an angle of approximately 30 degrees.
(NCI)
Terminology codelist used with ECG Findings and                      CDISC SDTM ECG Finding
Abnormalities within CDISC.                                          Terminology
A heart rate of more than 100 beats per minute, with its origin      Sinus Tachycardia
in the sinus node. (NCI)
A heart rate of less than 60 beats per minute, with its origin in    Sinus Bradycardia
the sinus node. (NCI)
A ventricular arrhythmia characterized by syncopal episodes          Long QT Syndrome
and a long QT interval, sometimes leading to sudden death
due to paroxysmal ventricular arrhythmia. This arrhythmia is
associated with a prolongation of repolarisation following
depolarization of the cardiac ventricles. The prolongation of
the Q-T interval combined with torsades de pointes manifests
as several different forms; some may be acquired or
congenital; some may lead to serious arrhythmia and sudden
cardiac death. (NCI)

A condition characterized by the activation of the whole or          Pre-Excitation Syndrome
some part of the ventricle by the transmission of an atrial
impulse along an accessory pathway rather than by way of the
normal specific conduction system which includes a delay at
the atrioventricular node. (NCI)
A supraventricular tachycardia due to reentry along a circuit        Atrioventricular Nodal Reentry
contained within the AV node. AVNRT is the most common               Tachycardia
form of supraventricular tachycardia and usually presents as a
narrow QRS complex tachycardia at a rate between 150 and
250 beats per minute. (NCI)
An automatic tachycardia originating in the atrioventricular         Junctional Tachycardia
junction, typically arising in the conduction tissues surrounding
the atrioventricular node. A junctional tachycardia tends to be
a regular, narrow complex tachycardia and usually occurs
during myocardial infarction, after heart surgery, or in digitalis
intoxication. The rate may range from 140 to 250 beats per
minute. (NCI)

A generic expression for any tachycardia that originates in the Supraventricular Tachycardia
atria or the atrioventricular node. (NCI)
A type of ventricular pre-excitation resulting from the         Wolff-Parkinson-White
activation of an accessory pathway known as the Bundle of       Syndrome
Kent. This pathway presents an abnormal electrical
communication from the atria to the ventricles. Wolff-
Parkinson-White syndrome is characterized by a short PR
interval and a long QRS interval with a delta wave. (NCI)
Any rapid heart rhythm originating in the atria. Atrial fibrillation Atrial Tachycardia
and atrial flutter are varieties of atrial tachycardia. Atrial
tachycardia is an electrical circuit originating in the upper or
atrial chambers. This electrical circuit or focus takes over and
generates rapid impulses across the atrial chambers. These
impulses are transmitted to the ventricular chambers resulting
in a rapid rate. These arrhythmias may originate from a
variety of places across the atria. They may exist as an
isolated problem or be related to an ongoing structural
problem within the heart. (NCI)

A supraventricular arrhythmia characterized by uncoordinated Atrial Fibrillation
atrial myocardium activation due to multiple reentry circuits
with consequent deterioration of atrial mechanical function.
Instead of intermittently contracting, the atria quiver
continuously in a chaotic pattern, causing a totally irregular,
often tachycardia ventricular rate. On the ECG it is described
by the replacement of consistent P waves by rapid oscillations
or fibrillatory waves that vary in size, shape, and timing,
associated with an irregular, frequently rapid ventricular
response when atrioventricular conduction is intact. (NCI)

Complete failure of atrial electrical impulse conduction        AV Block Third Degree
through the AV node to the ventricles. (NCI)
An atypical rapid polymorphic ventricular tachycardia with a    Torsades De Pointes
characteristic rotation of the QRS complex around the
isoelectric baseline. In addition the QRS complex displays a
periodic waxing and waning of amplitude on the electrogram.
(NCI)
An arrhythmia characterized by an irregular pattern of high or Ventricular Fibrillation
low-amplitude waves that cannot be differentiated into QRS
complexes or T waves. These electrocardiographic waves
occur as a result of fibrillary contractions of the ventricular
muscle due to rapid repetitive excitation of myocardial fibers
without coordinated contraction of the ventricle. (NCI)

A ventricular tachyarrhythmia characterized by a high          Ventricular Flutter
ventricular rate (180 and 250 beats per minute) with a regular
rhythm. The electrocardiogram shows large oscillating sine
wave-like complexes occurring as a result of QRS complexes
and T waves being merged. The P wave is not visible. (NCI)

A tachycardia arising distal to bundle of His, with a rate         Ventricular Tachycardia
greater than 100 beats per minute. (NCI)
An electrocardiographic finding of an organized rhythmic           Atrial Flutter
contraction of the atria which generally at a rate of 200-300
beats per minute. (NCI)
An electrocardiographic finding phenomena in which the R           R On T Phenomenon
wave occurs on top of the T wave; this can trigger ventricular
fibrillation or ventricular tachycardia. (NCI)
A delay in the time required for the conduction of an electrical AV Block First Degree
impulse through the atrioventricular (AV) node beyond 0.2
seconds; prolongation of the PR interval beyond 200
milliseconds. (NCI)
Intermittent failure of atrial electrical impulse conduction     AV Block Second Degree
through the atrioventricular (AV) node to the ventricles. (NCI)

A ventricular tachycardia in which the ventricular activation      Monomorphic Ventricular
sequence is constant. The morphology of the                        Tachycardia
electrocardiographic waveform is unchanging and is referred
to as monomorphic. (NCI)
A ventricular tachycardia in which the ventricular activation      Polymorphic Ventricular
sequence is variable. The morphology of the                        Tachycardia
electrocardiographic waveform is variable and is referred to
as polymorphic. (NCI)
Irregularity of the heartbeat due to a variation in the sinus      Sinus Arrhythmia
rhythm resulting in cyclic changes in the heart rate during
breathing. This rhythm is most commonly seen with breathing
due to fluctuations in parasympathetic vagal tone. During
inspiration stretch receptors in the lungs stimulate the
cardioinhibitory centers in the medulla via fibers in the vagus
nerve. Irregularity of the heartbeat due to a variation in the
sinus rhythm resulting in cyclic changes in the heart rate
during breathing. This rhythm is most commonly seen with
breathing due to fluctuations in parasympathetic vagal tone.
During inspiration stretch receptors in the lungs stimulate the
cardioinhibitory centers in the medulla via fibers in the vagus
nerve. (NCI)
A condition characterized by the site of origin of impulses,       Wandering Atrial Pacemaker
controlling the heart rate, changing within the atria, including
the sinus node. Variations within P waves and PR intervals
occur and an irregular rate of impulse formation is observed.
(NCI)
A failure of impulse formation in the sinus node. Sinus arrest     Sinus Arrest
is indistinguishable from third degree sinoatrial exit block on
the standard ECG. (NCI)
A derangement in the normal functioning of the sinoatrial          Sinus Node Dysfunction
node. Typically, SA node dysfunction is manifest as sinoatrial
exit block or sinus arrest, but may present as an absolute or
relative bradycardia in the presence of a stressor. It may be
associated with bradycardia-tachycardia syndrome. (NCI)

A constellation of signs and symptoms which may include            Sick Sinus Syndrome
syncope, fatigue, dizziness, and alternating periods of
bradycardia and atrial tachycardia, which is caused by
sinoatrial node dysfunction. (NCI)
A cardiac rhythm resulting from either an abnormal electrical Ectopic Atrial Rhythm
focus in the atria or intra-atrial reentry. Atrial ectopic beats
(AEB) refer to a contraction of the upper heart chamber which
occurs before it would be expected. Atrial ectopic beats are
also known as premature atrial beats, premature atrial
complex (PAC), or atrial extrasystole. (NCI)

A PR interval of less than 0.12 seconds. (NCI)                    Short PR Interval
A PR interval of more than 0.20 seconds in adults. (NCI)          Prolonged PR Interval
A type of atrioventricular dissociation characterized by atria    Isorhythmic Atrioventricular
and ventricles beating at similar rates, although                 Dissociation
independently. (NCI)
Sudden onset AV block, often associated with preexisting          Paroxysmal Atrioventricular
conduction disorders. (NCI)                                       Block
Inappropriate sinus tachycardia (IST) is a rare form of           Inappropriate Sinus Tachycardia
supraventricular tachycardia involving the sinus node, in
which a patient has an abnormally high heart rate, occurring
both at rest and in response to stressors (such as physical
activity). (NCI)
Ectopic impulses originating in the ventricles. (NCI)             Ventricular Premature Complex

Ectopic impulses originating in the atria. (NCI)                  Atrial Premature Complex

An initial slurring (delta wave) of the QRS complex due to the    EKG Delta Wave
presence of an accessory pathway. This characteristic EKG
pattern is typically seen in Wolff-Parkinson-White syndrome.
(NCI)
Two sequential ventricular premature complexes. An                Ventricular Couplet
otherwise normal finding, but possibly indicative of electrical
heart disease particularly in comparison with a single
ventricular premature complexes. (NCI)
A supraventricular tachycardia due to reentry along a circuit     Atrioventricular Reentrant
including a concealed AV nodal bypass tract. This tachycardia     Tachycardia
circuit proceeds in an antegrade fashion through the AV node
and then is conducted retrograde through the bypass tract
into the atria. (NCI)
The term accelerated idioventricular rhythm describes an          Accelerated Idioventricular
ectopic ventricular rhythm with 3 or more consecutive             Rhythm
ventricular premature beats with a rate faster than the normal
ventricular intrinsic escape rate of 30 to 40 beats per minute,
but slower than ventricular tachycardia. Accelerated
idioventricular rhythm differs from ventricular tachycardia by
additional features such as the onset with a long coupling
interval and the end by a gradual decrease of the ventricular
rate or increase of the sinus rate. (NCI)
An impairment of transmission of the cardiac electrical            Left Anterior Fascicular Block
impulse along the fibers of the left anterior fascicle. In left
anterior fascicular block (LAFB) the posteroinferior regions of
the left ventricular endocardium are activated abnormally
before the anterosuperior left ventricular area. After emerging
from the posteroinferior division of the left bundle branch, the
impulse first propagates in an inferior, rightward, and usually
anterior direction for a short period of time. This orientation is
responsible for the small Q waves in leads 1 and aVL and for
the R waves in leads II, III, and aVF. (NCI)

An impairment of transmission of the cardiac electrical           Left Posterior Fascicular Block
impulse along the fibers of the left posterior fascicle. In pure
left posterior fascicular block (LPFB), the impulse emerges
from the unblocked anterosuperior division, thus producing
small q waves in leads II, III, and aVF. Thereafter, the impulse
moves through the electrically predominant left ventricle in an
inferior and rightward direction, thus explaining the S waves in
leads I and aVL as well as the R waves in leads II, III, and
aVF. (NCI)
An impairment of transmission of the cardiac electrical           Left Bundle Branch Block
impulse along the fibers of the left main bundle branch, or
both the left anterior fascicle and left posterior fascicle. This
conduction disturbance is characterized by wide (greater than
0.11s) QRS complexes. The diagnostic criteria consist of
prolongation of the QRS complexes (over 0.11s) with neither
a Q wave nor an S wave in lead V1 and in the properly placed
V6. A wide R wave with a notch on its top (plateau) is seen in
these leads. In hearts with an electrical (and anatomic)
vertical position a small Q wave may be seen in AVL in the
absence of MI. Right chest lead V1 may or may not show an
initial R wave, but the latter should be present in lead V2.
(NCI)
An impairment of transmission of the cardiac electrical           Right Bundle Branch Block
impulse along the fibers of the right bundle branch. A
"complete RBBB pattern" (with QRS duration > 0.11s) does
not necessarily reflect the existence of a total conduction
block in the right branch. This pattern only indicates that the
entire or major parts of both ventricles are activated by the
impulse emerging from the left branch. Thus, a significant
degree of conduction delay ("high-grade" or "incomplete
RBBB") can produce a similar pattern. (NCI)

A delay in transmission of cardiac electrical impulses in the Nonspecific Intraventricular
His-Purkinje system, diagnosed when the QRS is modestly       Conduction Delay
prolonged (< 120 msec) and the QRS pattern and axis are not
typical of a hemiblock. The conduction delay is considered to
occur beyond the Purkinje's myocardial gates and arises from
slow cell-to-cell conduction. The phenomenon is common in
patients with acute MI. (NCI)
An electrocardiographic finding of the ST segment elevation        ST Segment Abnormality
or depression which is not indicative of ischemia or infarction.
(NCI)
An electrocardiographic finding of ST segment depression           ST Depression
below the baseline, often described as up sloping, down
sloping or horizontal. (NCI)
An electrocardiographic finding of ST segment elevation            ST Elevation
above the baseline. (NCI)
An electrocardiographic finding of ST changes consistent with      ST Elevation Pericarditis
pericarditis. (NCI)
Elevation of the J point above the baseline; the J point           J Point Elevation
represents the end of ventricular depolarization and located at
the terminus of the QRS complex. (NCI)
An electrocardiographic finding of changes in the ST segment       Non-Specific ST-T Changes
and T wave that do not meet criteria for ischemia or infarction.
(NCI)
Any depression occuring in a positive t wave. (NCI)                Notched T-Waves
Lack of progression of R wave height across precordial leads.      Poor R Wave Progression
(NCI)
A QT interval that is prolonged. The length of the QT interval     Prolonged QT Interval
varies with the heart rate. (NCI)
An electrocardiographic finding in which there is an alternating   Electrical Alternans
pattern of any of the waveform components. (NCI)

A blockage of electrical conduction within the sinoatrial node     Sinoatrial Node Exit Block
resulting in the failure of impulse transmission from the
sinoatrial node. (NCI)
An electrocardiographic finding which comprises left, right or     EKG Finding Atrial Enlargement
bilateral atrial enlargement. (NCI)
An electrocardiographic finding suggesting underlying              P-mitrale
hypertrophy or dilatation of the left atrium.
Electrocardiographic criteria used for the diagnosis of left
atrial abnormality may include a bifid p wave, a biphasic p
wave and/or a p wave duration of greater than 0.12 seconds.
(NCI)
An electrocardiographic finding suggesting underlying              P-pulmonale
hypertrophy or dilatation of the right atrium.
Electrocardiographic criteria used for the diagnosis of right
atrial abnormality may include a peaked p wave greater than
2.5 millimeters in amplitude in the inferior leads. (NCI)

A cardiac rhythm resulting from either an abnormal electrical Ectopic Ventricular Rhythm
focus in the ventricle. Ventricular ectopic beats (VEB) refer to
a contraction of the lower heart chamber which occurs before
it would be expected. Ventricular ectopic beats are also
known as premature ventricular beats, premature ventricular
complex (PVC), or ventricular extrasystole. (NCI)

An electrocardiographic finding of a rhythm originating at a       Ectopic Supraventricular Rhythm
site other than the sinoatrial node, which is also above the
atrioventricular node. (NCI)
A electrocardiographic finding of an electrical phenomenon in      2:1 Atrioventricular Block
which the ratio of electrical impulse generated above the
atrioventricular node to the number of impulses conducted
through to the ventricles is 2:1. (NCI)
An electrocardiographic finding in which the electrical activity   Atrioventricular Dissociation
of the atria and ventricles are causally independent of one
another. (NCI)
An electrocardiographic finding comprising right bundle            Bifascicular Block
branch block and left anterior fascicular block, or right bundle
branch block and left posterior fascicular block. Defects
occuring in two of the three divisions of the conduction system
of the heart are considered bifascicular blocks. Technically
left bundle branch block may be considered a bifascicular
block. (NCI)
An partial impairment of transmission of the cardiac electrical    Incomplete Left Bundle Branch
impulse along the fibers of the left bundle branch. (NCI)          Block

Various mechanisms may result in a pattern showing an            Incomplete Right Bundle Branch
incomplete right bundle branch block (RBBB). These include Block
different degrees of conduction delay through the main trunk
of the right bundle branch; increased conduction time through
an elongated right bundle branch; diffuse Purkinje-myocardial
delay due to right ventricular stretch or dilatation; surgical
trauma or disease-related interruption of the major
ramifications of the right branch (distal RBBB or right
fascicular blocks); congenital variations of the distribution of
the major ramifications resulting in a slight delay in the
activation of the crista supraventricularis. (NCI)

An electrocardiographic finding of bundle branch block which       Incomplete Bundle Branch Block
does not meet the criteria for a more specific bundle branch
block. (NCI)
An electrocardiographic finding in which the electrical axis of    Multifocal Atrial Tachycardia
the p wave is variable and the rate is greater than 100 beats
per minute. To meet criteria for multifocal atrial tachycardia,
the p wave must exhibit three distinct morphologies on the
rhythm strip. (NCI)
An electrocardiographic finding in which the pacer of the heart    Junctional Rhythm
is located in the AV junction, normally presenting with a
narrow QRS complex and a rate of 60-100 beats per minute.
(NCI)
An electrocardiographic finding of ventricular tachycardia         Sustained Ventricular
greater than 30 seconds in duration. (NCI)                         Tachycardia
An electrocardiographic finding of ventricular tachycardia less    Non-Sustained Ventricular
than 30 seconds in duration. (NCI)                                 Tachycardia
An electrocardiographic finding of a normal QRS followed by        Bigeminy
a premature ventricular contraction; a rhythmic pairing of
normal and abnormal beats originating in the ventricles in a 1-
1 ratio. (NCI)
An electrocardiographic finding of normal QRS followed by a       Trigeminy
premature ventricular contraction; a rhythmic pairing of
normal and abnormal beats originating from the ventricles in a
1-2 ratio. (NCI)
Multiple, temporally related, episodes of ventricular             Ventricular Tachycardia Storm
tachycardia or fibrillation, occurring three or more times in a
24 hour period. (NCI)
A condition that occurs as a result of cAMP-mediated              Adenosine-Sensitive Ventricular
triggered activity and typically originates from the right        Tachycardia
ventricular outflow tract (RVOT). This type of tachycardia
occurs in patients with apparently normal hearts. (NCI)
A well-recognized condition that is believed to result from       Verapamil-Sensitive Ventricular
triggered activity. Despite its uniform response to verapamil,    Tachycardia
however, this uncommon form of ventricular tachycardia may
not be as homogeneous a condition as first believed. (NCI)

A condition characterized by a pattern of right bundle branch Brugada Syndrome
block (RBBB) and ST-segment elevation within
electrocardiogram (ECG) leads V1-V3 . This pattern emerges
as a result of a defect in ion channel genes, resulting in
abnormal electrophysiological activity in the right ventricle and
a propensity to malignant tachyarrhythmias. (NCI)

Ventricular tachyarrhythmias occurring in association with        Short QT Syndrome
short QT syndrome. (NCI)

A distinct subgroup of idiopathic ventricular tachycardia (VT) Fascicular Tachycardia
that may be confused with either typical VT or
supraventricular tachycardia (SVT). It is characterised by the
absence of structural heart disease and classic
electrocardiographic and electrophysiological features. It
originates from the region of the posterior fascicle (or
occasionally the anterior fascicle) of the left bundle branch
and is partly propagated by the His-Purkinje network. It
therefore produces QRS complexes of relatively short
duration (0.11-0.14)s. (NCI)
An uncommon form of ventricular tachycardia (VT)               Bundle Branch Re-Entrant
incorporating both bundle branches into the reentry circuit.   Ventricular Tachycardia
Surface electrocardiogram (ECG) of sinus rhythm (SR)
characteristically shows intraventricular conduction defects.
Patients typically present with presyncope, syncope or sudden
death because of VT with fast rates frequently above 200
beats per minute. The QRS morphology during VT is a typical
bundle branch block pattern, usually left bundle branch block,
and may be identical to that in SR. (NCI)
Idiopathic ventricular tachycardia (VT) is a type of ventricular   Idiopathic Right Bundle Branch
tachycardia occurring unrelated to any organic cardiac             Block
disease. The abnormality is probably congenital, be it a focus
of abnormal automaticity or myocardial tissue that can sustain
re-entry. The clinical presentation for idiopathic VT can be
very much like a paroxysmal supraventricular tachycardia.
That is, most patients are generally younger without overt
cardiac disease and present with paroxysmal palpitations.
Idiopathic ventricular tachycardia is not generally life-
threatening. (NCI)
Right ventricular outflow tract tachycardia (RVOT) is the most     Right Ventricular Outflow Tract
common with a female predominance. It is often exercise            Tachycardia
induced or enhanced. The site of origin is the right ventricular
outflow tract and hence the electrocardiographic appearance
is that of left bundle branch block and inferior axis. The
mechanism is thought to be abnormal automaticity that is
sensitive to adenosine. (NCI)

Electrocardiographic finding showing a current of injury in        Acute Anterior Wall Myocardial
leads corresponding to the anatomic region of the anterior         Infarction
wall of the heart. (NCI)
Electrocardiographic finding showing a current of injury in        Acute Inferior Wall Myocardial
leads corresponding to the anatomic region of the inferior wall    Infarction
of the heart. (NCI)
Electrocardiographic finding showing a current of injury in        Acute Lateral Wall Myocardial
leads corresponding to the anatomic region of the lateral wall     Infarction
of the heart. (NCI)
Electrocardiographic finding showing a current of injury in        Acute Posterior Wall Myocardial
leads corresponding to the anatomic region of the posterior        Infarction
wall of the heart. (NCI)
Electrocardiographic finding showing an injury in leads            Anterior Wall Myocardial
corresponding to the anatomic region of the anterior wall of       Infarction
the heart. (NCI)
Electrocardiographic finding showing an injury in leads            Inferior Wall Myocardial
corresponding to the anatomic region of the inferior wall of the   Infarction
heart. (NCI)
A delay in impulse propagation through the atria. (NCI)            Intra-Atrial Conduction Delay

An electrocardiographic finding in which the pacer of the heart    Junctional Bradycardia
is located in the AV junction, normally presenting with a
narrow QRS complex at a rate less than 60 beats per minute.
(NCI)
Electrocardiographic finding showing an injury in leads            Lateral Wall Myocardial
corresponding to the anatomic region of the lateral wall of the    Infarction
heart. (NCI)
Electrocardiographic findings suggestive of a hypertrophic left    Left Ventricular Hypertrophy
ventricle. (NCI)
Electrocardiographic findings suggestive of an enlarged right      Right Ventricular Hypertrophy
ventricle. (NCI)
An electrocardiographic finding of a QRS amplitude less than       Low QRS Voltage
or equal to 5mm in the limb leads or QRS amplitude less than
or equal to 10mm in the precordial leads. (NCI)
A myocardial infarction in the absence of observable Q wave     Non Q Wave Myocardial
abnormalities in the ECG. (NCI)                                 Infarction
Electrocardiographic finding showing an injury in leads         Posterior Wall Myocardial
corresponding to the anatomic region of the posterior wall of   Infarction
the heart. (NCI)
Electrocardiographic findings suggesting an infarction in the   Septal Myocardial Infarction
anatomic location of the cardiac septum. (NCI)
An electrocardiographic finding of a T wave which appears       T Wave Abnormality
peaked, inverted, flattened or biphasic. (NCI)
Electrocardiographic findings suggestive of enlarged cardiac    Ventricular Hypertrophy
ventricles. (NCI)
An electrocardiographic finding of an inversion of the T wave   T Wave Inversion
from the expected axis. (NCI)
An electrocardiographic finding in which the T wave appears     T Wave Peaked
increased in amplitude and cresting at a point. (NCI)

An electrocardiographic finding in which the T wave is          T Waves Biphasic
asymmetric. (NCI)
An electrocardiographic finding in which the T wave appears     T Waves Flat
decreased in amplitude. (NCI)
An electrocardiographic finding of a small hump following the   U Waves
T wave occuring during the final phase of Purkinje
repolarization. (NCI)
An electrocardiographic finding of a QRS complex. (NCI)         Wide QRS Tachycardia
Q axis from -30 to -90 degrees. (NCI)                           Q Axis Left Axis Deviation
Q axis from +90 to +180 degrees. (NCI)                          Q Axis Right Axis Deviation
Corrected QT interval longer than 500 msec, in accordance       QTcB Prolongation Greater Than
with Bazett's correction formula. (NCI)                         500 msec
Corrected QT interval greater than 500 msec, in accordance      QTcF Prolongation Greater Than
with Fridericia's correction formula. (NCI)                     500 msec
Terminology codelist used with ECG Tests within CDISC.          CDISC SDTM ECG Test
                                                                Terminology by Code
The minimum time between successive cycles of contraction       Maximum Heart Rate
and subsequent relaxation of the heart, usually expressed as
beats per minute, obtained from a set of measurements of the
heart rate. (NCI)
The average (mean) duration (time) of the PR interval,         EKG Mean PR Duration
obtained from a set of measurements of the PR interval. The
PR interval is defined as the time from the beginning of the P
wave (representing the onset of atrial depolarization) to the
beginning of the R wave (representing the onset of ventricular
depolarization). In some cases, a Q wave will precede the R
wave, in which case the PR interval is measured from the
beginning of the P wave to the beginning of the Q wave. (NCI)

The average (mean) duration (time) of the QRS interval,          EKG Mean QRS Duration
obtained from a set of measurements of the QRS interval.
The QRS interval is defined as the time from the beginning of
the QRS complex to the end of the QRS complex,
representing the time it takes for the ventricles to depolarize.
(NCI)
The average (mean) duration (time) of the QT interval,         EKG Mean QT Duration
obtained from a set of measurements of the QT interval. The
QT interval is defined as the time from the beginning of the
QRS complex to the end of the T wave, representing the time
it takes for the ventricles to depolarize and subsequently
repolarize. In some cases, the Q wave will be absent, in which
case the QT interval is measured from the beginning of the R
wave to the end of the T wave. (NCI)

The average (mean) duration (time) of the RR interval,          EKG Mean RR Duration
obtained from a set of measurements of the RR interval. The
RR interval is defined as the time between successive peaks
of the R wave and can be used to measure the ventricular
rate. (NCI)
The minimum duration (time) between successive peaks of R       EKG Minimum RR Duration
waves in a particular set of RR intervals. (NCI)
The maximum duration (time) between successive peaks of R       EKG Maximum RR Duration
waves in a particular set of RR intervals. (NCI)
The average (mean) number of cycles of contraction and          Mean Heart Rate
subsequent relaxation of the heart, usually expressed as
beats per minute, obtained from a set of measurements of the
heart rate. (NCI)
The maximum time between successive cycles of contraction       Minimum Heart Rate
and subsequent relaxation of the heart, usually expressed as
beats per minute, obtained from a set of measurements of the
heart rate. (NCI)
A formula which takes into account the physiologic shortening   QTcB-Bazett's Correction
of the QT interval which occurs as the heart rate increases,    Formula
permitting comparison of the QT interval across a range of
rates. It is mathematically defined as: QTcB =
QT/SqRootRR(seconds) and theoretically corrects the QT
interval to that which would be observed at a heart rate of 1
cycle per second. (NCI)
A formula which takes into account the physiologic shortening   QTcF-Fridericia's Correction
of the QT interval which occurs as the heart rate increases,    Formula
permitting comparison of the QT interval across a range of
rates. It is mathematically defined as: QTcF =
QT/CubeRootRR(seconds) and theoretically corrects the QT
interval to that which would be observed at a heart rate of 1
cycle per second. (NCI)
A formula which takes into account the physiologic shortening   QTcLC-Linear Correction
of the QT interval which occurs as the heart rate increases,    Formula
permitting comparison of the QT interval across a range of
rates. The linear correction formula uses population-based
data obtained and validated using a large cohort of subjects.
This method theoretically corrects the QT interval to that
which would be observed at a heart rate of 1 cycle per
second. (NCI)
The average (mean) duration (time) of the JT interval,              EKG Mean JT Duration
obtained from a set of measurements of the JT interval. The
JT interval is defined as the time from the J point (end of
ventricular depolarization, the point at which the QRS meets
the ST segment) to the end of the T wave (representing the
end of ventricular repolarization). (NCI)
The minimum duration (time) of the JT interval, obtained from       EKG Minimum JT Duration
a set of measurements of the JT interval. The JT interval is
defined as the time from the J point (end of ventricular
depolarization, the point at which the QRS meets the ST
segment) to the end of the T wave (representing the end of
ventricular repolarization). (NCI)
The maximum duration (time) of the JT interval, obtained from       EKG Maximum JT Duration
a set of measurements of the JT interval. The JT interval is
defined as the time from the J point (end of ventricular
depolarization, the point at which the QRS meets the ST
segment) to the end of the T wave (representing the end of
ventricular repolarization). (NCI)
A formula which takes into account the physiologic shortening       JTcB-Bazett's Correction
of the JT interval which occurs as the heart rate increases,        Formula
permitting comparison of the JT interval across a range of
rates. It is mathematically defined as: JTcB =
JT/SqRootRR(seconds) and theoretically corrects the JT
interval to that which would be observed at a heart rate of 1
cycle per second. (NCI)
A formula which takes into account the physiologic shortening       JTcF-Fridericia's Correction
of the JT interval which occurs as the heart rate increases,        Formula
permitting comparison of the JT interval across a range of
rates. It is mathematically defined as: JTcF =
JT/CubeRootRR(seconds) and theoretically corrects the JT
interval to that which would be observed at a heart rate of 1
cycle per second. (NCI)
A formula which takes into account the physiologic shortening       JTcLC-Linear Correction
of the JT interval which occurs as the heart rate increases,        Formula
permitting comparison of the JT interval across a range of
rates. The linear correction formula uses population-based
data obtained and validated using a large cohort of subjects.
Using this method, the corrected JT interval is independent of
the ventricular rate. (NCI)
The mean (average) direction (range -180 degrees to 180             EKG Mean P Axis
degrees) of the electrical potential generated by atrial
depolarization in a particular plane (usually the frontal plane).
(NCI)
The average (mean) duration (time) from the onset of atrial         EKG Mean P Wave Duration
depolarization to the completion of atrial depolarization (length
of the P wave), obtained from a set of measurements of the
time from beginning to end of atrial depolarization. (NCI)
The average (mean) height (usually measured in mm) of the EKG Mean P Wave Height
maximum deflection from baseline of the P wave
(representing atrial depolarization), obtained from a set of
measurements of the P wave, from a single lead or set of
leads. Typically this measurement is obtained by analysis of
Lead II. (NCI)
The minimum duration (time) of the PR interval, obtained from EKG Minimum PR Duration
a set of measurements of the PR interval. The PR interval is
defined as the time from the beginning of the P wave
(representing the onset of atrial depolarization) to the
beginning of the R wave (representing the onset of ventricular
depolarization). In some cases, a Q wave will precede the R
wave, in which case the PR interval is measured from the
beginning of the P wave to the beginning of the Q wave. (NCI)

The maximum duration (time) of the PR interval, obtained       EKG Maximum PR Duration
from a set of measurements of the PR interval. The PR
interval is defined as the time from the beginning of the P
wave (representing the onset of atrial depolarization) to the
beginning of the R wave (representing the onset of ventricular
depolarization). In some cases, a Q wave will precede the R
wave, in which case the PR interval is measured from the
beginning of the P wave to the beginning of the Q wave. (NCI)

The mean (average) direction of the electrical potential         Mean QRS Axis
generated by ventricular depolarization. (NCI)
The minimum duration (time) of the QT interval, obtained from    Minimum QT Duration
a set of measurements of the QT interval. The QT interval is
defined as the time from the beginning of the QRS complex to
the end of the T wave, representing the time it takes for the
ventricles to depolarize and subsequently repolarize. In some
cases, the Q wave will be absent, in which case the QT
interval is measured from the beginning of the R wave to the
end of the T wave. (NCI)
The maximum duration (time) of the QT interval, obtained         EKG Maximum QT Duration
from a set of measurements of the QT interval. The QT
interval is defined as the time from the beginning of the QRS
complex to the end of the T wave, representing the time it
takes for the ventricles to depolarize and subsequently
repolarize. In some cases, the Q wave will be absent, in which
case the QT interval is measured from the beginning of the R
wave to the end of the T wave. (NCI)
The average (mean) amplitude (usually in mm) of the R wave,      EKG Mean R Wave Amplitude
obtained from a set of measurements of the R wave, in a
particular lead or set of leads. (NCI)
The average (mean) amplitude (usually in mm) of the S wave,      EKG Mean S Wave Amplitude
obtained from a set of measurements of the S wave, in a
particular lead or set of leads. (NCI)
The average (mean) amplitude (usually in mm) of the              EKG Mean R+S Amplitude
summation of the R and S waves, obtained from a set of
measurements of the R and S waves, in a particular lead or
set of leads. (NCI)
The duration (time) of the ST segment, measured from the J       EKG Mean ST Segment
point at the end of the QRS complex to the beginning of the T    Duration
wave. (NCI)
The mean (average) direction of the electrical potential         EKG Mean T Wave Axis
generated by ventricular repolarization. (NCI)
The average (mean) duration (time) from the onset of             EKG Mean T Wave Duration
ventricular repolarization to the completion of ventricular
repolarization (length of the T wave), obtained from a set of
measurements of the time from beginning to end of
ventricular repolarization. (NCI)
The average (mean) area under the curve of the deflection        EKG Mean T Wave Area
from baseline of the T wave (representing ventricular
repolarization), obtained from a set of measurements of the T
wave, from a single lead or set of leads. (NCI)
The average (mean) height (usually measured in mm) of the        EKG Mean T Wave Height
maximum deflection from baseline of the T wave
(representing ventricular repolarization), obtained from a set
of measurements of the T wave, from a single lead or set of
leads. (NCI)
The average (mean) number of cycles of contraction and           Mean Ventricular Heart Rate
subsequent relaxation of the ventricles, usually expressed as
beats per minute, obtained from a set of measurements of the
ventricular rate. (NCI)
The minimum time between successive cycles of contraction        Minimum Ventricular Heart Rate
and subsequent relaxation of the ventricles, usually
expressed as beats per minute, obtained from a set of
measurements of the ventricular rate. (NCI)
The maximum time between successive cycles of contraction        Maximum Ventricular Heart Rate
and subsequent relaxation of the ventricles, usually
expressed as beats per minute, obtained from a set of
measurements of the ventricular rate. (NCI)
The average (mean) deviation (distance from baseline,            EKG Mean ST Deviation
positive or negative, usually measured in mm) of the ST
segment, obtained from a set of measurements of the
deviation of the ST segment. (NCI)
The minimum deviation (distance from baseline, positive or       EKG Minimum ST Deviation
negative, usually measured in mm) of the ST segment,
obtained from a set of measurements of the deviation of the
ST segment. (NCI)
The maximum deviation (distance from baseline, positive or       EKG Maximum ST Deviation
negative, usually measured in mm) of the ST segment,
obtained from a set of measurements of the deviation of the
ST segment. (NCI)
The average (mean) elevation (positive deflection from           EKG Mean ST Segment
baseline, usually measured in mm) of the ST segment,             Elevation
obtained from a set of measurements of the elevation of the
ST segment. (NCI)
The minimum elevation (positive deflection from baseline,        EKG Minimum ST Segment
usually measured in mm) of the ST segment, obtained from a       Elevation
set of measurements of the elevation of the ST segment.
(NCI)
The maximum elevation (positive deflection from baseline,        EKG Maximum ST Segment
usually measured in mm) of the ST segment, obtained from a       Elevation
set of measurements of the elevation of the ST segment.
(NCI)
The average (mean) depression (negative deflection from          EKG Mean ST Segment
baseline, usually measured in mm) of the ST segment,             Depression
obtained from a set of measurements of the depression of the
ST segment. (NCI)
The minimum depression (negative deflection from baseline,       EKG Minimum ST Segment
usually measured in mm) of the ST segment, obtained from a       Depression
set of measurements of the depression of the ST segment.
(NCI)
The maximum depression (negative deflection from baseline,       EKG Maximum ST Segment
usually measured in mm) of the ST segment, obtained from a       Depression
set of measurements of the depression of the ST segment.
(NCI)
Terminology codelist used with ECG Test Names within             CDISC SDTM ECG Test Name
CDISC.                                                           Terminology
The minimum time between successive cycles of contraction        Maximum Heart Rate
and subsequent relaxation of the heart, usually expressed as
beats per minute, obtained from a set of measurements of the
heart rate. (NCI)
The average (mean) duration (time) of the PR interval,           EKG Mean PR Duration
obtained from a set of measurements of the PR interval. The
PR interval is defined as the time from the beginning of the P
wave (representing the onset of atrial depolarization) to the
beginning of the R wave (representing the onset of ventricular
depolarization). In some cases, a Q wave will precede the R
wave, in which case the PR interval is measured from the
beginning of the P wave to the beginning of the Q wave. (NCI)

The average (mean) duration (time) of the QRS interval,          EKG Mean QRS Duration
obtained from a set of measurements of the QRS interval.
The QRS interval is defined as the time from the beginning of
the QRS complex to the end of the QRS complex,
representing the time it takes for the ventricles to depolarize.
(NCI)
The average (mean) duration (time) of the QT interval,           EKG Mean QT Duration
obtained from a set of measurements of the QT interval. The
QT interval is defined as the time from the beginning of the
QRS complex to the end of the T wave, representing the time
it takes for the ventricles to depolarize and subsequently
repolarize. In some cases, the Q wave will be absent, in which
case the QT interval is measured from the beginning of the R
wave to the end of the T wave. (NCI)

The average (mean) duration (time) of the RR interval,      EKG Mean RR Duration
obtained from a set of measurements of the RR interval. The
RR interval is defined as the time between successive peaks
of the R wave and can be used to measure the ventricular
rate. (NCI)
The minimum duration (time) between successive peaks of R       EKG Minimum RR Duration
waves in a particular set of RR intervals. (NCI)
The maximum duration (time) between successive peaks of R       EKG Maximum RR Duration
waves in a particular set of RR intervals. (NCI)
The average (mean) number of cycles of contraction and          Mean Heart Rate
subsequent relaxation of the heart, usually expressed as
beats per minute, obtained from a set of measurements of the
heart rate. (NCI)
The maximum time between successive cycles of contraction       Minimum Heart Rate
and subsequent relaxation of the heart, usually expressed as
beats per minute, obtained from a set of measurements of the
heart rate. (NCI)
A formula which takes into account the physiologic shortening   QTcB-Bazett's Correction
of the QT interval which occurs as the heart rate increases,    Formula
permitting comparison of the QT interval across a range of
rates. It is mathematically defined as: QTcB =
QT/SqRootRR(seconds) and theoretically corrects the QT
interval to that which would be observed at a heart rate of 1
cycle per second. (NCI)
A formula which takes into account the physiologic shortening   QTcF-Fridericia's Correction
of the QT interval which occurs as the heart rate increases,    Formula
permitting comparison of the QT interval across a range of
rates. It is mathematically defined as: QTcF =
QT/CubeRootRR(seconds) and theoretically corrects the QT
interval to that which would be observed at a heart rate of 1
cycle per second. (NCI)
A formula which takes into account the physiologic shortening   QTcLC-Linear Correction
of the QT interval which occurs as the heart rate increases,    Formula
permitting comparison of the QT interval across a range of
rates. The linear correction formula uses population-based
data obtained and validated using a large cohort of subjects.
This method theoretically corrects the QT interval to that
which would be observed at a heart rate of 1 cycle per
second. (NCI)
The average (mean) duration (time) of the JT interval,          EKG Mean JT Duration
obtained from a set of measurements of the JT interval. The
JT interval is defined as the time from the J point (end of
ventricular depolarization, the point at which the QRS meets
the ST segment) to the end of the T wave (representing the
end of ventricular repolarization). (NCI)
The minimum duration (time) of the JT interval, obtained from   EKG Minimum JT Duration
a set of measurements of the JT interval. The JT interval is
defined as the time from the J point (end of ventricular
depolarization, the point at which the QRS meets the ST
segment) to the end of the T wave (representing the end of
ventricular repolarization). (NCI)
The maximum duration (time) of the JT interval, obtained from   EKG Maximum JT Duration
a set of measurements of the JT interval. The JT interval is
defined as the time from the J point (end of ventricular
depolarization, the point at which the QRS meets the ST
segment) to the end of the T wave (representing the end of
ventricular repolarization). (NCI)
A formula which takes into account the physiologic shortening       JTcB-Bazett's Correction
of the JT interval which occurs as the heart rate increases,        Formula
permitting comparison of the JT interval across a range of
rates. It is mathematically defined as: JTcB =
JT/SqRootRR(seconds) and theoretically corrects the JT
interval to that which would be observed at a heart rate of 1
cycle per second. (NCI)
A formula which takes into account the physiologic shortening       JTcF-Fridericia's Correction
of the JT interval which occurs as the heart rate increases,        Formula
permitting comparison of the JT interval across a range of
rates. It is mathematically defined as: JTcF =
JT/CubeRootRR(seconds) and theoretically corrects the JT
interval to that which would be observed at a heart rate of 1
cycle per second. (NCI)
A formula which takes into account the physiologic shortening       JTcLC-Linear Correction
of the JT interval which occurs as the heart rate increases,        Formula
permitting comparison of the JT interval across a range of
rates. The linear correction formula uses population-based
data obtained and validated using a large cohort of subjects.
Using this method, the corrected JT interval is independent of
the ventricular rate. (NCI)
The mean (average) direction (range -180 degrees to 180             EKG Mean P Axis
degrees) of the electrical potential generated by atrial
depolarization in a particular plane (usually the frontal plane).
(NCI)
The average (mean) duration (time) from the onset of atrial         EKG Mean P Wave Duration
depolarization to the completion of atrial depolarization (length
of the P wave), obtained from a set of measurements of the
time from beginning to end of atrial depolarization. (NCI)

The average (mean) height (usually measured in mm) of the EKG Mean P Wave Height
maximum deflection from baseline of the P wave
(representing atrial depolarization), obtained from a set of
measurements of the P wave, from a single lead or set of
leads. Typically this measurement is obtained by analysis of
Lead II. (NCI)
The minimum duration (time) of the PR interval, obtained from EKG Minimum PR Duration
a set of measurements of the PR interval. The PR interval is
defined as the time from the beginning of the P wave
(representing the onset of atrial depolarization) to the
beginning of the R wave (representing the onset of ventricular
depolarization). In some cases, a Q wave will precede the R
wave, in which case the PR interval is measured from the
beginning of the P wave to the beginning of the Q wave. (NCI)
The maximum duration (time) of the PR interval, obtained       EKG Maximum PR Duration
from a set of measurements of the PR interval. The PR
interval is defined as the time from the beginning of the P
wave (representing the onset of atrial depolarization) to the
beginning of the R wave (representing the onset of ventricular
depolarization). In some cases, a Q wave will precede the R
wave, in which case the PR interval is measured from the
beginning of the P wave to the beginning of the Q wave. (NCI)

The mean (average) direction of the electrical potential         Mean QRS Axis
generated by ventricular depolarization. (NCI)
The minimum duration (time) of the QT interval, obtained from    Minimum QT Duration
a set of measurements of the QT interval. The QT interval is
defined as the time from the beginning of the QRS complex to
the end of the T wave, representing the time it takes for the
ventricles to depolarize and subsequently repolarize. In some
cases, the Q wave will be absent, in which case the QT
interval is measured from the beginning of the R wave to the
end of the T wave. (NCI)
The maximum duration (time) of the QT interval, obtained         EKG Maximum QT Duration
from a set of measurements of the QT interval. The QT
interval is defined as the time from the beginning of the QRS
complex to the end of the T wave, representing the time it
takes for the ventricles to depolarize and subsequently
repolarize. In some cases, the Q wave will be absent, in which
case the QT interval is measured from the beginning of the R
wave to the end of the T wave. (NCI)
The average (mean) amplitude (usually in mm) of the R wave,      EKG Mean R Wave Amplitude
obtained from a set of measurements of the R wave, in a
particular lead or set of leads. (NCI)
The average (mean) amplitude (usually in mm) of the S wave,      EKG Mean S Wave Amplitude
obtained from a set of measurements of the S wave, in a
particular lead or set of leads. (NCI)
The average (mean) amplitude (usually in mm) of the              EKG Mean R+S Amplitude
summation of the R and S waves, obtained from a set of
measurements of the R and S waves, in a particular lead or
set of leads. (NCI)
The average (mean) duration (time) from the end of               EKG Mean ST Segment
ventricular depolarization (end of QRS complex) to the end of    Duration
ventricular repolarization (end of the T wave). (NCI)
The mean (average) direction of the electrical potential         EKG Mean T Wave Axis
generated by ventricular repolarization. (NCI)
The average (mean) duration (time) from the onset of             EKG Mean T Wave Duration
ventricular repolarization to the completion of ventricular
repolarization (length of the T wave), obtained from a set of
measurements of the time from beginning to end of
ventricular repolarization. (NCI)
The average (mean) area under the curve of the deflection        EKG Mean T Wave Area
from baseline of the T wave (representing ventricular
repolarization), obtained from a set of measurements of the T
wave, from a single lead or set of leads. (NCI)
The average (mean) height (usually measured in mm) of the        EKG Mean T Wave Height
maximum deflection from baseline of the T wave
(representing ventricular repolarization), obtained from a set
of measurements of the T wave, from a single lead or set of
leads. (NCI)
The average (mean) number of cycles of contraction and           Mean Ventricular Heart Rate
subsequent relaxation of the ventricles, usually expressed as
beats per minute, obtained from a set of measurements of the
ventricular rate. (NCI)
The minimum time between successive cycles of contraction        Minimum Ventricular Heart Rate
and subsequent relaxation of the ventricles, usually
expressed as beats per minute, obtained from a set of
measurements of the ventricular rate. (NCI)
The maximum time between successive cycles of contraction        Maximum Ventricular Heart Rate
and subsequent relaxation of the ventricles, usually
expressed as beats per minute, obtained from a set of
measurements of the ventricular rate. (NCI)
The average (mean) deviation (distance from baseline,            EKG Mean ST Deviation
positive or negative, usually measured in mm) of the ST
segment, obtained from a set of measurements of the
deviation of the ST segment. (NCI)
The minimum deviation (distance from baseline, positive or       EKG Minimum ST Deviation
negative, usually measured in mm) of the ST segment,
obtained from a set of measurements of the deviation of the
ST segment. (NCI)
The maximum deviation (distance from baseline, positive or       EKG Maximum ST Deviation
negative, usually measured in mm) of the ST segment,
obtained from a set of measurements of the deviation of the
ST segment. (NCI)
The average (mean) elevation (positive deflection from           EKG Mean ST Segment
baseline, usually measured in mm) of the ST segment,             Elevation
obtained from a set of measurements of the elevation of the
ST segment. (NCI)
The minimum elevation (positive deflection from baseline,        EKG Minimum ST Segment
usually measured in mm) of the ST segment, obtained from a       Elevation
set of measurements of the elevation of the ST segment.
(NCI)
The maximum elevation (positive deflection from baseline,        EKG Maximum ST Segment
usually measured in mm) of the ST segment, obtained from a       Elevation
set of measurements of the elevation of the ST segment.
(NCI)
The average (mean) depression (negative deflection from          EKG Mean ST Segment
baseline, usually measured in mm) of the ST segment,             Depression
obtained from a set of measurements of the depression of the
ST segment. (NCI)
The minimum depression (negative deflection from baseline,       EKG Minimum ST Segment
usually measured in mm) of the ST segment, obtained from a       Depression
set of measurements of the depression of the ST segment.
(NCI)
The maximum depression (negative deflection from baseline,           EKG Maximum ST Segment
usually measured in mm) of the ST segment, obtained from a           Depression
set of measurements of the depression of the ST segment.
(NCI)
Terminology codelist used with ECG Test Methods within               CDISC SDTM ECG Test Method
CDISC.                                                               Terminology
An electrocardiogram (ECG) lead placement whereby 12                 12 Lead Placement Unspecified
leadpoints are recorded but the position of the leads is
unspecified. (NCI)
An electrocardiogram (ECG) lead placement whereby 12                 12 Lead Placement Standard
leads are recorded, with each lead representing an electrical
view of the heart. The six leads recorded in the frontal plane
are derived from the placement of 3 electrodes (RA or Right
Arm, LA, or Left Arm, and LL or Left Leg). These bipolar
frontal leads form the basis of Einthoven's triangle, and are
represented by leads I, II, and III. Three other derived (or
augmented) bipolar frontal vectors are also recorded on a
standard 12-lead EKG, aVR, aVF, and aVL. 6 unipolar leads,
corresponding to V1 - V6 measure the electrical activity in the
horizontal plane. The placement for the V leads is as follows:
V1: right 4th intercostal space,V2: left 4th intercostal space,
V3: halfway between V2 and V4, V4: left 5th intercostal space,
mid-clavicular line, V5: horizontal to V4, anterior axillary line,
V6: horizontal to V5, mid-axillary line. (NCI)

An electrocardiogram (ECG) lead placement whereby 12                 12 Lead Placement Mason Likar
leadpoints are recorded but the standard lead positions have
been modified for ECG recording during exercise. Exercise
stress testing requires moving the limb electrodes to more
central positions on the thorax. The electrodes are placed in
bony prominences close to the bases of the respective limbs
in order to avoid skeletal muscle artifact, provide stability for
recording electrodes and to record waveforms similar to the
standard limb sites. (NCI)

An electrocardiogram (ECG) lead placement whereby 12                 12 Lead Placement Mason Likar
leadpoints are recorded but the Mason Likar lead positions           Modified
have been modified so that V1 to V6 on the chest are part of a
single electrode pad. In addition, lead CM5 is substituted for
lead aVR. (NCI)
An electrocardiogram (ECG) lead placement whereby 12                 12 Lead Placement Chest
leadpoints are recorded but the standard lead positions have
been modified so that all leads on the chest are part of a
single electrode pad. (NCI)
An electrocardiogram (ECG) lead placement whereby the limb           12 Lead Placement Non-
leads are placed on the torso for easier and faster application      Standard
in emergency situations. (NCI)
Limb leads on the back (shoulder and on the hips). (NCI)             Lead Placement Bicycle
An electrocardiogram (ECG) lead placement whereby the               12 Lead Placement Cabrera
display of the 12 standard ECG leads is in an orderly
sequence in a single horizontal display of: aVL, I, -aVR, II,
aVF, III, V1 to V6. In the Cabrera display the limb lead aVR is
inverted (-aVR) to obtain the same positive leftward
orientation as the other 5 limbs. (NCI)
An electrocardiographic lead placement schema in which the          Lead Placement Standard
V leads are placed one intercostal space cephalad to the            Intercostal Space Higher
position they would have in the standard lead placement
schema. (NCI)
An electrocardiogram (ECG) lead placement for determining 3         Lead Placement Frank
orthogonal components X (right to left direction), Y (foot to
head direction) and Z (back to front direction) of the heart. For
this method a minimum of 4 electrodes are needed that
represent the right arm, left arm, left leg and back. However,
usually 7 electrodes are used to avoid dependence on the
dipole location and facilitate interpretation. (NCI)

An electrocardiogram (ECG) lead placement for determining 3         Lead Placement McFee-
orthogonal components X (back to front), Y (right to left) and      Parungao
Z (foot to head) of the heart. This system places the
electrodes closer to the heart to achieve better orthogonality
and a homogeneous lead field. (NCI)
An electrocardiogram (ECG) lead placement that is a type of         Lead Placement Cube
uncorrected vectorcardiograph. This lead system is based on
a rectangular body axis. It uses an extra number of electrodes
to make it three-dimensional. (NCI)
An electrocardiogram (ECG) lead placement whereby the X+            Lead Placement Bipolar
lead is placed at the right mid-axillary line ate the 4th           Uncorrected XYZ
intercostal space, X- at the left mid-axillary line at he 4th
intercostal space, Y+ at the proximal left leg, Y- at the
superior aspect of the manubrium, Z+ at the direct posterior to
Z- and Z- at the 4th intercostal space at the left sternal
margin. (NCI)
An electrocardiogram (ECG) lead placement that allows               Lead Placement Pseudo
monitoring and recording of cardiac electrical activity. A V1-      Orthogonal XYZ
type lead is used whose positive electrode is localized in the
4th intercostal space, 2.5cm from the sternum. Its negative
electrode is placed below the left clavicle. An addition of lead
V5 and aVF can be made to facilitate interpretation. (NCI)

An electrocardiogram (ECG) lead placement whereby 4 chest Lead Placement EASI Dower
electrodes and 1 reference electrode are used to allow for   Transformation
continuous monitoring at the clinical level. This placement
creates a 12 lead ECG that allows the acquisition of
simultaneous events in the frontal, horizontal and sagittal
heart planes with the linear transformation of vectors. This
system provides a three-dimensional portrayal of the heart
and uses mathematical and fixed coefficients for each lead.
(NCI)
An electrocardiogram (ECG) lead placement whereby 12               12 Lead Placement 1 Lead
leadpoints are recorded but one standard lead position is          Missing
missing therefore requiring a Mortara source consistency
filter. (NCI)
An electrocardiogram (ECG) lead placement whereby 12               12 Lead Placement Standard
leadpoints are recorded but the standard lead positions have       And CC5-CM5-CH5
been modified so that the bipolar lead groups place the
negative of the reference electrode over the manubrium
(CM5), the right scapula (CB5), V5R (CC5) or on the forehead
(CH5) and the active electrode at V5. (NCI)
An electrocardiogram (ECG) lead placement whereby 12               12 Lead Placement Standard
leadpoints are recorded but the standard lead positions have       And CC5-CM5-ML
been modified so that the negative reference is at CM5 and
the active electrode is at the left leg position. (NCI)

An electrocardiogram (ECG) lead placement whereby the              12 Lead Placement Standard
rightward oriented V leads progress from V1R, placed instead       Extended Right
of the standard V2, to V6R. The V3 lead in the standard
placement is replaced by V4R. (NCI)
An electrocardiogram (ECG) lead placement whereby the              12 Lead Placement Standard
standard lead placement is modified by having leads V7, V8         Extended Left
and V9. (NCI)
A recording of the electrical activity of the heart displayed in   Vectorcardiograph Corrected
the form of a vector loop, corrected for anatomic
inconsistencies. (NCI)
A recording of the electrical activity of the heart displayed in   Vectorcardiograph Uncorrected
the form of a vector loop, uncorrected for anatomic
inconsistencies. (NCI)
Terminology codelist used for units within CDISC.                  CDISC SDTM Unit of Measure
                                                                   Terminology

A unit of absorbed radiation dose. One gray is equal to an         Gray
absorbed dose of one joule per kilogram of matter, or to 100
rads.(NCI)
The special unit for absorbed radiation dose, which is the         Rad
amount of energy from any type of ionizing radiation (e.g.,
alpha, beta, gamma, neutrons, etc.) deposited in any medium
(e.g., water, tissue, air). A dose of one rad means the
absorption of 100 ergs per gram of absorbing tissue. One rad
is equal to 0.01 gray.(NCI)
The time for Earth to make a complete rotation on its axis;        Day
ordinarily divided into twenty-four hours. This also refers to a
specific day. (NCI)
A unit measure of time equal to 3,600 seconds or 60 minutes.       Hour
It is approximately 1/24 of a median day.(NCI)
A fraction or ratio with 100 understood as the                     Percentage
denominator.(NCI)
A unit of measure equal to one thousandth of a meter.(NCI)         Millimeter
The basic SI unit of mass. It is defined as the mass of an           Kilogram
international prototype in the form of a platinum-iridium
cylinder kept at Sevres in France. It is the only basic unit still
defined in terms of a material object, and also the only one
with a prefix [kilo] already in place. A kilogram is equal to
1,000 grams and 2.204 622 6 pounds. (NCI)
The unit of mass equal to one thousandth of a gram or 1000           Milligram
micrograms. One milligram equals approximately 0.015432
grain or 35.274 x 10E-6 ounce.(NCI)
The unit of volume equal to one thousandth of a liter, one           Milliliter
cubic centimeter, 10E-6 cubic meter, or approximately to
0.061 023 7 cubic inch.(NCI)
Any period of seven consecutive days.(NCI)                           Week
One of the 12 divisions of a year as determined by a calendar.       Month
It corresponds to the unit of time of approximately to one cycle
of the moon's phases, about 30 days or 4 weeks.(NCI)

The period of time that it takes for earth to make a complete        Year
revolution around the sun, approximately 365 days; a specific
one year period.(NCI)
A meter is defined as the length of the path traveled by light in    Meter
a vacuum during a time interval of 1/299 792 458 of a second
and is equal to 1.093 61 yards.(NCI)
A unit of time, which is equal to one thousandth of a                Millisecond
second.(NCI)
The second is a unit of time with a duration of 919 263 177 0        Second
periods of the specified light radiation corresponding to the
transition between the two hyperfine levels of the cesium 133
atom in its ground state at 0 K. According to the convention,
60 seconds constitute one minute; 3,600 seconds constitute
one hour. Abbreviation Sec. is acceptable in non-scientific
usage only.(NCI)
A unit of electric current, named after the French physicist         Ampere
Andre Ampere. It is that constant current which, if maintained
in two straight parallel conductors of infinite length and zero
diameter separated by one meter in a vacuum, would produce
between these conductors a force equal to 2(10E7) Newton
per meter of length. This is dependent upon the definitions of
the meter, kilogram, and second. One Ampere represents
6.24 x 10(E18) unit electric charge carriers, such as electrons,
passing a specified fixed point in one second.(NCI)

The candela is the basic unit of luminous intensity. It is the       Candela
luminous intensity in a given direction of a small
monochromatic light source at 540 terahertz emitting 1/683
watt per steradian in that direction. This is dependent upon
the definitions of the meter, kilogram, and second.(NCI)
A unit defined as the amount of substance that contains as           Mole
many elementary units as there are atoms in 0.012 kg of
carbon-12. When the mole is used, the elementary entities
must be specified and may be atoms, molecules, ions,
electrons, other particles, or specified groups of such
particles.(NCI)
A unit of frequency equal to one cycle per second.(NCI)              Hertz
A unit of force which, when applied in a vacuum to a body            Newton
having a mass of one kilogram, causes an acceleration of one
meter/sec(2). It is equal to 10E5 dynes.(NCI)
A unit of pressure equivalent to one Newton per square meter         Pascal
or 10 bars or to 1.45x10(E-4) pounds per square inch.(NCI)

A unit of electrical, mechanical, and thermal energy (as well    Joule
as work and quantity of heat), equal to the work done when
the point of application of a force of one Newton is displaced
through a distance of one meter in the direction of the force or
the work done when a current of one Ampere passes through
a resistance of one ohm for one second. One joule is equal to
0.23889 gram-calorie (mean).(NCI)

A unit of power equal to the power which in one second               Watt
produces or transfers the energy of one joule. The unit is used
in measurements of power emitted, transferred or received as
radiation, sound waves, heat flow rate, and rate of energy
transfer. Equal to 1/746 of horsepower.(NCI)
A unit of quantity of electricity, equal to the quantity of charge   Coulomb
transferred in one second across a conductor in which there
is a constant current of one Ampere.(NCI)
A unit of electric potential and electromotive force, equal to       Volt
the difference of electric potential between two points on a
conducting wire carrying a constant current of one Ampere
when the power dissipated between the points is one watt.
This is equivalent to the potential difference across a
resistance of one ohm when one Ampere of current flows
through it.(NCI)
A unit of capacitance equal to the capacitance of a capacitor        Farad
having an equal and opposite charge of one coulomb on each
plate and a potential difference of one volt between the
plates.(NCI)
A unit of equivalent radiation dose. One Sv is received when         Sievert
the actual absorbed dose of ionizing radiation, after being
multiplied by the dimensionless factors Q (the relative
biological efficiency or quality factor) and N (the product of
any other multiplying factors that takes into account the
distribution of energy throughout the dose), is one joule per
kilogram. In this scheme, the relationship between the
absorbed dose of radiation D and the dose equivalent H is,
therefore, given by H = QND. Both Q and N are stipulated by
the International Commission on Radiological Protection. One
Sv is equal to 100 rem.(NCI)
A unit of electrical resistance equal to the resistance between Ohm
two points on a conductor when a potential difference of one
volt between them produces a current of one Ampere. Ohm is
also used to measure impedance and reactance for complex
resistance. A measurement in ohms is the reciprocal of a
measurement in siemens.(NCI)
A unit of electrical conductance, admittance, and                Siemens
susceptance. A conductor has a conductance of one siemens
if an electrical potential difference of one volt produces a one
Ampere current in it. The conductance in siemens is the
reciprocal of its resistance in ohms.(NCI)
A unit of magnetic flux, equal to the flux that produces in a    Weber
circuit of one turn an electromotive force of one volt, when the
flux is uniformly reduced to zero within one second.(NCI)

A unit of magnetic flux density equal to the magnitude of the Tesla
magnetic field vector necessary to produce a force of one
Newton on a charge of one coulomb moving perpendicular to
the direction of the magnetic field vector with a velocity of one
meter per second. It is equivalent to one Weber per square
meter.(NCI)
A unit of electric inductance. A coil with an inductance of one Henry
Henry requires a flux of one weber for each Ampere of
induced current. If it is the current which changes, then the
induced field will generate a potential difference within the
coil: if the inductance is one henry a current change of one
Ampere per second generates a potential difference of one
volt. The Henry is a large unit; inductances in practical circuits
are measured in millihenrys or microhenrys.(NCI)

A unit of temperature, named after the Swedish astronomer            Degree Celsius
Anders Celsius, who first proposed the temperature scale
designed so that the freezing point of water is 0 degrees and
the boiling point is 100 degrees at standard atmospheric
pressure. The current official definition of the Celsius sets
0.01 C to be at the triple point of water and a degree to be
1/273.16 of the difference in temperature between the triple
point of water and absolute zero. One degree Celsius
represents the same temperature difference as one
Kelvin.(NCI)
A unit of luminous flux. It is the amount of light that falls on a   Lumen
unit area at unit distance from a source of one candela.(NCI)

A unit of illuminance equal to the direct illumination on a          Lux
surface that is everywhere one meter from a uniform point
source of one candela; a unit of illuminance that is equal to
one lumen per square meter.(NCI)
A unit of activity of a radionuclide, equal to one nuclear           Becquerel
disintegration or other nuclear transition from a particular
energy state occurring in an amount of a radionuclide during
one second-long time interval.(NCI)
A unit for measuring catalytic (e.g. enzymatic) activity, the       Katal
ability of the compound to accelerate the chemical reaction by
providing a lower energy pathway between the reactants and
the products. One katal is that catalytic activity which will raise
the rate of reaction by one mole per second in a specified
assay system. When the katal is used, the measurand should
be specified by reference to the measurement procedure; the
measurement procedure must identify the indicator reaction.
The katal is not used to express a rate of reaction itself, which
should be expressed in moles per second.(NCI)

The SI unit of area measurement equal to a square whose              Square Meter
sides are one meter long. Square meter is equal to 10,000
square centimeters; 0.01 are; 1.196 square yards; 10.76
square feet; 1550 square inches. (NCI)
A unit of volume or capacity equal to the volume of a cube           Cubic Meter
with edges one meter in length. It is equal to 1,000 liters;
1,000 cubic decimeters; 10(E6) cubic centimeters; 25.3 cubic
feet; 6.29 barrels.(NCI)
A unit of both speed (scalar) and velocity (vector), defined as      Meter Per Second
the distance of one meter travelled per unit time equal to one
second.(NCI)
A unit of mass concentration defined as the concentration of         Kilogram per Cubic Meter
one kilogram of a substance per unit volume of the mixture
equal to one cubic meter, or the concentration of one
milligram of a substance per unit volume of the mixture equal
to one milliliter, or one gram of a substance per one liter of the
mixture. It is also a unit of mass density (volumic mass)
defined as the density of substance which mass equal to one
milligram occupies the volume one milliliter.(NCI)

The Fahrenheit temperature scale is named after the German Degree Fahrenheit
physicist Gabriel Fahrenheit (1686-1736), who proposed it in
1724. In this scale, the freezing point of water is 32 degrees
Fahrenheit and the boiling point is 212 degrees, placing the
boiling and melting points of water 180 degrees apart. In this
scale a degree Fahrenheit is 5/9ths of a Kelvin (or of a degree
Celsius), and minus 40 degrees Fahrenheit is equal to minus
40 degrees Celsius. (NCI)(NCI)

A measure of the acidity or alkalinity of a fluid on a scale of 0    pH
to 14.(NCI)
The unit of mass equal to one millionth of a gram or one             Microgram
thousandth of a milligram.(NCI)
A unit measure of time equal to 60 seconds.(NCI)                     Minute
A metric unit of mass equal to one one thousandth of a               Gram
kilogram. (NCI)
A unit of area measurement equal to a square measuring one           Square Centimeter
centimeter on each side. One square centimeter is equal to
10E-4 square meter.(NCI)
A unit of area equal to 144 square inches, 929.0304 square           Square Foot
centimeters, or 9.290304E-2 square meters.(NCI)
A unit of radioactivity defined as 3.7 E10 atomic                  Curie
disintegrations or other nuclear transformations per second.
One Curie is equal to 37 gigabecquerels.(NCI)
A dosing measurement based on the ampule unit.(NCI)                Ampule Dosing Unit
A dosing measurement based on the bag unit.(NCI)                   Bag Dosing Unit
A dosing measurement based on the bar unit.(NCI)                   Bar Dosing Unit
A dosing measurement based on the bolus unit.(NCI)                 Bolus Dosing Unit
A dosing measurement based on the bottle unit.(NCI)                Bottle Dosing Unit
A dosing measurement based on the box unit.(NCI)                   Box Dosing Unit
A dosing measurement based on the can unit.(NCI)                   Can Dosing Unit
A dosing measurement based on the capsule unit.(NCI)               Capsule Dosing Unit
A dosing measurement based on the cartridge unit.(NCI)             Cartridge Dosing Unit
A dosing measurement based on the coat unit.(NCI)                  Coat Dosing Unit
A dosing measurement based on the container unit.(NCI)             Container Dosing Unit
A dosing measurement based on the cylinder unit.(NCI)              Cylinder Dosing Unit
A dosing measurement based on the disk unit.(NCI)                  Disk Dosing Unit
A dosing measurement based on the drum unit.(NCI)                  Drum Dosing Unit
A unit of mass derived from the weight of a grain and equal to     Grain
one seven-thousandth of a pound, or 1/480 troy ounce, or
64.79891 milligrams. The original English grain unit based on
the mass of a ripe grain barleycorn was larger the
corresponding grain units of France and other European
nations which were based on the weight of the smaller wheat
grain.(NCI)
A dosing measurement based on the homeopathic dilution             Homeopathic Dilution Unit
unit.(NCI)
A dosing measurement based on the implant unit.(NCI)               Implant Dosing Unit
A traditional unit of length equal to 2.54 centimeters. (NCI)      Inch
A dosing measurement based on the inhalation unit.(NCI)            Inhalation Dosing Unit
A dosing measurement based on the jar unit.(NCI)                   Jar Dosing Unit
A dosing measurement based on the Kallikrein inhibitor             Kallikrein Inhibitor Unit
unit.(NCI)
A dosing measurement based on the kit unit.(NCI)                   Kit Dosing Unit
A unit of volume equal to a cubic decimeter, or one                Liter
thousandth of cubic meter, or 1000 cubic centimeters, or
approximately 61.023 744 cubic inches.(NCI)
A dosing measurement based on the lozenge unit.(NCI)               Lozenge Dosing Unit
A unit of radioactivity equal to one millionth of a Curie or 37    Microcurie
kilobecquerels, and corresponding to a radioactivity of 37 000
atomic disintegrations per second.(NCI)
A unit of amount of substance equal to one millionth (10E-6)       Micromole
of a mole.(NCI)
A unit of length in metric system equal to 10E-6 meter, or         Micron
micrometer.(NCI)
A unit of radioactivity equal to one thousandth of a Curie or 37   Millicurie
megabecquerels, and corresponding to a radioactivity of 37
millions of atomic disintegrations per second.(NCI)

A unit of relative amount of a substance equal to one              Milliequivalent
thousandth of an equivalent weight.(NCI)
A unit of amount of substance equal to 0.001 mole.(NCI)            Millimole
A unit of mass equal to one billionth (10E-9) of a gram, or one     Nanogram
millionth (10E-6) of a milligram.(NCI)
A unit of amount of substance equal to one billionth (10E-9) of     Nanomole
a mole.(NCI)
A unit of mass, the avoirdupois ounce is equal to 1/16 pound,       Ounce
or 28.3495 grams, or 0.911 457 troy ounce.(NCI)
A dosing measurement based on the package unit.(NCI)                Package Dosing Unit
A dosing measurement based on the packet unit.(NCI)                 Packet Dosing Unit
A unit of measurement referring to one entity counted per one       Part Per Million
million entities.(NCI)
A dosing measurement based on the patch unit.(NCI)                  Patch Dosing Unit
A dosing measurement based on the pellet unit.(NCI)                 Pellet Dosing Unit
A percent ratio of weight to volume, defined by the equation:       Percent Mass per Volume
[weight of solute (in gm)/volume of solution (in dl)](100). Since
the numerator and denominator of this ratio have different
units, it is not a true percentage. A 1% w/v solution is defined
as being 1 gram of solute dissolved in 100 milliliters of
solvent.(NCI)
A percent ratio of weight to weight, defined by the equation:       Percent Mass per Mass
[weight of solute (in gm)/weight of solution (in gm)](100).(NCI)

A dosing measurement based on the pouch unit.(NCI)                  Pouch Dosing Unit
A traditional unit of mass. By international agreement, one         Pound
avoirdupois pound is equal to exactly 0.453 592 37 kilogram,
16 ounces, or 1.215 28 troy pounds. (NCI)
A dosing measurement based on the pressor unit.(NCI)                Pressor Unit
A dosing measurement based on the scoopful unit.(NCI)               Scoopful Dosing Unit
A dosing measurement based on the spray unit.(NCI)                  Spray Dosing Unit
A dosing measurement based on the strip unit.(NCI)                  Strip Dosing Unit
A dosing measurement based on the suppository unit.(NCI)            Suppository Dosing Unit

A dosing measurement based on the syringe unit.(NCI)                Syringe Dosing Unit
A unit of volume informally used in pharmacy. The tablespoon        Tablespoon Dosing Unit
has been standardized at 15 milliliters in US, Britain, Canada,
and New Zealand, and at 20 milliliters in Australia and some
European countries.(NCI)
A dosing measurement based on the tablet unit.(NCI)                 Tablet Dosing Unit
A dosing measurement based on the tampon unit.(NCI)                 Tampon Dosing Unit
A unit of volume used in pharmacy equal to 5 milliliters.(NCI)      Teaspoon Dosing Unit

An extremely small amount.(NCI)                                     Trace Dosing Unit
A dosing measurement based on the troche unit.(NCI)                 Troche Dosing Unit
A dosing measurement based on the tube unit.(NCI)                   Tube Dosing Unit
A dosing measurement based on the vial unit.(NCI)                   Vial Dosing Unit
A dosing measurement based on the wafer unit.(NCI)                  Wafer Dosing Unit
A unit of length equal to 3 feet, or 36 inches, or 0.9144           Yard
meter.(NCI)
A unit of concentration (molarity unit) equal to one mole of        Mole per Liter
solute in one liter of solution.(NCI)
A percent ratio of volume to volume, defined by the equation:       Percent Volume per Volume
[volume of solute (in ml)/ volume of solution (in ml)](100),
typically used for admixtures of solutions.(NCI)
The unitage assigned by the WHO (World Health                  International Unit
Organization) to International Biological Standards -
substances, classed as biological according to the criteria
provided by WHO Expert Committee on Biological
Standardization (e.g. hormones, enzymes, and vaccines), to
enable the results of biological and immunological assay
procedures to be expressed in the same way throughout the
world. The definition of an international unit is generally
arbitrary and technical, and has to be officially approved by
the International Conference for Unification of Formulae.(NCI)

A quantity of an ingredient or product needed to bring up a        Quantity Sufficient
volume or weight of the preparation to a final amount as it is
indicated in the prescription; also refers to a determination of
an adequate supply of medicine to fulfill either a prescribed
amount or a sufficient quantity to provide treatment over a
specified time frame.(NCI)
A basic unit of length equal to one hundredth of a meter or        Centimeter
approximately 0.393 700 787 inch (NCI)
A unit of pressure equal to 0.001316 atmosphere and equal to       Millimeter of Mercury
the pressure indicated by one millimeter rise of mercury in a
barometer at the Earth's surface.(NCI)
A unit expressed as kilogram of mass per square meter of           Kilogram Per Square Meter
area.(NCI)
The number of heartbeats measured per minute time.(NCI)            Beats per Minute
The number of breaths (inhalation and exhalation) taken per        Breaths per Minute
minute time.(NCI)
A dosing measurement based on the cup unit.(NCI)                   Cup Dosing Unit
A unit of pressure, equal to a barometer reading of 760 mm         Atmosphere
Hg. 1 atmosphere is 101325 pascals and 1.01325 bar. This
unit of pressure is roughly equal to the average atmospheric
pressure at sea level on the earth.(NCI)
A dosing measurement based on the ring unit.(NCI)                  Ring Dosing Unit
A unit of concentration (molarity unit) equal to one thousandth    Millimole per Liter
of a mole (10E-3 mole) of solute per one liter of solution.(NCI)


A unit of mass equal to one trillionth of a gram (10E-12           Picogram
gram).(NCI)
A unit of mass equal to one quadrillionth of a gram (10E-15        Femtogram
gram).(NCI)
A unit of mass equal to one quintillionth of a gram (10E-18        Attogram
gram).(NCI)
A unit of mass equal to one hundredth of a gram.(NCI)              Centigram
A unit of mass equal to 1/16 Avoirdupois ounce or 1/256            Dram Mass Unit
Avoirdupois pound. One dram equals approximately
1.7718451953125 grams.(NCI)
A unit of mass concentration defined as the concentration of         Kilogram per Liter
one kilogram of a substance in unit volume of the mixture
equal to one liter. The concept also refers to the unit of mass
density (volumic mass) defined as the density of substance
which mass equal to one kilogram occupies the volume one
liter.(NCI)
A unit of mass concentration equal to the concentration of one       Microgram per Milliliter
gram of a substance per unit volume of the mixture equal to
one cubic meter. The concept also refers to the metric unit of
mass density (volumic mass) defined as the density of
substance which mass equal to one gram occupies the
volume one cubic meter.(NCI)
A metric unit of volumetric flow rate defined as the rate at         Milliliter per Minute
which one milliliter of matter travels during the period of time
equal to one minute.(NCI)
A unit of mass concentration defined as the concentration of         Gram per Deciliter
one gram of a substance per unit volume of the mixture equal
to one deciliter (100 milliliters). The concept also refers to the
metric unit of mass density (volumic mass) defined as the
density of substance which mass equal to one gram occupies
the volume one deciliter.(NCI)
A unit of amount of substance equal to a trillionth (10E-12) of      Picomole
a mole.(NCI)
A means of delivering a defined dose of a therapeutic                Puff Dosing Unit
aerolized solution into either the upper or lower respiratory
tract. Metered-dose inhalers or spray pumps are devices that
provide a puff dose for delivery into either the oral or the nasal
cavity.(NCI)
A unit of area measurement equal to a square measuring one           Square Millimeter
millimeter on each side. One square millimeter is equal to
10(E-2) square centimeter and 10(E-6) square meter.(NCI)

An arbitrary unit of tuberculin dosage defined by comparison         Tuberculin Unit
of clinical response with a preparation of the purified protein
derivative standardized for use in humans for tuberculin skin
test reaction.(NCI)
A unit of volumetric flow rate defined as the rate at which one      Milliliter per Hour
milliliter of matter travels during the period of time equal to
one hour.(NCI)
The number of occurrences of something within a second of            Per Second
time.(NCI)
The number of occurrences of something within a minute of            Per Minute
time.(NCI)
A unit of mass flow rate equivalent to the rate at which one         Milligram per Hour
thousandth of a gram of matter travels to a given object or
space over a period of time equal to one hour.(NCI)
A unit of mass concentration defined as the concentration of Milligram per Deciliter
one milligram of a substance in unit volume of the mixture
equal to one cubic deciliter or 100 cubic centimeters. It is also
a unit of mass density (volumic mass) defined as the density
of substance which mass equal to one milligram occupies the
volume one cubic deciliter or 100 cubic centimeters.(NCI)

A measurement of nutritional energy. The quantity of thermal calorie
energy required to raise one gram of water one degree
Centigrade under standard conditions. 1 calorie equals 4.186
joules. (NCI)
A unit of energy defined as the amount of heat required to      Calorie
raise the temperature of one kilogram of pure water by one
degree Centigrade under standard conditions (the specific
heat of the water at 15 degrees Celsius and the constant
pressure of 101.325 kilopascals or one atm being defined as
unity), equal to approximately 4.1855 kJ. It is also is used by
nutritionists in measuring the energy-producing potential of
food as a unit of potential energy contained by a substance,
which can be liberated when the material is oxidized, usually
by combustion in the presence of oxygen.(NCI)

A measure of viable infectious entities (e.g. viral particle or Plaque Forming Unit
group of particles) in the specimen or product defined as the
smallest quantity that can produce a cytopathic effect in the
host cell culture challenged with the defined inoculum, visible
under the microscope or/and to the naked eye as a plaque. A
number of plaque forming units (PFU) per unit volume is a
conventional way to refer the titer of an infective entity in a
specimen or preparation.(NCI)

A unit of relative amount of a substance that combines with or Equivalent Weight
displaces 8.0 grams of oxygen or 1.008 gram of hydrogen.
The unit is usually expressed in grams and is equal to the
amount of substance that gains or loses one mole of
electrons in a redox reaction, or to the amount of substances
that releases or accepts one mole of hydrogen ions in a
neutralization reaction; or to the amount of electrolyte that
carries one mole of positive or negative charge. This is a large
unit and measurements are more often done in its derivatives,
e.g. in milliequivalents.(NCI)

The area visible under the maximum magnification power of      High Power Field
the objective being used in microscopy.(NCI)
A unit of area density defined as a spread rate at which one   Gram per Square Meter
gram of a substance is spread over the area of one square
meter. It is equal to approximately 0.029 4935 ounce per
square yard. Also used as a dose calculation unit.(NCI)
A unit of mass concentration defined as the concentration of       Microgram per Liter
one microgram of a substance per unit volume of the mixture
equal to one liter. The concept also refers to the unit of mass
density (volumic mass) defined as the density of substance
which mass equal to one microgram occupies the volume one
liter.(NCI)
The area visible in one view field of the microscope under the     Low Power Field
low magnification of the objective being used in
microscopy.(NCI)
A unit of electric potential and electromotive force equal to      Millivolt
one thousandth of a volt.(NCI)
A unit of mass concentration defined as the concentration of       Nanogram per Deciliter
one nanogram of a substance in unit volume of the mixture
equal to one deciliter. The concept also refers to the unit of
mass density (volumic mass) defined as the density of
substance which mass equal to one nanogram occupies the
volume one deciliter.(NCI)
A unit of mass concentration defined as the concentration of       Nanogram per Liter
one nanogram of a substance per one liter of the mixture, or
one picogram of a substance in unit volume of the mixture
equal to one milliliter, or one microgram of a substance per
one cubic meter of the mixture. The concept also refers to the
metric unit of mass density (volumic mass) defined as the
density of substance which mass equal to one nanogram
occupies the volume one liter.(NCI)

A unit of length equal to one billionth of a meter (10E-9        Nanometer
meter). Nanometer is used as a unit for light wavelength
measurement.(NCI)
A unit of osmotic pressure equal to that of an ideal solution of Osmole
a nondissociating substance that has a concentration of one
mole of solute per liter of solution.(NCI)

A unit of pressure equivalent to 6.894757 kilopascals, or          Pound per Square Inch
703.0696 kilograms per square meter, or 51.71507
millimeters of mercury.(NCI)
A unit of biological activity equal to one million international   Million International Units
units.(NCI)
A unit of radioactivity equal to one billionth of Curie or 37      Nanocurie
Becquerels, and corresponding to a radioactivity of 37 atomic
disintegrations per second.(NCI)
Unit of arbitrary substance concentration (biologic activity       International Unit per Liter
concentration) defined as the concentration of one
international unit per one liter of system volume.(NCI)
Unit of arbitrary substance concentration (biologic activity       International Unit per Milliliter
concentration) defined as the concentration of one
international unit per one milliliter of system volume.(NCI)
An arbitrary unit of substance content expressed in                International Unit per Kilogram
international units of biological activity per one kilogram of
mass of the system. It is also used as a dose calculation unit
expressed in international units of biological activity per one
kilogram of body mass.(NCI)
Unit of arbitrary substance concentration (biologic activity         International Unit per Milligram
concentration) defined as the concentration of one
international unit per one milligram of substance.(NCI)
A unit of volumetric flow rate defined as the rate at which one      Liter per Minute
liter of matter travels during the period of time equal to one
minute.(NCI)
A unit of mass flow rate equivalent to the rate at which one         Microgram per Hour
millionth of a gram of matter travels to a given object or space
over a period of time equal to one hour.(NCI)
A unit of a mass fraction expressed as a number of                   Microgram per Kilogram
micrograms of substance per kilogram of mixture. The unit is
also used as a dose calculation unit.(NCI)
Unit of catalytic activity concentration defined as activity equal   Microkatal per Liter
to one millionth of katal per one liter of the system
volume.(NCI)
A unit of measure referring to the ratio between mass                Milligram per 24 Hours
expressed in milligrams per day.(NCI)
A unit of a mass fraction expressed as a number of milligrams        Milligram per Kilogram
of substance per kilogram of mixture. The unit is also used as
a dose calculation unit.(NCI)
A unit of area density equal to approximately 2.94935E-5             Milligram per Square Meter
ounce per square yard. Also used as a dose calculation
unit.(NCI)
A unit of amount of substance flow rate equivalent to the rate       Micromole per 24 Hours
at which one millionth of a mole of substance travels to a
given object or space over a period of time equal to 24
hours.(NCI)
A unit of both speed (scalar) and velocity (vector), defined as      Millimeter per Hour
the distance of one millimeter travels per unit time equal to
one hour.(NCI)
A unit of amount of substance flow rate equivalent to the rate       Millimole per 24 Hours
at which one thousandth of a mole of substance travels or is
delivered to a given object or space over a period of time
equal to 24 hours.(NCI)
A unit of concentration (molarity unit) equal to one billionth of    Nanomole per Liter
a mole (10E-9 mole) of solute in one liter of solution.(NCI)

A unit of concentration (molarity unit) equal to one trillionth of   Picomole per Liter
a mole (10E-12 mole) in one liter of solution.(NCI)

The unit of concentration of Ribonucleic Acid (RNA) copies     RNA Copy per Milliliter
expressed as a number of copies in unit volume equal to one
milliliter.(NCI)
A unit of relative amount of substance flow rate equivalent to Milliequivalent per 24 Hours
the rate at which one thousandth of an equivalent of
substance travels to a given object or space over a period of
time equal to twenty four hours.(NCI)
A concentration unit measured as a number of                   Milliequivalent per Liter
milliequivalents of solute per liter of solution.(NCI)
A unit of relative amount of substance content equivalent to        Milliequivalent per Kilogram
the content at which one kilogram of mixture contains one
thousandth of an equivalent of a component. The unit is also
used as a dose calculation unit.(NCI)
A unit of plane angle measurement equal to the length of the        Degree Unit of Plane Angle
arc cut out by the angle, divided by the circumference of the
circle, and multiplied by 360. The symbol for degrees is a
small superscript circle. One radian is about 57 degrees and
one degree is pi/180 radians.(NCI)
A unit of amount of substance equal to one tenth of a mole          Decimole
(10E-1 mole).(NCI)
A unit of amount of substance equal to one hundredth of a           Centimole
mole (10E-2 mole).(NCI)
A unit amount of substance content (molality unit) defined as       Mole per Kilogram
one mole of solute per one kilogram of solvent.(NCI)
A unit of amount of substance equal to one quadrillionth of a       Femtomole
mole (10E-15 mole).(NCI)
A unit of amount of substance equal to one quintillionth of a       Attomole
mole (10E-18 mole).(NCI)
A unit used in physical chemistry to express the amount of          Standard Cubic Meter
substance of an ideal gas in one cubic meter at standard
conditions: temperature 273.15 K and pressure of one
atmosphere (101.325 kilopascals).(NCI)
A unit used in physical chemistry to express the amount of          Standard Cubic Foot
substance of an ideal gas in one cubic foot at 60 degrees
Fahrenheit and pressure of one atmosphere.(NCI)
A unit of area equal to the area of a square with sides of one      Square Inch
inch. It is equal to 6.4516 square centimeters.(NCI)
A unit for measuring concentration or/and reactivity of a test      Enzyme-Linked Immunosorbent
substance (an antigen or antibody of interest) as defined in        Assay Unit
the literature reference standard for the particular quantitative
enzyme-linked immunosorbent assay method. The enzyme-
linked immunosorbent assay unit is used to express potency
of immunologically active substances and products, e.g.
vaccines.(NCI)
A unit for measuring potency of immunologically active              Enzyme-Linked Immunosorbent
substance in a product determined as reactivity in a                Assay Unit per Dose
quantitative immunoassay for particular antigen or antibody
and expressed per quantity of preparation used as a single
dose.(NCI)
A unit for measuring potency of immunologically active              Enzyme-Linked Immunosorbent
substance in a product determined as reactivity in a                Assay Unit per Milliliter
quantitative immunoassay for particular antigen or antibody
and expressed per unit volume equal to one milliliter.(NCI)

A logarithmic-scale (base 10) unit for measuring                Log10 Enzyme-Linked
concentration and/or reactivity of a test substance (an antigen Immunosorbent Assay Unit
or antibody of interest) as defined in the literature reference
for the particular quantitative enzyme-linked immunosorbent
assay method.(NCI)
A logarithmic-scale (base 10) unit for measuring potency of       Log10 Enzyme-Linked
immunologically active substance in a product determined as       Immunosorbent Assay Unit per
reactivity in a quantitative immunoassay for particular antigen   Dose
or antibody and expressed per quantity of preparation used as
a single dose.(NCI)
A unit of concentration (molarity unit) equal to one mole of      Mole per Milliliter
solute in one milliliter of solution.(NCI)
A unit of amount of substance content (molality unit) defined     Millimole per Kilogram
as one thousandth of mole (10E-3 mole) of solute per one
kilogram of solvent.(NCI)
A unit of amount of substance content (molality unit) defined     Mole per Gram
as one mole of solute per one gram of solvent.(NCI)

A unit of amount of substance content (molality unit) defined     Mole per Milligram
as one mole of solute per one milligram of solvent.(NCI)

A unit of measurement of viable bacterial numbers equal to        Thousand Colony Forming Units
10E3 colony forming units.(NCI)
A unit of measurement of viable bacterial numbers equal to        Million Colony Forming Units
10E6 colony forming units.(NCI)
A unit of measurement of viable bacterial numbers equal to        Billion Colony Forming Units
10E9 colony forming units.(NCI)
A unit of measurement of viable bacterial organisms in a unit     Colony Forming Unit per Gram
mass of substance of interest defined as the number of
colony forming units in one gram of substance.(NCI)
A unit of measurement of viable bacterial organisms in a unit     Thousand Colony Forming Units
mass of substance of interest defined as the number of            per Gram
thousand colony forming units (10E3CFU) in one gram of
substance.(NCI)
A unit of measurement of viable bacterial organisms in a unit     Million Colony Forming Units per
mass of substance of interest defined as the number of            Gram
million colony forming units (10E6CFU) in one gram of
substance.(NCI)
A unit of measurement of viable bacterial organisms in a unit     Billion Colony Forming Units per
mass of substance of interest defined as the number of billion    Gram
colony forming units (10E9CFU) in one gram of
substance.(NCI)
A unit of measurement of viable bacterial organisms in a unit     Colony Forming Unit per Milliliter
volume of substance of interest defined as the number of
colony forming units in one milliliter of substance.(NCI)
A unit of measurement of viable bacterial organisms in a unit     Thousand Colony Forming Units
volume of substance of interest defined as the number of          per Milliliter
thousand colony forming units (10E3CFU) in one milliliter of
substance.(NCI)
A unit of measurement of viable bacterial organisms in a unit     Million Colony Forming Units per
volume of substance of interest defined as the number of          Milliliter
million colony forming units (10E6CFU) in one milliliter of
substance.(NCI)
A unit of measurement of viable bacterial organisms in a unit     Billion Colony Forming Units per
volume of substance of interest defined as the number of          Milliliter
billion colony forming units (10E9CFU) in one milliliter of
substance.(NCI)
The unit of magnetic flux density. A field of one Gauss exerts    Gauss
a force on a conductor, placed in the field of 0.1 dyne per
Ampere of current per centimeter of conductor. One Gauss
represents a magnetic flux of one Maxwell per square
centimeter of cross-section perpendicular to the field. One
Gauss equals 10-4 tesla.(NCI)
A unit of spread rate of a substance by mass expressed in         Kilogram Per Square Centimeter
kilograms per area unit equal to one square centimeter, used
also as a measure of area density and as a dose calculation
unit.(NCI)
A unit of a mass fraction expressed as a number of grams of       Gram per Kilogram
substance per kilogram of mixture. The unit is also used as a
dose calculation unit.(NCI)
A unit of proportion equal to 10E-3.(NCI)                         Part per Thousand
A unit of length equal to one trillionth of a meter (10E-12       Picometer
meter).(NCI)
A unit of volume fraction expressed as a number of microliters    Microliter per Milliliter
of the constituent per the volume of the system represented in
milliliters.(NCI)
A unit of volume equal to one billionth of a liter (10E-9         Nanoliter
liter).(NCI)
A unit of volume equal to 0.05 milliliter (20 drops/ml).(NCI)     Medical Drop
A unit of fraction expressed as the ratio of the amount of        Mole per Mole
substance of solute in moles to the amount of substance of
the mixture in moles.(NCI)
A unit of frequency equal to one revolution per unit of time      Revolution per Minute
equal to one minute.(NCI)
A unit of force defined as the force that accelerates a mass of   Dyne
one gram at the rate of one centimeter per second squared.
One dyne is equal to 10E-5 Newton and 2.248E-6 pounds of
force.(NCI)
A potency unit for measuring infectious activity of a biologic    Log10 50 Percent Embryo
product or infectious agent equal to a base-10 logarithm of       Infective Dose
amount of product or agent preparation that causes infection
in the 50% of embryos (such as chicken embryos) used in the
product potency assay or pathogen activity assay.(NCI)

A logarithmic-scale (base 10) potency unit for measuring          Log10 50 Percent Embryo
infectious activity of a biologic product or infectious agent     Infective Dose per Dose
preparation equal to the potency at which one dose of
infectious material contains one 50 percent embryo infective
dose.(NCI)
A potency unit for measuring infectious activity of a biologic    Log10 50 Percent Cell Culture
product or infectious agent preparation equal to a base-10        Infective Dose
logarithm of amount of product or agent preparation that
causes infection in the 50% of the cell culture-containing
vessels inoculated with that dilution of infectious material in
the product potency assay or pathogen activity assay.(NCI)
A logarithmic-scale (base 10) potency unit for measuring             Log10 50 Percent Cell Culture
infectious activity of a biologic product or infectious agent        Infective Dose per Dose
preparation equal to the potency at which one dose of
infectious material contains one 50 percent cell culture
infective dose.(NCI)
A potency unit for measuring infectious activity of a biologic       Log10 50 Percent Tissue Culture
product or infectious agent preparation equal to a base-10           Infective Dose
logarithm of amount of product or agent preparation that
causes infection in the 50% of the tissue culture-containing
flasks inoculated with that dilution of infectious material in the
product potency assay or pathogen activity assay.(NCI)

A logarithmic-scale (base 10) potency unit for measuring             Log10 50 Percent Tissue Culture
infectious activity of a biologic product or infectious agent        Infective Dose per Dose
preparation equal to the potency at which one dose of
infectious material contains one 50 percent tissue culture
infective dose.(NCI)
A unit equal to one thousand international units.(NCI)               Kilointernational Unit
A unit of measure of quantity of substance per unit mass,            International Unit per Gram
expressed in terms of the International Unit per grams.(NCI)

A unit of unfractionated or low molecular weight heparin             Anti-Xa Activity International Unit
anticoagulation potency determined as the amount that
neutralizes one unit of coagulation factor Xa preparation
defined as an international biological standard by WHO
(World Health Organization) First International Low Molecular
Weight Heparin Reference Standard.(NCI)
A specific anticoagulation activity of unfractionated or low         Anti-Xa Activity International Unit
molecular weight heparin on factor Xa, expressed as a                per Milliliter
number of international anti-Xa heparin units per one milliliter
of plasma.(NCI)
A measure of an antigen potency defined as a number of               Antigen Unit per Milliliter
antigen units per one milliliter of product.(NCI)
A unit of potency of poliovirus vaccine used for poliomyelitis       D Antigen Unit
prevention. The unit is poliovirus type-specific.(NCI)

A unit of potency of poliovirus vaccine expressed as a number D Antigen Unit per Milliliter
of D antigen units per one milliliter of vaccine
formulation.(NCI)
Unit of measure of potency of allergenic product expressed as Allergy Unit per Milliliter
a number of allergy units per one milliliter of formulation.(NCI)

A unit used for standardization of an allergenic product based Bioequivalent Allergy Unit
on evaluation of product potency against reference standard
in combined in vivo (skin test) and in vitro (IgE-based ELISA)
testing.(NCI)
A unit of biologic activity of tuberculin expressed as a number Tuberculin Unit per Milliliter
of arbitrary units of tuberculin in one milliliter of
preparation.(NCI)
A unit of catalytic activity measurement equal to one           Millikatal
thousandth of one katal (10E-3 katal).(NCI)
A unit of catalytic activity measurement equal to one billionth        Nanokatal
of one katal (10E-9 katal).(NCI)
A unit of catalytic activity measurement equal to trillionth of        Picokatal
one katal (10E-12 katal).(NCI)
A unit of catalytic activity concentration defined as the catalytic    Nanokatal per Liter
activity of the component equal to one billionth of one katal
(10E-9 katal) in the unit volume of the system equal to one
liter.(NCI)
A unit of radioactivity equal to one thousand nuclear                  Kilobecquerel
disintegrations or other nuclear transformations per second,
or to 10E3 becquerels.(NCI)
A unit of radioactivity equal to one million nuclear                   Megabecquerel
disintegrations or other nuclear transformations per second,
or to 10E6 becquerels.(NCI)
A unit of radioactivity equal to one billion nuclear                   Gigabecquerel
disintegrations or other nuclear transformations per second,
or to 10E9 becquerels.(NCI)
A unit of specific radioactivity (massic activity) equal to activity   Becquerel per Kilogram
of one Becquerel of the sample with total mass of one
kilogram.(NCI)
A unit of specific radioactivity (massic activity) equal to activity   Becquerel per Gram
of one Becquerel of the sample with total mass of one
gram.(NCI)
A unit of specific radioactivity (massic activity) equal to activity   Becquerel per Microgram
of one Becquerel of the sample with total mass of one
microgram.(NCI)



A unit of specific radioactivity (massic activity) equal to activity Becquerel per Milligram
of one Becquerel of the sample with total mass of one
milligram.(NCI)
A unit of specific radioactivity (massic activity) equal to activity Gigabecquerel per Gram
of one gigabecquerel of the sample with total mass of one
gram.(NCI)
A unit of specific radioactivity (massic activity) equal to activity Gigabecquerel per Microgram
of one gigabecquerel of the sample with total mass of one
microgram.(NCI)

A unit of specific radioactivity (massic activity) equal to activity Gigabecquerel per Milligram
of one gigabecquerel of the sample with total mass of one
milligram.(NCI)
A unit of specific radioactivity (massic activity) equal to activity Curie per Gram
of one Curie of the sample with total mass of one gram.(NCI)


A unit of specific radioactivity (massic activity) equal to activity Curie per Kilogram
of one Curie of the sample with total mass of one
kilogram.(NCI)
A unit of specific radioactivity (massic activity) equal to activity Curie per Microgram
of one Curie of the sample with total mass of one
microgram.(NCI)
A unit of specific radioactivity (massic activity) equal to activity   Curie per Milligram
of one Curie of the sample with total mass of one
milligram.(NCI)
Amount of infectious agent or biological product that causes           50 Percent Embryo Infective
infection in the 50% of embryos such as chicken embryos                Dose
used in the product potency assay or pathogen activity
assay.(NCI)
A potency unit for measuring infectious activity of a biologic         50 Percent Embryo Infective
product or an infectious agent preparation equal to the                Dose per Dose
potency at which one dose of infectious material contains one
50 percent embryo infective dose.(NCI)
A potency unit defined as a minimal dose of infectious                 50 Percent Cell Culture Infective
material at which preparation causes cytopathic effects                Dose
(changes in the morphology and metabolism of cell culture
cells, indicating cell death, due to suspected infection) in the
50% of the cell culture-containing vessels inoculated with that
dilution of infectious material.(NCI)
A potency unit equal to the potency at which one dose of               50 Percent Cell Culture Infective
preparation contains one 50 percent cell culture infective             Dose per Dose
dose.(NCI)
A potency unit equal to the potency at which one dose of               50 Percent Tissue Culture
preparation contains one 50 percent tissue culture infective           Infective Dose per Dose
dose.(NCI)
A unit of catalytic activity measurement equal to one millionth        Microkatal
of katal (10E-6 katal).(NCI)
A unit of measure referring to one entity counted per one              Per Billion
billion entities.(NCI)
A unit of measure referring to one entity counted per one              Per Trillion
trillion entities.(NCI)
A unit of specific radioactivity (massic activity) equal to activity   Millicurie per Kilogram
of one millicurie of the sample with total mass of one
kilogram.(NCI)
A unit of specific radioactivity (massic activity) equal to activity   Microcurie per Kilogram
of one microcurie of the sample with total mass of one
kilogram.(NCI)
A unit of exposure to ionizing radiation. One Roentgen is the          Roentgen
amount of gamma or x-rays required to produce ions resulting
in a charge of 2.58E-4 Coulombs/kilogram of air under
standard conditions.(NCI)
A concentration unit measured as a number of                           Milliequivalent per Microliter
milliequivalents of solute per microliter of solution.(NCI)
A unit of relative amount of substance content equivalent to           Milliequivalent per Gram
the content at which one gram of mixture contains one
thousandth of an equivalent of a component. The unit is also
used as a dose calculation unit.(NCI)
A unit of relative amount of substance content equivalent to           Milliequivalent per Microgram
the content at which one millionth of a gram of mixture
contains one thousandth of an equivalent of a component.
The unit is also used as a dose calculation unit.(NCI)
A unit of volumetric radioactivity concentration defined as a          Becquerel per Liter
concentration of a radionuclide with an activity equal to one
Becquerel per unit volume equal to one liter.(NCI)
A unit of volumetric radioactivity concentration defined as a      Becquerel per Microliter
concentration of a radionuclide with an activity equal to one
Becquerel per unit volume equal to one millionth of a
liter.(NCI)
A unit of volumetric radioactivity concentration defined as a      Becquerel per Milliliter
concentration of a radionuclide with an activity equal to one
Becquerel per unit volume equal to one milliliter or one
kilobecquerel per liter.(NCI)
A unit of volumetric radioactivity concentration defined as a      Kilobecquerel per Microliter
concentration of a radionuclide with an activity equal to one
thousand becquerels per unit volume equal to one millionth of
a liter.(NCI)
A unit of volumetric radioactivity concentration defined as a      Megabecquerel per Microliter
concentration of a radionuclide with an activity equal to one
million Becquerels per unit volume equal to one millionth of a
liter.(NCI)
A unit of volumetric radioactivity concentration defined as a      Curie per Liter
concentration of a radionuclide with an activity equal to one
Curie per unit volume equal to one liter.(NCI)
A unit of volumetric radioactivity concentration defined as a      Curie per Microliter
concentration of a radionuclide with an activity equal to one
Curie per unit volume equal to one millionth of a liter.(NCI)

A unit of volumetric radioactivity concentration defined as a      Curie per Milliliter
concentration of a radionuclide with an activity equal to one
Curie per unit volume equal to one milliliter.(NCI)
A unit of volumetric radioactivity concentration defined as a      Microcurie per Liter
concentration of a radionuclide with an activity equal to one
millionth of a Curie per unit volume equal to one liter.(NCI)

A unit of volumetric radioactivity concentration defined as a  Millicurie per Liter
concentration of a radionuclide with an activity equal to one
thousandth of a Curie per unit volume equal to one liter.(NCI)

A unit of an electric potential and electromotive force equal to   Microvolt
one millionth of a volt.(NCI)
A unit of frequency equal to the frequency at which one            Cycle per Minute
complete execution of a periodically repeated phenomenon,
alternation, event, or sequence of events occurs per unit of
time equal to one minute.(NCI)
A unit of distance equal to 1000 meters, 0.621 miles, 1094         Kilometer
yards, or 3281 feet.(NCI)
A unit of distance equal to 5280 international feet, 1760          Mile
international yards, or 1609.344 meters.(NCI)
A unit of arbitrary substance concentration (biologic activity     100 International Units per
concentration) defined as the concentration of one hundred         Milliliter
international units per one milliliter of system volume.(NCI)

A unit of measure of quantity of organisms expressed in            Thousand Organisms
thousands.(NCI)
A unit of measure of quantity of organisms expressed in            Million Organisms
millions.(NCI)
A unit of measure of quantity of organisms expressed in              Billion Organisms
billions.(NCI)
A unit of measure of organism content expressed in                   Thousand Organisms per Gram
thousands of organisms per unit of mass equal to one
gram.(NCI)
A unit of measure of organism content expressed in millions          Million Organisms per Gram
of organisms per unit of mass equal to one gram.(NCI)

A unit of measure of organism content expressed in billions of Billion Organisms per Gram
organisms per unit of mass equal to one gram.(NCI)

A unit of measure of organism content expressed in millions          Million Organisms per Milligram
of organisms per unit of mass equal to one milligram.(NCI)

A unit of measure of organism content expressed in billions of Billion Organisms per Milligram
organisms per unit of mass equal to one milligram.(NCI)

A unit of measure of organism concentration expressed in             Thousand Organisms per
thousands of organisms per unit of volume equal to one               Milliliter
milliliter.(NCI)
A unit of measure of organism concentration expressed in             Million Organisms per Milliliter
millions of organisms per unit of volume equal to one
milliliter.(NCI)
A unit of measure of organism concentration expressed in             Billion Organisms per Milliliter
billions of organisms per unit of volume equal to one
milliliter.(NCI)
A unit of potency of a biological product expressed as a             Plaque Forming Unit per Dose
quantity of viable infectious entities capable to produce a
cytopathic effect in the appropriate cell culture per a single
dose of the preparation.(NCI)
A unit of potency of a biological product expressed as a             Plaque Forming Unit per Milliliter
quantity of viable infectious entities capable to produce a
cytopathic effect in the appropriate cell culture per one
milliliter of the preparation.(NCI)
A logarithmic ratio unit (base-10 logarithms) used to express        Bel
relative magnitude of a physical quantity (usually power or
intensity) in comparison with a specified or implied reference
level. Particularly, Bel is used as a unit of relative sound
intensity. In the latter context it is equal to ten decibels or to
approximately 1.151293 nepers.(NCI)
A unit of area density defined as a spread rate at which one         Gram per Square Centimeter
gram of a substance is spread over the area of one square
centimeter. The unit is also used as a dose calculation
unit.(NCI)
A unit of potency equal to one thousand US Pharmacopoeia             Kilo United States
Units.(NCI)                                                          Pharmacopoeia Unit
A unit of both speed (scalar) and velocity (vector), defined as      Kilometer per Hour
the distance of one thousand meters travelled per unit time
equal to one hour.(NCI)
A unit of measurement based on the nebule dosing unit.(NCI)          Nebule Dosing Unit
A unit of mass flow rate equivalent to the rate at which one     Microgram per Day
millionth of a gram of matter travels to a given object or space
over a period of time equal to twenty four hours. Microgram
per day is also a dose administration rate unit equal to the
rate at which one millionth of a gram of a product is
administered per unit of time equal to twenty four hours.(NCI)

A dose calculation unit equal to one thousandth of a gram of a     Milligram per Kilogram per
preparation per one kilogram of body mass administered per         Minute
unit of time equal to one minute.(NCI)
A dose calculation unit equal to one international unit (an        International Unit per Kilogram
arbitrary unit of biological activity) of a product per one        per Hour
kilogram of body mass administered per unit of time equal to
one hour.(NCI)
A dose calculation unit equal to one millionth of a gram of a      Microgram per Kilogram per
preparation per one kilogram of body mass administered per         Minute
unit of time equal to one minute.(NCI)

A unit of mass flow rate equivalent to the rate at which one     Microgram per Minute
millionth of a gram of matter travels to a given object or space
over a period of time equal to one minute. Microgram per
minute is also a dose administration rate unit equal to the rate
at which one millionth of a gram of a product is administered
per unit of time equal to one minute.(NCI)

A unit of length defined by the U.S. National Bureau of            International Foot
Standards as 30.48 centimeters. It is equal to 0.3048 meter,
12 inches, or to approximately 0.999998 survey foot.(NCI)

An arbitrary dosing unit used predominantly for semisolid           Fingertip Unit
topical formulations such as cream, ointment, paste, etc. One
fingertip unit is the amount of a product that is squeezed out
from a standard tube with 5-millimeter diameter nozzle along
an adult's fingertip. A fingertip length is defined from the tip of
the index finger to the first finger crease. A fingertip dosing
unit varies with age and size of the body. The average
fingertip unit is equal to approximately 0.5 gram for an adult
male and 0.4 gram for an adult female.(NCI)

A dosing unit that contains a solid pharmaceutical preparation     Sachet Dosing Unit
in the form of a small packet or bag made from a flexible,
often porous material.(NCI)
A dose calculation unit equal to one thousandth of a gram of a     Milligram per Kilogram per Hour
preparation per one kilogram of body mass administered per
unit of time equal to one hour.(NCI)
A unit of frequency equal to the frequency at which one            Cycle per Second
complete execution of a periodically repeated phenomenon,
alternation, event, or sequence of events occurs per unit of
time equal to one second.(NCI)
Terminology codelist used for anatomical location within           CDISC SDTM Anatomical
CDISC.                                                             Location Terminology
Fleshy fold which surrounds the opening of the mouth. (NCI)         Lip

The bony anterior part of the roof of the mouth separating the      Hard Palate
nose from the mouth. (NCI)
The lower part of the pharynx that connects to the esophagus.       Hypopharynx
(NCI)
The area around the esophagogastric mucosal junction where          Gastric Cardia
the esophageal mucosa transitions into the gastric mucosa.
(NCI)
The portion of the stomach that lies above the cardiac notch.       Fundus of the Stomach
It allows for the accumulation of gases produced by chemical
digestion. (NCI)
The main section of the digestive tube that connects the            Body of Stomach
esophagus to the small intestine. The body proper excludes
the upper and lower sections of the fundus and pyloric portion
respectively. (NCI)
The initial part of the pyloric canal of the stomach. This site     Antrum Pylori
contains endocrine cells that produce gastrin and
somatostatin. (NCI)
The lateral and inferior border of the stomach. Attached to it is   Greater Curvature of the
the greater omentum. (NCI)                                          Stomach
The part of the ear including the eardrum and ossicles. The         Middle Ear
middle ear leads to the inner ear. (NCI)
A pyramidal-shaped, thin-walled, air-filled cavity located in the   Maxillary Sinus
maxilla. It is lined by mucus membrane and periosteum
(mucoperiosteum) which contains cilia. It is adjacent to the
nasal cavity and communicates with the middle meatus of the
nose. It is the largest paranasal sinus and is composed of
three recesses: alveolar, zygomatic, and infraorbital. (NCI)
A sinus of the meatuses of the nasal cavity. (NCI)                  Ethmoid Sinus
The paired, mucosal lined air spaces located above the orbit        Frontal Sinus
and communicating with the nasal passages. (NCI)
The area of the larynx below the vocal cords down to the            Subglottis
trachea. (NCI)
The lower jaw bone holding the lower teeth. (NCI)                   Mandible
The skin or integument surrounding the trunk of the body.           Skin of the Trunk
(NCI)
The pigmented protuberance on the surface of the breast             Nipple
through which milk is drawn from the breast. (NCI)
The lower part of the uterus occupying the region between the       Cervix Uteri
isthmus of the uterus and the vagina. It is divided into
supravaginal and vaginal portions. (NCI)
The smooth muscle lining the uterus. (NCI)                          Myometrium
The subserous connective tissue of the pelvic floor of the          Parametrium
supracervical portion of the uterus. The parametrium extends
laterally between the layers of the broad ligament. (NCI)

A thin, transparent tissue divided into the palpebral               Conjunctiva
conjunctiva (covering the inner side of the eye lid) and the
bulbar conjunctiva (covering the eyeball). (NCI)
A dome-shaped, transparent, avascular tissue covering the          Cornea
front of the eye. It is composed of five layers: squamous
epithelium, Bowman's membrane, stroma, Descemet's
membrane, and endothelium. Refraction of light contributing
to eye's focusing ability is its characteristic function. It
contains unmyelinated nerve endings which are responsible
for the high sensitivity of the tissue. (NCI)

A light-sensitive membrane that lines the back wall of the         Retina
eyeball. The retina is continuous with the optic nerve and this
way transmits optical images to the brain. (NCI)
The bony cavity of the skull which contains the eye, anterior      Orbit
portion of the optic nerve, ocular muscles and ocular adnexa.
Seven bones contribute to the structure of the orbit: the
frontal, maxillary, zygomatic, sphenoid, lacrimal, ethmoid, and
palatine bones. (NCI)
The part of the brain located anterior to the parietal lobes at    Frontal Lobe
the front of each cerebral hemisphere. (NCI)
One of the lobes of the cerebral hemisphere located                Parietal Lobe
superiorly to the occipital lobe and posteriorly to the frontal
lobe. Cognition and visuospatial processing are its main
function. (NCI)
The four connected cavities (hollow spaces) centrally located      Brain Ventricle
within the brain that connect posteriorly with the central canal
of the spinal cord. (NCI)
Any lymph node within the pelvic region. (NCI)                     Pelvic Lymph Node
Connective tissue that forms the skeletal components of the        Bone
body. (NCI)
A blood vessel that carries blood away from the heart. (NCI)       Artery

A pear-shaped organ located under the liver that stores and        Gallbladder
concentrates bile secreted by the liver. From the gallbladder
the bile is delivered through the bile ducts into the intestine
thereby aiding the digestion of fat-containing foods. (NCI)

The system that includes the esophagus, stomach, small and Gastrointestinal System
large intestine, anus, liver, biliary tract, and pancreas. (NCI)

A muscular tube that extends from the end of the small          Large Intestine
intestine to the anus. (NCI)
Small tissue projection existing as a cecal diverticulum with a Appendix
questionable history of vestigial versus specialized organ.
(NCI)
The part of the large intestine measured from the cecum to      Colon
the rectum consisting of ascending, transverse, descending
and sigmoid portions. The purpose of the colon is to remove
water from digested food prior to excretion. (NCI)
The section of the intestines between the pylorus and cecum.           Small Intestine
The small intestine is approximately 20 feet long and consists
of the duodenum, the jejunum, and the ileum. Its main
function is to absorb nutrients from food as the food is
transported to the large intestine. (NCI)
The final section of the small intestine. (NCI)                        Ileum
The portion of the small intestine that extends from the               Jejunum
duodenum to the ileum. (NCI)
The portion of the digestive canal between the pharynx and             Esophagus
stomach. It is about 25 cm long and consists of three parts:
the cervical part, from the cricoid cartilage to the thoracic inlet;
thoracic part, from thoracic inlet to the diaphragm; and
abdominal part, below the diaphragm to the cardiac opening
of the stomach. (NCI)
An organ located under the diaphragm, between the liver and            Stomach
the spleen as well as between the esophagus and the small
intestine. The stomach is the primary organ of food digestion.
(NCI)
A triangular-shaped organ located under the diaphragm in the           Liver
right hypochondrium. It is the largest internal organ of the
body, weighting up to 2 kg. Metabolism and bile secretion are
its main functions. It is composed of cells which have the
ability to regenerate. (NCI)
An organ behind the lower part of the stomach that is the              Pancreas
shape of a fish and about the size of a hand. It is a compound
gland composed of both exocrine and endocrine tissues. The
endocrine pancreas makes insulin so that the body can use
glucose (sugar) for energy. The exocrine pancreas makes
enzymes that help the body digest food. Spread all over the
pancreas are areas called the Islets of Langerhans. The cells
in these areas each have a special purpose. The alpha cells
make glucagon, which raises the level of glucose in the blood;
the beta cells make insulin; the delta cells make somatostatin.
There are also PP cells and D1 cells, about which little is
known. (NCI)
A sense organ needed for the detection of sound and for                Ear
establishing balance. The outer ear consists of the auricle, the
ear canal as well as the tympanic membrane. The middle ear
is made up of an air-filled cavity behind the tympanic
membrane that contains the ossicles (malleus, incus and
stapes). The inner ear is made up of the cochlea needed for
hearing and the vestibular apparatus required for balance.
(NCI)
An endocrine gland located at the base of the neck that                Thyroid Gland
produces and secretes thyroxine and other hormones.
Thyroxine is important for metabolic control. (NCI)
The organ of sight or vision. (NCI)                                    Eye
One of a pair of tubes that extend from the uterus to each of          Fallopian Tube
the ovaries. Following ovulation the egg travels down the
fallopian tube to the uterus where fertilization may or may not
occur. (NCI)
One of the paired female reproductive glands containing the Ovary
ova or germ cells; the ovary's stroma is a vascular connective
tissue containing numbers of ovarian follicles enclosing the
ova. (NCI)
A hollow, thick-walled, muscular organ located within the      Uterus
pelvic cavity of a woman. Within the uterus the fertilized egg
implants and the fetus develops during pregnancy. (NCI)
The female genital canal, extending from the uterus to the         Vagina
vulva. (NCI)
The external, visible part of the female genitalia surrounding     Vulva
the urethral and vaginal opening. The vulva includes the
clitoris and inner as well as outer labia. (NCI)
The male organ of urination and copulation. (NCI)                  Penis
The walnut shaped accessory sex gland of the male                  Prostate Gland
reproductive system. It is located in the pelvis just below the
bladder, surrounding the prostatic part of the urethra. The
prostate gland secretes a fluid which is part of the semen.
(NCI)
Either of the paired male reproductive glands that produce the     Testis
male germ cells and the male hormones. (NCI)
The organs involved in the creation and excretion of urine.        Urinary System
(NCI)
The distensible sac-like organ that functions as a reservoir of    Bladder
urine, collecting from the kidneys and eliminating via the
urethra. (NCI)
One of the two bean-shaped organs located on each side of          Kidney
the spine in the retroperitoneum. The right kidney is located
below the liver and the left kidney below the diaphragm. The
kidneys filter and secret the metabolic products and minerals
from the blood, thus maintaining the homeostasis. On the
superior pole of each kidney there is an adrenal gland. Each
kidney and adrenal gland is surrounded by fat. (NCI)

The thick-walled tube that carries urine from each kidney to       Ureter
the bladder. (NCI)
The tube carrying urine from the bladder to outside of the         Urethra
body. (NCI)
The anterior and superior part of a human or animal bearing        Head
the mouth, the brain and sensory organs.
The cartilaginous structure of the respiratory tract between the   Larynx
pharynx and the trachea. It contains elastic vocal cords
required for sound production. (NCI)
The cavity located at the upper end of the alimentary canal,       Oral Cavity
behind the teeth and gums that is bounded on the outside by
the lips, above by the hard and soft palates and below by the
tongue. (NCI)
The muscular organ located in the floor of the mouth and           Tongue
serving as the principal organ of taste and modification of the
voice in speech. (NCI)
The part of the pharynx in the back of the throat, at and above    Nasopharynx
the soft palate. The nasopharynx is continuous with the nasal
passages. (NCI)
The proximal portion of the respiratory passages on either   Nasal Cavity
side of the nasal septum lying between the floor of the
cranium and the roof of the mouth and extending from the
face to the pharynx. The nasal cavity is lined with ciliated
mucosa, extending from the nares to the pharynx. (NCI)
A hollow tube that starts posterior to the mouth and nasal   Pharynx
cavity and ends superior to the trachea and esophagus. (NCI)

The largest of the three paired salivary glands, located in front Parotid Gland
of the ear. (NCI)
The fibrocartilaginous, mucous-lined tube passing from the        Trachea
larynx to the bronchi. (NCI)
A body region referring to an upper or lower extremity. (NCI) Limb

An organ that is part of the hematopoietic and immune                Spleen
systems. It is composed of the white pulp and the red pulp
and is surrounded by a capsule. It is located in the left
hypochondriac region. Its functions include lymphocyte
production, blood cell storage, and blood cell destruction.
(NCI)
A bi-lobed organ surrounded by a connective tissue capsule. Thymus Gland
It is located in the upper anterior portion of the chest, behind
the sternum. It is composed predominantly of lymphocytes
and fewer epithelial cells. Connective tissue septa separate
the lobes into lobules. The lobules contain an outer portion
(cortical zone) which is rich in lymphocytes and an inner
portion (medullary zone) which is rich in epithelial cells. It is an
organ essential for the development of the immune system.
Its function is the maturation of the progenitor lymphoid cells
to thymocytes and subsequently to mature T-cells. It reaches
its greatest weight at puberty and subsequently begins to
involute. (NCI)

A liquid tissue; its major function is to transport oxygen        Blood
throughout the body. It also supplies the tissues with nutrients,
removes waste products, and contains various components of
the immune system defending the body against infection.
Several hormones also travel in the blood. (NCI)

Tissue responsible for the body movements and the shape        Muscle Tissue
and size changes of interna organs. Muscle tissue is
composed of specialized contractile cells. There are two types
of muscle tissue recognized: striated and smooth muscle. The
striated muscle tissue is further subdivided into skeletal,
visceral striated, and cardiac muscle. (NCI)
An organ composed of grey and white matter containing          Brain
billions of neurons that is the center for intelligence and
reasoning. It is protected by the bony cranium. (NCI)
The lower portion of the brainstem located between the pons         Medulla Oblongata
and brainstem. This structure contains several descending
and ascending tracts, lower cranial nerve nuclei, a significant
proportion of the reticular system of the brainstem and other
structures. (NCI)
Clusters of neurons comprising the globus pallidus, putamen,        Basal Ganglia
caudate, nucleus accumbens, substantia nigra and
subthalamic nucleus. They are involved with high level
aspects of inhibitory motor activity in coordination with the
excitation commands issued from the cerebellum. (NCI)
The largest and most lateral of the basal ganglia lying             Putamen
between the lateral medullary lamina of the globus pallidus
and the external capsule. It is part of the neostriatum and
forms part of the lentiform nucleus along with the globus
pallidus. (MeSH) (NCI)
An ovoid mass composed predominantly of gray substance              Thalamus
and associated laminae of white substance. The thalamus is
divided into anterior, medial, and lateral parts. The function of
the thalamus is to relay sensory impulses and cerebellar and
basal ganglia projections to the cerebral cortex. The thalamus
is positioned within the posterior part of the diencephalon
forming most of each lateral wall of the third ventricle. (NCI)

One of a pair of viscera occupying the pulmonary cavities of Lung
the thorax, the organs of respiration in which aeration of the
blood takes place. As a rule, the right lung is slightly larger
than the left and is divided into three lobes (an upper, a
middle, and a lower or basal), while the left has two lobes (an
upper and a lower or basal). Each lung is irregularly conical in
shape, presenting a blunt upper extremity (the apex), a
concave base following the curve of the diaphragm, an outer
convex surface (costal surface), an inner or mediastinal
surface (mediastinal surface), a thin and sharp anterior
border, and a thick and rounded posterior border. (NCI)

An organ that constitutes the external surface of the body. It      Skin
consists of the epidermis, dermis, and skin appendages.
(NCI)
A thin membrane that separates the external auditory canal          Tympanic Membrane
from the middle ear. The movement of the tympanic
membrane in response to air pressure changes in the
external ear facilitates the transmission of sound energy by
causing vibration of the ossicular chain. (NCI)
A honeycombed section of bone located near the base of the          Mastoid Process
skull, protruding behind the outer ear. It is connected to the
middle ear. (NCI)
The portion of the body that lies between the thorax and the        Abdominal Cavity
pelvis. (NCI)
Suprarenal gland. A flattened, roughly triangular body resting Adrenal Gland
upon the upper end of each kidney; it is one of the ductless
glands furnishing internal secretions (epinephrine and
norepinephrine from the medulla and steroid hormones from
the cortex). (NCI)
The major arterial trunk that carries oxygenated blood from       Aorta
the left ventricle into the ascending aorta behind the heart, the
aortic arch, through the thorax as the descending aorta and
through the abdomen as the abdominal aorta; it bifurcates into
the left and right common iliac arteries. (NCI)

The underside concavity where the arm and the shoulder are Axilla
joined. (NCI)
The duct system that transports bile from its origination by     Biliary Tract
hepatocytes in the liver to the small intestine. It is comprised
of the common bile duct that connects the liver and gall
bladder to the small intestine and the cystic duct that connects
the gall bladder to the common bile duct. (NCI)

A tubular structure through which the blood circulates in the     Blood Vessel
body. Blood vessels constitute a network composed of
arteries, arterioles, capillaries, venules, and veins. (NCI)
An artery originating at the axillary artery and branching into   Brachial Artery
the radial and ulnar arteries. (NCI)
A nerve network originating from C5 to T1 that supplies           Brachial Plexus
cutaneous and muscular innervation to the arm and hand.
(NCI)
Tubular structure in continuation with the trachea, serving as    Bronchus
air passage. It terminates in the lung (terminal bronchiole).
(NCI)
One of two arteries that supply oxygenated blood to the head      Carotid Artery
and neck; the left common carotid branches from the aorta
and the right common carotid from the innominate
(brachiocephalic artery). (NCI)
Any one of the seven vertebrae that start with C1, connecting     Cervical Vertebra
the skull to the spine, and ends with C7, which joins the
cervical with the thoracic spine. (NCI)
One of a pair of bones linking the scapula and the sternum.       Clavicle
The clavicle is part of the pectoral girdle. (NCI)
A small bone located at the bottom of the spine. The coccyx is    Coccyx
a result of 3-5 fused rudimentary vertebrae. (NCI)

A small cartilagenous flap-like valve that closes over the          Epiglottis
larynx during swallowing to prevent food entering the lungs.
(NCI)
A light and spongy bone that is cubical in shape. This bone is Ethmoid Bone
positioned at the anterior part of the cranium, sitting between
the two orbits, at the roof of the nose. It consists of four parts:
a horizontal or cribriform plate; a perpendicular plate; and two
lateral masses or labyrinths. (NCI)
A thin membrane of skin with the purpose of covering and          Eyelid
protecting an eye. (NCI)
An artery that starts within the inguinal region and extends to    Femoral Artery
the lower extremities. (NCI)
A vein that starts within the inguinal region and extends to the   Femoral Vein
lower extremities. (NCI)
The upper leg bone positioned between the pelvis and the           Femur
knee. (NCI)
The small, lateral calf bone extending from the knee to the        Fibula
ankle. (NCI)
A cluster of nervous tissue principally composed of neuronal       Ganglion
cell bodies external to the central nervous system (CNS).
(NCI)
The space in which the vocal cords are located. (NCI)              Glottis
The lower region of the anterior abdominal wall located            Inguinal Region
laterally to the pubic region. (NCI)
A hollow muscular organ which receives the blood from the          Heart
veins and propels it into the arteries. It is divided by a
musculomembranous septum into two halves -- right or
venous and left or arterial -- each of which consists of a
receiving chamber (atrium) and an ejecting chamber
(ventricle). (NCI)
The upper arm bone between the shoulder and elbow. (NCI)           Humerus
The portion of the gastrointestinal tract between the stomach Intestine
and the anus. It includes the small intestine and large
intestine. (NCI)
A biconvex transparent structure of the eye through which         Lens
light is focused on the retina. The lens sits behind the iris and
is supported by the zonule, which connects it to the ciliary
body. The lens is an avascular structure. (NCI)
One of the five bones situated between the thoracic vertebrae Lumbar Vertebra
and the sacrum in the lower part of the spine. (NCI)

A bean-shaped organ surrounded by a connective tissue         Lymph Node
capsule. It is part of the lymphatic system and is found
through out the body. It is composed predominantly of
lymphocytes and its main function is immune protection. (NCI)

A group of organs surrounded by loose connective tissue,        Mediastinum
separating the two pleural sacs, between the sternum
anteriorly and the vertebral column posteriorly as well as from
the thoracic inlet superiorly to the diaphragm inferiorly. The
mediastinum contains the heart and pericardium, the bases of
the great vessels, the trachea and bronchi, esophagus,
thymus, lymph nodes, thoracic duct, phrenic and vagus
nerves, and other structures and tissues. (NCI)

A bone belonging to the middle part of the foot located       Metatarsal Bone
between toes and ankle. There are 5 metatarsal bones and
they are numbered from the medial side. (NCI)
A structure of special sense serving as an organ of the sense Nose
of smell and as an entrance to the respiratory tract. (NCI)

The second cranial nerve. (NCI)                                    Optic Nerve
An air-filled cavity adjacent to the nasal cavity lined by a       Paranasal Sinus
mucous membrane and located in the bones of the skull.
There are four paranasal sinuses on each side of the face:
ethmoid, frontal, maxillary, and sphenoid sinus. (NCI)
The bony, basin-shaped structure formed by the hipbones            Pelvis
and the base of the backbone supporting the lower limbs in
humans. (NCI)
Any nerve outside the brain or spinal cord that connects with      Peripheral Nerve
peripheral receptors or effectors. (NCI)
The tissue that lines the wall of the abdominal cavity,            Peritoneum
intestine, and mesentery. It consists of the parietal peritoneum
that covers the inside of the abdominal wall and the visceral
peritoneum that covers the surface of the intestine and
mesentery. (NCI)
Any one of the paired bones, 12 on either side, extending          Rib
from the thoracic vertebrae toward the median line on the
ventral aspect of the trunk. The long curved bones which form
the rib cage. Generally, ribs 1 to 7 are connected to the
sternum' by their costal cartilages and are called true ribs,
whereas ribs 8 to 12 are termed false ribs. (NCI)
The flat triangle-shaped bone that connects the humerus with       Scapula
the clavicle in the back of the shoulder. (NCI)
The musculocutaneous pouch that encloses the testicles.            Scrotum
(NCI)
The bone in the proximal row of carpal bones that lies             Lunate Bone
between the scaphoid and triquetral bones. (NCI)
The bones that form the head, made up of the bones of the          Skull
braincase and face. (NCI)
The long, flat bone connecting with the cartilages of the first    Sternum
seven ribs and the clavicle. (NCI)
A large irregular bone situated at the base and side of the        Temporal Bone
skull, connected with the mandible via the temporomandibular
joint. The temporal bone consists of the squamous, tympanic
and petrous parts. The petrous portion of the temporal bone
contains the vestibulocochlear organ of the inner ear. (NCI)

One of 12 vertebrae in the human vertebral column. The             Thoracic Vertebra
thoracic vertebrae are situated between the seventh cervical
vertebra down to the first lumbar vertebra. (NCI)
The division of the body lying between the neck and the            Thorax
abdomen. (NCI)
A bone located between the femur and the tarsus, being part        Tibia
of the lower leg. (NCI)
The two organs situated in the throat on either side of the        Tonsil
narrow passage from the mouth to the pharynx. They are
composed of lymphoid tissues. (NCI)
The cranial nerve that controls the superior oblique muscle of     Trochlear Nerve
the eye. (NCI)
The pigmented layer of the eyeball between the tough, white        Uvea
outer coat of the eye and the retina. (NCI)
A blood vessel that carries blood towards the heart.               Vein
A large vein which returns blood from the head, neck and             Vena Cava
extremities to the heart. (NCI)
A pair of small bands of muscle that stretch from the thyroid        Vocal Cord
cartilage in front to the arytenoid cartilage in back of the
larynx. The vocal cords help prevent food entering the lungs
and produce sound through vibration. (NCI)
The branch of the brachial artery that passes down the               Radial Artery
forearm. (NCI)
The cavity lined by the pleura, located in the thorax and            Pleural Cavity
contains heart and lungs. (NCI)
A principal artery that originates in the aorta. It supplies blood   Coronary Artery
to the muscular tissue of the heart. (NCI)
One of the usually five fused vertebrae forming the triangular       Sacral Vertebra
bone just below the lumbar vertebrae. (NCI)
A nut-shaped bone of the wrist located in the radial site of the     Scaphoid Bone
hand. It is one of the eight carpal bones. (NCI)
The medial bone of the proximal row of carpal bones. (NCI)           Pisiform Bone

The largest of eight carpal bones, located in the center of the      Capitate Bone
hand. (NCI)
A carpal bone on the thumb side of the hand that articulates         Trapezial Bone
with the 1st and 2nd metacarpals. (NCI)
A carpal bone located between the lunate and pisiform bones.         Triangular Bone
(NCI)
A carpal bone located between the trapezium and capitate             Trapezoid Bone
bones. (NCI)
The medial bone in the distal row of carpal bones. (NCI)             Hamate Bone
A lymph node which is located above the clavicle. (NCI)              Supraclavicular Lymph Node

One of approximately 20-30 lymph nodes in chain formation            Axillary Lymph Node
that traverse the concavity of the underarm to the clavicle.
(NCI)
One of two hemispheric projections of variable size situated in      Breast
the subcutaneous layer over the pectoralis major muscle on
either side of the chest. (NCI)
A series of bones, muscles, tendons, and other tissues               Vertebral Column
reaching from the base of the skull to the tailbone. The
vertebral column forms the axis of the skeleton and encloses
as well as protects the spinal cord and the fluid surrounding
the spinal cord. (NCI)
A conical membranous sac filled with serous fluid in which the       Pericardium
heart as well as the roots of the aorta and other large blood
vessels are contained. (NCI)
The entire physical structure of an organism. It is composed         Body
of anatomic systems, regions, cavities, and spaces. (NCI)

The connection point between two bones or skeletal             Joint
elements. The joint may be fixed or movable. (NCI)
Band of fibrous tissue connecting bone to bone or cartilage to Ligament
bone thereby supporting or strengthening a joint. (NCI)
Striated muscles that are under voluntary control of the            Skeletal Muscle Tissue
organism. They are connected at either or both ends to a
bone and are utilized for locomotion and other movements.
(NCI)
The dorsal area between the base of the neck and the                Back
sacrum. (NCI)
The region that connects the head to the rest of the body.          Neck
(NCI)
The anterior portion of the head extending from the forehead        Face
to the chin and ear to ear. The facial structures contain the
eyes, nose and mouth, cheeks and jaws. (NCI)

Mucous membrane. (NCI)                                              Mucosa
Relating to the stomach. (NCI)                                      Gastric
Pertaining to, affecting, or associated with the liver. (NCI)       Hepatic
A natural or surgically-induced connection between tubular          Anastomosis
structures in the body. (NCI)
The region of the body between the neck and the upper arm.          Shoulder
(NCI)
The anterior side of the thorax from the neck to the abdomen.       Chest
The shape of the chest is often regarded as potential insight
into a disease process, as in the case of barrel chest and
respiratory dysfunction. (NCI)
Refers to the area associated with the hilum. (NCI)                 Hilar
A group of cells that remain of the Graafian follicle following     Corpus Luteum
ovulation. This structure is composed of endocrine tissue and
produces progesterone. This is needed to prepare the uterine
lining for implantation by the fertilized egg. (NCI)

The upper jawbone in vertebrates: it is fused to the cranium.       Maxilla
(NCI)
Two cup shaped areas, one each on the lateral side of the           Acetabulum
lower pelvis that house the head of the femur to form the ball
and socket joint of the hip. (NCI)
The junction of the upper distal end of the scapula to the distal   Acromioclavicular Joint
edge of the collarbone, also known as the acromion and the
clavicle. (NCI)
The upper distal process of the scapula. (NCI)                      Acromion
A gliding joint between the distal ends of the tibia and fibula     Ankle Joint
and the proximal end of the talus. (NCI)
The curved section of the aorta between the ascending and           Aortic Arch
the descending tracts. The brachiocephalic, left common
carotid and left subclavian arteries branch from the aorta at
this section. (NCI)
The portion of the upper extremity between the shoulder and         Arm
the elbow. For clinical purposes this term is also used to refer
to the whole superior limb. (NCI)
One of the moderately large superficial veins of the forearm        Basilic Vein
that transports blood from the hand and the medial aspect of
the forearm to the axillary vein. (NCI)
The first of the seven cervical vertebrae. (NCI)                    C1 Vertebra
The second of the seven cervical vertebrae. (NCI)                   C2 Vertebra
The third of the seven cervical vertebrae. (NCI)                     C3 Vertebra
The fourth of the seven cervical vertebrae. (NCI)                    C4 Vertebra
The fifth of the seven cervical vertebrae. (NCI)                     C5 Vertebra
The sixth of the seven cervical vertebrae. (NCI)                     C6 Vertebra
The seventh of the seven cervical vertebrae. (NCI)                   C7 Vertebra
A single-cusped (pointed) and usually single-rooted tooth            Canine Tooth
located between the incisors and premolars. (NCI)
One of five superficial veins of the upper extremity, beginning      Cephalic Vein
at the radial aspect of the wrist area, wrapping around the
forearm and emptying into the axillary vein. (NCI)

Any of the lymph nodes located in the neck. (NCI)                    Cervical Lymph Node
Four vertebral segments positioned at the base of the spine          Coccygeal Vertebra
that are fused. (NCI)
The cartilage positioned between the anterior end of the rib         Costal Cartilage
and the sternum. Its elasticity allows the ribcage to expand
while breathing. (NCI)
A bone on the lateral side of the tarsus between the                 Cuboid Bone
calcaneus and the fourth and fifth metatarsal bones. (NCI)
An artery of the dorsal surface of the foot, originating from the    Dorsalis Pedis Artery
anterior tibial artery of the lower leg. The following arterial
branches originate from the dorsalis pedis artery: the arcuate
artery of the foot and deep plantar artery. (NCI)
A type of hinge joint located between the forearm and upper          Elbow Joint
arm. (NCI)
A space inside the uterus lined by a layer of mucus                  Endometrial Cavity
membranes called the endometrium. (NCI)
A synovial joint between two adjacent vertebrae. The facet           Facet Joint
joint links the articular process of one vertebra and the inferior
articular process of the adjacent vertebra. (NCI)
Any of the digits of the hand. (NCI)                                 Finger
The nail at the end of a finger. (NCI)                               Fingernail
The structure found below the ankle joint required for               Foot
locomotion. (NCI)
The structure on the upper limb, between the elbow and the           Forearm
wrist. (NCI)
The anatomical location where the esophagus joins to the             Gastroesophageal Junction
stomach. (NCI)
The soft tissue surrounding the neck of individual teeth as well     Gingiva
as covering the alveolar bone. The tissue is fibrous and
continuous with the periodontal ligament and mucosal
covering. (NCI)
The trough in the head of the scapula that receives the head         Glenoid Fossa
of the humerus to form the shoulder joint. (NCI)
A large, irregular, quadrilateral area of bone found at the neck     Great Trochanter
of the femur. (NCI)
The filamentous outgrowth of the epidermis. (NCI)                    Hair
The distal portion of the upper extremity. It consists of the        Hand
carpus, metacarpus, and digits. (NCI)
The upper rounded part of the humerus that fits into the             Head of the Humerus
glenoid cavity of the scapula. (NCI)
A ball-and-socket joint between the head of the femur and the         Hip Joint
acetabulum. (NCI)
A U-shaped bone supporting the tongue. This bone is located           Hyoid Bone
at the base of the tongue and is suspended from the tips of
the styloid processes of the temporal bones by the stylohyoid
ligaments. (NCI)
One of the three lymph nodes of the pelvis: the superior              Iliac Lymph Node
gluteal, interior gluteal or sacral. (NCI)
The broad, dorsal, upper, and widest of the three principal           Ilium
bones composing either half of the pelvis. (NCI)
One of the teeth in front of the canines in either jaw designed       Incisor
for cutting or gnawing. (NCI)
One of the three bones comprising the middle ear. This anvil-         Incus
shaped bone is positioned between the malleus and the
stapes. (NCI)
A superficial or deep lymph node located in the inguinal area.        Inguinal Lymph Node
(NCI)
The hinge synovial joints between the phalanges of the                Interphalangeal Joint of the Hand
fingers. (NCI)
The most posterior and ventral bone making up the pelvis.             Ischium
(NCI)
The joint between the head of the lower mandible and the              Jaw Joint
temporal bone. (NCI)
A joint connecting the lower part of the femur with the upper         Knee Joint
part of the tibia. The lower part of the femur and the upper
part of the tibia are attached to each other by ligaments. Other
structures of the knee joint include the upper part of the fibula,
located below and parallel to the tibia, and the patella which
moves as the knee bends. (NCI)

The first lumbar vertebra counting from the top down. (NCI)           L1 Vertebra
The second lumbar vertebra counting from the top down.                L2 Vertebra
(NCI)
The third lumbar vertebra counting from the top down. (NCI)           L3 Vertebra

The fourth lumbar vertebra counting from the top down. (NCI) L4 Vertebra

The fifth lumbar vertebra counting from the top down. (NCI)           L5 Vertebra
A small rectangular thin plate forming part of the medial orbit       Lacrimal Bone
wall. It is located posterior to the frontal process of the maxilla
and articulates with the inferior nasal concha, ethmoid, frontal,
and maxillary bones. (NCI)
One of the two lower extremities in humans used for                   Leg
locomotion and support. (NCI)
The transverse fissure on the visceral surface of the liver           Liver Fissure
where the portal vein and hepatic artery enter and the hepatic
ducts leave. (NCI)
The concave side of the lymph node. (NCI)                             Lymph Node Hilum
A hammer-shaped bone, part of three interconnected small              Malleus
bones located in the middle ear. It is attached to the inner
surface of the tympanic membrane and its function is to
transmit sound vibrations. (NCI)
A lymph node located in the mediastinum. Mediastinal lymph           Mediastinal Lymph Node
nodes are arranged in three groups, one on the lateral,
another on the medial, and a third on the anterior aspect of
the vessels; the third group is, however, sometimes absent.
(NCI)
A spheroid joint located between the heads of the metatarsal         Metatarsophalangeal Joint
bone and the base of the proximal phalanx of the toe. (NCI)

The cutaneous plate on the dorsal surface of the distal end of       Nail
a finger or toe. (NCI)
One of two small oblong bones placed side by side at the             Nasal Bone
middle and upper part of the face. (NCI)
The thin wall between the two nasal cavities. (NCI)                  Nasal Septum
An oval-shaped bone of the tarsus found on the medial side of        Navicular Bone
the foot. (NCI)
One of the two channels of the nose, from the point where            Nostril
they divide to the external opening. (NCI)
A prominence at the proximal end of the ulna. It forms the tip       Olecranon
of the elbow. (NCI)
The part of the nasal mucosa composed of neuroepithelial             Olfactory Mucosa
tissue and mucus-producing Bowman's glands. The mucus
moistens the epithelium and helps dissolve odor-containing
gases. (NCI)
A lymph node located close to, on, or within the parotid gland.      Parotid Gland Lymph Node
(NCI)
A small flat triangular bone in front of the knee that articulates   Patella
with the femur and protects the knee joint. (NCI)

The caudal portion of the trunk, bounded anteriorly and          Pelvic Bone
laterally by the two hip bones incorporating the socket portion
of the hip joint for each leg. Posteriorly it is bounded by the
sacrum and coccyx. (NCI)
The area located between the anus and vulva in females, and Perineum
anus and scrotum in males. (NCI)
A fold of lymphatic tissue covered by ciliated epithelium at the Pharyngeal Tonsil
very back of the nose, in the roof of the nasopharynx. (NCI)

A short thick trunk vein that transports blood containing the        Portal Vein
absorbed products of digestion from the intestine directly to
the liver. (NCI)
The muscular structure at the distal portion of the stomach,         Pyloric Sphincter
opening into the duodenum. (NCI)
The joint located between the sacrum and the ilium. (NCI)            Sacroiliac Joint
The triangular bone, made up of 5 fused bones of the spine,          Sacrum
located in the lower area of the spine between the fifth lumbar
vertebra and the coccyx. (NCI)
A ball-and-socket joint at the upper end of the humerus,             Shoulder Joint
located at the junction of humerus and scapula. (NCI)
A recess, cavity, or channel. (NCI)                                  Sinus
The synovial juncture between the medial end of the clavicle         Sternoclavicular Joint
and the anterior segment of the sternum. (NCI)
A viscid fluid secreted by the synovial membrane, serving as a Synovial Fluid
lubricant. (NCI)
The first thoracic vertebra counting from the top down. (NCI) T1 Vertebra

The tenth thoracic vertebra counting from the top down. (NCI) T10 Vertebra

The eleventh thoracic vertebra counting from the top down.          T11 Vertebra
(NCI)
The twelfth thoracic vertebra counting from the top down.           T12 Vertebra
(NCI)
The second thoracic vertebra counting from the top down.            T2 Vertebra
(NCI)
The third thoracic vertebra counting from the top down. (NCI)       T3 Vertebra

The fourth thoracic vertebra counting from the top down.            T4 Vertebra
(NCI)
The fifth thoracic vertebra counting from the top down. (NCI)       T5 Vertebra

The sixth thoracic vertebra counting from the top down. (NCI) T6 Vertebra

The seventh thoracic vertebra counting from the top down.     T7 Vertebra
(NCI)
The eighth thoracic vertebra counting from the top down.      T8 Vertebra
(NCI)
The ninth thoracic vertebra counting from the top down. (NCI) T9 Vertebra

Any one of the seven bones forming the instep of the foot.    Tarsus Bone
(NCI)
A part of the lower limb, located between hip and knee. (NCI) Thigh

One of the terminal digits of the foot. (NCI)                       Toe
A thin, horny translucent plate covering the end of each toe.       Toenail
(NCI)
One of a pair of flat, large, triangular muscles that extend from   Trapezius Muscle
the external occipital protuberance and the medial third of the
superior nuchal line of the occipital bone to the middle of the
back. The trapezius muscle is involved in moving the shoulder
and arm. (NCI)
A bony protrusion on the femoral bone to which muscles are          Trochanter
attached. (NCI)
The body excluding the head and neck and limbs. (NCI)               Trunk
The inner most layer of the blood vessel wall. The consistency      Tunica Intima
of the intima will vary depending on the type of blood vessel,
but will always have an endothelial layer with a basal lamina. It
may contain collagen and elastic fibers. (NCI)

A thin, paired or unpaired, trapezoidal bone of the skull           Vomer
located in the floor of the nasal cavity. The vomer forms the
posterior and inferior parts of the nasal septum. (NCI)
A joint between the distal end of the radius and the proximal       Wrist Joint
row of carpal bones. (NCI)
The cartilage just below the sternal body. (NCI)                    Xiphoid Process
The upper gastrointestinal (GI) tract is comprised of mouth,       Gastrointestinal Tract
pharynx, esophagus and stomach while the lower GI tract
consists of intestines and anus. The primary function of the GI
tract is to ingest, digest, absorb and ultimately excrete food
stuff. (NCI)
The lower opening of the digestive tract, lying in the cleft       Anus
between the buttocks, through which fecal matter is extruded.
(NCI)
A lymph node that drains lymph from a region of interest.          Regional Lymph Node
(NCI)
The upper segment of the sternum, quadrangular in shape, as        Sternal Manubrium
well as wider superiorly and narrower inferiorly. The sternal
manubrium articulates with the clavicle and first two ribs.
(NCI)
An irregularly shaped bone positioned at the back part of the      Palatine Bone
nasal cavity between the maxilla and the pterygoid process of
the sphenoid. It forms the posterior part of the hard palate and
the lateral wall of the nasal fossa and helps to form the floor
of the orbit as well as several adjoining parts. (NCI)

The skin or integument surrounding the leg. (NCI)                  Leg Skin
The skin or integument covering the arm. (NCI)                     Arm Skin
The skin or integument surrounding the abdomen. (NCI)              Abdominal Skin
The ninth rib counting from the top of the rib cage down. (NCI)    Rib 9

The eighth rib counting from the top of the rib cage down.      Rib 8
(NCI)
The seventh rib counting from the top of the rib cage down.     Rib 7
(NCI)
The sixth rib counting from the top of the rib cage down. (NCI) Rib 6

The fifth rib counting from the top of the rib cage down. (NCI) Rib 5

The fourth rib counting from the top of the rib cage down.      Rib 4
(NCI)
The third rib counting from the top of the rib cage down. (NCI) Rib 3

The second rib counting from the top of the rib cage down.         Rib 2
(NCI)
The twelfth rib counting from the top of the rib cage down.        Rib 12
(NCI)
The eleventh rib counting from the top of the rib cage down.       Rib 11
(NCI)
The tenth rib counting from the top of the rib cage down.          Rib 10
(NCI)
The first rib counting from the top of the rib cage down. (NCI)    Rib 1

A bone of the hand. (NCI)                                          Hand Phalanx
A bone of the foot. (NCI)                                          Foot Phalanx
The bone of the foot that connects with the tibia and fibula to    Talus
form the ankle joint. (NCI)
The longest single nerve that is formed by the merging of the      Sciatic Nerve
ventral rami of the L4, L5, and S1 in the pelvis and passes
down the lower limb where it divides into the common
peroneal and tibial nerves. (NCI)
The narrow passage from the mouth to the cavity at the back        Throat
of the mouth. (NCI)
The short, constricted portion of the thigh bone between the       Femoral Neck
femur head and the trochanter. (NCI)
Male internal and external organs of reproduction.                 Male Genitalia
Female internal and external organs of reproduction.               Female Genitalia
A portion of the pancreas that extends behind the superior         Uncinate Process of Pancreas
mesenteric artery and superior mesenteric vein. (NCI)
The total system of structures outside the lungs that move as      Chest Wall
a part of breathing; it includes all structures from the skin to
the parietal pleura. (NCI)
A lymph node located in the area below the clavicle. (NCI)         Infraclavicular Lymph Node

Any bone that contributes to the facial structures, except         Facial Bone
those bones that are part of the braincase. (NCI)
The abdominal circumference at the navel. (NCI)                    Waist
The lateral prominence of the pelvis from the waist to the         Hip
thigh. (NCI)
A lymph node at the base of the celiac artery. (NCI)               Celiac Lymph Node
The anatomic space in the root of a tooth that contains            Tooth Canal
nerves, blood vessels, and connective tissue. (NCI)
A bone prominence to which ligaments and tendons of the            Epicondyle
joints are attached. (NCI)
Classifications that describe and group pertinent events that      CDISC SDTM Category For
occur throughout the conduct of a clinical trial.                  Disposition Event Terminology

Occurrences within some epochs that are initiated by a             Protocol Milestone
protocol-specified event. The most common protocol
milestone is "Informed Consent Obtained" which usually
documents the start of the study.
Other important events that occur during a trial but are not       Protocol Event
driven by protocol requirements.
The group of incidents that occur during a clinical trial and      Protocol Disposition Event
describe whether a subject completed the study epoch or the
reason this event did not occur. The subject's disposition is
often described for each phase of the study.
A classification system used to categorize the sensitivity of a    CDISC SDTM Fitzpatrick Skin
subject's skin to sunlight.                                        Classification Terminology


Individuals who never tan and always sunburn if exposed to         Fitzpatrick Skin Type I
any appreciable amount of sunlight, primarily red headed
individuals and lightly complected blondes. (Reference:
Fitzpatrick TB: The validity and practicality of sun-reactive skin
types I through VI. Arch. Dermatol. 1998 124: 869-871)
Individuals who frequently burn but are able to tan to a small     Fitzpatrick Skin Type II
degree after extended sun exposure. (Reference: Fitzpatrick
TB: The validity and practicality of sun-reactive skin types I
through VI. Arch. Dermatol. 1998 124: 869-871)

Individuals who burn infrequently and tan readily. (Reference: Fitzpatrick Skin Type III
Fitzpatrick TB: The validity and practicality of sun-reactive skin
types I through VI. Arch. Dermatol. 1998 124: 869-871)

Individuals who rarely burn and tan heavily with moderate sun Fitzpatrick Skin Type IV
exposures, especially individuals of Asian, American Indian,
Mediterranean and Latin American descent. (Reference:
Fitzpatrick TB: The validity and practicality of sun-reactive skin
types I through VI. Arch. Dermatol. 1998 124: 869-871)

Individuals who have dark constitutive pigmentation but            Fitzpatrick Skin Type V
become noticeably darker with sun exposure, especially light
complected black individuals, those of Indian descent.
(Reference: Fitzpatrick TB: The validity and practicality of sun-
reactive skin types I through VI. Arch. Dermatol. 1998 124:
869-871)
Individuals who have the heaviest constitutive pigmentation, Fitzpatrick Skin Type VI
especially dark skinned black individuals. (Reference:
Fitzpatrick TB: The validity and practicality of sun-reactive skin
types I through VI. Arch. Dermatol. 1998 124: 869-871)

A distinctive characteristic of the skin marked by the amount      CDISC SDTM Skin Type
of sebum secreted by sebaceous glands.                             Terminology

The pores of the skin are generally large and visible with a       Oily Skin
coarse or thick texture. It has a tendency to look dull and
greasy and feels oily to the touch.
The pores are generally fine with a papery thin texture that       Dry Skin
feels dry to the touch. Usually flaky and dull looking.
The pores are visible but not large. The texture is neither fine   Normal Skin
or thick and it neither feels dry or oily to the touch.
A unique code representing each Subject Characteristic.            CDISC SDTM Subject
                                                                   Characteristic Code Terminology



Years of education that a person has completed.                    Education Level
A demographic parameter indicating a person's current              Marital Status
conjugal status.
A code specifying the job performed by the employee for the        Occupation
employer. For example, accountant, programmer analyst,
patient care associate, staff nurse, etc.
A classification system used to categorize the sensitivity of a    Fitzpatrick Classification Scale
subject's skin to sunlight.
A distinctive characteristic of the skin marked by the amount      Skin Type
of sebum secreted by sebaceous glands.
A code qualifying the employment in various ways, such as,         Employee Job Class
full-time vs. part time, etc.
A code specifying the method used by the employer to              Employee Salary Type
compute the employee's salary or wages. For example,
hourly, annual, or commission.
A demographic parameter indicating a person's current             Marital Status Terminology
conjugal status.
Marriage contract has been declared null and to not have          Annulled
existed. (HL7)
Marrige contract has been declared dissolved and inactive.        Divorced
(HL7)
Temporary order issued during the course of litigation. (HL7)     Interlocutory

A person living apart from his/her spouse by legal                Separated
arrangement. (HL7)
A current marriage contract is active. (HL7)                      Married
No marriage contract has ever been entered. (HL7)                 Never Married
The spouse has died. (HL7)                                        Widowed
More than 1 current spouse. (HL7)                                 Polygamous
Person declares that a domestic partnership relationship          Domestic Partnership
exists. (HL7)
Terminology codelist used to identify the race of an individual   CDISC SDTM Race Terminology
within the Clinical Data Interchange Standards Consortium
Study Data Tabulation Model.
A person having origins in any of the black racial groups of      African American
Africa. Terms such as "Haitian" or "Negro" can be used in
addition to "Black or African American." (FDA)
A person having origins in any of the original peoples of North   American Indian or Alaska
and South America (including Central America), and who            Native
maintains tribal affiliation or community attachment. (FDA)

A person having origins in any of the original peoples of the  Asian
Far East, Southeast Asia, or the Indian subcontinent
including, for example, Cambodia, China, India, Japan, Korea,
Malaysia, Pakistan, the Philippine Islands, Thailand, and
Vietnam. (FDA)
Denotes a person having origins in any of the original peoples Native Hawaiian or Other Pacific
of Hawaii, Guam, Samoa, or other Pacific Islands. The term     Islander
covers particularly people who identify themselves as part-
Hawaiian, Native Hawaiian, Guamanian or Chamorro,
Carolinian, Samoan, Chuu. (FDA)

Denotes a person with European, Middle Eastern, or North          White
African ancestral origin who identifies, or is identified, as
White. (FDA)
The name of the test for the drug accountability assessment.      CDISC SDTM Drug
                                                                  Accountability Test Terminology
The quantity of a product that has been dispensed. (NCI)          by Name
                                                                  Dispensed Amount

The quantity of a product that has been returned. (NCI)           Returned Amount

The short name, or code, of the test for the drug                 CDISC SDTM Drug
accountability assessment.                                        Accountability Test Terminology
                                                                  by Code
The quantity of a product that has been dispensed. (NCI)          Dispensed Amount

The quantity of a product that has been returned. (NCI)           Returned Amount

The physical state or quality of a biological specimen.           CDISC SDTM Specimen
                                                                  Condition Terminology
A specimen that has been subjected to and immobilized by          Frozen Specimen
severe cold. (NCI)
A specimen that has undergone the destruction of red blood        Hemolysis in Specimen
cells followed by the release of the hemoglobin. (NCI)

A specimen that consists of or contains excessive amounts of      Lipemic Specimen
fat and fatty substances. (NCI)
A specimen that has been kept or preserved at a low               Refrigerated Specimen
temperature in a refrigerator. (NCI)
A specimen that has been subjected to and adjusted to the         Specimen at Room Temperature
average ambient temperature of a room, usually considered
to be around 20° C (68° F). (NCI)
A specimen that has undergone calcification. (NCI)                Calcified Specimen
A specimen that has become coagulated. (NCI)                      Clotted Specimen
A specimen that has undergone autolysis, or self-digestion by     Autolized Specimen
the specimen's own digestive enzymes. (NCI)
The name and description of a biological specimen.                CDISC SDTM Specimen Type
                                                                  Terminology
A specialized form of connective tissue consisting primarily of   Adipose Tissue
adipocytes (fat cells), surrounded by a meshwork of collagen
fibers. (NCI)
The fluid within the amniotic cavity which surrounds and          Amniotic Fluid
protects the developing embryo. (NCI)
The watery fluid which is present in the anterior and posterior   Aqueous Humor
chambers of the eye. (NCI)
Oxygenated blood which is transported with nutrients to body      Arterial Blood
tissues through the arterial system. The exception is blood
within the pulmonary artery which carries deoxygenated blood
to the lungs. (NCI)
Fatty tissue which is deposited in the inner lining of the arterial Atherosclerotic Plaque
wall. (NCI)
Fluid composed of waste products, bile acids, salts,                Bile
cholesterol, and electrolytes. It is secreted by the liver
parenchyma and stored in the gallbladder. (NCI)
A liquid tissue with the primary function of transporting oxygen Blood
and carbon dioxide. It supplies the tissues with nutrients,
removes waste products, and contains various components of
the immune system defending the body against infection.

Calcified connective tissue that forms the skeletal           Bone
components of the body. (NCI)
The tissue occupying the spaces of bone. It consists of blood Bone Marrow
vessel sinuses and a network of hematopoietic cells which
give rise to the red cells, white cells, and megakaryocytes.
(NCI)
Milk produced by females for the purpose of feeding their           Breast Milk
young. (NCI)
Accumulated material from the secretions of an organ. It is         Stone
solid and representative examples include gallbladder stones,
kidney stones, and salivary gland stones. (NCI)
The fluid that is contained within the brain ventricles, the        Cerebrospinal Fluid
subarachnoid space and the central canal of the spinal cord.
(NCI)
A wax secreted by glands in the ear canal.                          Cerumen
A thick, protein-rich substance secreted by the breasts during      Colostrum
the second half of pregnancy and for a few days after birth
before the breast milk comes in.
Stomach contents that have returned to the mouth or are             Vomitus
ejected beyond the mouth. (NCI)
The air that moves out of the chest during expiration. It           Expired Air
contains a higher percentage of carbon dioxide and a lower
percentage of oxygen compared to the inhaled air. (NCI)
Fluid, cells or cellular debris that escapes from the blood         Exudate
vessels and accumulates in nearby tissues. It is the result of
inflammation and is rich in proteins.
Liquid substances produced by the body.                             Body Fluid or Substance
The filamentous outgrowth of the epidermis. (NCI)                   Hair
Vaginal discharge occurring during the post-partum period. It       Lochia
consists of a mixture of blood, mucus, and placental
remnants. (NCI)
Pulmonary surfactant lines the lung epithelium and lowers           Lung Surfactant
surface tension to prevent collapse at end-expiration.
Deficiency of pulmonary surfactant results in respiratory
distress syndrome (RDS) in premature infants. Lung
surfactant is synthesized in alveolar type II cells, stored in
lamellar bodies and secreted via exocytosis. (NCI)
A clear, transparent, sometimes faintly yellow and slightly         Lymph
opalescent fluid that is collected from the tissues throughout
the body, flows in the lymphatic vessels (through the lymph
nodes), and is eventually added to the venous blood
circulation. Lymph consists of a clear liquid portion, varying
numbers of white blood cells (chiefly lymphocytes), and a few
red blood cells. (NCI)
The newborn’s first intestinal discharge. It is a dark-green,       Meconium
thick substance composed of mucus, intestinal secretions,
hair, and intestinal mucosa cells. (NCI)
The discharged blood from the uterus during the reproductive        Menstrual Blood
years. The discharge occurs approximately once a month.
(NCI)
The thick fluid secreted by the mucus glands in the                 Mucus
aerodigestive tract and the vagina. (NCI)
The cutaneous plate on the dorsal surface of the distal end of      Nail
a finger or toe. (NCI)
Plasma is the fluid (acellular) portion of the circulating blood,   Plasma
as distinguished from the serum that is the fluid portion of the
blood obtained by removal of the fibrin clot and blood cells
after coagulation.
A yellowish substance produced during bacterial                    Pus
inflammation. It contains necrotic cells and cells fighting the
infection. (NCI)
A clear liquid secreted into the mouth by the salivary glands      Saliva
and mucous glands of the mouth; moistens the mouth and
starts the digestion of starches. (NCI)
A thick, oily substance produced by the sebaceous glands           Sebum
located in the dermis. (NCI)
The thick, whitish secretion of the male reproductive organs. It   Semen
is composed of spermatozoa in their nutrient plasma,
secretions from the prostate, seminal vesicles, and various
other glands, epithelial cells, and minor constituents.
Part of the ejaculated fluid. It contains secretions from the      Seminal Fluid
seminal vesicles, Cowper gland, and prostate gland.
The clear portion of the blood that remains after the removal      Serum
of the blood cells and the clotting proteins. (NCI)
A white secretion of the sebaceous glands of the foreskin.         Smegma
(NCI)
Material containing mucus, cellular debris, microorganisms         Sputum
and sometimes blood or pus. It is ejected through the mouth
from the lungs, bronchi, and trachea. (NCI)
The material discharged from the bowel during defecation. It       Feces
consists of undigested food, intestinal mucus, epithelial cells,
and bacteria. (NCI)
The liquid secreted by the sweat glands. (NCI)                     Sweat
An anatomical structure consisting of similarly specialized        Tissue
cells and intercellular matrix, aggregated according to
genetically determined spatial relationships, performing a
specific function. (NCI)
The fluid that passes through the wall of the veins and            Transudate
capillaries to the surrounding tissues because of increased
intravascular pressure. It has low protein content. (NCI)
The fluid that is excreted by the kidneys. It is stored in the     Urine
bladder and discharged through the urethra. (NCI)
Deoxygenated blood containing urea and other waste                 Venous Blood
products which is transported through the venous system to
the heart and lungs. The exception is blood within the
pulmonary vein which is oxygenated and travels from the
lungs to the left atrium of the heart. (NCI)
The role that the individual or entity plays with respect to a     CDISC SDTM Evaluator
specific situation or person.                                      Terminology
The primary person in charge of the care of a patient, usually Caregiver
a family member or a designated health care professional.
(NCI) or a daughter.
A son                                                          Child
A mother or a father.                                          Parent
A person to whom a clinical investigator delegates routine            Clinical Coordinator
administrative requirements of a protocol. The duties and
responsibilities of a clinical research coordinator may vary
across different infrastructures. Generally, the coordinator
manages the subject's clinical trial participation and provides
a vital linkage between the subject, the investigator, and the
sponsor. (NCI)
A person who is employed by a study sponsor or by a contract          Clinical Research Associate
research organization (CRO), operates independently from
the clinical study site and functions as a monitor, and/or
auditor, and/or a project director within a particular trial or
institution. (NCI)
An entity that is responsible for the initiation, management,         Clinical Study Sponsor
and/or financing of a clinical study.
A person qualified to be engaged in activity directed at              Health Care Professional
preservation of mental and physical health by diseases
prevention and treatment as a source of livelihood. (NCI)
An individual qualified to perform an evaluation who is               Independent Rater
masked from a subject's data in order to minimize bias or
maximize consistency and quality. (NCI)
A person responsible for the conduct of the clinical trial at a       Investigator
trial site. If a trial is conducted by a team of individuals at the
trial site, the investigator is the responsible leader of the team
and may be called the principle investigator.
A person whom an individual knows, likes, and trusts. (NCI)           Friend

An individual who is observed, analyzed, examined,                    Study Subject
investigated, experimented upon, or/and treated in the course
of a particular study.
A person's partner in marriage. (NCI)                                 Spouse
A person who is a member of an unmarried couple, including            Domestic Partnership
same sex couples living together in longstanding
relationships, that are registered or unregistered. (NCI)
An external committee whose purpose is to evaluate study              Adjudication Committee
data and decide whether a study endpoint or other criterion
has been met. (NCI)
An individual who is authorized under applicable State or local       Guardian
law to consent on behalf of a child or incapable person to
general medical care including participation in clinical
research. (NCI)
A description of the results relative to the normal or expected       CDISC SDTM Reference Range
range of values.                                                      Indicator
Reported values within the typical or expected range. (NCI)           Normal Reference Range

Reported values outside the typical or expected range. (NCI)          Abnormal Reference Range

Reported values above the typical or expected range. (NCI)            Value Above Reference Range

Reported values below the typical or expected range. (NCI)            Value Below Reference Range
The description of relationship types between a record or set   CDISC SDTM Relationship Type
of records.                                                     Terminology
A textual representation of the numeral 1.                      One
More than one. (NCI)                                            Many
A classification of usage or experience that falls into three   CDISC SDTM
categories; never, current, or former.                          Never/Current/Former
                                                                Classification Terminology
Not ever; at no time in the past.                               Never

Occurring in or belonging to the present time. (NCI)            Current

Occurring prior to something else. (NCI)                        Previous
Pre-release/
Production

Production



Production




Production




Production




Production



Production




Production
Production




Production



Production




Production




Production




Production




Production
Production




Production

Production




Production


Production


Production


Production




Production


Production


Production


Production

Production
Production




Production




Production




Production




Production




Production
Production




Production

Production


Production


Production



Production


Production


Production



Production


Production




Production


Production

Production
Production


Production




Production


Production




Production




Production



Production




Production




Production

Production


Production



Production
Production


Production

Production



Production




Production




Production




Production
Production




Production




Production




Production




Production
Production




Production




Production
Production




Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production



Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production


Production




Production




Production
Production




Production




Production




Production




Production

Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production


Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production




Production




Production
Production




Production

Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production




Production
Production




Production




Production

Production




Production




Production




Production




Production




Production
Production




Production




Production




Production

Production




Production




Production




Production




Production


Production
Production




Production




Production




Production




Production




Production




Production




Production
Production




Production




Production


Production




Production


Production




Production


Production




Production
Production


Production


Production

Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production



Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production



Production
Production




Production




Production




Production




Production




Production




Production



Production



Production




Production
Production




Production

Production




Production


Production

Production

Production

Production


Production

Production


Production




Production

Production
Production


Production

Production

Production

Production


Production

Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production



Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production



Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production



Production




Production




Production




Production

Production

Production
Production




Production




Production

Production

Production

Production
Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production


Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production

Production



Production


Production



Production

Production

Production


Production
Production



Production


Production




Production




Production


Production




Production
Production


Production




Production




Production


Production




Production




Production

Production

Production


Production


Production
Production

Production

Production


Production

Production


Production

Production

Production

Production

Production




Production

Production

Production

Production

Production



Production




Production

Production
Production




Production

Production



Production


Production

Production

Production

Production

Production

Production


Production

Production

Production



Production

Production




Production




Production

Production
Production


Production



Production




Production



Production



Production




Production



Production

Production




Production




Production



Production
Production




Production




Production


Production

Production



Production

Production




Production




Production




Production
Production




Production

Production




Production




Production

Production


Production



Production


Production




Production


Production
Production




Production




Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production



Production
Production




Production




Production




Production




Production


Production




Production
Production




Production




Production




Production




Production




Production




Production




Production
Production




Production




Production


Production

Production

Production

Production



Production
Production

Production

Production

Production

Production

Production
Production

Production

Production

Production

Production
Production

Production

Production

Production

Production

Production

Production
Production
Production

Production

Production

Production

Production
Production

Production

Production

Production

Production
Production

Production
Production
Production

Production

Production

Production

Production

Production
Production

Production
Production


Production

Production


Production
Production


Production

Production




Production

Production

Production
Production
Production

Production

Production
Production
Production

Production
Production

Production

Production

Production

Production

Production

Production

Production
Production

Production


Production

Production

Production

Production

Production
Production

Production

Production

Production

Production

Production

Production

Production
Production

Production

Production

Production


Production

Production


Production


Production

Production

Production
Production

Production

Production


Production


Production

Production

Production

Production


Production


Production

Production



Production


Production

Production

Production

Production

Production

Production

Production

Production

Production
Production

Production

Production

Production



Production

Production

Production

Production

Production

Production


Production


Production


Production



Production

Production


Production




Production


Production
Production


Production

Production


Production




Production


Production


Production



Production


Production



Production

Production

Production

Production

Production

Production


Production

Production

Production

Production
Production

Production

Production

Production

Production

Production
Production

Production

Production
Production

Production

Production

Production

Production

Production


Production

Production

Production

Production

Production

Production

Production

Production


Production
Production


Production



Production



Production


Production

Production

Production


Production


Production

Production

Production

Production

Production

Production

Production


Production

Production

Production

Production

Production
Production

Production
Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production
Production

Production
Production

Production

Production

Production

Production


Production

Production

Production

Production

Production

Production

Production
Production

Production

Production

Production

Production

Production

Production


Production

Production

Production


Production

Production

Production

Production

Production

Production

Production

Production

Production

Production


Production

Production

Production

Production
Production

Production

Production
Production
Production

Production

Production

Production

Production

Production
Production

Production

Production

Production

Production

Production

Production

Production


Production


Production

Production

Production


Production


Production

Production
Production

Production

Production

Production


Production

Production
Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production



Production

Production

Production

Production

Production

Production

Production
Production


Production


Production


Production


Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production


Production

Production

Production

Production

Production


Production
Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production
Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production


Production


Production
Production


Production


Production


Production


Production

Production

Production

Production

Production

Production

Production

Production


Production
Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production
Production

Production

Production

Production

Production


Production
Production

Production

Production

Production

Production

Production


Production

Production
Production
Production
Production
Production
Production

Production

Production

Production
Production

Production

Production
Production
Production
Production


Production
Production

Production

Production



Production
Production

Production

Production

Production

Production

Production
Production

Production

Production

Production

Production


Production

Production

Production

Production

Production

Production

Production
Production
Production

Production

Production
Production

Production
Production

Production

Production

Production

Production
Production

Production
Production
Production

Production

Production

Production

Production

Production
Production

Production

Production


Production

Production


Production
Production


Production

Production
Production

Production

Production
Production
Production

Production

Production
Production
Production

Production
Production

Production

Production

Production

Production

Production

Production

Production

Production

Production


Production

Production

Production

Production

Production
Production

Production

Production
Production

Production

Production

Production

Production
Production

Production

Production

Production


Production

Production


Production


Production

Production

Production

Production

Production

Production


Production


Production

Production

Production

Production
Production


Production

Production



Production


Production

Production

Production

Production

Production

Production

Production

Production

Production



Production

Production

Production

Production



Production

Production

Production

Production

Production
Production


Production


Production


Production



Production

Production


Production




Production


Production



Production


Production

Production


Production




Production


Production
Production



Production


Production



Production

Production

Production

Production

Production

Production


Production

Production

Production

Production

Production

Production

Production

Production

Production

Production
Production

Production

Production
Production

Production
Production

Production

Production

Production


Production

Production

Production

Production

Production

Production

Production

Production


Production



Production


Production



Production



Production


Production

Production

Production
Production


Production

Production

Production

Production

Production

Production

Production


Production

Production

Production

Production

Production
Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production
Production

Production
Production

Production
Production

Production

Production

Production

Production


Production

Production

Production

Production

Production

Production

Production


Production

Production

Production

Production

Production

Production

Production


Production

Production
Production


Production

Production

Production

Production

Production

Production

Production

Production

Production

Production


Production

Production

Production

Production

Production

Production

Production
Production
Production

Production

Production

Production

Production

Production
Production
Production

Production

Production

Production

Production

Production

Production


Production


Production

Production

Production


Production


Production

Production

Production

Production

Production

Production


Production

Production
Production

Production

Production

Production
Production

Production

Production

Production

Production

Production

Production



Production

Production

Production

Production

Production

Production

Production

Production


Production


Production


Production


Production

Production

Production

Production

Production
Production

Production

Production

Production

Production

Production

Production


Production

Production

Production

Production

Production


Production



Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production
Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production
Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production


Production


Production


Production


Production


Production


Production


Production

Production

Production

Production

Production
Production

Production

Production


Production
Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production


Production
Production

Production

Production

Production

Production
Production


Production

Production
Production
Production
Production
Production
Production

Production

Production

Production
Production

Production

Production
Production
Production
Production

Production

Production
Production


Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production


Production

Production

Production

Production

Production


Production

Production

Production
Production
Production


Production

Production

Production

Production




Production




Production




Production




Production

Production
Production




Production




Production

Production




Production




Production




Production

Production


Production
Production



Production


Production



Production



Production




Production




Production


Production




Production
Production




Production
Production
Production


Production

Production




Production

Production

Production



Production



Production




Production
Production




Production




Production




Production




Production
Production


Production


Production

Production

Production


Production


Production
Production

Production

Production


Production


Production

Production




Production




Production




Production
Production



Production


Production




Production


Production




Production


Production




Production



Production

Production

Production
Production



Production


Production



Production




Production




Production


Production




Production
Production




Production




Production


Production


Production


Production


Production


Production


Production

Production



Production


Production

Production

Production
Production

Production


Production

Production

Production

Production

Production


Production

Production

Production


Production
Production
Production
Production

Production

Production

Production



Production




Production
Production




Production




Production

Production

Production



Production



Production




Production




Production
Production




Production




Production




Production




Production




Production




Production



Production
Production




Production




Production




Production

Production




Production




Production


Production


Production
Production


Production

Production




Production



Production




Production



Production



Production



Production



Production



Production



Production



Production
Production



Production



Production



Production



Production

Production



Production




Production




Production




Production
Production

Production

Production



Production



Production




Production




Production




Production




Production




Production
Production




Production




Production




Production



Production




Production




Production
Production




Production

Production




Production




Production


Production


Production



Production


Production

Production




Production
Production




Production



Production



Production



Production



Production



Production



Production



Production



Production



Production



Production
Production



Production

Production


Production




Production




Production




Production



Production


Production
Production




Production



Production




Production




Production



Production




Production




Production
Production



Production




Production




Production



Production


Production


Production


Production


Production


Production




Production


Production

Production

Production
Production




Production


Production


Production
Production



Production


Production


Production

Production




Production




Production
Production




Production
Production


Production


Production




Production




Production


Production




Production



Production
Production




Production




Production



Production




Production




Production




Production


Production



Production
Production




Production



Production



Production


Production




Production




Production

Production

Production
Production

Production


Production
Production


Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production
Production




Production

Production
Production
Production
Production
Production

Production
Production


Production
Production


Production

Production

Production



Production

Production
Production

Production

Production

Production
Production
Production

Production
Production
Production




Production


Production
Production


Production
Production
Production
Production
Production

Production
Production



Production
Production
Production

Production
Production
Production
Production
Production
Production

Production

Production
Production




Production




Production

Production


Production

Production
Production

Production
Production



Production
Production



Production

Production

Production

Production
Production
Production




Production




Production


Production




Production

Production




Production



Production



Production


Production

Production

Production
Production




Production



Production




Production




Production




Production

Production
Production




Production


Production

Production




Production




Production


Production



Production


Production

Production


Production


Production


Production
Production


Production


Production


Production


Production


Production

Production


Production


Production



Production


Production



Production


Production


Production


Production



Production
Production



Production




Production

Production

Production

Production

Production

Production



Production


Production

Production




Production




Production




Production
Production




Production

Production


Production


Production


Production

Production

Production

Production


Production



Production



Production



Production


Production



Production



Production
Production




Production



Production


Production
Production

Production


Production

Production
Production


Production

Production



Production




Production




Production
Production




Production




Production




Production
Production


Production




Production



Production

Production


Production


Production


Production



Production


Production
Production

Production

Production



Production


Production


Production


Production


Production


Production




Production


Production


Production



Production


Production



Production


Production
Production


Production



Production



Production




Production


Production


Production

Production

Production

Production


Production


Production



Production

Production



Production



Production
Production



Production



Production



Production



Production


Production



Production


Production



Production



Production

Production



Production

Production

Production



Production

Production
Production

Production


Production


Production


Production


Production


Production


Production


Production


Production



Production



Production




Production



Production

Production


Production
Production




Production


Production



Production



Production




Production



Production




Production


Production


Production



Production
Production

Production

Production

Production


Production


Production



Production


Production

Production

Production




Production
Production

Production

Production
Production

Production

Production


Production
Production



Production
Production




Production


Production




Production

Production



Production


Production
Production

Production

Production




Production


Production

Production


Production
Production




Production
Production

Production




Production



Production




Production




Production




Production


Production
Production
Production



Production



Production

Production


Production
Production




Production

Production

Production


Production




Production

Production

Production

Production


Production



Production


Production
Production




Production


Production

Production

Production

Production




Production




Production




Production




Production
Production




Production




Production




Production




Production




Production


Production




Production


Production
Production




Production




Production

Production




Production


Production

Production


Production


Production



Production


Production

Production


Production


Production




Production
Production

Production

Production

Production

Production


Production
Production

Production




Production
Production


Production



Production


Production




Production




Production


Production


Production
Production



Production


Production

Production




Production




Production

Production

Production

Production

Production

Production




Production


Production

Production

Production


Production

Production

Production
Production

Production



Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production
Production

Production


Production


Production




Production


Production


Production

Production
Production



Production

Production

Production



Production
Production
Production
Production

Production

Production



Production
Production




Production

Production


Production


Production
Production

Production



Production


Production


Production
Production
Production
Production
Production
Production
Production
Production

Production



Production
Production

Production


Production

Production




Production

Production

Production


Production
Production
Production

Production

Production

Production



Production

Production

Production
Production

Production
Production

Production



Production

Production

Production

Production


Production

Production

Production

Production

Production




Production
Production

Production

Production

Production
Production



Production

Production


Production
Production
Production




Production


Production

Production

Production
Production

Production

Production

Production



Production

Production


Production



Production

Production


Production


Production

Production
Production


Production

Production
Production
Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production
Production

Production




Production

Production
Production




Production


Production

Production
Production




Production


Production

Production



Production




Production
Production
Production
Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production

Production
Production
Production
Production



Production

Production

Production
Production
Production

Production


Production

Production

Production
Production

Production
Production

Production

Production


Production



Production

Production



Production




Production
Production




Production



Production




Production




Production




Production


Production


Production

Production

Production




Production
Production

Production


Production

Production

Production
Production


Production

Production

Production

Production

Production

Production
Production
Production
Production
Production

Production


Production


Production



Production




Production




Production


Production

Production

Production

Production
Production

Production

Production

Production

Production


Production

Production

Production


Production
Production
Production

Production

Production


Production

Production

Production




Production

Production


Production




Production

Production
Production

Production


Production


Production
Production


Production

Production


Production


Production
Production
Production


Production




Production




Production


Production


Production

Production

Production
Production


Production


Production

Production




Production

Production

Production

Production


Production


Production
Production



Production


Production

Production




Production

Production

Production
Production
Production




Production




Production

Production


Production


Production



Production

Production


Production
Production


Production


Production



Production

Production

Production

Production

Production
Production

Production
Production
Production


Production

Production

Production
Notes (Reference for CDISC PT)




E2B Code
Organization Name: EMEA
Document Title: ICH E2B (M) Clinical Safety Data Management: Data Element For Transmission
of Individual Case Safety Reports
Date: November 16, 2000
Chapter: 2. Guideline Content of the Data Elements
Codelist_Name: B.4.k.16
E2B Code
Organization Name: EMEA
Document Title: ICH E2B (M) Clinical Safety Data Management: Data Element For Transmission
of Individual Case Safety Reports
Date: November 16, 2000
Chapter: 2. Guideline Content of the Data Elements
Codelist_Name: B.4.k.16
E2B Code
Organization Name: EMEA
Document Title: ICH E2B (M) Clinical Safety Data Management: Data Element For Transmission
of Individual Case Safety Reports
Date: November 16, 2000
Chapter: 2. Guideline Content of the Data Elements
Codelist_Name: B.4.k.16
Not an E2B code



E2B Code
Organization Name: EMEA
Document Title: ICH E2B (M) Clinical Safety Data Management: Data Element For Transmission
of Individual Case Safety Reports
Date: November 16, 2000
Chapter: 2. Guideline Content of the Data Elements
Codelist_Name: B.4.k.16
E2B Code
Organization Name: EMEA
Document Title: ICH E2B (M) Clinical Safety Data Management: Data Element For Transmission
of Individual Case Safety Reports
Date: November 16, 2000
Chapter: 2. Guideline Content of the Data Elements
Codelist_Name: B.4.k.16
E2B Code
Organization Name: EMEA
Document Title: ICH E2B (M) Clinical Safety Data Management: Data Element For Transmission
of Individual Case Safety Reports
Date: November 16, 2000
Chapter: 2. Guideline Content of the Data Elements
Codelist_Name: B.4.k.16




E2B code
Organization Name: EMEA
Document Title: ICH E2B (M) Clinical Safety Data Management: Data Element For Transmission
of Individual Case Safety Reports
Document Version: Not Applicable
Date: November 16, 2000
Chapter: 2. Guideline Content of the Data Elements
Codelist_Name: B


E2B code
Organization Name: EMEA
Document Title: ICH E2B (M) Clinical Safety Data Management:   Data Element For Transmission
of Individual Case Safety Reports
Document Version: Not Applicable
Date: November 16, 2000
Chapter: 2. Guideline Content of the Data Elements
Codelist_Name: B
E2B code
Organization Name: EMEA
Document Title: ICH E2B (M) Clinical Safety Data Management:   Data Element For Transmission
of Individual Case Safety Reports
Document Version: Not Applicable
Date: November 16, 2000
Chapter: 2. Guideline Content of the Data Elements
Codelist_Name: B
E2B code
Organization Name: EMEA
Document Title: ICH E2B (M) Clinical Safety Data Management:   Data Element For Transmission
of Individual Case Safety Reports
Document Version: Not Applicable
Date: November 16, 2000
Chapter: 2. Guideline Content of the Data Elements
Codelist_Name: B
E2B code
Organization Name: EMEA
Document Title: ICH E2B (M) Clinical Safety Data Management:   Data Element For Transmission
of Individual Case Safety Reports
Document Version: Not Applicable
Date: November 16, 2000
Chapter: 2. Guideline Content of the Data Elements
Codelist_Name: B
E2B code
Organization Name: EMEA
Document Title: ICH E2B (M) Clinical Safety Data Management: Data Element For Transmission
of Individual Case Safety Reports
Document Version: Not Applicable
Date: November 16, 2000
Chapter: 2. Guideline Content of the Data Elements
Codelist_Name: B


Detailed guidance on the European clinical trials database (EUDRACT Database), April, 2003,
page 18




Detailed guidance on the European clinical trials database (EUDRACT Database), April, 2003,
page 18

Detailed guidance on the European clinical trials database (EUDRACT Database), April, 2003,
page 18

Detailed guidance on the European clinical trials database (EUDRACT Database), April, 2003,
page 18

Detailed guidance on the European clinical trials database (EUDRACT Database), April, 2003,
page 18




Detailed guidance on the European clinical trials database (EUDRACT Database), April, 2003,
page 18

Detailed guidance on the European clinical trials database (EUDRACT Database), April, 2003,
page 18

Detailed guidance on the European clinical trials database (EUDRACT Database), April, 2003,
page 18



Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter: 5.1.1
Page: 36
Field Name: Controlled Terms or Format
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter: 5.1.1
Page: 36
Field Name: Controlled Terms or Format
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter: 5.1.1
Page: 36
Field Name: Controlled Terms or Format
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter: 5.1.1
Page: 36
Field Name: Controlled Terms or Format
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter: 5.1.1
Page: 36
Field Name: Controlled Terms or Format




Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter: 6.3.2
Page: 70
Field Name: Controlled Terms or Format
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter: 6.3.2
Page: 70
Field Name: Controlled Terms or Format
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter: 6.2.1
Page: 55
Field Name: CDISC Notes for AETOXGR - "Value should contain valid numbers only; datatype will
be changed to numeric in future version of SDTM."


Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter: 6.2.1
Page: 55
Field Name: CDISC Notes for AETOXGR - "Value should contain valid numbers only; datatype will
be changed to numeric in future version of SDTM."
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter: 6.2.1
Page: 55
Field Name: CDISC Notes for AETOXGR - "Value should contain valid numbers only; datatype will
be changed to numeric in future version of SDTM."
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter: 6.2.1
Page: 55
Field Name: CDISC Notes for AETOXGR - "Value should contain valid numbers only; datatype will
be changed to numeric in future version of SDTM."
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter: 6.2.1
Page: 55
Field Name: CDISC Notes for AETOXGR - "Value should contain valid numbers only; datatype will
be changed to numeric in future version of SDTM."




Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC


Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Organization Name:HL7 RIM 3
Document Version: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: HL7
Document Title: HL7 Vocabulary Domain
Document Version: HL7 RIM 3
Chapter: 2.1 HL7 Vocabulary Domain Values
Codelist_Name: Country
Field Name: MNEMONIC
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter: 4.1.5 Other Assumptions / 4.1.5.1
Page: 31




Organization Name: FDA
Document Title: Guidance for Industry Collection of Race and Ethnicity Data in Clinical Trials
Date: September, 2005
Chapter: III COLLECTING RACE AND ETHNICITY DATA IN CLINICAL TRIALS
Codelist_Name: ETHNIC


Organization Name: FDA
Document Title: Guidance for Industry Collection of Race and Ethnicity Data in Clinical Trials
Date: September, 2005
Chapter: III COLLECTING RACE AND ETHNICITY DATA IN CLINICAL TRIALS
Codelist_Name: ETHNIC
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name




Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name




Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name



Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name

Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name



Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name


Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name




Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name

Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name

Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage
Organization Name: FDAForm
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised November 28, 2006
Codelist_Name: Dosage Form
Identifier: C-DRG-00201
Field Name: Name
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:4.1.4 Actual and Relative Time Assumptions / 4.1.4.7
Page: 29
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:4.1.4 Actual and Relative Time Assumptions / 4.1.4.7
Page: 29
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:4.1.4 Actual and Relative Time Assumptions / 4.1.4.7
Page: 29
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:4.1.4 Actual and Relative Time Assumptions / 4.1.4.7
Page: 29
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:4.1.4 Actual and Relative Time Assumptions / 4.1.4.7
Page: 29
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME

Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11,
Organization Name: FDA 2006
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME
Organization Name: FDA
Document Title: CDER Data Standards Manual
Document Version: 002
Date: Revised January 11, 2006
Codelist_Name: Route of Administration
Identifier: C-DRG-00301
Field Name: NAME




E2A Code
Organization Name: EMEA
Document Title: ICH Topic E2A Clinical Safety Data Management: Definitions and Standards for
Expedited Reporting
Document Version: CPMP/ICH/377/95
Date: November 1994
Chapter: B. Serious Adverse Event or Adverse Drug Reaction
Page:
E2A Code
Organization Name: EMEA
Document Title: ICH Topic E2A Clinical Safety Data Management: Definitions and Standards for
Expedited Reporting
Document Version: CPMP/ICH/377/95
Date: November 1994
Chapter: B. Serious Adverse Event or Adverse Drug Reaction
Page:
E2A Code
Organization Name: EMEA
Document Title: ICH Topic E2A Clinical Safety Data Management: Definitions and Standards for
Expedited Reporting
Document Version: CPMP/ICH/377/95
Date: November 1994
Chapter: B. Serious Adverse Event or Adverse Drug Reaction




Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter 5.1.1
Page: 36
Field Name: Controlled Terms or Format
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter 5.1.1
Page: 36
Field Name: Controlled Terms or Format
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter 5.1.1
Page: 36
Field Name: Controlled Terms or Format

Value is consistent with HL7 (Health Level 7).



Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter: 10
Page: 170
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter: 10
Page: 170
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter: 10
Page: 170




Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain



Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.1 Reserved Domain Codes
Page: 165/166
Field Name: CODE & Domain
???
ICH M5 EWG Units and Measurements Controlled Vocabulary, 10 May 2005




ICH M5 EWG Units and Measurements Controlled Vocabulary, 10 May 2005
ICH M5 EWG Units and Measurements Controlled Vocabulary, 10 May 2005




ICH M5 EWG Units and Measurements Controlled Vocabulary, 10 May 2005




ICH M5 EWG Units and Measurements Controlled Vocabulary, 10 May 2005


ICH M5 EWG Units and Measurements Controlled Vocabulary, 10 May 2005




Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.3 Vital Signs Test Codes
Page: 167
Field Name:
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.3 Vital Signs Test Codes
Page: 167
Field Name:
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.3 Vital Signs Test Codes
Page: 167
Field Name:
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.3 Vital Signs Test Codes
Page: 167
Field Name:
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.3 Vital Signs Test Codes
Page: 167
Field Name:
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.3 Vital Signs Test Codes
Page: 167
Field Name:
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.3 Vital Signs Test Codes
Page: 167
Field Name:
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.3 Vital Signs Test Codes
Page: 167
Field Name:
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.3 Vital Signs Test Codes
Page: 167
Field Name:
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.3 Vital Signs Test Codes
Page: 167
Field Name:
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.3 Vital Signs Test Codes
Page: 167
Field Name:
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.3 Vital Signs Test Codes
Page: 167
Field Name:



Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.3 Vital Signs Test Codes
Page: 167
Field Name:




Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.3 Vital Signs Test Codes
Page: 167
Field Name:
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.3 Vital Signs Test Codes
Page: 167
Field Name:
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.3 Vital Signs Test Codes
Page: 167
Field Name:
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.3 Vital Signs Test Codes
Page: 167
Field Name:
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.3 Vital Signs Test Codes
Page: 167
Field Name:
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26 CDISC
Organization Name:
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.3 Vital Signs Test Codes
Page: 167
Field Name:
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.3 Vital Signs Test Codes
Page: 167
Field Name:
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.3 Vital Signs Test Codes
Page: 167
Field Name:
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.3 Vital Signs Test Codes
Page: 167
Field Name:
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.3 Vital Signs Test Codes
Page: 167
Field Name:
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide:   Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.3 Vital Signs Test Codes
Page: 167
Field Name:



Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:10.3.3 Vital Signs Test Codes
Page: 167
Field Name:




Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:4.1.3 Coding and Controlled Terminology Assumptions / 4.1.3.7
Page: 25
Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:4.1.3 Coding and Controlled Terminology Assumptions / 4.1.3.7
Page: 25




Organization Name: CDISC
Document Title: Study Data Tabulation Model Implementation Guide: Human Clinical Trials
Document Version: 3.1.1
Date: 2005-08-26
Chapter:4.1.3 Coding and Controlled Terminology Assumptions / 4.1.3.7
Page: 25

				
DOCUMENT INFO
Shared By:
Categories:
Tags:
Stats:
views:35
posted:7/28/2011
language:English
pages:1628